{
  "meta": {
    "title": "73_Mission_Neet_Pg-Inicet_Grand_Test-29_-_24-08-2025",
    "url": "https://brainandscalpel.vercel.app/73-mission-neet-pg-inicet-grand-test-29-24-08-2025-16390129.html",
    "scrapedAt": "2025-11-29T17:24:13.471Z"
  },
  "questions": [
    {
      "id": 89843,
      "choices": [
        {
          "id": 357764,
          "text": "<p><span style=\"font-size:14.0pt;\">Interscalene brachial plexus block</span></p>"
        },
        {
          "id": 357765,
          "text": "<p><span style=\"font-size:14.0pt;\">Supraclavicular brachial plexus block</span></p>"
        },
        {
          "id": 357766,
          "text": "<p><span style=\"font-size:14.0pt;\">Infraclavicular brachial plexus block</span></p>"
        },
        {
          "id": 357767,
          "text": "<p><span style=\"font-size:14.0pt;\">Axillary brachial plexus block</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">What is the most likely block being performed?</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_OoYmgNG.png\" width=\"940\" height=\"555\"></span></p>",
      "unique_key": "Q3129634",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Interscalene brachial plexus block</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>interscalene block</strong> targets the <strong>roots/trunks of the brachial plexus</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">On ultrasound, they appear as <strong>round hypoechoic structures</strong> situated <strong>between the anterior and middle scalene muscles</strong>, typically at the level of <strong>C6 (cricoid cartilage)</strong>.</span></li><li><span style=\"font-size:14.0pt;\">The layout is often referred to as a <strong>“traffic signal&nbsp;sign”</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Supraclavicular brachial plexus block:</strong> The plexus appears as a <strong>cluster lateral to the subclavian artery</strong> above the first rib and pleura.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Infraclavicular brachial plexus block:</strong> Cords are seen <strong>around the axillary artery</strong>, deeper, under the clavicle.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.&nbsp; Axillary brachial plexus block:</strong> Nerves surround the <strong>axillary artery and vein</strong>, visualized in the axilla.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The interscalene brachial plexus block targets the roots/trunks of the plexus between the anterior and middle scalene muscles, visible as round hypoechoic structures at the level of C6 on ultrasound.</span></p>",
      "correct_choice_id": 357764,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89843/NEET_PG_Aug_ANESTHESIA_Question_3.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        19
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89843/NEET_PG_Aug_ANESTHESIA_Question_3.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90216,
      "choices": [
        {
          "id": 359236,
          "text": "<p><span style=\"font-size:14.0pt;\">Cryotherapy of the cervix</span></p>"
        },
        {
          "id": 359237,
          "text": "<p><span style=\"font-size:14.0pt;\">Large-loop excision of the transformation zone (LLETZ)</span></p>"
        },
        {
          "id": 359238,
          "text": "<p><span style=\"font-size:14.0pt;\">Repeat Pap smear in 6 months</span></p>"
        },
        {
          "id": 359239,
          "text": "<p><span style=\"font-size:14.0pt;\">Total abdominal hysterectomy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 29-year-old woman undergoes a cervical biopsy after an abnormal Pap smear. The histopathology reveals cells with irregular nuclei consistent with cervical intraepithelial neoplasia grade 3 (CIN3). What is the most appropriate next step in management to prevent progression to invasive cervical cancer?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q5625039",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Large-loop excision of the transformation zone (LLETZ)</strong>&nbsp;</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The biopsy report confirms CIN3, which is a high-grade cervical intraepithelial neoplasia.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">CIN3 is considered a precancerous lesion with a significant risk of progression to invasive carcinoma if left untreated.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">To effectively treat CIN3 and prevent progression, the standard and most commonly used method is <strong>large-loop excision of the transformation zone (LLETZ)</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This technique involves the removal of abnormal cervical tissue using a diathermy loop and is highly effective, well-tolerated, and fertility-preserving.</span></li><li><span style=\"font-size:14.0pt;\"><strong>The document specifically states that:</strong> \"CIN needs to be treated to prevent progression over several years to cervical carcinoma. The commonest treatment is large-loop excision of the transformation zone (LLETZ) – removal of abnormal cervical tissue with a diathermy loop.\"</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Cryotherapy of the cervix:</strong> Although used for low-grade lesions (e.g., CIN1), cryotherapy is <strong>not effective</strong> for CIN3 as it does not allow for histological confirmation of margin clearance or precise removal of transformation zone tissue.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Repeat Pap smear in 6 months:</strong> CIN3 is a <strong>high-grade</strong> lesion and requires immediate intervention. Observation or delayed follow-up is not appropriate due to the high risk of malignant progression.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Total abdominal hysterectomy:</strong> While this is a treatment option in women with recurrent CIN3 or if malignancy is confirmed, <strong>it is not the first-line treatment</strong> for initial CIN3 in a young woman, especially one desiring future fertility.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">High-grade cervical intraepithelial neoplasia (CIN3) should be promptly treated with large-loop excision of the transformation zone (LLETZ) to prevent progression to cervical carcinoma.</span></p>",
      "correct_choice_id": 359237,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90216/NEET_PG_aug_2025_OBG_Question_4.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90216/NEET_PG_aug_2025_OBG_Question_4.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89950,
      "choices": [
        {
          "id": 358184,
          "text": "<p><span style=\"font-size:14.0pt;\">Kirby–Bauer disk diffusion</span></p>"
        },
        {
          "id": 358185,
          "text": "<p><span style=\"font-size:14.0pt;\">Epsilometer (E-test) strip on agar</span></p>"
        },
        {
          "id": 358186,
          "text": "<p><span style=\"font-size:14.0pt;\">Disk diffusion with increased incubation time</span></p>"
        },
        {
          "id": 358187,
          "text": "<p><span style=\"font-size:14.0pt;\">Gram stain and morphology</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 65-year-old man with bacterial endocarditis due to Enterococcus faecalis requires precise dosing of ampicillin. The lab reports a large zone of inhibition around an ampicillin disk, suggesting susceptibility, but the clinician needs the exact MIC to tailor therapy. Which of the following methods will provide the MIC value for ampicillin against this organism?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q9341317",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Epsilometer (E-test) strip on agar</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The <strong>E-test</strong> combines diffusion and dilution principles: a plastic strip with a gradient of antibiotic yields an <strong>elliptical zone</strong> of inhibition whose intersection with the strip’s scale indicates the <strong>MIC</strong> in µg/mL.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Kirby–Bauer disk diffusion:</strong> Provides only <strong>categorical</strong> results (S, I, R) based on zone diameters, not a numeric MIC.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Disk diffusion with increased incubation time:</strong> Does not convert qualitative zone sizes into quantitative MIC values.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Gram stain and morphology:</strong> Offers rapid identification, but <strong>no susceptibility</strong> data.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The <strong>E-test</strong> strip is a viable, agar-based method to obtain a <strong>quantitative MIC</strong> directly from zone-of-inhibition endpoints.</span></p>",
      "correct_choice_id": 358185,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89950/NEET_PG_aug_2025_MICROBIOLOGY_Question_14.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        6
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89950/NEET_PG_aug_2025_MICROBIOLOGY_Question_14.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90239,
      "choices": [
        {
          "id": 359328,
          "text": "<p><span style=\"font-size:14.0pt;\">Vitiligo</span></p>"
        },
        {
          "id": 359329,
          "text": "<p><span style=\"font-size:14.0pt;\">Nevus depigmentosus</span></p>"
        },
        {
          "id": 359330,
          "text": "<p><span style=\"font-size:14.0pt;\">Nevus anaemicus</span></p>"
        },
        {
          "id": 359331,
          "text": "<p><span style=\"font-size:14.0pt;\">Indeterminate leprosy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A hypopigmented patch is noted on the trunk since birth. It appears chalky to dull white under Wood’s lamp, and Diascopy is negative (no blanching). What is the most likely diagnosis?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q9406408",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Nevus depigmentosus</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Congenital onset (since birth):</strong> Points toward developmental causes of hypopigmentation such as nevus depigmentosus or nevus anaemicus.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Wood’s lamp shows chalky/dull white enhancement:</strong> Suggests some degree of <strong>melanin reduction</strong>, not complete loss.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Diascopy is negative (no blanching): Supports&nbsp;</strong>nevus depigmentosus.</span></li><li><span style=\"font-size:14.0pt;\">Congenital lesion due to <strong>defective melanosome transfer</strong> (not complete melanocyte absence).</span></li><li><span style=\"font-size:14.0pt;\"><strong>Chalky/dull white appearance</strong> under Wood’s lamp (partial pigment loss).</span></li><li><span style=\"font-size:14.0pt;\"><strong>Diascopy is negative</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Stable in size and distribution over time.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Classic presentation.</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-08-20%20132717.jpeg\" width=\"531\" height=\"387\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Vitiligo:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Acquired</strong> autoimmune depigmentation.</span></li><li><span style=\"font-size:14.0pt;\">Shows <strong>brilliant bright white enhancement</strong> under Wood’s lamp due to <strong>total absence of melanin</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Not congenital.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Ruled out.</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Nevus anaemicus:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Also congenital, but due to <strong>vascular hypersensitivity</strong> causing localized vasoconstriction.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Does not enhance</strong> under Wood’s lamp because melanin is <strong>normal</strong>.</span></li><li><span style=\"font-size:14.0pt;\">On diascopy, the lesion becomes indistinguishable from surrounding&nbsp;skin<strong>.</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Ruled out based on Wood’s lamp.</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-08-20%20161954.jpeg\" width=\"446\" height=\"339\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Indeterminate leprosy:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Acquired</strong>, not congenital.</span></li><li><span style=\"font-size:14.0pt;\">Often associated with <strong>loss of sensation</strong>, which is not mentioned here.</span></li><li><span style=\"font-size:14.0pt;\">May show subtle enhancement on Wood’s lamp depending on pigment status.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Eliminated.</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Nevus depigmentosus</strong> is a <strong>congenital hypopigmented macule</strong> caused by <strong>defective melanosome transfer</strong>, showing <strong>partial enhancement</strong> under Wood’s lamp.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It remains <strong>stable over time</strong>, and diascopy is generally <strong>not helpful</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It should be distinguished from vitiligo (acquired, complete depigmentation) and nevus anaemicus (vascular origin, no enhancement under Wood's lamp).</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-08-20%20132844.jpeg\" width=\"912\" height=\"739\"></span></p>",
      "correct_choice_id": 359329,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90239/Neet_Pg_Aug_2025_Derma_Question_4.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        18
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90239/Neet_Pg_Aug_2025_Derma_Question_4.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89848,
      "choices": [
        {
          "id": 357784,
          "text": "<p><span style=\"font-size:14.0pt;\">Detection of infection in a mycotic aortic aneurysm</span></p>"
        },
        {
          "id": 357785,
          "text": "<p><span style=\"font-size:14.0pt;\">Characterization of a solitary pulmonary nodule</span></p>"
        },
        {
          "id": 357786,
          "text": "<p><span style=\"font-size:14.0pt;\">Staging of lung cancer</span></p>"
        },
        {
          "id": 357787,
          "text": "<p><span style=\"font-size:14.0pt;\">Assessment of lymph node involvement by malignancy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following is not an appropriate indication for positron emission tomography (PET)?&nbsp;</span></p>",
      "unique_key": "Q3006855",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Detection of infection in a mycotic aortic aneurysm</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">While 18-FDG‑PET can identify metabolically active processes, it is <strong>not the first‑line</strong> modality for diagnosing mycotic (infected) aneurysms.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">CT angiography combined with blood cultures and inflammatory markers is more reliable.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">PET lacks sufficient anatomic resolution, and increased uptake may be nonspecific in the aorta.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Characterization of a solitary pulmonary nodule:</strong> PET accurately differentiates <strong>benign vs. malignant</strong> nodules based on FDG uptake, with high sensitivity and specificity.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Staging of lung cancer:</strong> Whole‑body PET/CT is standard for <strong>detecting both regional nodal and distant metastases</strong>, guiding treatment decisions.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Assessment of lymph node involvement by malignancy:</strong> PET identifies <strong>hypermetabolic lymph nodes</strong> even when they are not enlarged on CT, improving nodal staging across many cancers.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Use PET primarily for <strong>oncologic indications</strong>—characterizing nodules, staging cancers, and evaluating lymph nodes—while relying on <strong>CT angiography</strong> and clinical/lab data to diagnose and manage <strong>mycotic aortic aneurysms</strong>.</span></p>",
      "correct_choice_id": 357784,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89848/NEET_PG_aug_2025_RADIO_Question_4.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        17
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89848/NEET_PG_aug_2025_RADIO_Question_4.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90218,
      "choices": [
        {
          "id": 359244,
          "text": "<p><span style=\"font-size:14.0pt;\">Luteal phase defect</span></p>"
        },
        {
          "id": 359245,
          "text": "<p><span style=\"font-size:14.0pt;\">Balanced translocation in one parent</span></p>"
        },
        {
          "id": 359246,
          "text": "<p><span style=\"font-size:14.0pt;\">Antiphospholipid syndrome</span></p>"
        },
        {
          "id": 359247,
          "text": "<p><span style=\"font-size:14.0pt;\">Progesterone receptor mutation</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 29-year-old woman presents for evaluation of recurrent pregnancy loss. She has had three consecutive first-trimester miscarriages. Laboratory evaluation reveals a positive anticardiolipin antibody on two separate occasions, 8 weeks apart. Which of the following is the most likely diagnosis?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q6533719",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Antiphospholipid syndrome</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This patient meets both <strong>clinical and hematological criteria</strong> for <strong>Antiphospholipid Syndrome (APS)</strong> as defined in the provided reference:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Clinical feature:</strong> Three or more consecutive miscarriages (a major obstetric criterion for APS)</span></li><li><span style=\"font-size:14.0pt;\"><strong>Hematological feature:</strong> Lupus anticoagulant positivity detected on two occasions at least 6 weeks apart</span></li></ul></li><li><span style=\"font-size:14.0pt;\">APS is an autoimmune, prothrombotic condition that can lead to recurrent miscarriage, particularly in the first trimester.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It is a key cause of <strong>recurrent pregnancy loss</strong> and must be differentiated from chromosomal, anatomic, or hormonal causes.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Luteal phase defect</strong>: This involves <strong>insufficient progesterone</strong> production in the luteal phase, which may contribute to infertility or early miscarriage but is <strong>not diagnosed by antibody testing</strong>, and it does <strong>not fulfill APS criteria</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Balanced translocation in one parent</strong>: While parental chromosomal translocations can lead to recurrent pregnancy loss, this would be identified by <strong>karyotyping</strong>, not by <strong>antibody tests</strong>, and is <strong>not associated with thrombosis or autoimmune markers</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Progesterone receptor mutation</strong>: This is a <strong>rare genetic cause</strong> of pregnancy failure, often implicated in <strong>implantation issues</strong>, and is not connected to recurrent thrombosis or immunologic abnormalities like lupus anticoagulant.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">To diagnose <strong>antiphospholipid syndrome</strong>, there must be at least <strong>one clinical criterion</strong> (e.g., ≥3 consecutive miscarriages, fetal loss, severe pre-eclampsia, or thrombosis) and <strong>one hematologic criterion</strong> (positive lupus anticoagulant or anticardiolipin antibody on 2 occasions ≥6 weeks apart).</span></p>",
      "correct_choice_id": 359246,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90218/NEET_PG_aug_2025_OBG_Question_6.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90218/NEET_PG_aug_2025_OBG_Question_6.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90844,
      "choices": [
        {
          "id": 361716,
          "text": "<p><span style=\"font-size:14.0pt;\">Cardiac MRI</span></p>"
        },
        {
          "id": 361717,
          "text": "<p><span style=\"font-size:14.0pt;\">Coronary angiography</span></p>"
        },
        {
          "id": 361718,
          "text": "<p><span style=\"font-size:14.0pt;\">Coronary CT angiography (CTA)</span></p>"
        },
        {
          "id": 361719,
          "text": "<p><span style=\"font-size:14.0pt;\">Repeat pharmacologic stress test with perfusion imaging</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 32-year-old man with a 3-week history of intermittent exertional substernal chest pain undergoes an ECG exercise stress test. Report: Exercise capacity of 4 METs (stopped due to angina). His ECG during peak exercise is shown. What is the next step?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_6248V7m.png\" width=\"873\" height=\"469\"></strong></span></p>",
      "unique_key": "Q5102933",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;B) Coronary</strong> <strong>angiography</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Exertional chest pain with high-risk stress test (angina @ 4 METs, diffuse ST depressions, aVR elevation) suggests severe CAD (left main or multivessel).</span></li><li><span style=\"font-size:14.0pt;\">Poor exercise tolerance and ECG changes indicate significant ischemia.</span></li><li><span style=\"font-size:14.0pt;\">Angiography defines anatomy for revascularization (PCI/CABG).</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Cardiac MRI:</strong> For viability, not high-risk CAD.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Coronary CT angiography (CTA):</strong> For low-intermediate risk, not high-risk.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Repeat pharmacologic stress test with perfusion imaging:</strong> Redundant with clear high-risk findings.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">High-risk stress test requires urgent angiography.</span></li><li><span style=\"font-size:14.0pt;\">ST depressions and aVR elevation suggest severe CAD.</span></li><li><span style=\"font-size:14.0pt;\">Angiography guides revascularization.</span></li></ul>",
      "correct_choice_id": 361717,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90844/NEET_PG_aug_2025_MEDICINE_Question_10.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90844/NEET_PG_aug_2025_MEDICINE_Question_10.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89986,
      "choices": [
        {
          "id": 358324,
          "text": "<p><span style=\"font-size:14.0pt;\">Intervertebral disc</span></p>"
        },
        {
          "id": 358325,
          "text": "<p><span style=\"font-size:14.0pt;\">Epiglottis</span></p>"
        },
        {
          "id": 358326,
          "text": "<p><span style=\"font-size:14.0pt;\">Articular surfaces of joints&nbsp;</span></p>"
        },
        {
          "id": 358327,
          "text": "<p><span style=\"font-size:14.0pt;\">External ear</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following anatomical locations is most likely lined by this type of cartilage given in the image below?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_sc5ilAO.png\" width=\"556\" height=\"364\"></strong></span></p>",
      "unique_key": "Q2448807",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Articular surfaces of joints</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The tissue described—smooth, glassy, avascular cartilage with chondrocytes in lacunae embedded in a homogeneous matrix—is&nbsp;<strong>hyaline cartilage</strong>, which is the predominant cartilage type found on the <strong>articular surfaces of joints</strong>.</span></li><li><span style=\"font-size:14.0pt;\">&nbsp;It provides low-friction articulation and resists compressive forces due to its high water content and type II collagen fibers.</span></li><li><span style=\"font-size:14.0pt;\">In the histological slide, the lacunae with single or grouped chondrocytes and a translucent extracellular matrix are classical for hyaline cartilage, confirming the tissue identity.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Importantly, hyaline cartilage in articular surfaces lacks perichondrium, further differentiating it from other sites where it might be found.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option&nbsp;A. Intervertebral disc</strong>:&nbsp;Incorrect. This region contains&nbsp;<strong>fibrocartilage</strong>, not hyaline cartilage. Fibrocartilage has dense type I collagen bundles and fewer chondrocytes, typically arranged in rows between the collagen fibers.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option&nbsp;B. Epiglottis</strong>:&nbsp;Incorrect. The epiglottis is composed of&nbsp;<strong>elastic cartilage</strong>, which contains elastin fibers, making it flexible and resilient. It also differs histologically by having a darker staining due to elastin content and presence of perichondrium.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. External ear</strong>:&nbsp;Incorrect. Like the epiglottis, the external ear (auricle) is made of&nbsp;<strong>elastic cartilage</strong>, not hyaline cartilage. Elastic cartilage provides structural support with flexibility, and the presence of elastic fibers is a distinguishing feature.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Articular surfaces of synovial joints are lined by hyaline cartilage, characterized histologically by chondrocytes in lacunae and an avascular matrix composed primarily of type II collagen.</span></p>",
      "correct_choice_id": 358326,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89986/NEET_PG_aug_2025_ANATOMY_Question_7.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        3
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89986/NEET_PG_aug_2025_ANATOMY_Question_7.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90894,
      "choices": [
        {
          "id": 361912,
          "text": "<p><span style=\"font-size:14.0pt;\">Vasopressin antagonist</span></p>"
        },
        {
          "id": 361913,
          "text": "<p><span style=\"font-size:14.0pt;\">V2 selective action</span></p>"
        },
        {
          "id": 361914,
          "text": "<p><span style=\"font-size:14.0pt;\">Given orally</span></p>"
        },
        {
          "id": 361915,
          "text": "<p><span style=\"font-size:14.0pt;\">Used in the treatment of hypernatremia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following statements is true regarding conivaptan?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q8693893",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Vasopressin antagonist</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Conivaptan</strong> is a <strong>non-selective vasopressin (ADH) receptor antagonist</strong>, targeting both <strong>V1A and V2 receptors</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It promotes <strong>free water excretion without electrolyte loss</strong>, making it useful in the treatment of <strong>euvolemic and hypervolemic hyponatremia</strong>, such as in <strong>SIADH</strong> or heart failure. It is administered <strong>intravenously</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. V2 selective action</strong>: Incorrect. <strong>Tolvaptan</strong>, not conivaptan, is selective for V2 receptors.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Given orally</strong>: Incorrect. Conivaptan is available <strong>only as an IV preparation</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Used in the treatment of hypernatremia</strong>: Incorrect. It <strong>raises serum sodium</strong> and is used to <strong>correct hyponatremia</strong>, not hypernatremia.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Conivaptan is a non-selective V1A and V2 vasopressin receptor antagonist used intravenously to treat euvolemic and hypervolemic hyponatremia.</span></p>",
      "correct_choice_id": 361912,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90894/NEET_PG_aug_2025_PHARMACOLOGY_Question_17.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90894/NEET_PG_aug_2025_PHARMACOLOGY_Question_17.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89948,
      "choices": [
        {
          "id": 358176,
          "text": "<p><span style=\"font-size:14.0pt;\">Paragonimus westermani</span></p>"
        },
        {
          "id": 358177,
          "text": "<p><span style=\"font-size:14.0pt;\">Opisthorchis viverrini</span></p>"
        },
        {
          "id": 358178,
          "text": "<p><span style=\"font-size:14.0pt;\">Fasciola hepatica</span></p>"
        },
        {
          "id": 358179,
          "text": "<p><span style=\"font-size:14.0pt;\">Clonorchis sinensis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 38-year-old woman from rural Southeast Asia presents with a 3-month history of chronic cough with rusty-colored sputum, intermittent pleuritic chest pain, and low-grade fever. She often consumes undercooked freshwater crabs. The image below shows the adult form of a trematode found in sputum. Which of the following is the most likely parasite responsible for her condition?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_BmTRrWu.png\" width=\"446\" height=\"251\"></strong></span></p>",
      "unique_key": "Q9275142",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Paragonimus westermani</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Paragonimus westermani is known as the <strong>lung fluke&nbsp;</strong>(as it is the only trematode that affects the lungs).</span></li><li><span style=\"font-size:14.0pt;\">Transmission: Ingestion of <strong>undercooked freshwater crabs or crayfish</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Clinical features:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Chronic cough</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Rusty (hemoptysis-like) sputum</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Pleuritic chest pain</strong></span></li><li><span style=\"font-size:14.0pt;\">May mimic <strong>tuberculosis</strong></span></li></ul></li><li><span style=\"font-size:14.0pt;\">Diagnosis: Finding <strong>eggs or adult worms in sputum</strong>; the adult worm is <strong>thick, ovoid</strong>, and often pigmented as seen in the image.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Opisthorchis viverrini:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">A liver fluke found in Southeast Asia, but causes <strong>biliary tract disease</strong>, not pulmonary symptoms.</span></li><li><span style=\"font-size:14.0pt;\">Associated with <strong>cholangiocarcinoma</strong>, not cough or hemoptysis.</span></li><li><span style=\"font-size:14.0pt;\"><strong>2<sup>nd</sup> intermittent host is fresh water fish</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Fasciola hepatica:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Also a liver fluke.</span></li><li><span style=\"font-size:14.0pt;\">Causes <strong>hepatic symptoms</strong> (RUQ pain, hepatomegaly), not lung disease.</span></li><li><span style=\"font-size:14.0pt;\">Ingested from contaminated <strong>water plants</strong> (like watercress - <strong>2<sup>nd</sup> intermittent host</strong>), not crabs.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Clonorchis sinensis:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Also affects the <strong>biliary tract</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Found in East Asia, transmitted via <strong>raw freshwater fish (2<sup>nd</sup> intermittent host)</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Causes <strong>cholangitis</strong>, not respiratory symptoms.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Paragonimus westermani</strong> is the cause of <strong>chronic cough with hemoptysis-like sputum</strong> in patients from endemic areas who consume <strong>raw or undercooked crabs (2<sup>nd</sup> intermittent host)</strong>, and differentiate it from other <strong>trematodes</strong> based on organ system involvement.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Note – For all trematodes 1<sup>st</sup> intermittent host is Snail</span></p>",
      "correct_choice_id": 358176,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89948/NEET_PG_aug_2025_MICROBIOLOGY_Question_12.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        6
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89948/NEET_PG_aug_2025_MICROBIOLOGY_Question_12.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89932,
      "choices": [
        {
          "id": 358120,
          "text": "<p><span style=\"font-size:14.0pt;\">Evidence of tumor invasion through the capsule and into blood vessels</span></p>"
        },
        {
          "id": 358121,
          "text": "<p><span style=\"font-size:14.0pt;\">Complete absence of colloid in thyroid follicles</span></p>"
        },
        {
          "id": 358122,
          "text": "<p><span style=\"font-size:14.0pt;\">Sudden and rapid increase in tumor size</span></p>"
        },
        {
          "id": 358123,
          "text": "<p><span style=\"font-size:14.0pt;\">Detection of metastatic spread to regional lymph nodes</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 50-year-old woman presents with a slowly enlarging neck mass over the past year. Fine-needle aspiration suggests a follicular-patterned thyroid neoplasm, but a definitive diagnosis is deferred until surgical excision. Histopathologic examination after lobectomy confirms malignant transformation. Which of the following best defines malignancy in this type of thyroid cancer?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q8666890",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Evidence of tumor invasion through the capsule and into blood vessels</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In <strong>follicular carcinoma of the thyroid</strong>, the hallmark criterion for malignancy is <strong>capsular and/or vascular invasion</strong> on histologic examination.</span></li><li><span style=\"font-size:14.0pt;\">Follicular carcinoma cannot be definitively distinguished from follicular adenoma on cytology alone because both can have a follicular growth pattern.</span></li><li><span style=\"font-size:14.0pt;\">The diagnosis requires <strong>histopathologic confirmation</strong> showing the tumor breaching the capsule and/or invading blood vessels.</span></li><li><span style=\"font-size:14.0pt;\">This invasive behavior enables hematogenous spread, commonly to <strong>lungs, bones, and liver</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Complete absence of colloid in thyroid follicles</strong>: Follicles without colloid can be seen in hyperplastic nodules or other thyroid pathologies but do not define malignancy in follicular carcinoma.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Sudden and rapid increase in tumor size</strong>: While rapid growth may suggest aggressive behavior or anaplastic transformation, it is <strong>not the histologic criterion</strong> for malignancy in follicular carcinoma.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Detection of metastatic spread to regional lymph nodes</strong>: Lymphatic spread is more typical of <strong>papillary carcinoma</strong> of the thyroid. Follicular carcinoma primarily spreads via <strong>hematogenous routes</strong> rather than to lymph nodes.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Follicular carcinoma of the thyroid</strong> is diagnosed by <strong>histologic evidence of capsular and/or vascular invasion</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Fine-needle aspiration cannot distinguish adenoma from carcinoma; surgical excision and pathology are necessary for diagnosis.</span></li></ul>",
      "correct_choice_id": 358120,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89932/NEET_PG_aug_2025_PATHOLOGY_Question_13.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89932/NEET_PG_aug_2025_PATHOLOGY_Question_13.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89989,
      "choices": [
        {
          "id": 358336,
          "text": "<p><span style=\"font-size:14.0pt;\">1 and 2</span></p>"
        },
        {
          "id": 358337,
          "text": "<p><span style=\"font-size:14.0pt;\">2 and 4</span></p>"
        },
        {
          "id": 358338,
          "text": "<p><span style=\"font-size:14.0pt;\">1 and 3</span></p>"
        },
        {
          "id": 358339,
          "text": "<p><span style=\"font-size:14.0pt;\">3 and 4</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following statements regarding the anterior cerebral artery (ACA) and its branches are incorrect?</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">The pericallosal artery, a branch of the ACA, supplies the lateral surface of the frontal lobe.</span></li><li><span style=\"font-size:14.0pt;\">The ACA supplies the paracentral lobule, which is involved in coordination of voluntary eye movement.</span></li><li><span style=\"font-size:14.0pt;\">The ACA supplies the paracentral lobule, which governs micturition and defecation control.</span></li><li><span style=\"font-size:14.0pt;\">The ACA territory includes the medial surface of the motor cortex responsible for lower limb movement.</span></li></ol>",
      "unique_key": "Q7309023",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong>&nbsp;<strong>A) 1 and 2</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 1.</strong> <strong>The pericallosal artery, a branch of the ACA, supplies the lateral surface of the frontal lobe:</strong>&nbsp;Incorrect. The <strong>pericallosal artery</strong>, a branch of the&nbsp;<strong>ACA</strong>, supplies the&nbsp;<strong>medial</strong> (not lateral) surfaces of the <strong>frontal and parietal lobes</strong>, especially the <strong>genu of the corpus callosum</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 2.</strong> <strong>The ACA supplies the paracentral lobule, which is involved in coordination of voluntary eye movement:&nbsp;</strong>Incorrect. The&nbsp;<strong>paracentral lobule</strong>, supplied by the ACA, governs <strong>micturition and defecation</strong>, not <strong>voluntary eye movement</strong> (which is controlled by the frontal eye field supplied by the middle cerebral artery).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Correct Statements:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 3.</strong>&nbsp;<strong>The ACA supplies the paracentral lobule, which governs micturition and defecation control:&nbsp;</strong>Correct. The&nbsp;<strong>ACA</strong> does indeed supply the&nbsp;<strong>paracentral lobule</strong>, critical for <strong>pelvic floor function</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 4.</strong> <strong>The ACA territory includes the medial surface of the motor cortex responsible for lower limb movement:&nbsp;</strong>Correct. The&nbsp;<strong>ACA</strong> supplies the <strong>medial portion of the precentral gyrus</strong>, which corresponds to <strong>lower limb motor function</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>The anterior cerebral artery (ACA)</strong> supplies the <strong>medial frontal and parietal lobes</strong>, including the&nbsp;<strong>paracentral lobule</strong> and <strong>genu of the corpus callosum</strong>, which are crucial for <strong>lower limb movement</strong> and&nbsp;<strong>visceral motor control</strong> such as <strong>micturition</strong> and <strong>defecation</strong>.</span></p>",
      "correct_choice_id": 358336,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89989/NEET_PG_aug_2025_ANATOMY_Question_9.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        3
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89989/NEET_PG_aug_2025_ANATOMY_Question_9.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90845,
      "choices": [
        {
          "id": 361720,
          "text": "<p><span style=\"font-size:14.0pt;\">Hypermagnesemia</span></p>"
        },
        {
          "id": 361721,
          "text": "<p><span style=\"font-size:14.0pt;\">Coronary dissection</span></p>"
        },
        {
          "id": 361722,
          "text": "<p><span style=\"font-size:14.0pt;\">Aortic dissection</span></p>"
        },
        {
          "id": 361723,
          "text": "<p><span style=\"font-size:14.0pt;\">STEMI</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 36-year-old G1P1, 5 days postpartum, presents with severe substernal burning chest pain and diaphoresis for 45 minutes, HR 120 bpm, BP 90/74 mmHg, and ECG is shown below. What is the likely diagnosis?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_ZDbEntg.png\" width=\"940\" height=\"455\"></strong></span></p>",
      "unique_key": "Q1981728",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;B) Coronary dissection</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In <strong>young postpartum women</strong> presenting with acute coronary syndrome (ACS) symptoms and <strong>ST-elevation</strong>, the most likely etiology is <strong>Spontaneous Coronary Artery Dissection (SCAD)</strong>.</span></li><li><span style=\"font-size:14.0pt;\">SCAD is a <strong>non-atherosclerotic</strong> cause of MI and is <strong>strongly associated with pregnancy and the postpartum period</strong>, especially within the first few weeks after delivery.</span></li><li><span style=\"font-size:14.0pt;\">It typically affects <strong>young women without traditional cardiac risk factors</strong>, and the anterior leads may be involved if the <strong>left anterior descending artery (LAD)</strong> is affected.</span></li><li><span style=\"font-size:14.0pt;\">Hypotension and tachycardia further support a <strong>hemodynamically significant event</strong> such as coronary dissection.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Hypermagnesemia:</strong> Typically causes <strong>hyporeflexia, bradycardia, and hypotension</strong>—not ST elevation or chest pain.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Aortic dissection:</strong> Presents with <strong>tearing chest/back pain</strong>, often radiating, with <strong>pulse deficits</strong>; not typically associated with <strong>ST elevation in anterior leads</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. STEMI:</strong> Possible, but in a <strong>young, postpartum woman without risk factors</strong>, <strong>SCAD is more likely</strong> than classic plaque rupture.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Spontaneous Coronary Artery Dissection (SCAD)</strong> is the most likely cause of <strong>ACS in young postpartum women</strong>.</span></li><li><span style=\"font-size:14.0pt;\">SCAD commonly presents with <strong>ST elevation</strong>, chest pain, and occurs <strong>within weeks postpartum</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Always consider <strong>SCAD over atherosclerotic STEMI</strong> in <strong>young women with no risk factors but suggestive ECG and symptoms</strong>.</span></li></ul>",
      "correct_choice_id": 361721,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90845/Neet_Pg_Aug_2025_Medicine_Question_11.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90845/Neet_Pg_Aug_2025_Medicine_Question_11.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89846,
      "choices": [
        {
          "id": 357776,
          "text": "<p><span style=\"font-size:14.0pt;\">Schistosomiasis</span></p>"
        },
        {
          "id": 357777,
          "text": "<p><span style=\"font-size:14.0pt;\">Genitourinary tuberculosis</span></p>"
        },
        {
          "id": 357778,
          "text": "<p><span style=\"font-size:14.0pt;\">Neurogenic bladder</span></p>"
        },
        {
          "id": 357779,
          "text": "<p><span style=\"font-size:14.0pt;\">Pelvic abscess</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 28‑year‑old man from rural area presents with painless hematuria and irritative voiding symptoms. Abdominal X-ray is shown below. This radiographic pattern is most characteristic of:&nbsp;&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_R8BNhbN.png\" width=\"485\" height=\"389\"></span></p>",
      "unique_key": "Q8938841",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A)&nbsp;Schistosomiasis</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Peripheral calcification of the bladder will be seen which is called as fetal skull sign, which is suggestive of Schistosomiasis.</span></li><li><span style=\"font-size:14.0pt;\">Chronic <strong>Schistosoma haematobium</strong> infection leads to granulomatous inflammation around deposited eggs in the bladder mucosa.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Over time, these granulomas calcify in a thin, uniform rim, producing the classic “eggshell” or “pipe-stem” calcification of the bladder wall visible on plain X-ray.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Genitourinary tuberculosis:</strong> Causes irregular, amorphous calcifications in the renal pelvis or ureter (“putty kidney”), not smooth rim calcification of the bladder.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Neurogenic bladder:</strong> Leads to trabeculation or diverticula on imaging, but does <strong>not</strong> produce bladder wall calcification.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Pelvic abscess:</strong> May calcify centrally if chronic, but would appear as a localized mass rather than a uniform bladder wall rim.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The radiographic hallmark of <strong>bladder wall calcification</strong> in <strong>Schistosoma haematobium</strong> infection and distinguish it from other causes of genitourinary calcification.</span></p>",
      "correct_choice_id": 357776,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89846/NEET_PG_aug_2025_RADIO_Question_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        17
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89846/NEET_PG_aug_2025_RADIO_Question_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90551,
      "choices": [
        {
          "id": 360568,
          "text": "<p><span style=\"font-size:14.0pt;\">Administer IV bolus of Hartmann solution</span></p>"
        },
        {
          "id": 360569,
          "text": "<p><span style=\"font-size:14.0pt;\">Recheck blood glucose after 20 minutes</span></p>"
        },
        {
          "id": 360570,
          "text": "<p><span style=\"font-size:14.0pt;\">Administer IV glucose and recheck blood glucose after 20 minutes</span></p>"
        },
        {
          "id": 360571,
          "text": "<p><span style=\"font-size:14.0pt;\">Start oral feeds and observe</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A newborn, born to a diabetic mother, presents after 24 hours of life with a blood glucose level of &lt;35 mg/dL. The baby is symptomatic. What is the next best step in management?&nbsp;</span></p>",
      "unique_key": "Q1016045",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Administer IV glucose and recheck blood glucose after 20 minutes</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In a <strong>symptomatic neonate</strong> with <strong>hypoglycemia (&lt;45 mg/dL)</strong>, and especially one born to a <strong>diabetic mother</strong>, the <strong>standard of care is immediate correction of glucose</strong> via <strong>IV glucose administration</strong>.</span></li><li><span style=\"font-size:14.0pt;\">The threshold for treatment is <strong>&lt;40 mg/dL in first 24 hours</strong>, and <strong>&lt;45 mg/dL after 24 hours</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Since this baby is &gt;24 hours old, symptomatic, and blood glucose is &lt;35 mg/dL, <strong>urgent IV glucose is indicated</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Typically, <strong>10% dextrose (D10W)</strong> is given as an IV bolus (2 mL/kg), followed by continuous infusion.</span></li><li><span style=\"font-size:14.0pt;\">Rechecking glucose after 20–30 minutes ensures effective correction and guides further management.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Administer IV bolus of Hartmann solution:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Hartmann (Ringer’s lactate) does not contain glucose.</span></li><li><span style=\"font-size:14.0pt;\">It is not indicated for treating hypoglycemia and may <strong>dilute serum glucose further</strong>, worsening the condition.</span></li><li><span style=\"font-size:14.0pt;\">Not appropriate for neonates in hypoglycemic crisis.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Recheck blood glucose after 20 minutes:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Delaying treatment in a <strong>symptomatic</strong> neonate is dangerous.</span></li><li><span style=\"font-size:14.0pt;\">Observation without intervention can lead to <strong>seizures, coma, or brain damage</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Rechecking is essential <strong>after</strong> intervention, not as an isolated step.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Start oral feeds and observe:&nbsp;</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This may be suitable in <strong>asymptomatic neonates</strong> with borderline glucose levels (&gt;25–30 mg/dL in first 4 hours).</span></li><li><span style=\"font-size:14.0pt;\">However, in symptomatic babies with severe hypoglycemia, <strong>IV route is preferred</strong> due to rapid effect.</span></li><li><span style=\"font-size:14.0pt;\">Oral feeds are slower and less reliable in acute settings.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">In a symptomatic neonate with blood glucose &lt;45 mg/dL, immediate IV glucose administration is the first-line treatment, followed by glucose monitoring to prevent neurological complications.</span></p>",
      "correct_choice_id": 360570,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90551/NEET_PG_Aug_PEDIATRICS_Question_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        13
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90551/NEET_PG_Aug_PEDIATRICS_Question_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90221,
      "choices": [
        {
          "id": 359256,
          "text": "<p><span style=\"font-size:14.0pt;\">Uterine artery embolization</span></p>"
        },
        {
          "id": 359257,
          "text": "<p><span style=\"font-size:14.0pt;\">Laparoscopic myomectomy</span></p>"
        },
        {
          "id": 359258,
          "text": "<p><span style=\"font-size:14.0pt;\">Hysteroscopic evaluation</span></p>"
        },
        {
          "id": 359259,
          "text": "<p><span style=\"font-size:14.0pt;\">GnRH analogues</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 32-year-old married woman presents for evaluation of infertility. Her menstrual cycles are regular, and she reports no history of pelvic infections or surgeries. Transvaginal ultrasound reveals two intramural fibroids—one measuring 7x5 cm at the right cornual region and another 5x3 cm at the left cornual end of the uterus. Her husband’s semen analysis is within normal parameters. What is the next best step in management?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q4618155",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Laparoscopic myomectomy&nbsp;</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This patient is a young woman with <strong>infertility</strong> and <strong>significant intramural fibroids located at the cornual ends</strong>, which may interfere with implantation or embryo transport.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Intramural fibroids</strong>, particularly those &gt;4 cm or those impinging on the endometrial cavity, can distort the uterine architecture and impact fertility.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Laparoscopic myomectomy</strong> is the preferred treatment in women desiring fertility, as it removes the fibroids while preserving the uterus.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Uterine artery embolization: </strong>Incorrect. While effective for symptom control in fibroid-related menorrhagia, this is not preferred in women seeking fertility due to potential effects on ovarian reserve and endometrial perfusion.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Hysteroscopic evaluation:</strong> Incorrect. Hysteroscopy is useful for <strong>submucosal fibroids</strong> or endometrial polyps. This patient has <strong>intramural fibroids at the cornual ends</strong>, which are better visualized and treated via laparoscopy.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. GnRH analogues:</strong> Incorrect. GnRH analogues can temporarily shrink fibroids but are not a definitive treatment. They are often used preoperatively to reduce fibroid size, <strong>not as standalone treatment</strong> in a woman actively seeking fertility.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Laparoscopic myomectomy is the treatment of choice for symptomatic or fertility-impairing intramural fibroids in women desiring future pregnancy.</span></p>",
      "correct_choice_id": 359257,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90221/NEET_PG_aug_2025_OBG_Question_9.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90221/NEET_PG_aug_2025_OBG_Question_9.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90886,
      "choices": [
        {
          "id": 361880,
          "text": "<p><span style=\"font-size:14.0pt;\">Infliximab</span></p>"
        },
        {
          "id": 361881,
          "text": "<p><span style=\"font-size:14.0pt;\">Adalimumab</span></p>"
        },
        {
          "id": 361882,
          "text": "<p><span style=\"font-size:14.0pt;\">Certolizumab</span></p>"
        },
        {
          "id": 361883,
          "text": "<p><span style=\"font-size:14.0pt;\">Denosumab</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 34-year-old patient with moderate to severe Crohn’s disease is being evaluated for biologic therapy. Which of the following agents is not typically used in the management of Crohn’s disease?</span></p>",
      "unique_key": "Q9263810",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>D) Denosumab</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">For&nbsp;<strong>moderate to severe Crohn’s disease</strong>, biologic therapies include:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Anti-TNF agents</strong>: infliximab, adalimumab, certolizumab.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Anti-integrins</strong>: natalizumab, vedolizumab.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Anti-IL-12/23</strong>: ustekinumab.</span></li></ul></li><li><span style=\"font-size:14.0pt;\"><strong>Denosumab</strong>&nbsp;is a monoclonal antibody against&nbsp;<strong>RANKL</strong>, used in&nbsp;<strong>osteoporosis, bone metastases, and giant cell tumor of bone</strong>, but it has no role in inflammatory bowel disease.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Denosumab</strong>&nbsp;is <strong>not used in Crohn’s disease</strong>. It targets RANKL to inhibit osteoclast activity and bone resorption; indicated in osteoporosis and malignancy-associated bone loss.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Infliximab</strong>: Used in Crohn’s disease. Chimeric monoclonal antibody against TNF-α. Especially helpful in fistulizing disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Adalimumab</strong>: Used in Crohn’s disease. Fully human monoclonal antibody against TNF-α.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Certolizumab</strong>: Used in Crohn’s disease. Pegylated anti-TNF antibody fragment.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Denosumab is not used in Crohn’s disease, it is used for treatment of osteoporosis.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The drugs used for Crohn’s disease are TNF-α inhibitors like infliximab, adalimumab and certolizumab.&nbsp;</span></li></ul>",
      "correct_choice_id": 361883,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90886/NEET_PG_aug_2025_PHARMACOLOGY_Question_9.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90886/NEET_PG_aug_2025_PHARMACOLOGY_Question_9.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89945,
      "choices": [
        {
          "id": 358164,
          "text": "<p><span style=\"font-size:14.0pt;\">It is inhibited by bile salts</span></p>"
        },
        {
          "id": 358165,
          "text": "<p><span style=\"font-size:14.0pt;\">It requires added cysteine and iron</span></p>"
        },
        {
          "id": 358166,
          "text": "<p><span style=\"font-size:14.0pt;\">It grows only at 42 °C</span></p>"
        },
        {
          "id": 358167,
          "text": "<p><span style=\"font-size:14.0pt;\">It is acid-fast</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">During an outbreak investigation at a hotel, environmental water samples are sent for microbiology. Technicians inoculate both standard blood agar and BCYE agar. After 3 days, only the BCYE plate shows growth of small, gray-white colonies. This selective growth pattern confirms which of the following about Legionella pneumophila?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q8989260",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) It requires added cysteine and iron</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The fact that Legionella grows on BCYE (which contains L-cysteine and iron) but not on blood agar indicates a <strong>nutritional requirement</strong> for those supplements.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">BCYE’s activated charcoal also neutralizes toxic metabolites.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The lack of growth on blood agar is not due to temperature preference, bile sensitivity, or acid-fast properties.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. It is inhibited by bile salts:</strong> Legionella’s absence on blood agar has nothing to do with bile; blood agar contains no bile salts.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. It grows only at 42 °C:</strong> Legionella grows optimally at <strong>35–37 °C</strong>; it is not a thermophile.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. It is acid-fast:</strong> Legionella is a gram-negative rod, <strong>not</strong> acid-fast like Mycobacterium.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Selective isolation of Legionella hinges on its <strong>specific nutritional needs</strong>—it does not grow on routine media lacking L-cysteine and iron.</span></p>",
      "correct_choice_id": 358165,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89945/NEET_PG_aug_2025_MICROBIOLOGY_Question_9.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        6
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89945/NEET_PG_aug_2025_MICROBIOLOGY_Question_9.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90850,
      "choices": [
        {
          "id": 361740,
          "text": "<p><span style=\"font-size:14.0pt;\">Anakinra</span></p>"
        },
        {
          "id": 361741,
          "text": "<p><span style=\"font-size:14.0pt;\">Infliximab</span></p>"
        },
        {
          "id": 361742,
          "text": "<p><span style=\"font-size:14.0pt;\">Tocilizumab</span></p>"
        },
        {
          "id": 361743,
          "text": "<p><span style=\"font-size:14.0pt;\">Abatacept</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 32-year-old female with non-erosive seropositive RA, unable to tolerate methotrexate or hydroxychloroquine due to gastrointestinal intolerance. She also has a history of Stevens-Johnson syndrome after sulfamethoxazole/trimethoprim, and she wants an efficacious biological DMARD. Which agent is least likely to achieve good disease control?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q8906956",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;A) Anakinra</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Anakinra (IL-1 receptor antagonist) is less effective for RA than TNF inhibitors (infliximab), IL-6 inhibitors (tocilizumab), or costimulation modulators (abatacept).</span></li><li><span style=\"font-size:14.0pt;\">IL-1 plays a minor role in RA compared to TNF-α or IL-6, limiting anakinra’s efficacy.</span></li><li><span style=\"font-size:14.0pt;\">Pregnancy planning favors abatacept for safety; infliximab and tocilizumab are effective but require caution.</span></li><li><span style=\"font-size:14.0pt;\">Anti-IL-1 molecules like anakinra are important in treatment of autoinflammatory syndromes like familial Mediterranean fever, and some acquired autoinflammatory syndromes like gout.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Infliximab:</strong> Potent TNF-α inhibitor for RA.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Tocilizumab:</strong> Effective IL-6 inhibitor for RA.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Abatacept:</strong> Inhibits T-cell activation, effective for RA.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Anakinra is less effective for RA than other biologics.</span></li><li><span style=\"font-size:14.0pt;\">Consider pregnancy safety in DMARD selection.</span></li><li><span style=\"font-size:14.0pt;\">TNF-α/IL-6 inhibitors target key RA pathways.</span></li></ul>",
      "correct_choice_id": 361740,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90850/NEET_PG_aug_2025_MEDICINE_Question_16.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90850/NEET_PG_aug_2025_MEDICINE_Question_16.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90889,
      "choices": [
        {
          "id": 361892,
          "text": "<p><span style=\"font-size:14.0pt;\">High lipid solubility for passive reabsorption</span></p>"
        },
        {
          "id": 361893,
          "text": "<p><span style=\"font-size:14.0pt;\">Ability to inhibit sodium-chloride symporters</span></p>"
        },
        {
          "id": 361894,
          "text": "<p><span style=\"font-size:14.0pt;\">Complete tubular secretion without filtration</span></p>"
        },
        {
          "id": 361895,
          "text": "<p><span style=\"font-size:14.0pt;\">Free filtration at glomerulus and lack of tubular reabsorption</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following pharmacokinetic properties is essential for a drug to function effectively as an osmotic diuretic?</span></p>",
      "unique_key": "Q4431381",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>D) Free filtration at glomerulus and lack of tubular reabsorption</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">For a drug to act as an&nbsp;<strong>osmotic diuretic</strong>&nbsp;(e.g., mannitol), it must:</span><ol style=\"list-style-type:decimal;\"><li><span style=\"font-size:14.0pt;\">Be&nbsp;<strong>freely filtered</strong>&nbsp;at the glomerulus → so that it enters the tubular fluid easily.</span></li><li><span style=\"font-size:14.0pt;\">Not undergo&nbsp;<strong>tubular reabsorption</strong>&nbsp;→ so that it stays in the tubular lumen, retaining water by osmotic effect.</span></li><li><span style=\"font-size:14.0pt;\">Be pharmacologically inert (not binding to receptors significantly).</span></li></ol></li><li><span style=\"font-size:14.0pt;\">This property ensures that the agent increases tubular fluid osmolality, preventing water reabsorption and producing diuresis.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. High lipid solubility for passive reabsorption</strong>: Incorrect. Osmotic diuretics must&nbsp;<i>not</i>&nbsp;be reabsorbed; lipid-soluble drugs get reabsorbed easily and won’t act as osmotic diuretics.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Ability to inhibit sodium-chloride symporters</strong>: Incorrect. That’s the mechanism of&nbsp;<strong>thiazide diuretics</strong>, not osmotic diuretics.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Complete tubular secretion without filtration</strong>: Incorrect. Tubular secretion is not their primary pathway. For osmotic effect, filtration at the glomerulus is essential.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">To act effectively as an osmotic diuretic, a drug must be <strong>freely filtered at the glomerulus</strong>, remain <strong>inert</strong>, and <strong>not undergo reabsorption</strong> in the renal tubules, thereby drawing water into the urine via osmotic gradients.</span></p>",
      "correct_choice_id": 361895,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90889/NEET_PG_aug_2025_PHARMACOLOGY_Question_12.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90889/NEET_PG_aug_2025_PHARMACOLOGY_Question_12.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90510,
      "choices": [
        {
          "id": 360404,
          "text": "<p><span style=\"font-size:14.0pt;\">Arterial ulcer</span></p>"
        },
        {
          "id": 360405,
          "text": "<p><span style=\"font-size:14.0pt;\">Venous ulcer</span></p>"
        },
        {
          "id": 360406,
          "text": "<p><span style=\"font-size:14.0pt;\">Diabetic ulcer</span></p>"
        },
        {
          "id": 360407,
          "text": "<p><span style=\"font-size:14.0pt;\">Neuropathic ulcer</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Identify the type of ulcer.<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-08-11%20101318.jpeg\" width=\"468\" height=\"622\"></strong></span></p>",
      "unique_key": "Q2852146",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Venous ulcer</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Venous ulcers are classically seen above the medial malleolus, with irregular borders, granulation tissue, and often accompanied by pigmentation due to hemosiderin deposition.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Arterial ulcer</strong>: Painful, punched-out, found over pressure points like toes, lateral malleolus.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Diabetic ulcer</strong>: Typically on pressure &nbsp;points like metatarsal heads, often painless.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Neuropathic ulcer</strong>: Painless, deep, on weight-bearing surfaces in patients with neuropathy.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Venous ulcers occur over the medial malleolus with irregular edges and are associated with chronic venous insufficiency.</span></p>",
      "correct_choice_id": 360405,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90510/NEET_PG_aug_2025_Surgery_Question_12.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90510/NEET_PG_aug_2025_Surgery_Question_12.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90532,
      "choices": [
        {
          "id": 360492,
          "text": "<p><span style=\"font-size:14.0pt;\">Alanine&nbsp;</span></p>"
        },
        {
          "id": 360493,
          "text": "<p><span style=\"font-size:14.0pt;\">Aspartate&nbsp;</span></p>"
        },
        {
          "id": 360494,
          "text": "<p><span style=\"font-size:14.0pt;\">Serine&nbsp;</span></p>"
        },
        {
          "id": 360495,
          "text": "<p><span style=\"font-size:14.0pt;\">Tyrosine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">As part of a standard neonatal screen, an infant is diagnosed with a loss of function genetic defect in the enzyme phenylalanine hydroxylase. Defects in this enzyme can result in a condition known as phenylketonuria (PKU), which results from the toxic effects of phenylalanine derived phenylketones. Fortunately, this condition can be managed by regulating the amount of phenylalanine provided in the diet. Which of the following nonessential amino acids will need to be supplied in the diet of this infant?</span></p>",
      "unique_key": "Q1750999",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Tyrosine</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In phenylketonuria (PKU) due to phenylalanine hydroxylase deficiency, phenylalanine cannot be converted to tyrosine.</span></li><li><span style=\"font-size:14.0pt;\">This makes tyrosine an essential amino acid for the patient, even though it is normally nonessential (because the body usually synthesizes it from phenylalanine).</span></li><li><span style=\"font-size:14.0pt;\">Without supplementation, tyrosine deficiency can impair protein synthesis, melanin production, and catecholamine synthesis.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Biochemical pathway:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Phenylalanine — (phenylalanine hydroxylase + BH4) → Tyrosine → Melanin</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Alanine:&nbsp;</strong>Remains nonessential; synthesized from pyruvate via transamination.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Aspartate:&nbsp;</strong>Remains nonessential; synthesized from oxaloacetate.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Serine: </strong>Remains nonessential; synthesized from 3-phosphoglycerate.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">In phenylketonuria due to phenylalanine hydroxylase deficiency, tyrosine becomes an essential amino acid because it can no longer be synthesized from phenylalanine and must be obtained through the diet.</span></p>",
      "correct_choice_id": 360495,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90532/NEET_PG_aug_2025_BIOCHEM_Question_9.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        1
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90532/NEET_PG_aug_2025_BIOCHEM_Question_9.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90562,
      "choices": [
        {
          "id": 360608,
          "text": "<p><span style=\"font-size:14.0pt;\">Tetralogy of Fallot</span></p>"
        },
        {
          "id": 360609,
          "text": "<p><span style=\"font-size:14.0pt;\">Total anomalous pulmonary venous connection</span></p>"
        },
        {
          "id": 360610,
          "text": "<p><span style=\"font-size:14.0pt;\">Transposition of the great arteries</span></p>"
        },
        {
          "id": 360611,
          "text": "<p><span style=\"font-size:14.0pt;\">Coarctation of the aorta</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 5-year-old child presents with exertional dyspnea and a history of cyanotic spells. On examination, there is clubbing and a harsh systolic murmur heard at the left upper sternal border. Chest X-ray is shown below. What is the most likely diagnosis?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_Nhux8Dz.png\" width=\"480\" height=\"464\"></strong></span></p>",
      "unique_key": "Q7036500",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Tetralogy of Fallot</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This is the most common cyanotic congenital heart disease beyond infancy.</span></li><li><span style=\"font-size:14.0pt;\">The classic presentation includes cyanosis, exertional dyspnea, clubbing, and \"tet spells\" (hypercyanotic episodes).&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The murmur is due to right ventricular outflow tract obstruction. A “boot-shaped heart” on chest X-ray (caused by right ventricular hypertrophy) is pathognomonic.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B.</strong> <strong>Total anomalous pulmonary venous connection:&nbsp;</strong>Usually presents earlier in life with severe cyanosis and may show a \"snowman\" sign in the supracardiac type on X-ray.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Transposition of the great arteries:&nbsp; </strong>Presents in neonates with cyanosis and an “egg-on-string” appearance on X-ray.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Coarctation of aorta:&nbsp;</strong>Presents with differential cyanosis and radio-femoral delay, not boot-shaped heart or cyanosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Tetralogy of Fallot is identified by cyanosis, systolic murmur, and characteristic boot-shaped heart on imaging.</span></li><li><span style=\"font-size:14.0pt;\">It is the most common cyanotic heart disease in children beyond infancy.</span></li></ul>",
      "correct_choice_id": 360608,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90562/NEET_PG_Aug_PEDIATRICS_Question_7.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        13
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90562/NEET_PG_Aug_PEDIATRICS_Question_7.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90843,
      "choices": [
        {
          "id": 361712,
          "text": "<p><span style=\"font-size:14.0pt;\">Initiate tissue plasminogen activator (tPA) immediately</span></p>"
        },
        {
          "id": 361713,
          "text": "<p><span style=\"font-size:14.0pt;\">Administer aspirin and monitor in the hospital</span></p>"
        },
        {
          "id": 361714,
          "text": "<p><span style=\"font-size:14.0pt;\">Start anticoagulation therapy for stroke prevention</span></p>"
        },
        {
          "id": 361715,
          "text": "<p><span style=\"font-size:14.0pt;\">Perform an MRI of the brain to rule out a hemorrhagic stroke</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 58-year-old woman presents to the emergency department with sudden-onset right-sided weakness, slurred speech, and difficulty walking starting about 2 hours ago, with a history of hypertension, hyperlipidemia, and smoking. Examination shows right-sided hemiparesis, facial droop, dysarthria, and NIHSS score of 12. Non-contrast CT of the head is shown below. What is the most appropriate treatment?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_gQcJTpx.png\" width=\"355\" height=\"360\"></strong></span></p>",
      "unique_key": "Q9124977",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;A) Initiate tissue plasminogen activator (tPA) immediately</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Sudden weakness, dysarthria, and NIHSS 12 indicate acute ischemic stroke.</span></li><li><span style=\"font-size:14.0pt;\">No hemorrhage on CT and 2-hour onset are within tPA’s 3-4.5-hour window.</span></li><li><span style=\"font-size:14.0pt;\">tPA dissolves clots, improving outcomes; risk factors (hypertension, smoking) support ischemic etiology.</span></li><li><span style=\"font-size:14.0pt;\">NIHSS 12 indicates moderate stroke, benefiting from thrombolysis.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Administer aspirin and monitor in the hospital:</strong> For secondary prevention, not acute.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Start anticoagulation therapy for stroke prevention:</strong> For long-term, not acute management.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Perform an MRI of the brain to rule out a hemorrhagic stroke:</strong> CT sufficient; MRI delays tPA.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">tPA is for ischemic stroke within 4.5 hours if no hemorrhage.</span></li><li><span style=\"font-size:14.0pt;\">Time is critical for stroke outcomes.</span></li><li><span style=\"font-size:14.0pt;\">NIHSS guides treatment decisions.</span></li></ul>",
      "correct_choice_id": 361712,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90843/Neet_Pg_Aug_2025_Medicine_Question_9.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90843/Neet_Pg_Aug_2025_Medicine_Question_9.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90533,
      "choices": [
        {
          "id": 360496,
          "text": "<p><span style=\"font-size:14.0pt;\">Fructose-1-phosphate aldolase (aldolase B)</span></p>"
        },
        {
          "id": 360497,
          "text": "<p><span style=\"font-size:14.0pt;\">Fructose-1,6-bisphosphate aldolase (aldolase A)</span></p>"
        },
        {
          "id": 360498,
          "text": "<p><span style=\"font-size:14.0pt;\">Fructokinase</span></p>"
        },
        {
          "id": 360499,
          "text": "<p><span style=\"font-size:14.0pt;\">Hexokinase</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Two children with genetic issues in fructose metabolism were seen by the same doctor. The parents of the first child were advised to restrict dietary fructose due to health risks. However, the second child’s parents were informed that their child was unlikely to experience any symptoms, despite the presence of fructose in the urine. Based on this information, which enzyme is likely deficient in the second child?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q9325056",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Fructokinase</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Essential fructosuria is caused by fructokinase deficiency.</span></li><li><span style=\"font-size:14.0pt;\">Fructose from the diet is not phosphorylated in the liver → it is freely filtered into the urine.</span></li><li><span style=\"font-size:14.0pt;\">Key features:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Benign, asymptomatic condition</span></li><li><span style=\"font-size:14.0pt;\">Fructosuria is the only finding</span></li><li><span style=\"font-size:14.0pt;\">No hypoglycemia, no liver damage</span></li></ul></li><li><span style=\"font-size:14.0pt;\">Hence, parents are told no dietary restriction is needed.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Fructose-1-phosphate aldolase (aldolase B):</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Deficiency → Hereditary fructose intolerance (HFI).</span></li><li><span style=\"font-size:14.0pt;\">Fructose-1-P accumulates → inhibits glycogenolysis → severe hypoglycemia, vomiting, liver damage after fructose ingestion.</span></li><li><span style=\"font-size:14.0pt;\">Requires strict avoidance of fructose, sucrose, sorbitol.</span></li><li><span style=\"font-size:14.0pt;\">This fits the first child in the question, not the second.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option&nbsp;B. Fructose-1,6-bisphosphate aldolase (aldolase A):</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Involved in glycolysis, not fructose metabolism per se.</span></li><li><span style=\"font-size:14.0pt;\">Deficiency causes hemolysis &amp; myopathy, not isolated fructosuria.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Hexokinase:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Phosphorylates glucose (and to a small extent fructose) in peripheral tissues.</span></li><li><span style=\"font-size:14.0pt;\">Deficiency → affects glycolysis broadly, not just fructose metabolism.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Fructokinase deficiency causes essential fructosuria, a benign condition where fructose appears in the urine but causes no systemic illness. Unlike hereditary fructose intolerance, it requires no dietary restriction.</span></p>",
      "correct_choice_id": 360498,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90533/NEET_PG_aug_2025_BIOCHEM_Question_10.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        1
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90533/NEET_PG_aug_2025_BIOCHEM_Question_10.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90824,
      "choices": [
        {
          "id": 361636,
          "text": "<p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-08-21%20111708.jpeg\" width=\"419\" height=\"183\"></p>"
        },
        {
          "id": 361637,
          "text": "<p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-08-21%20111720.jpeg\" width=\"471\" height=\"150\"></p>"
        },
        {
          "id": 361638,
          "text": "<p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-08-21%20111731.jpeg\" width=\"665\" height=\"153\"></p>"
        },
        {
          "id": 361639,
          "text": "<p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-08-21%20111745.jpeg\" width=\"837\" height=\"156\"></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following actin–myosin crossbridge pair correctly represents the point (B–C) shown on length–tension relationship in the sarcomere curve?&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-08-16%20183426.jpg\" width=\"780\" height=\"559\"></span></p>",
      "unique_key": "Q1613965",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B)</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-08-21%20111720_jS4gbfr.jpeg\" width=\"471\" height=\"150\"></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>length–tension relationship</strong> in skeletal muscle describes how the amount of force (tension) a muscle fiber can generate depends on the sarcomere length at the onset of contraction.</span></li><li><span style=\"font-size:14.0pt;\"><strong>B–C segment on the curve</strong> corresponds to <strong>optimal sarcomere length (~2.0–2.2 µm)</strong>, where maximal active tension is produced.</span></li><li><span style=\"font-size:14.0pt;\">At this length, there is <strong>maximal overlap</strong> between actin (thin) and myosin (thick) filaments <strong>without interference from opposite actin filaments</strong>, allowing the maximum number of <strong>crossbridges</strong> to form.</span></li><li><span style=\"font-size:14.0pt;\">The diagram in option <strong>B</strong> shows exactly this optimal overlap:</span></li><li><span style=\"font-size:14.0pt;\">All myosin heads have access to binding sites on actin.</span></li><li><span style=\"font-size:14.0pt;\">There is no excessive filament overlap that would reduce binding sites.</span></li><li><span style=\"font-size:14.0pt;\">There is no overstretch preventing crossbridge formation.</span></li><li><span style=\"font-size:14.0pt;\">Therefore, option B correctly represents the <strong>crossbridge geometry</strong> at the optimal length producing <strong>maximum active force</strong>.</span></li></ul><p><br><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.</strong> Represents sarcomere length <strong>shorter than optimal</strong> (left of point B), with <strong>actin filaments overlapping each other</strong> and potentially interfering with myosin binding. This <strong>reduces tension</strong> because some crossbridges cannot form effectively and actin–actin interference occurs.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C.</strong> Shows sarcomere length <strong>longer than optimal</strong> (right of point C), with <strong>reduced actin–myosin overlap</strong>. Fewer crossbridges form, lowering active tension despite no filament interference.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.&nbsp;</strong>Represents <strong>extreme stretch</strong> — little to no actin–myosin overlap. Almost no crossbridges form, so active force approaches zero.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:&nbsp;</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">At <strong>optimal sarcomere length (~2.0–2.2 µm)</strong>, the maximum number of actin–myosin crossbridges can form, producing <strong>peak active tension</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Shorter lengths lead to actin–actin interference and reduced crossbridge binding, while longer lengths decrease overlap and thus reduce the number of possible crossbridges.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The <strong>B–C range</strong> on the length–tension curve reflects this physiological optimum for force generation in skeletal muscle.</span></li></ul>",
      "correct_choice_id": 361637,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90824/NEET_PG_aug_2025_PHYSIOLOGY_Question_1.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        2
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90824/NEET_PG_aug_2025_PHYSIOLOGY_Question_1.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90873,
      "choices": [
        {
          "id": 361828,
          "text": "<p><span style=\"font-size:14.0pt;\">Intravenous&nbsp;diphenhydramine</span></p>"
        },
        {
          "id": 361829,
          "text": "<p><span style=\"font-size:14.0pt;\">Intramuscular adrenaline</span></p>"
        },
        {
          "id": 361830,
          "text": "<p><span style=\"font-size:14.0pt;\">Intravenous hydrocortisone</span></p>"
        },
        {
          "id": 361831,
          "text": "<p><span style=\"font-size:14.0pt;\">High-flow oxygen and IV fluids</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 24-year-old woman suddenly develops dyspnea, hypotension, and generalized rash after receiving an intramuscular injection of ceftriaxone. She is wheezing and her blood pressure is 74/42 mm Hg. Which of the following is the most immediate and life-saving intervention?</span></p>",
      "unique_key": "Q1444144",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Intramuscular adrenaline</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This is a case of anaphylactic shock caused by beta lactams like penicillins and cephalosporins&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">In <strong>anaphylactic shock</strong>, <strong>intramuscular adrenaline (epinephrine)</strong> is the <strong>only life-saving</strong> intervention.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It acts by reversing airway obstruction, vasodilation, and hypotension through <strong>alpha- and beta-adrenergic effects</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The recommended adult dose is <strong>0.5 mg IM</strong> (0.5 mL of 1:1000 solution), repeated every <strong>5–10 minutes</strong> if needed.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Intravenous diphenhydramine</strong>: H1 blockers help with cutaneous symptoms but <strong>do not address life-threatening airway or circulatory collapse</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Intravenous hydrocortisone</strong>: Helpful for prolonged or biphasic reactions, but its effect is <strong>delayed</strong> (onset &gt;4 hours).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. High-flow</strong> <strong>oxygen and IV fluids</strong>: Supportive, but <strong>not sufficient alone</strong>; adrenaline is mandatory.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Intramuscular adrenaline is the first-line and only life-saving treatment in anaphylactic shock and should be administered immediately.</span></p>",
      "correct_choice_id": 361829,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90873/NEET_PG_aug_2025_PHARMACOLOGY_Question_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90873/NEET_PG_aug_2025_PHARMACOLOGY_Question_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89867,
      "choices": [
        {
          "id": 357860,
          "text": "<p><span style=\"font-size:14.0pt;\">Providing transitional shelter and social services</span></p>"
        },
        {
          "id": 357861,
          "text": "<p><span style=\"font-size:14.0pt;\">Conducting mass immunization campaigns</span></p>"
        },
        {
          "id": 357862,
          "text": "<p><span style=\"font-size:14.0pt;\">Distributing food, clothing, and employment assistance</span></p>"
        },
        {
          "id": 357863,
          "text": "<p><span style=\"font-size:14.0pt;\">Organizing community rehabilitation and livelihood programs</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A multidisciplinary relief team is organizing post‑disaster interventions. They categorize activities according to the disaster cycle. During the tertiary phase, which of the following is least appropriate?&nbsp;</span></p>",
      "unique_key": "Q2229133",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;B) Conducting mass immunization campaigns</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Phases of health and medical relief in the disaster cycle:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Primary (0–6 h):</strong> First aid, search and rescue, field care</span></li><li><span style=\"font-size:14.0pt;\"><strong>Secondary (6–24 h):</strong> Transportation, sanitation, <strong>immunization</strong>, disease surveillance</span></li><li><span style=\"font-size:14.0pt;\"><strong>Tertiary (1–60 days):</strong> Food, clothing, shelter assistance; social services; employment; rehabilitation</span></li></ul></li><li><span style=\"font-size:14.0pt;\">Mass immunization campaigns are a <strong>secondary phase</strong> activity.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">By the tertiary phase, focus shifts to restoring normalcy through shelter, nutrition, social support, and livelihood rebuilding.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Providing transitional shelter and social services: </strong>Central to tertiary relief—helps displaced families regain stability.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Distributing food, clothing, and employment assistance: </strong>Essential tertiary tasks that address longer‑term survival and well‑being.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Organizing community rehabilitation and livelihood programs: </strong>Core tertiary objective: rebuilding infrastructure, skills, and economic opportunity.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Disaster cycle phases</strong> have distinct priorities:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Secondary phase</strong> includes <strong>immunization</strong>,</span></li><li><span style=\"font-size:14.0pt;\"><strong>Tertiary phase</strong> focuses on <strong>rehabilitation, shelter, nutrition, and social services</strong>.</span></li></ul></li></ul>",
      "correct_choice_id": 357861,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89867/NEET_PG_aug_2025_PSM_Question_7.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89867/NEET_PG_aug_2025_PSM_Question_7.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89894,
      "choices": [
        {
          "id": 357968,
          "text": "<p><span style=\"font-size:14.0pt;\">Annual risk of infection</span></p>"
        },
        {
          "id": 357969,
          "text": "<p><span style=\"font-size:14.0pt;\">Prevalence of TB infection</span></p>"
        },
        {
          "id": 357970,
          "text": "<p><span style=\"font-size:14.0pt;\">Percentage of primary drug resistance</span></p>"
        },
        {
          "id": 357971,
          "text": "<p><span style=\"font-size:14.0pt;\">Percentage of multidrug resistance</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A national tuberculosis (TB) control program manager needs to monitor long‑term trends in TB transmission that are not immediately altered by recent case control strategies. Which of the following indicators best reflects such a trend?&nbsp;</span></p>",
      "unique_key": "Q8241560",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;A) Annual risk of infection</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Prevalence of TB infection is 40%</span></li><li><span style=\"font-size:14.0pt;\">The <strong>annual risk of infection (ARI)</strong> estimates the proportion of the population newly infected with Mycobacterium tuberculosis each year.</span></li><li><span style=\"font-size:14.0pt;\">In ARI incidence of infection is 1-2%. This can be found by TCI (Tuberculin conversion index – Mantoux test negative to positive conversion).</span></li><li><span style=\"font-size:14.0pt;\">Because it captures <strong>new</strong> infections before disease detection or treatment, ARI directly reflects transmission intensity and is <strong>unaffected</strong> by changes in case‑finding or treatment effectiveness.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">ARI is derived from periodic tuberculin surveys in children, offering a real‑time measure of force of infection.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Prevalence of TB infection:</strong> Reflects cumulative, <strong>historic</strong> infections over many years and changes only slowly; it does not indicate current transmission dynamics.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Percentage of primary drug resistance:</strong> Measures the proportion of new cases with resistant strains; influenced by past treatment practices and secondary transmission, not a direct measure of overall transmission trend.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Percentage of multidrug resistance:</strong> Depends on both transmission of resistant strains and treatment failures; it is sensitive to drug‑management programs and does not isolate the trend in <strong>all</strong> TB transmission.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Annual risk of infection</strong> provides the most direct, <strong>current</strong> measure of TB transmission intensity, independent of case detection and treatment program performance.</span></p>",
      "correct_choice_id": 357968,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89894/NEET_PG_aug_2025_PSM_Question_8.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89894/NEET_PG_aug_2025_PSM_Question_8.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89933,
      "choices": [
        {
          "id": 358124,
          "text": "<p><span style=\"font-size:14.0pt;\">Deposition of immunoglobulin light chains due to plasma cell dyscrasia</span></p>"
        },
        {
          "id": 358125,
          "text": "<p><span style=\"font-size:14.0pt;\">Deposition of β2-microglobulin from chronic hemodialysis</span></p>"
        },
        {
          "id": 358126,
          "text": "<p><span style=\"font-size:14.0pt;\">Deposition of serum amyloid A protein from chronic inflammation</span></p>"
        },
        {
          "id": 358127,
          "text": "<p><span style=\"font-size:14.0pt;\">Deposition of misfolded transthyretin due to mutation in the TTR gene</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 35-year-old man was found unresponsive at home and could not be resuscitated. His family reports a 2-year history of progressive exertional dyspnea, lower limb swelling, and occasional dizziness. His father died suddenly at the age of 40 from a similar cardiac condition. Autopsy and histopathology of the heart is shown below. Which of the following is the most likely underlying cause of this patient’s fatal cardiac disease?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_45XmbWO.png\" width=\"696\" height=\"250\"></strong></span></p>",
      "unique_key": "Q1815259",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>D) Deposition of misfolded transthyretin due to mutation in the TTR gene</strong>&nbsp;</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>gross image</strong> shows a markedly thickened left ventricular free wall with a <strong>pale, waxy appearance</strong>, characteristic of <strong>amyloid infiltration</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">In this case, the presentation, young age, and positive family history indicate <strong>Hereditary Transthyretin-related (ATTR) Amyloidosis</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Pathophysiology:</strong> Mutation in the <strong>TTR gene</strong> → abnormal transthyretin protein misfolds → amyloid fibrils deposit in the myocardium → <strong>restrictive cardiomyopathy</strong>, arrhythmias, and eventual <strong>sudden cardiac death</strong>, as seen in this patient.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Histology:</strong> Amyloid appears as <strong>slightly pale, eosinophilic, amorphous, homogenous material filling up the interstitium</strong> on hematoxylin and eosin (H&amp;E) staining. The <strong>cardiac myocytes appear atrophic</strong> due to the compressive effect of the amyloid deposits. Congo red staining reveals <strong>apple-green birefringence</strong> under polarized light.</span></li><li><span style=\"font-size:14.0pt;\">These deposits cause <strong>restrictive cardiomyopathy</strong>, arrhythmias, and conduction abnormalities, predisposing to <strong>sudden cardiac death</strong>, as in this patient. The strong family history supports the hereditary form.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Deposition of immunoglobulin light chains due to plasma cell dyscrasia:</strong> Usually secondary to <strong>multiple myeloma</strong>; patient’s age, family history, and lack of plasma cell disorder make this unlikely.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B.&nbsp;Deposition of β2-microglobulin from chronic hemodialysis:</strong> Seen in <strong>dialysis-related amyloidosis</strong>, affecting joints/tendons; no history of renal failure or dialysis here.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Deposition of serum amyloid A protein from chronic inflammation: </strong>Associated with chronic inflammatory conditions (e.g., RA, TB); typically affects kidneys, liver, and spleen, not isolated familial cardiac amyloidosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Hereditary ATTR amyloidosis is caused by <strong>TTR gene mutation</strong>, leading to transthyretin misfolding and amyloid deposition in the myocardium.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It manifests as restrictive cardiomyopathy, conduction abnormalities, and high risk of sudden cardiac death.</span></li></ul>",
      "correct_choice_id": 358127,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89933/NEET_PG_aug_2025_PATHOLOGY_Question_14.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89933/NEET_PG_aug_2025_PATHOLOGY_Question_14.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90831,
      "choices": [
        {
          "id": 361664,
          "text": "<p><span style=\"font-size:14.0pt;\">Rise and fall rapidly</span></p>"
        },
        {
          "id": 361665,
          "text": "<p><span style=\"font-size:14.0pt;\">Gradually rise and fall</span></p>"
        },
        {
          "id": 361666,
          "text": "<p><span style=\"font-size:14.0pt;\">Remain elevated</span></p>"
        },
        {
          "id": 361667,
          "text": "<p><span style=\"font-size:14.0pt;\">1st it rises then remains elevated</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Blood glucose was raised 2–3 times and then maintained for a consistent period. Which of the following is correct regarding the insulin secretion?&nbsp;</span></p>",
      "unique_key": "Q6709432",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D)</strong> <strong>1st it rises then remains elevated</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">When plasma glucose is abruptly increased and then held at a constant elevated level, <strong>insulin secretion shows a biphasic pattern</strong>:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>First phase:</strong> A rapid, sharp rise in insulin secretion within the first few minutes, reflecting release of pre‑formed insulin from β‑cell storage granules.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Second phase:</strong> After this spike, secretion plateaus at a sustained but lower level, representing ongoing synthesis and release of new insulin in response to persistent hyperglycaemia.</span></li></ul></li><li><span style=\"font-size:14.0pt;\">This biphasic response is a hallmark of normal pancreatic β‑cell physiology and is essential for effective glucose homeostasis.</span></li></ul><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/WhatsApp%20Image%202025-08-21%20at%2010.50.58.jpeg\" width=\"994\" height=\"487\"></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Rise and fall rapidly:</strong> Describes only the first phase of insulin release but ignores the sustained second phase. It does not fit the prolonged elevation scenario described.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Gradually rise and fall:</strong> Suggests a slow onset and decline, which is not the physiological response to an acute step‑up in glucose. This would also miss the sharp initial surge.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Remain elevated:</strong> Implies a constant high plateau without the initial spike, which is inaccurate because normal β‑cells respond with an immediate first‑phase release.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">A <strong>sudden and sustained rise in blood glucose</strong> elicits a <strong>biphasic insulin secretion pattern</strong>: an early rapid spike from release of stored insulin, followed by a sustained lower plateau from ongoing synthesis.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This pattern is lost in early type 2 diabetes, where the first phase is diminished or absent — contributing to postprandial hyperglycaemia.</span></li></ul>",
      "correct_choice_id": 361667,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90831/NEET_PG_aug_2025_PHYSIOLOGY_Question_4.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        2
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90831/NEET_PG_aug_2025_PHYSIOLOGY_Question_4.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90544,
      "choices": [
        {
          "id": 360540,
          "text": "<p><span style=\"font-size:14.0pt;\">Iris-claw intraocular lens</span></p>"
        },
        {
          "id": 360541,
          "text": "<p><span style=\"font-size:14.0pt;\">Scleral-fixated intraocular lens</span></p>"
        },
        {
          "id": 360542,
          "text": "<p><span style=\"font-size:14.0pt;\">Capsular tension ring</span></p>"
        },
        {
          "id": 360543,
          "text": "<p><span style=\"font-size:14.0pt;\">Intracorneal stromal ring</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Refer to the image below. Which of the following intraocular devices is shown?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_2cliZhX.png\" width=\"534\" height=\"514\"></strong></span></p>",
      "unique_key": "Q4055776",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Capsular tension ring</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">A <strong>capsular tension ring (CTR)</strong> is a thin, flexible polymethylmethacrylate ring with eyelet ends, designed to be inserted into the equator of the lens capsule during cataract surgery when zonular support is compromised.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It redistributes forces evenly around the capsular bag, ensuring a stable, round implant platform for the intraocular lens (IOL).</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-08-20%20133337.jpeg\" width=\"562\" height=\"563\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Iris-claw IOL:&nbsp;</strong>Rigid, claw-shaped haptics that clip to the mid-peripheral iris, not a continuous circular ring.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Scleral-fixated IOL:&nbsp;</strong>A posterior chamber IOL with sutures through the sclera; no ring structure.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Intracorneal stromal ring:&nbsp;</strong>Often made of PMMA segments implanted within the corneal stroma to flatten keratoconic corneas; they are thicker and arc-shaped, not equatorial capsular rings.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">In cases of zonular dialysis (e.g., pseudoexfoliation, trauma, Marfan syndrome), early insertion of a <strong>capsular tension ring</strong> after capsulorhexis helps maintain a <strong>symmetric, stable</strong> capsular bag for optimal IOL positioning and long-term centration.</span></p>",
      "correct_choice_id": 360542,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90544/NEET_PG_aug_2025_OPTHALMOLOGY_Question_4.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        8
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90544/NEET_PG_aug_2025_OPTHALMOLOGY_Question_4.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89981,
      "choices": [
        {
          "id": 358304,
          "text": "<p><span style=\"font-size:14.0pt;\">Para-aortic</span></p>"
        },
        {
          "id": 358305,
          "text": "<p><span style=\"font-size:14.0pt;\">External iliac&nbsp;</span></p>"
        },
        {
          "id": 358306,
          "text": "<p><span style=\"font-size:14.0pt;\">Superficial inguinal</span></p>"
        },
        {
          "id": 358307,
          "text": "<p><span style=\"font-size:14.0pt;\">Deep inguinal</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 35-year-old woman is undergoing evaluation for cervical dysplasia. Imaging and biopsy reveal involvement limited to the cervix and upper part of the vagina. Which of the following lymph nodes are most likely to be involved in this metastatic spread?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q2870295",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) External iliac</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>upper part of the vagina</strong> and&nbsp;<strong>cervix</strong> primarily drain into the&nbsp;<strong>external iliac</strong> and <strong>internal iliac lymph nodes</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">These nodes are part of the pelvic lymphatic drainage system, which receives lymph from deep pelvic organs including the cervix and upper vagina.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This is clinically significant in the staging and spread of gynecologic cancers such as cervical carcinoma.</span></li></ul><p>&nbsp;</p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_9B6kgkL.png\" width=\"940\" height=\"676\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option&nbsp;A. Para-aortic:</strong>&nbsp;These nodes receive lymph from the ovaries, fallopian tubes, and upper uterus. They are <strong>not the primary drainage site</strong> for the cervix or upper vagina.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option&nbsp;C. Superficial inguinal:</strong>&nbsp;These drain the <strong>vulva, perineum, and lower third of the vagina</strong>, not the upper portion or the cervix.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Deep inguinal:</strong>&nbsp;These drain lymph from the <strong>superficial inguinal nodes and parts of the lower limb</strong>, not primarily the cervix or upper vagina.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>The cervix and upper vagina primarily drain into the external and internal iliac lymph nodes</strong>, which is important for understanding the spread of cervical and upper vaginal malignancies.</span></p>",
      "correct_choice_id": 358305,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89981/NEET_PG_aug_2025_ANATOMY_Question_3.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        3
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89981/NEET_PG_aug_2025_ANATOMY_Question_3.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90214,
      "choices": [
        {
          "id": 359228,
          "text": "<p><span style=\"font-size:14.0pt;\">Clomifene citrate 100 mg on days 14–18; check FSH on day 21</span></p>"
        },
        {
          "id": 359229,
          "text": "<p><span style=\"font-size:14.0pt;\">Letrozole 50 mg on days 2–6; check LH on day 14</span></p>"
        },
        {
          "id": 359230,
          "text": "<p><span style=\"font-size:14.0pt;\">Clomifene citrate 50 mg on days 2–6; check progesterone on day 21</span></p>"
        },
        {
          "id": 359231,
          "text": "<p><span style=\"font-size:14.0pt;\">Clomifene citrate 50 mg on days 10–14; check estradiol on day 21</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 30-year-old woman with a 1-year history of infertility is found to have anovulatory cycles. She is started on treatment to induce ovulation. Which of the following is the most appropriate regimen and follow-up for this patient?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q9741215",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Clomifene citrate 50 mg on days 2–6; check progesterone on day 21</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Clomifene citrate is a <strong>first-line agent</strong> used to induce ovulation in women with anovulatory infertility.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The standard regimen involves administering <strong>50 mg of clomifene citrate daily from day 2 to day 6 of the menstrual cycle</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Day 21 progesterone</strong> level is checked to confirm ovulation; a mid-luteal progesterone level &gt;3 ng/mL typically indicates that ovulation has occurred.</span></li><li><span style=\"font-size:14.0pt;\">This protocol is based on the assumption of a <strong>28-day cycle</strong>, with ovulation occurring around <strong>day 14</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Clomifene citrate 100 mg on days 14–18; check FSH on day 21:</strong> Incorrect. The dosage is excessive for a first-line regimen, and clomifene is not given this late in the cycle. <strong>FSH</strong> is not the appropriate marker to confirm ovulation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Letrozole 50 mg on days 2–6; check LH on day 14:</strong> Incorrect. Although <strong>letrozole</strong> is an alternative ovulation induction agent, the dose is incorrect and <strong>LH</strong> is not the preferred hormone to confirm ovulation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Clomifene citrate 50 mg on days 10–14; check estradiol on day 21:</strong> Incorrect. This timing does not coincide with the follicular phase needed for clomifene to be effective. <strong>Estradiol</strong> levels are not used to confirm ovulation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">For PCOS, preferred drug is Letrozole 2.5 mg (max upto 7.5 mg) from day 2 to day 6.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">OR&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Clomifene citrate 50 mg/day (max upto 150 mg) from day 2 to day 6 and&nbsp;</span></p><p><span style=\"font-size:14.0pt;\">later USG required for follicular monitoring.</span></p>",
      "correct_choice_id": 359230,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90214/NEET_PG_aug_2025_OBG_Question_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90214/NEET_PG_aug_2025_OBG_Question_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89982,
      "choices": [
        {
          "id": 358308,
          "text": "<p><span style=\"font-size:14.0pt;\">Renal artery</span></p>"
        },
        {
          "id": 358309,
          "text": "<p><span style=\"font-size:14.0pt;\">Ureter</span></p>"
        },
        {
          "id": 358310,
          "text": "<p><span style=\"font-size:14.0pt;\">Inferior vena cava</span></p>"
        },
        {
          "id": 358311,
          "text": "<p><span style=\"font-size:14.0pt;\">Inferior mesenteric artery&nbsp;</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 45-year-old woman undergoes abdominal and pelvic imaging to evaluate lower abdominal discomfort. Initial pelvic ultrasound reveals a large ovarian cyst. A subsequent CT scan of the abdomen and pelvis incidentally shows the renal structure as shown in the image below. Which of the following anatomical structures most commonly prevents the full ascent of this renal anomaly during embryologic development?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_sQRyFE5.png\" width=\"582\" height=\"469\"></strong></span></p>",
      "unique_key": "Q4700528",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Inferior mesenteric artery</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Horseshoe kidney is a congenital anomaly in which the lower poles of the kidneys are fused.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">During embryologic ascent, this fused structure typically gets trapped under the <strong>inferior mesenteric artery (IMA)</strong>, preventing it from reaching the normal retroperitoneal position.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">These kidneys remain abnormally low in the abdomen and are often discovered incidentally, as in this case during imaging for an ovarian cyst.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Renal artery:</strong>&nbsp;The renal arteries originate at varying levels during kidney ascent, adjusting accordingly. They do not hinder renal migration.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option&nbsp;B. Ureter:</strong>&nbsp;The ureter is a passive structure that follows the kidney’s position. It is not a limiting factor in renal ascent.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option&nbsp;C. Inferior vena cava:</strong>&nbsp;Although anatomically adjacent, the IVC does not interfere with renal migration during development.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The <strong>inferior mesenteric artery</strong> is the most frequent anatomical barrier to the <strong>ascent of a horseshoe kidney</strong>, which is often identified incidentally on imaging done for unrelated abdominal or pelvic pathology.</span></p>",
      "correct_choice_id": 358311,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89982/NEET_PG_aug_2025_ANATOMY_Question_4.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        3
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89982/NEET_PG_aug_2025_ANATOMY_Question_4.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89907,
      "choices": [
        {
          "id": 358020,
          "text": "<p><span style=\"font-size:14.0pt;\">Impaired function of δ-aminolevulinic acid synthase due to vitamin B6 deficiency</span></p>"
        },
        {
          "id": 358021,
          "text": "<p><span style=\"font-size:14.0pt;\">Deficiency of ferrochelatase leading to impaired incorporation of iron into protoporphyrin</span></p>"
        },
        {
          "id": 358022,
          "text": "<p><span style=\"font-size:14.0pt;\">Inhibition of aminolevulinic acid dehydratase by lead</span></p>"
        },
        {
          "id": 358023,
          "text": "<p><span style=\"font-size:14.0pt;\">Decreased transferrin synthesis leading to impaired iron delivery to erythroid precursors</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 45-year-old man with a history of chronic alcohol use presents with progressive fatigue and pallor. Laboratory studies show: Hemoglobin: 8.4 g/dl, MCV: 72 fl, increased ferritin, increased serum iron, increased % saturation and reduced TIBC. Bone marrow biopsy is shown below. Which of the following best explains the underlying defect in this patient’s condition?</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_0oN4C2q.png\" width=\"377\" height=\"313\"></span></p>",
      "unique_key": "Q7719403",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Impaired function of δ-aminolevulinic acid synthase due to vitamin B6 deficiency</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Sideroblastic anemia is characterized by defective protoporphyrin synthesis, which prevents the incorporation of iron into heme.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">As a result, iron becomes trapped within the mitochondria of erythroid precursors, forming <strong>ringed sideroblasts</strong>.</span></li><li><span style=\"font-size:14.0pt;\">The <strong>rate-limiting step</strong> in protoporphyrin synthesis is catalyzed by <strong>ALA synthase (ALAS)</strong>, which requires <strong>vitamin B6 (pyridoxal phosphate)</strong> as a cofactor.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">In chronic alcoholics or patients receiving isoniazid (for TB), vitamin B6 deficiency is common, leading to impaired ALAS activity and sideroblastic anemia.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Alcohol itself can also inhibit <strong>ALA synthase</strong> through <strong>acetaldehyde</strong>.&nbsp;</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Deficiency of ferrochelatase leading to impaired incorporation of iron into protoporphyrin:</strong> Seen in <strong>lead poisoning</strong>, but the patient’s history of alcohol abuse and vitamin B6 deficiency makes ALAS dysfunction more likely here.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Inhibition of aminolevulinic acid dehydratase by lead</strong>: Also seen in <strong>lead poisoning</strong>, but again, history of alcoholism strongly points to vitamin B6 deficiency as the cause.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Decreased transferrin synthesis leading to impaired iron delivery to erythroid precursors</strong>: This describes anemia of chronic disease, not sideroblastic anemia. In sideroblastic anemia, iron is present but cannot be utilized due to defective protoporphyrin synthesis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Sideroblastic anemia results from defective protoporphyrin synthesis, most commonly due to vitamin B6 deficiency impairing ALA synthase activity. It is associated with alcoholism, isoniazid therapy, and ringed sideroblasts on bone marrow biopsy.</span></p>",
      "correct_choice_id": 358020,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89907/NEET_PG_aug_2025_PATHOLOGY_Question_1.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89907/NEET_PG_aug_2025_PATHOLOGY_Question_1.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89906,
      "choices": [
        {
          "id": 358016,
          "text": "<p><span style=\"font-size:14.0pt;\">It occurs more commonly in children than in adults</span></p>"
        },
        {
          "id": 358017,
          "text": "<p><span style=\"font-size:14.0pt;\">Every infective mosquito bite leads to clinical disease</span></p>"
        },
        {
          "id": 358018,
          "text": "<p><span style=\"font-size:14.0pt;\">The ratio of apparent (symptomatic) to inapparent infections is approximately 1:1,000</span></p>"
        },
        {
          "id": 358019,
          "text": "<p><span style=\"font-size:14.0pt;\">An epidemic can be signaled by as few as 2–3 cases within a village</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A rural health officer is reviewing Japanese encephalitis (JE) epidemiology to prepare for an upcoming awareness campaign. Which of the following statements about JE is false?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q6690369",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;B) Every infective mosquito bite leads to clinical disease</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Most JE virus infections are <strong>subclinical</strong>. Fewer than 1 in 1,000 infected individuals develop encephalitis; the vast majority have inapparent or mild illness.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Thus, <strong>an infective bite does not always result in disease</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.</strong> <strong>It occurs more commonly in children than in adult:</strong> True. Children account for most clinical JE cases because adults in endemic areas often develop partial immunity. 1-15 years of age</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C.</strong> <strong>The ratio of apparent (symptomatic) to inapparent infections is approximately 1:1,000:</strong> True. The symptomatic-to-asymptomatic infection ratio is about <strong>1:1,000</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.</strong> <strong>An epidemic can be signaled by as few as 2–3 cases within a village:</strong> True. In hyperendemic regions, <strong>2–3 cases</strong> in a village over a brief period may constitute an epidemic threshold.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Not every JE‑infected mosquito bite causes clinical disease; only about <strong>0.1%</strong> of infections become overt encephalitis.</span></p>",
      "correct_choice_id": 358017,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89906/NEET_PG_aug_2025_PSM_Question_20.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89906/NEET_PG_aug_2025_PSM_Question_20.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90816,
      "choices": [
        {
          "id": 361604,
          "text": "<p><span style=\"font-size:14.0pt;\">Lactulose</span></p>"
        },
        {
          "id": 361605,
          "text": "<p><span style=\"font-size:14.0pt;\">IV antibiotics</span></p>"
        },
        {
          "id": 361606,
          "text": "<p><span style=\"font-size:14.0pt;\">Transjugular intrahepatic portosystemic shunt</span></p>"
        },
        {
          "id": 361607,
          "text": "<p><span style=\"font-size:14.0pt;\">Propranolol</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 55-year-old woman with cirrhosis and recent gastrointestinal bleeding presents with confusion, asterixis and poor concentration. Labs: AST 60 U/L, ALT 50 U/L, and INR 1.5. What is the most appropriate initial treatment?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q1098410",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;A) Lactulose</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Confusion and asterixis in cirrhosis indicate hepatic encephalopathy from ammonia accumulation.</span></li><li><span style=\"font-size:14.0pt;\">Gastrointestinal bleeding is a common precipitant, increasing ammonia production.</span></li><li><span style=\"font-size:14.0pt;\">Lactulose acidifies the colon, promoting ammonia excretion, improving mental status.</span></li><li><span style=\"font-size:14.0pt;\">Treat precipitants (e.g., bleeding) alongside lactulose.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. IV antibiotics:</strong> Adjunct (e.g., rifaximin), not initial therapy.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Transjugular intrahepatic portosystemic shunt:</strong> For ascites or variceal bleeding, not encephalopathy. Contraindicated in encephalopathy.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Propranolol:</strong> For variceal prophylaxis, not encephalopathy.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Hepatic encephalopathy presents with confusion and asterixis.</span></li><li><span style=\"font-size:14.0pt;\">Lactulose is first-line to reduce ammonia.</span></li><li><span style=\"font-size:14.0pt;\">Address precipitants like bleeding.</span></li></ul>",
      "correct_choice_id": 361604,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90816/NEET_PG_aug_2025_MEDICINE_Question_4.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90816/NEET_PG_aug_2025_MEDICINE_Question_4.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89923,
      "choices": [
        {
          "id": 358084,
          "text": "<p><span style=\"font-size:14.0pt;\">Overexpression of the c-MYC oncogene leading to uncontrolled cell proliferation&nbsp;</span></p>"
        },
        {
          "id": 358085,
          "text": "<p><span style=\"font-size:14.0pt;\">Loss of function of the RB1 tumor suppressor gene leading to dysregulated G1/S transition</span></p>"
        },
        {
          "id": 358086,
          "text": "<p><span style=\"font-size:14.0pt;\">Activation of BCL2 gene resulting in inhibition of apoptosis</span></p>"
        },
        {
          "id": 358087,
          "text": "<p><span style=\"font-size:14.0pt;\">Mutation of the APC gene leading to impaired regulation of β-catenin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 10-year-old boy from East Africa presents with a rapidly enlarging, painless mass on the jaw. He has also experienced fever and night sweats. Biopsy of the lesion is shown below. Cytogenetic studies reveal a translocation responsible for these findings<strong>. </strong>Which of the following best explains the underlying molecular mechanism of this malignancy?</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_c6TCoi8.png\" width=\"334\" height=\"306\"></span></p>",
      "unique_key": "Q7411669",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Overexpression of the c-MYC oncogene leading to uncontrolled cell proliferation</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>t(8;14) translocation</strong> is characteristic of <strong>Burkitt lymphoma</strong>, where the <strong>c-MYC oncogene</strong> (chromosome 8) is translocated next to the immunoglobulin heavy chain locus (chromosome 14).</span></li><li><span style=\"font-size:14.0pt;\">This results in <strong>c-MYC overexpression</strong>, driving rapid cellular proliferation.</span></li><li><span style=\"font-size:14.0pt;\">The classic <strong>histologic “starry sky” appearance</strong> arises from tumor cells with dark blue cytoplasm interspersed with macrophages that ingest apoptotic debris.</span></li><li><span style=\"font-size:14.0pt;\">Endemic cases are often associated with <strong>EBV infection</strong>, with the jaw being the most common site of involvement.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Loss of function of the RB1 tumor suppressor gene</strong> <strong>leading to dysregulated G1/S transition:</strong> Seen in <strong>retinoblastoma and osteosarcoma</strong>, not Burkitt lymphoma.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Activation of BCL2 gene</strong> <strong>resulting in inhibition of apoptosis:</strong> Found in <strong>follicular lymphoma t(14;18))</strong>, leading to impaired apoptosis, not Burkitt lymphoma.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Mutation of the APC gene leading to impaired regulation of β-catenin:</strong> Associated with <strong>familial adenomatous polyposis (FAP)</strong> and colorectal carcinoma, not with Burkitt lymphoma.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Burkitt lymphoma</strong> is a highly aggressive B-cell non-Hodgkin lymphoma strongly associated with <strong>EBV (endemic type)</strong> and characterized by <strong>t(8;14) translocation</strong>, which causes <strong>c-MYC overexpression</strong> and uncontrolled cell proliferation.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Classic pathology shows a <strong>“starry sky” appearance</strong> with tingible body macrophages.</span></li></ul>",
      "correct_choice_id": 358084,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89923/NEET_PG_aug_2025_PATHOLOGY_Question_4.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89923/NEET_PG_aug_2025_PATHOLOGY_Question_4.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90211,
      "choices": [
        {
          "id": 359216,
          "text": "<p><span style=\"font-size:14.0pt;\">Mantoux test</span></p>"
        },
        {
          "id": 359217,
          "text": "<p><span style=\"font-size:14.0pt;\">Probe test</span></p>"
        },
        {
          "id": 359218,
          "text": "<p><span style=\"font-size:14.0pt;\">Split skin smear</span></p>"
        },
        {
          "id": 359219,
          "text": "<p><span style=\"font-size:14.0pt;\">PCR</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A patient presents with a plaque on the face showing central atrophy as seen in the image. Chest X-ray reveals apical calcification. What is the next best step to confirm the diagnosis?</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-08-11%20114843.jpeg\" width=\"392\" height=\"470\"></p>",
      "unique_key": "Q4827190",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) PCR</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The skin lesion shown is a large annular plaque with central atrophy, suggestive of lupus vulgaris (cutaneous TB).</span></li><li><span style=\"font-size:14.0pt;\">Apical calcification on chest X-ray strongly suggests past pulmonary tuberculosis, reinforcing a tuberculous etiology.</span></li><li><span style=\"font-size:14.0pt;\">The combination of chronic facial plaque with central atrophy, and pulmonary TB signs (apical calcification) – strongly favours lupus vulgaris, a form of cutaneous tuberculosis.</span></li><li><span style=\"font-size:14.0pt;\">PCR is highly sensitive and specific for detecting Mycobacterium tuberculosis DNA from skin biopsy or tissue samples.</span></li><li><span style=\"font-size:14.0pt;\">It is preferred in cutaneous TB when classical histopathology and culture are not diagnostic or too slow.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Mantoux test:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">May be positive in TB but is not confirmatory and has low specificity, especially in endemic areas where many people have latent TB.</span></li><li><span style=\"font-size:14.0pt;\">Cannot differentiate between cutaneous and pulmonary TB or between TB and other granulomatous diseases.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Probe test:&nbsp;</strong>Used in chronic sinus tracts or ulcers, such as in tuberculous ulcers, not for plaque-type lesions like lupus vulgaris.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Split skin smear:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Used to identify Mycobacterium leprae in leprosy.</span></li><li><span style=\"font-size:14.0pt;\">Not helpful in tuberculosis, especially cutaneous TB.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">In suspected cases of cutaneous tuberculosis like lupus vulgaris, especially with supporting systemic findings such as apical calcification, PCR is the best diagnostic test to confirm the presence of M. tuberculosis DNA in skin lesions.</span></p>",
      "correct_choice_id": 359219,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90211/NEET_PG_aug_2025_DERMA_Question_1.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        18
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90211/NEET_PG_aug_2025_DERMA_Question_1.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90511,
      "choices": [
        {
          "id": 360408,
          "text": "<p><span style=\"font-size:14.0pt;\">Give bolus of 10 ml/kg Hartmann solution</span></p>"
        },
        {
          "id": 360409,
          "text": "<p><span style=\"font-size:14.0pt;\">Give colloid bolus</span></p>"
        },
        {
          "id": 360410,
          "text": "<p><span style=\"font-size:14.0pt;\">Wait for 2 hours and reassess</span></p>"
        },
        {
          "id": 360411,
          "text": "<p><span style=\"font-size:14.0pt;\">Give bolus at 30 ml/kg</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 7-year-old male child was brought to the ER after a burn and was found to have 20% BSA burns. He was resuscitated as per Parkland’s equation. After 6 hours, he was found to have cool extremities and hypotension, and urine output of 0.3ml/kg/hour. What is the next step in management?</span></p>",
      "unique_key": "Q3414371",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Give bolus of 10 ml/kg&nbsp;Hartmann solution</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This child is in <strong>burn with shock</strong> (tachycardia, hypotension, oliguria).</span></li><li><span style=\"font-size:14.0pt;\">The <strong>initial management is crystalloid resuscitation</strong> with <strong>a bolus of 10–20 ml/kg</strong>, preferably 10 ml/kg in this situation, followed by monitoring and titration.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Give colloid bolus</strong>: Not first-line in initial resuscitation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C.</strong> <strong>Wait for 2 hours and reassess:</strong>Waiting further is not ideal</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Give bolus at 30 ml/kg&nbsp;</strong>: Too aggressive; risks fluid overload.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">In burn shock, prompt fluid resuscitation with isotonic crystalloids at 10 ml/kg is the initial management step to restore perfusion and urine output.</span></p>",
      "correct_choice_id": 360408,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90511/NEET_PG_aug_2025_Surgery_Question_13.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90511/NEET_PG_aug_2025_Surgery_Question_13.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89928,
      "choices": [
        {
          "id": 358104,
          "text": "<p><span style=\"font-size:14.0pt;\">JAK2 V617F mutation activating the tyrosine kinase pathway</span></p>"
        },
        {
          "id": 358105,
          "text": "<p><span style=\"font-size:14.0pt;\">t(9;22) translocation producing BCR-ABL fusion gene&nbsp;</span></p>"
        },
        {
          "id": 358106,
          "text": "<p><span style=\"font-size:14.0pt;\">t(15;17) translocation producing PML-RARA fusion gene</span></p>"
        },
        {
          "id": 358107,
          "text": "<p><span style=\"font-size:14.0pt;\">t(8;14) translocation leading to c-MYC overexpression</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 52-year-old man presents with progressive fatigue and abdominal fullness. Examination reveals marked splenomegaly. CBC shows leukocytosis with basophilia and peripheral smear demonstrates numerous immature myeloid cells. Bone marrow biopsy is hypercellular. Which of the following genetic alterations is responsible for this condition?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q2675101",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) t(9;22) translocation producing BCR-ABL fusion gene</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>Philadelphia chromosome</strong> results from a <strong>t(9;22) translocation</strong>, creating the <strong>BCR-ABL fusion gene</strong>.</span></li><li><span style=\"font-size:14.0pt;\">This fusion encodes a <strong>constitutively active tyrosine kinase</strong>, leading to uncontrolled myeloid proliferation.</span></li><li><span style=\"font-size:14.0pt;\">The classic triad includes: <strong>Splenomegaly + Marked leukocytosis with left-shifted myeloid cells + Basophilia.</strong></span></li><li><span style=\"font-size:14.0pt;\">This is the hallmark of <strong>chronic myeloid leukemia (CML)</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Targeted therapy with <strong>tyrosine kinase inhibitors (eg, imatinib)</strong> is highly effective.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_cdvPlXH.png\" width=\"706\" height=\"545\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. JAK2 V617F mutation activating the tyrosine kinase pathway:</strong> Seen in <strong>polycythemia vera, essential thrombocythemia, primary myelofibrosis</strong>, not CML.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. t(15;17) translocation producing PML-RARA fusion gene:</strong> Seen in <strong>APML</strong>, responsive to <strong>all-trans retinoic acid (ATRA)</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. t(8;14) translocation leading to c-MYC overexpression:</strong> Found in <strong>Burkitt lymphoma</strong>, not CML.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Chronic myeloid leukemia is defined by the Philadelphia chromosome t(9;22), which produces the BCR-ABL fusion gene encoding a constitutively active tyrosine kinase.</span></p>",
      "correct_choice_id": 358105,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89928/NEET_PG_aug_2025_PATHOLOGY_Question_10.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89928/NEET_PG_aug_2025_PATHOLOGY_Question_10.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90567,
      "choices": [
        {
          "id": 360628,
          "text": "<p><span style=\"font-size:14.0pt;\">Sweat chloride test</span></p>"
        },
        {
          "id": 360629,
          "text": "<p><span style=\"font-size:14.0pt;\">Lung biopsy</span></p>"
        },
        {
          "id": 360630,
          "text": "<p><span style=\"font-size:14.0pt;\">Chest X-ray</span></p>"
        },
        {
          "id": 360631,
          "text": "<p><span style=\"font-size:14.0pt;\">Nasal swab culture</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A child presents with recurrent sinusitis and repeated lung infections. Genetic testing shows a mutation in the CFTR gene. Which test is considered the gold standard to confirm the diagnosis?&nbsp;</span></p>",
      "unique_key": "Q4433043",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Sweat chloride test</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>sweat chloride test</strong> is the <strong>gold standard</strong> for the diagnosis of <strong>Cystic Fibrosis (CF)</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">CF is caused by mutations in the <strong>CFTR gene</strong>, leading to defective chloride transport across epithelial membranes.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This defect results in abnormally thick mucus in the lungs, sinuses, and other organs.</span></li><li><span style=\"font-size:14.0pt;\"><strong>In the sweat chloride test:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Pilocarpine iontophoresis stimulates sweat production.</span></li><li><span style=\"font-size:14.0pt;\">Sweat is collected and analyzed.</span></li><li><span style=\"font-size:14.0pt;\">A <strong>chloride concentration &gt;60 mmol/L</strong> (in children) confirms the diagnosis.</span></li><li><span style=\"font-size:14.0pt;\">Even if a genetic mutation is detected, <strong>functional confirmation</strong> via sweat chloride testing is essential, especially in borderline or novel mutations.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Lung biopsy:&nbsp;</strong>Lung biopsy is <strong>not required</strong> for diagnosis and is invasive. Histopathology is not diagnostic in CF; rather, it may show secondary changes like bronchiectasis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Chest X-ray:&nbsp;</strong>Chest X-ray may show signs of chronic lung disease (e.g., hyperinflation, bronchiectasis), but it is <strong>non-specific</strong> and not diagnostic. It's useful for monitoring complications, not confirmation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Nasal swab culture:&nbsp;</strong>While nasal cultures can grow organisms like Pseudomonas aeruginosa, which are common in CF patients, this test is <strong>not diagnostic</strong> or confirmatory of CF.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">In a child with recurrent respiratory infections and CFTR gene mutation, the sweat chloride test remains the gold standard to confirm cystic fibrosis by functionally demonstrating defective chloride transport.</span></p>",
      "correct_choice_id": 360628,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90567/NEET_PG_Aug_PEDIATRICS_Question_10.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        13
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90567/NEET_PG_Aug_PEDIATRICS_Question_10.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90607,
      "choices": [
        {
          "id": 360788,
          "text": "<p><span style=\"font-size:14.0pt;\">Modified radical mastoidectomy (MRM)</span></p>"
        },
        {
          "id": 360789,
          "text": "<p><span style=\"font-size:14.0pt;\">Myringoplasty</span></p>"
        },
        {
          "id": 360790,
          "text": "<p><span style=\"font-size:14.0pt;\">Atticotomy</span></p>"
        },
        {
          "id": 360791,
          "text": "<p><span style=\"font-size:14.0pt;\">Exploratory tympanotomy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 36-year-old man presents with a history of persistent foul-smelling ear discharge and progressive hearing loss in his right ear for several months. Otoscopic examination is as given below. There are no signs of acute infection, but the discharge has not resolved despite medical management. Which of the following is the most appropriate surgical management for this patient?</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_I6XOGES.png\" width=\"482\" height=\"372\"></span></p>",
      "unique_key": "Q7301698",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Modified radical mastoidectomy (MRM)</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The patient has <strong>active mucosal chronic suppurative otitis media (CSOM)</strong> with persistent discharge and granulation tissue, suggesting ongoing disease in the middle ear and mastoid air cells.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\"><strong>MRM</strong> is indicated in cases of unsafe CSOM (especially with persistent infection, granulation tissue, or cholesteatoma) to remove all diseased tissue while preserving as much normal anatomy as possible and maintaining a dry, safe ear.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Myringoplasty</strong>: Incorrect. A myringoplasty is performed for <strong>dry perforations</strong> without active infection or middle ear disease. This patient has ongoing infection and granulation tissue, making myringoplasty alone inadequate.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Atticotomy</strong>: Incorrect. Atticotomy is used in <strong>attic cholesteatoma</strong> or limited epitympanic disease, not in widespread mucosal disease with large perforation and granulation tissue.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Exploratory tympanotomy</strong>: Incorrect. This is performed to explore the middle ear for causes of conductive hearing loss (e.g., ossicular chain fixation), not for chronic infective pathology.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Modified radical mastoidectomy</strong> is the surgery of choice in unsafe CSOM with active infection, granulation tissue, or cholesteatoma to eradicate disease, create a safe ear, and prevent complications like facial nerve palsy or intracranial spread.</span></p>",
      "correct_choice_id": 360788,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90607/NEET_PG_aug_2025_ENT_Question_3.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        9
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90607/NEET_PG_aug_2025_ENT_Question_3.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90897,
      "choices": [
        {
          "id": 361924,
          "text": "<p><span style=\"font-size:14.0pt;\">Enalapril</span></p>"
        },
        {
          "id": 361925,
          "text": "<p><span style=\"font-size:14.0pt;\">Lisinopril</span></p>"
        },
        {
          "id": 361926,
          "text": "<p><span style=\"font-size:14.0pt;\">Losartan</span></p>"
        },
        {
          "id": 361927,
          "text": "<p><span style=\"font-size:14.0pt;\">Ramipril</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following medications is most appropriate as an alternative antihypertensive in patients who develop angioedema due to captopril?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q3806066",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Losartan</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Captopril-induced angioedema</strong> is caused by <strong>bradykinin accumulation</strong>, a class effect of ACE inhibitors.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\"><strong>Losartan</strong>, an angiotensin receptor blocker (ARB), works downstream by <strong>blocking angiotensin II receptors</strong> without affecting bradykinin metabolism.</span></li><li><span style=\"font-size:14.0pt;\">Thus, it <strong>does not carry the same risk of angioedema</strong> and is often considered a safe substitute for patients who cannot tolerate ACE inhibitors.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Enalapril</strong>: Another ACE inhibitor; also increases bradykinin and can trigger angioedema.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Lisinopril</strong>: Same class; contraindicated in patients with previous ACEI-induced angioedema.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Ramipril</strong>: Also an ACE inhibitor with the same risk profile for angioedema.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Angiotensin receptor blockers (ARBs), such as losartan, are appropriate alternatives for patients with ACE inhibitor–induced angioedema.</span></p>",
      "correct_choice_id": 361926,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90897/NEET_PG_aug_2025_PHARMACOLOGY_Question_20.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90897/NEET_PG_aug_2025_PHARMACOLOGY_Question_20.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90508,
      "choices": [
        {
          "id": 360396,
          "text": "<p><span style=\"font-size:14.0pt;\">Vertical mattress</span></p>"
        },
        {
          "id": 360397,
          "text": "<p><span style=\"font-size:14.0pt;\">Horizontal mattress</span></p>"
        },
        {
          "id": 360398,
          "text": "<p><span style=\"font-size:14.0pt;\">Subcuticular</span></p>"
        },
        {
          "id": 360399,
          "text": "<p><span style=\"font-size:14.0pt;\">Simple interrupted</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Identify the type of suturing technique.<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-08-14%20140831.jpeg\" width=\"715\" height=\"478\"></strong></span></p>",
      "unique_key": "Q7979249",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Simple interrupted</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Single loop sutures without vertical or horizontal looping pattern.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Vertical mattress:</strong> Sutures penetrate deeply and are designed to evert skin edges and reduce dead space. The image shows both deep and superficial bites on opposite sides of the wound, classic for vertical mattress.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-08-14%20140849.jpeg\" width=\"499\" height=\"399\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Horizontal mattress</strong>: These are placed parallel to the wound and remain more superficial.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-08-14%20140908.jpeg\" width=\"501\" height=\"396\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Subcuticular</strong>: Continuous stitches placed in the dermis, not the pattern shown.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-08-14%20140928.jpeg\" width=\"479\" height=\"378\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Single loop sutures without vertical or horizontal looping pattern.</span></p>",
      "correct_choice_id": 360399,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90508/NEET_PG_aug_2025_Surgery_Question_11.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90508/NEET_PG_aug_2025_Surgery_Question_11.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90868,
      "choices": [
        {
          "id": 361808,
          "text": "<p><span style=\"font-size:14.0pt;\">Increase the dose of lisinopril</span></p>"
        },
        {
          "id": 361809,
          "text": "<p><span style=\"font-size:14.0pt;\">Discontinue carvedilol temporarily</span></p>"
        },
        {
          "id": 361810,
          "text": "<p><span style=\"font-size:14.0pt;\">Add IV dobutamine infusion</span></p>"
        },
        {
          "id": 361811,
          "text": "<p><span style=\"font-size:14.0pt;\">Administer additional dose of IV furosemide</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 59-year-old man is presents with dyspnea at rest, bilateral rales, and elevated jugular venous pressure. His BP is 90/60 mm Hg, and pulse is 96/min. He is a known case of congestive heart failure and is currently on furosemide, lisinopril, and carvedilol. What is the next best step in management?</span></p>",
      "unique_key": "Q1610342",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Discontinue carvedilol temporarily</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This patient with CHF on guideline-directed therapy has now developed&nbsp;<strong>acute decompensated heart failure with hypotension and pulmonary congestion</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">In such cases,&nbsp;<strong>beta-blockers (like carvedilol)</strong>&nbsp;should be held or reduced because their negative inotropic effect can worsen acute decompensation.</span></li><li><span style=\"font-size:14.0pt;\">Once the patient is stabilized, beta-blocker therapy can be carefully restarted.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Increase the dose of lisinopril</strong>: Incorrect. ACE inhibitors are beneficial in chronic CHF, but in acute decompensation with low BP (90/60 mm Hg), increasing vasodilator dose would worsen hypotension and perfusion.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Add IV dobutamine infusion</strong>: Not the first step here. Inotropes like dobutamine are used in&nbsp;<strong>cardiogenic shock with severe hypotension and hypoperfusion</strong>, not as routine management of acute pulmonary congestion in a patient who is stable enough. Here, stopping the beta-blocker is the priority.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Administer additional dose of IV furosemide</strong>: This may help relieve congestion but does not address the precipitating problem of&nbsp;<strong>ongoing beta-blockade in acute decompensation with low BP</strong>. Giving more diuretics without correcting the beta-blocker effect could worsen hypotension and renal perfusion.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Beta-blockers should be stopped in acute decompensated heart failure and resumed only after stabilization.</span></p>",
      "correct_choice_id": 361809,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90868/NEET_PG_aug_2025_PHARMACOLOGY_Question_1.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90868/NEET_PG_aug_2025_PHARMACOLOGY_Question_1.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90548,
      "choices": [
        {
          "id": 360556,
          "text": "<p><span style=\"font-size:14.0pt;\">Flexor tenosynovitis</span></p>"
        },
        {
          "id": 360557,
          "text": "<p><span style=\"font-size:14.0pt;\">Cellulitis</span></p>"
        },
        {
          "id": 360558,
          "text": "<p><span style=\"font-size:14.0pt;\">Septic arthritis</span></p>"
        },
        {
          "id": 360559,
          "text": "<p><span style=\"font-size:14.0pt;\">Osteomyelitis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A patient presents with a swollen, semi-flexed index finger. The finger is exquisitely tender along its palmar aspect, and passive extension causes severe pain. Which of the following conditions is the most likely diagnosis?&nbsp;</span></p>",
      "unique_key": "Q1091115",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Flexor tenosynovitis</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The patient's symptoms are a perfect match for <strong>Kanavel's four cardinal signs</strong>, which are the definitive clinical criteria for this emergency hand infection:</span></li></ul><ol><li><span style=\"font-size:14.0pt;\"><strong>Uniform swelling</strong> of the affected finger.</span></li><li><span style=\"font-size:14.0pt;\">A <strong>semi-flexed posture</strong> of the digit.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Exquisite tenderness</strong> along the course of the flexor tendon sheath.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Severe pain with passive extension</strong> of the finger.</span></li></ol><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This condition requires urgent surgical drainage and broad-spectrum antibiotics to prevent permanent disability.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Cellulitis:</strong>&nbsp;</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This is a diffuse bacterial infection of the skin and subcutaneous tissue.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">While it causes redness, swelling, and warmth, the infection is not confined to the tendon sheath.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It lacks the specific signs of a semi-flexed posture and pain with passive extension, which are unique to tenosynovitis.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Septic arthritis:</strong>&nbsp;</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This is an infection of the joint space itself.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The pain and swelling would be localized to the joint, not along the entire length of the tendon sheath.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The pain would be most prominent with movement of the joint, but the specific finding of pain with passive extension of the entire digit is less characteristic.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Osteomyelitis:</strong>&nbsp;</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This is a serious infection of the bone.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It typically has a more insidious onset and presents with deep, localized pain.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">While it can cause swelling and tenderness, it does not typically produce the specific semi-flexed posture or tenderness along the tendon sheath that are characteristic of flexor tenosynovitis.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The educational objective is to recognize the classic clinical presentation of flexor tenosynovitis and differentiate it from other common hand infections. This is achieved by identifying Kanavel's four cardinal signs, which are pathognomonic for this condition.</span></p>",
      "correct_choice_id": 360556,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90548/NEET_PG_aug_2025_ORTHO_Question_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        15
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90548/NEET_PG_aug_2025_ORTHO_Question_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89841,
      "choices": [
        {
          "id": 357756,
          "text": "<p><span style=\"font-size:14.0pt;\">1-D, 2-B, 3-C, 4-A</span></p>"
        },
        {
          "id": 357757,
          "text": "<p><span style=\"font-size:14.0pt;\">1-B, 2-C, 3-A, 4-D</span></p>"
        },
        {
          "id": 357758,
          "text": "<p><span style=\"font-size:14.0pt;\">1-C, 2-B, 3-D, 4-A</span></p>"
        },
        {
          "id": 357759,
          "text": "<p><span style=\"font-size:14.0pt;\">1-A, 2-B, 3-C, 4-D&nbsp;</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Match the following clinical tests with what they assess in airway examination:&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-08-16%20163111.jpeg\" width=\"1262\" height=\"262\"></span></p>",
      "unique_key": "Q2002189",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>D) 1-A, 2-B, 3-C, 4-D</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>1-A.</strong> Thyromental distance evaluates mandibular space.</span></li><li><span style=\"font-size:14.0pt;\"><strong>2-B. </strong>Mallampati classification evaluates tongue-to-pharyngeal space.</span></li><li><span style=\"font-size:14.0pt;\"><strong>3-C.</strong> Upper lip bite test checks mandibular mobility.</span></li><li><span style=\"font-size:14.0pt;\"><strong>4-D.</strong> Sternomental distance evaluates neck extension and head movement.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:14.0pt;\">Proper airway examination includes tests assessing tongue size, jaw mobility, and neck extension to predict intubation difficulty.</span></p>",
      "correct_choice_id": 357759,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89841/NEET_PG_Aug_ANESTHESIA_Question_1.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        19
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89841/NEET_PG_Aug_ANESTHESIA_Question_1.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90228,
      "choices": [
        {
          "id": 359284,
          "text": "<p><span style=\"font-size:14.0pt;\">Tubal recanalization</span></p>"
        },
        {
          "id": 359285,
          "text": "<p><span style=\"font-size:14.0pt;\">Hysteroscopic adhesiolysis</span></p>"
        },
        {
          "id": 359286,
          "text": "<p><span style=\"font-size:14.0pt;\">In-vitro fertilization</span></p>"
        },
        {
          "id": 359287,
          "text": "<p><span style=\"font-size:14.0pt;\">Hysteroscopic septal resection</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 35-year-old woman presents with secondary infertility. She has a history of two first-trimester miscarriages. Hysteroscopic evaluation is performed and revealed below. Based on the image shown, what is the most appropriate next step in management?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_wpyOiaU.png\" width=\"254\" height=\"276\"></strong></span></p>",
      "unique_key": "Q3832751",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Hysteroscopic adhesiolysis</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The hysteroscopic image demonstrates intrauterine adhesions (also known as <strong>Asherman syndrome</strong>), which is a common cause of <strong>secondary infertility</strong>, especially following uterine instrumentation such as curettage after miscarriage.</span></li><li><span style=\"font-size:14.0pt;\">These adhesions may appear as fibrous bands within the endometrial cavity.</span></li><li><span style=\"font-size:14.0pt;\">In this case, the <strong>appropriate next step is hysteroscopic adhesiolysis</strong>, which involves direct visualization and dissection of the adhesions to restore the normal uterine cavity and improve fertility outcomes.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Tubal recanalization:</strong> Incorrect. Tubal recanalization is indicated in cases of <strong>tubal infertility</strong>, not when the problem lies within the <strong>uterine cavity</strong>, as seen here. There is no evidence of tubal obstruction in this case.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. In-vitro fertilization (IVF):</strong> Incorrect. IVF is typically reserved for cases of <strong>tubal factor infertility</strong>, <strong>severe male factor infertility</strong>, or <strong>refractory intrauterine causes</strong>. Intrauterine adhesions are a correctable structural cause of infertility and should be managed surgically before considering IVF.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Hysteroscopic septal resection:</strong> Incorrect. This procedure is performed in patients with <strong>congenital uterine anomalies</strong> like a <strong>septate uterus</strong>, not acquired conditions like adhesions. The hysteroscopic image does not show a septum but rather fibrotic adhesions between uterine walls.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Intrauterine adhesions (Asherman syndrome) are a common cause of secondary infertility, especially following uterine surgery or curettage.</span></li><li><span style=\"font-size:14.0pt;\">Hysteroscopic adhesiolysis is the definitive treatment.</span></li></ul>",
      "correct_choice_id": 359285,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90228/NEET_PG_aug_2025_OBG_Question_14.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90228/NEET_PG_aug_2025_OBG_Question_14.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90528,
      "choices": [
        {
          "id": 360476,
          "text": "<p><span style=\"font-size:14.0pt;\">Competitive inhibition</span></p>"
        },
        {
          "id": 360477,
          "text": "<p><span style=\"font-size:14.0pt;\">Uncompetitive inhibition</span></p>"
        },
        {
          "id": 360478,
          "text": "<p><span style=\"font-size:14.0pt;\">Mixed inhibition</span></p>"
        },
        {
          "id": 360479,
          "text": "<p><span style=\"font-size:14.0pt;\">Non-competitive inhibition</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 60-year-old male patient is started on a new medication that inhibits an enzyme involved in purine metabolism. A Lineweaver-Burk plot is generated to determine the mechanism of inhibition. The plot shows that the inhibitor increases the slope of the line but does not alter the y-intercept. Which type of enzyme inhibition is most likely occurring?</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_7cYhMxj.png\" width=\"734\" height=\"409\"></span></p>",
      "unique_key": "Q6641133",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Competitive inhibition</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Reasoning based on the plot:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In a Lineweaver–Burk plot,</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Y-intercept = 1/Vmax</span></li><li><span style=\"font-size:14.0pt;\">X-intercept = –1/Km</span></li><li><span style=\"font-size:14.0pt;\">Slope = Km/Vmax</span></li></ul></li><li><span style=\"font-size:14.0pt;\">In competitive inhibition:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">The inhibitor competes with the substrate for the active site → you can overcome the inhibition by increasing substrate concentration.</span></li><li><span style=\"font-size:14.0pt;\">Vmax remains unchanged → Y-intercept (1/Vmax) stays the same.</span></li><li><span style=\"font-size:14.0pt;\">Km increases → the absolute value of X-intercept decreases (moves toward zero), slope increases.</span></li></ul></li><li><span style=\"font-size:14.0pt;\">The image shows:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Blue line = no inhibitor.</span></li><li><span style=\"font-size:14.0pt;\">Red line (A) = with inhibitor → same Y-intercept but steeper slope.</span></li><li><span style=\"font-size:14.0pt;\">This is exactly the pattern for competitive inhibition.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Uncompetitive inhibition:&nbsp;</strong>Both Vmax and Km decrease → parallel lines (different y-intercept). Not seen here.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Mixed inhibition:&nbsp;</strong>Vmax decreases (y-intercept changes), Km can ↑ or ↓ depending on inhibitor's affinity → not matching the same y-intercept here.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Non-competitive inhibition:&nbsp;</strong>Vmax decreases (↑ y-intercept) with same Km → also not matching the given plot.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In competitive inhibition, the inhibitor competes with the substrate for the active site, increasing Km but leaving Vmax unchanged.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">On a Lineweaver–Burk plot, this produces a steeper slope with the same y-intercept.</span></li></ul>",
      "correct_choice_id": 360476,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90528/NEET_PG_aug_2025_BIOCHEM_Question_6.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        1
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90528/NEET_PG_aug_2025_BIOCHEM_Question_6.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90489,
      "choices": [
        {
          "id": 360320,
          "text": "<p><span style=\"font-size:14.0pt;\">Aspiration</span></p>"
        },
        {
          "id": 360321,
          "text": "<p><span style=\"font-size:14.0pt;\">Enucleation</span></p>"
        },
        {
          "id": 360322,
          "text": "<p><span style=\"font-size:14.0pt;\">Resection of cyst along with adjacent bowel</span></p>"
        },
        {
          "id": 360323,
          "text": "<p><span style=\"font-size:14.0pt;\">Conservative</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">What is the most appropriate treatment for an 8 cm chylo-lymphatic mesenteric cyst?</span></p>",
      "unique_key": "Q6107708",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Enucleation</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Chylolymphatic mesenteric cysts are benign and arise from lymphatic channels in the mesentery.</span></li><li><span style=\"font-size:14.0pt;\">If they are large or symptomatic (as in this 8 cm case), <strong>enucleation</strong> (removal without bowel resection) is the treatment of choice <strong>unless</strong> the cyst shares a common wall with bowel (i.e., enterogenous).</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Aspiration:&nbsp;</strong>Incorrect<strong>.</strong> Aspiration of mesenteric cysts often results in recurrence. It is not definitive treatment and is not recommended for large or symptomatic cysts.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Resection of cyst along with adjacent bowel:&nbsp;</strong>Incorrect<strong>.</strong> This is reserved for <strong>enterogenous cysts</strong>, which are adherent to bowel and cannot be separated. Not the preferred option for chylolymphatic cysts.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Conservative:&nbsp;</strong>Incorrect<strong>.</strong> Conservative management is not appropriate for a large (8 cm) mesenteric cyst, due to risk of infection, rupture, volvulus, or obstruction.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Enucleation is the preferred treatment for large chylolymphatic mesenteric cysts unless the cyst is enterogenous and requires bowel resection.</span></p>",
      "correct_choice_id": 360321,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90489/NEET_PG_aug_2025_Surgery_Question_5.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90489/NEET_PG_aug_2025_Surgery_Question_5.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90227,
      "choices": [
        {
          "id": 359280,
          "text": "<p><span style=\"font-size:14.0pt;\">Glucose tolerance test</span></p>"
        },
        {
          "id": 359281,
          "text": "<p><span style=\"font-size:14.0pt;\">Urinalysis</span></p>"
        },
        {
          "id": 359282,
          "text": "<p><span style=\"font-size:14.0pt;\">Hepatitis B surface antigen</span></p>"
        },
        {
          "id": 359283,
          "text": "<p><span style=\"font-size:14.0pt;\">Pap smear</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following laboratory tests is typically performed at the initial prenatal visit to screen for underlying health conditions and to provide a baseline for comparison throughout pregnancy?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q9375783",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Urinalysis</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">At the <strong>initial prenatal visit</strong>, <strong>urinalysis</strong> is routinely performed to:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Detect <strong>baseline renal function</strong></span></li><li><span style=\"font-size:14.0pt;\">Identify <strong>asymptomatic bacteriuria</strong>, which, if untreated, can lead to complications like pyelonephritis</span></li><li><span style=\"font-size:14.0pt;\">Screen for <strong>proteinuria</strong> or <strong>glucosuria</strong>, which may help assess early signs of hypertensive disorders or diabetes</span></li></ul></li><li><span style=\"font-size:14.0pt;\">Urinalysis serves as an essential <strong>baseline test</strong> that can be used for comparison throughout the pregnancy to monitor maternal health.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Glucose tolerance test:</strong> The <strong>oral glucose tolerance test (OGTT)</strong> is <strong>not performed at the initial prenatal visit</strong> unless the patient is at high risk for diabetes (e.g., obesity, previous GDM, family history). Typically, it is done between <strong>24–28 weeks of gestation</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Hepatitis B surface antigen:</strong> Although <strong>Hepatitis B screening</strong> is performed at the first prenatal visit, <strong>urinalysis</strong> is more appropriate as a <strong>baseline comparison</strong> tool throughout pregnancy. Hepatitis B screening is important for infection control and neonatal prophylaxis but not for longitudinal maternal monitoring.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Pap smear:</strong> A <strong>Pap smear</strong> is done only <strong>if the woman is due for cervical cancer screening</strong> based on age and previous results. It is not specifically required or repeated at every pregnancy, nor is it a baseline for health comparisons throughout pregnancy.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Urinalysis</strong> is a routine test at the <strong>first prenatal visit</strong> used to detect <strong>asymptomatic bacteriuria</strong>, assess <strong>renal function</strong>, and establish a <strong>baseline for maternal health monitoring</strong> during pregnancy.</span></p>",
      "correct_choice_id": 359281,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90227/NEET_PG_aug_2025_OBG_Question_13.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90227/NEET_PG_aug_2025_OBG_Question_13.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89905,
      "choices": [
        {
          "id": 358012,
          "text": "<p><span style=\"font-size:14.0pt;\">Withhold rabies vaccine and observe the dog for 10 days</span></p>"
        },
        {
          "id": 358013,
          "text": "<p><span style=\"font-size:14.0pt;\">Administer a cell culture rabies vaccine series</span></p>"
        },
        {
          "id": 358014,
          "text": "<p><span style=\"font-size:14.0pt;\">No further action is necessary</span></p>"
        },
        {
          "id": 358015,
          "text": "<p><span style=\"font-size:14.0pt;\">Euthanize the dog and send its brain for biopsy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 10‑year‑old child presents with an unprovoked dog bite to the forearm. The dog is a stray and its status is unknown. What is the most appropriate immediate action?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q2257950",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;B) Administer a cell‑culture rabies vaccine series</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">An <strong>unprovoked bite</strong> from a dog of unknown health status is considered a <strong>Category III exposure</strong> (transdermal bites or scratches).&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Such exposures carry a high risk of rabies transmission, and <strong>post‑exposure prophylaxis (PEP)</strong> should be initiated <strong>immediately</strong> with a WHO‑approved <strong>cell‑culture rabies vaccine</strong> (e.g., human diploid cell vaccine) along with rabies immunoglobulin infiltrated around the wound.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Delaying vaccine or relying on animal observation risks fatal rabies infection.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Withhold rabies vaccine and observe the dog for 10 days:</strong> Only dogs known to be vaccinated and available for reliable observation may be monitored; stray dogs cannot be assessed safely, so PEP must not be delayed.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. No further action is necessary:</strong> Failing to initiate PEP after a high‑risk bite is contraindicated and uniformly fatal if rabies develops.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Euthanize the dog and send its brain for biopsy:</strong> Brain testing confirms diagnosis but does not substitute for immediate PEP, which should start before test results and cannot wait for euthanasia or laboratory confirmation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The WHO rabies exposure categories and PEP recommendations:</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_8BftIL4.png\" width=\"612\" height=\"670\"></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">If previous PEP completed within the last 3 months, only two vaccine doses (Days 0 and 3) are given.</span><br><br>&nbsp;</li></ul><p><span style=\"font-size:14.0pt;\"><strong>Key regimens (abbreviations):</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>IPC (Institut Pasteur du Cambodge):</strong> 2‑site ID on Days 0, 3, 7 (1 week total)</span></li><li><span style=\"font-size:14.0pt;\"><strong>Essen (4‑dose IM):</strong> IM on Days 0, 7, 14, 28</span></li><li><span style=\"font-size:14.0pt;\"><strong>Zagreb (2‑1‑1 IM/ID):</strong> 2 sites on Day 0 + 1 site on Days 7, 21 (3 weeks total)</span></li></ul>",
      "correct_choice_id": 358013,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89905/NEET_PG_aug_2025_PSM_Question_19.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89905/NEET_PG_aug_2025_PSM_Question_19.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90839,
      "choices": [
        {
          "id": 361696,
          "text": "<p><span style=\"font-size:14.0pt;\">Iron deficiency</span></p>"
        },
        {
          "id": 361697,
          "text": "<p><span style=\"font-size:14.0pt;\">Kidney stones</span></p>"
        },
        {
          "id": 361698,
          "text": "<p><span style=\"font-size:14.0pt;\">Gallstones</span></p>"
        },
        {
          "id": 361699,
          "text": "<p><span style=\"font-size:14.0pt;\">Osteoporosis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 21-year-old woman with stricturing Crohn’s disease involving the ileum has undergone multiple ileal resections for bowel obstruction. Which of the following complications is she not at increased risk of?</span></p>",
      "unique_key": "Q4231550",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Iron deficiency</strong></span></p><p><span style=\"font-size:14.0pt;\"><strong>&nbsp;</strong></span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Ileal disease and resection</strong> are associated with multiple nutritional and metabolic complications due to <strong>malabsorption</strong> of bile salts and fat-soluble vitamins.</span></li><li><span style=\"font-size:14.0pt;\">Common complications include:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Gallstones</strong>: Due to impaired bile salt reabsorption → increased cholesterol saturation of bile.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Kidney stones</strong>: <strong>Oxalate stones</strong> form due to increased intestinal oxalate absorption (fat binds calcium, leaving oxalate free).</span></li><li><span style=\"font-size:14.0pt;\"><strong>Osteoporosis</strong>: Due to <strong>vitamin D and calcium malabsorption</strong>, chronic inflammation, and steroid use.</span></li></ul></li><li><span style=\"font-size:14.0pt;\">However, <strong>iron is primarily absorbed in the duodenum and proximal jejunum</strong>, <strong>not the ileum</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Therefore, <strong>iron deficiency is not typically a consequence of ileal resection</strong> unless there's active bleeding or proximal small bowel involvement.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Kidney stones:</strong> Increased risk due to <strong>hyperoxaluria</strong> from fat malabsorption after ileal resection.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Gallstones:</strong> Bile salt malabsorption leads to <strong>cholesterol supersaturation</strong> → gallstone formation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Osteoporosis:</strong> Risk from <strong>malabsorption of vitamin D and calcium</strong>, chronic inflammation, and corticosteroid use.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Ileal resection in Crohn’s disease</strong> increases risk of <strong>gallstones</strong>, <strong>oxalate kidney stones</strong>, and <strong>osteoporosis</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Iron absorption occurs proximally</strong>; thus, <strong>iron deficiency is not directly related to ileal disease or resection</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Fat malabsorption</strong> underlies many of these complications due to <strong>bile salt loss</strong> in ileal disease.</span></li></ul>",
      "correct_choice_id": 361696,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90839/NEET_PG_aug_2025_MEDICINE_Question_6.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90839/NEET_PG_aug_2025_MEDICINE_Question_6.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89958,
      "choices": [
        {
          "id": 358216,
          "text": "<p><span style=\"font-size:14.0pt;\">Extensor carpi radialis longus&nbsp;</span></p>"
        },
        {
          "id": 358217,
          "text": "<p><span style=\"font-size:14.0pt;\">Extensor pollicis brevis&nbsp;</span></p>"
        },
        {
          "id": 358218,
          "text": "<p><span style=\"font-size:14.0pt;\">Extensor pollicis longus&nbsp;</span></p>"
        },
        {
          "id": 358219,
          "text": "<p><span style=\"font-size:14.0pt;\">Extensor carpi radialis brevis&nbsp;</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 34-year-old right-handed male presents with progressive wrist pain, especially during thumb extension. The discomfort worsens with certain movements such as reaching or gripping. On examination, there is tenderness and crepitus near the dorsal aspect of the distal radius. The physician suspects&nbsp;tenosynovitis. Which of the following tendons is most likely affected?&nbsp;</span></p>",
      "unique_key": "Q2594784",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Extensor pollicis longus&nbsp;</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>third extensor compartment</strong> of the wrist contains the&nbsp;<strong>extensor pollicis longus (EPL)</strong> tendon.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This tendon wraps around the <strong>Lister's tubercle</strong> of the distal radius, making it particularly vulnerable to mechanical stress and&nbsp;<strong>tenosynovitis</strong>, especially in individuals with repetitive wrist and thumb use.&nbsp;</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_1LdUbeR.png\" width=\"772\" height=\"466\"></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Pain, swelling, and crepitus at this site are hallmark features.&nbsp;</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option&nbsp;A. Extensor carpi radialis longus (ECRL):&nbsp;</strong>This tendon lies within the <strong>second extensor compartment</strong>, not the third. It functions primarily in wrist extension and abduction.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option&nbsp;B. Extensor pollicis brevis (EPB):&nbsp;</strong>EPB passes through the <strong>first extensor compartment</strong>, along with abductor pollicis longus (APL). It helps in thumb extension but is not located in the third compartment.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option&nbsp;D. Extensor carpi radialis brevis (ECRB): </strong>Like ECRL, ECRB travels through the <strong>second extensor compartment</strong> and aids wrist extension. It is not associated with the third compartment pathology.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The third extensor compartment of the wrist contains the extensor pollicis longus (EPL) tendon, which wraps around Lister’s tubercle and is a common site for tenosynovitis in repetitive strain injuries.</span></p>",
      "correct_choice_id": 358218,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89958/NEET_PG_aug_2025_ANATOMY_Question_1.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        3
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89958/NEET_PG_aug_2025_ANATOMY_Question_1.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90610,
      "choices": [
        {
          "id": 360800,
          "text": "<p><span style=\"font-size:14.0pt;\">Antrochoanal polyp</span></p>"
        },
        {
          "id": 360801,
          "text": "<p><span style=\"font-size:14.0pt;\">Nasopharyngeal angiofibroma</span></p>"
        },
        {
          "id": 360802,
          "text": "<p><span style=\"font-size:14.0pt;\">Ethmoidal polyp</span></p>"
        },
        {
          "id": 360803,
          "text": "<p><span style=\"font-size:14.0pt;\">Rhinosporidiosis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 16-year-old boy presents with progressive nasal obstruction and recurrent episodes of epistaxis over the past several months. On nasal endoscopy, a reddish, lobulated mass is seen. Which of the following is the most likely diagnosis?&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_c4tHwvT.png\" width=\"330\" height=\"291\"></span></p>",
      "unique_key": "Q9808140",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Nasopharyngeal angiofibroma</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This benign but locally aggressive vascular tumor occurs <strong>almost exclusively in adolescent males</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It arises from the posterolateral wall of the nasal cavity near the sphenopalatine foramen.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Key Clues:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Teenage male</span></li><li><span style=\"font-size:14.0pt;\">Progressive nasal obstruction + recurrent, profuse epistaxis</span></li><li><span style=\"font-size:14.0pt;\">Imaging: vascular mass in nasopharynx extending into pterygopalatine fossa with bony remodeling (Holman-Miller sign)</span></li><li><span style=\"font-size:14.0pt;\">Endoscopic appearance: reddish, lobulated mass</span></li><li><span style=\"font-size:14.0pt;\">Biopsy is contraindicated due to the risk of <strong>severe hemorrhage</strong>. Diagnosis is made on the basis of <strong>clinical features and imaging (CT/MRI)</strong>. Surgical excision is the treatment of choice, often preceded by preoperative embolization.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Antrochoanal polyp</strong>: Incorrect. Originates from the maxillary sinus, passes through the sinus ostium into the choana. Typically nonvascular and presents without recurrent severe epistaxis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Ethmoidal polyp</strong>: Incorrect. Usually bilateral, pale, edematous masses seen in allergic rhinitis; do not cause massive bleeding.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Rhinosporidiosis</strong>: Incorrect. Chronic granulomatous infection caused by Rhinosporidium seeberi, producing friable, polypoid masses studded with white dots; not specific to adolescent males and without the typical pterygopalatine fossa extension. Strawberry like tumor will be seen&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Nasopharyngeal angiofibroma</strong> is a benign, highly vascular tumor seen almost exclusively in adolescent males.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It presents with nasal obstruction and recurrent epistaxis, and is diagnosed clinically with imaging; biopsy is avoided due to bleeding risk.</span></li></ul>",
      "correct_choice_id": 360801,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90610/NEET_PG_aug_2025_ENT_Question_5.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        9
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90610/NEET_PG_aug_2025_ENT_Question_5.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90605,
      "choices": [
        {
          "id": 360780,
          "text": "<p><span style=\"font-size:14.0pt;\">Vestibular schwannoma</span></p>"
        },
        {
          "id": 360781,
          "text": "<p><span style=\"font-size:14.0pt;\">Ménière disease</span></p>"
        },
        {
          "id": 360782,
          "text": "<p><span style=\"font-size:14.0pt;\">Otosclerosis</span></p>"
        },
        {
          "id": 360783,
          "text": "<p><span style=\"font-size:14.0pt;\">Paget disease</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 50-year-old man presents with tinnitus, a sensation of fullness in his right ear, and progressive hearing loss over several years. Seven years after symptom onset, he develops vertigo, headache, and progressive imbalance. Audiometry reveals moderate sensorineural hearing loss in the right ear. Histopathologic examination of a biopsy specimen shows Antoni A and Antoni B cell patterns. Which of the following is the most likely diagnosis?</span></p>",
      "unique_key": "Q3869834",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Vestibular schwannoma</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Vestibular schwannoma (acoustic neuroma) is a benign tumor of Schwann cells, most commonly involving the vestibular portion of the CN VIII.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Patients typically present with <strong>progressive unilateral sensorineural hearing loss, tinnitus, and imbalance</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">As the tumor enlarges, it can compress nearby cranial nerves and the brainstem, causing headache and ataxia.</span></li><li><span style=\"font-size:14.0pt;\">Histology showing <strong>Antoni A (densely cellular) and Antoni B (loose) areas</strong> is pathognomonic.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-08-21%20110352.jpeg\" width=\"568\" height=\"409\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Ménière disease</strong>: Incorrect. Characterized by episodic vertigo, fluctuating hearing loss, tinnitus, and ear fullness due to endolymphatic hydrops. Hearing loss is typically <strong>fluctuating</strong> rather than progressively worsening over years, and histopathology does not show Antoni patterns.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Otosclerosis</strong>: Incorrect<strong>.&nbsp;</strong>Affects the stapes footplate, causing <strong>conductive hearing loss</strong> due to abnormal bone remodeling. It does not cause sensorineural loss or vertigo, and histology is unrelated.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Paget disease:</strong> Incorrect. Involves abnormal bone turnover, which can affect the skull base, leading to conductive or mixed hearing loss. It is not associated with Antoni cell histology or isolated vestibular nerve tumors.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Vestibular schwannoma</strong> presents with unilateral progressive sensorineural hearing loss, tinnitus, and imbalance.</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Histology shows <strong>Antoni A and B cell patterns</strong>, confirming the diagnosis.</span></li></ul>",
      "correct_choice_id": 360780,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90605/NEET_PG_aug_2025_ENT_Question_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        9
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90605/NEET_PG_aug_2025_ENT_Question_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89897,
      "choices": [
        {
          "id": 357980,
          "text": "<p><span style=\"font-size:14.0pt;\">Encouraging individuals in all regions to exercise more</span></p>"
        },
        {
          "id": 357981,
          "text": "<p><span style=\"font-size:14.0pt;\">Assuming that every person in active regions is at low risk</span></p>"
        },
        {
          "id": 357982,
          "text": "<p><span style=\"font-size:14.0pt;\">Designing a randomized trial of exercise interventions</span></p>"
        },
        {
          "id": 357983,
          "text": "<p><span style=\"font-size:14.0pt;\">Adjusting for regional dietary patterns</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">An ecological analysis finds that regions with higher average physical activity have lower heart‑disease rates. Which flawed inference exemplifies the ecological fallacy?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q6872190",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Assuming that every person in active regions is at low risk</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>ecological fallacy</strong> arises when one infers <strong>individual</strong> risk or behavior from <strong>group‑level</strong> data.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Although counties with higher average activity show lower heart‐disease rates, not every individual in those counties benefits equally—some may be sedentary or have other risk factors.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.</strong> <strong>Encouraging individuals in all regions to exercise more:</strong> True inference. Promoting exercise is reasonable based on the group association, though individual trials are needed.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C.</strong> <strong>Designing a randomized trial of exercise interventions:</strong> It is appropriate next step. A randomized trial tests whether increasing an individual’s activity reduces their heart‐disease risk.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.</strong> <strong>Adjusting for regional dietary patterns:</strong> It is Sound analytic method. Adjusting for confounders like diet at the group level strengthens causal inference without committing the ecological fallacy.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Do not assume</strong> that relationships observed <strong>between populations</strong> (e.g., counties) necessarily apply to <strong>every individual</strong> within those populations; individual‐level studies are needed to confirm causality.</span></p>",
      "correct_choice_id": 357981,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89897/NEET_PG_aug_2025_PSM_Question_11.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89897/NEET_PG_aug_2025_PSM_Question_11.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90514,
      "choices": [
        {
          "id": 360420,
          "text": "<p><span style=\"font-size:14.0pt;\">Jefferson’s Fracture</span></p>"
        },
        {
          "id": 360421,
          "text": "<p><span style=\"font-size:14.0pt;\">Chance Fracture</span></p>"
        },
        {
          "id": 360422,
          "text": "<p><span style=\"font-size:14.0pt;\">Hangman’s Fracture</span></p>"
        },
        {
          "id": 360423,
          "text": "<p><span style=\"font-size:14.0pt;\">Odontoid Fracture</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 28-year-old male presents to the emergency department following a motor vehicle accident. He complains of severe neck pain and has limited neck movement. X-ray imaging of the cervical spine is performed and reveals the following findings. Based on the provided information, what is the most probable diagnosis for this patient?</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-08-14%20141045.jpeg\" width=\"373\" height=\"459\"></span></p>",
      "unique_key": "Q9669286",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Hangman’s Fracture</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">A Hangman's fracture is a fracture of the pars interarticularis of the axis (C2 vertebra).&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It is caused by a hyperextension-distraction injury, which is a common mechanism in a motor vehicle accident, especially when the patient's head snaps forward and then backward.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The fracture is a bilateral fracture through the pedicles of C2, with a resulting traumatic spondylolisthesis (forward displacement of C2 on C3).&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The name \"Hangman's\" comes from the historical finding of this fracture in victims of judicial hanging.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Jefferson’s Fracture:</strong>&nbsp;</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This is a burst fracture of the atlas (C1 vertebra).&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It is caused by an axial load on the head, such as a diving accident.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The fracture involves the anterior and posterior arches of C1 and is characterized by a displacement of the lateral masses.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">While it is a cervical spine fracture, its mechanism and location are different from a Hangman's fracture.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Chance Fracture:</strong>&nbsp;</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This is a fracture of the spine that results from a hyperflexion injury, often seen in motor vehicle accidents where the patient is restrained by a lap belt without a shoulder belt.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It primarily affects the thoracolumbar spine (T11-L2), not the cervical spine.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Odontoid Fracture:</strong>&nbsp;</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This is a fracture of the odontoid process (the dens), which is a tooth-like projection on the C2 vertebra.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It can be caused by various types of trauma, including flexion and extension injuries.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">While it's a C2 fracture, the specific finding of a fracture through the pars interarticularis points more specifically to a Hangman's fracture.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">One should be able to recognize a Hangman's fracture as a bilateral pars interarticularis fracture of C2, typically resulting from a hyperextension-distraction injury, which is a common finding in motor vehicle accidents.</span></p>",
      "correct_choice_id": 360422,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90514/NEET_PG_aug_2025_ORTHO_Question_4.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        15
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90514/NEET_PG_aug_2025_ORTHO_Question_4.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89847,
      "choices": [
        {
          "id": 357780,
          "text": "<p><span style=\"font-size:14.0pt;\">Radium</span></p>"
        },
        {
          "id": 357781,
          "text": "<p><span style=\"font-size:14.0pt;\">Technetium</span></p>"
        },
        {
          "id": 357782,
          "text": "<p><span style=\"font-size:14.0pt;\">Plutonium</span></p>"
        },
        {
          "id": 357783,
          "text": "<p><span style=\"font-size:14.0pt;\">Barium</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 54‑year‑old woman with memory loss and suspected Alzheimer’s disease is referred for functional neuroimaging. Her physician orders a brain SPECT scan. Which radionuclide is routinely used for this scan?&nbsp;</span></p>",
      "unique_key": "Q8171309",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B)&nbsp;Technetium</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Technetium‑99m</strong> is the most widely used radionuclide in SPECT imaging.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It emits a 140 keV gamma photon ideal for gamma‑camera detection, has a short physical half‑life (~6 hours) that limits radiation exposure, and can be readily bound to a variety of perfusion and receptor ligands for functional brain studies.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Radium:</strong> Emits alpha particles and gamma rays but has a long half‑life and poor imaging characteristics; it is not used for diagnostic SPECT.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Plutonium:</strong> A heavy alpha emitter used in nuclear weapons and fallout studies—totally unsuitable for medical imaging.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Barium:</strong> A radiopaque heavy metal used for X‑ray visualization of the gastrointestinal tract; it does not emit gamma photons and cannot be used for SPECT.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>SPECT</strong> uses <strong>technetium‑99m</strong> for its ideal gamma emission (140 keV) and short half‑life.</span></li><li><span style=\"font-size:14.0pt;\">Other radionuclides (radium, plutonium) or contrast agents (barium) lack the appropriate emission profile or chemistry for functional nuclear imaging.</span></li></ul>",
      "correct_choice_id": 357781,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89847/NEET_PG_aug_2025_RADIO_Question_3.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        17
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89847/NEET_PG_aug_2025_RADIO_Question_3.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90832,
      "choices": [
        {
          "id": 361668,
          "text": "<p><span style=\"font-size:14.0pt;\">0 mmHg</span></p>"
        },
        {
          "id": 361669,
          "text": "<p><span style=\"font-size:14.0pt;\">+1 mmHg</span></p>"
        },
        {
          "id": 361670,
          "text": "<p><span style=\"font-size:14.0pt;\">+2 mmHg</span></p>"
        },
        {
          "id": 361671,
          "text": "<p><span style=\"font-size:14.0pt;\">–2 mmHg</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A patient has the following values for Starling forces at a capillary bed:</span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Capillary hydrostatic pressure &nbsp;= 18 mmHg</span></li><li><span style=\"font-size:14.0pt;\">Capillary oncotic pressure = 27 mmHg</span></li><li><span style=\"font-size:14.0pt;\">Interstitial oncotic pressure = 7 mmHg</span></li></ul><p><span style=\"font-size:14.0pt;\">If there’s no net filtration across the capillaries, what is the value of the interstitial hydrostatic pressure (Pi)?&nbsp;</span></p>",
      "unique_key": "Q1693915",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) –2 mmHg</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-08-23%20100702.jpg\" width=\"884\" height=\"776\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">When there is no net filtration, the balance between hydrostatic and oncotic pressures determines the interstitial hydrostatic pressure.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">In normal physiology, Pi is often slightly negative (~–2 mmHg), helping maintain fluid movement equilibrium between capillaries and interstitial space.</span></li></ul>",
      "correct_choice_id": 361671,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90832/NEET_PG_aug_2025_PHYSIOLOGY_Question_5.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        2
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90832/NEET_PG_aug_2025_PHYSIOLOGY_Question_5.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90530,
      "choices": [
        {
          "id": 360484,
          "text": "<p><span style=\"font-size:14.0pt;\">Vitamin B9</span></p>"
        },
        {
          "id": 360485,
          "text": "<p><span style=\"font-size:14.0pt;\">Vitamin C</span></p>"
        },
        {
          "id": 360486,
          "text": "<p><span style=\"font-size:14.0pt;\">Vitamin D</span></p>"
        },
        {
          "id": 360487,
          "text": "<p><span style=\"font-size:14.0pt;\">Vitamin B12&nbsp;</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 60-year-old male with a history of gastric cancer underwent a total gastrectomy six months ago. He now presents with fatigue, pallor, and numbness in his hands and feet. Laboratory findings reveal macrocytic anemia, homocystinuria and methyl malonyl acid urea. Which of the following vitamin deficiencies is most likely responsible for his symptoms?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q2376112",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Vitamin B12</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">This patient’s presentation points toward Vitamin B12 deficiency:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">History – Total gastrectomy → loss of intrinsic factor production from parietal cells → impaired B12 absorption in the ileum.</span></li><li><span style=\"font-size:14.0pt;\">Symptoms – Fatigue, pallor → anemia; Numbness in hands &amp; feet → peripheral neuropathy due to demyelination.</span></li><li><span style=\"font-size:14.0pt;\">Lab clues:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Macrocytic anemia → megaloblastic anemia from impaired DNA synthesis.</span></li><li><span style=\"font-size:14.0pt;\">Homocystinuria → B12 is needed to convert homocysteine → methionine.</span></li><li><span style=\"font-size:14.0pt;\">Methylmalonic aciduria → B12 is required for conversion of methylmalonyl-CoA → succinyl-CoA.</span></li><li><span style=\"font-size:14.0pt;\">Elevated methylmalonic acid is specific for B12 deficiency, not folate deficiency.</span></li></ul></li></ol><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Vitamin B9 (Folate):&nbsp;</strong>Causes macrocytic anemia but no neurologic symptoms and methylmalonic acid remains normal.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Vitamin C:&nbsp;</strong>Deficiency causes scurvy (bleeding gums, poor wound healing), not macrocytosis or neuropathy.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Vitamin D:&nbsp;</strong>Deficiency causes bone problems (osteomalacia, rickets), not anemia or neuropathy.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Vitamin B12 deficiency after gastrectomy results from loss of intrinsic factor production, leading to impaired absorption in the terminal ileum. It presents with macrocytic anemia, neurologic deficits, homocystinuria, and elevated methylmalonic acid levels.</span></li></ul>",
      "correct_choice_id": 360487,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90530/NEET_PG_aug_2025_BIOCHEM_Question_8.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        1
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90530/NEET_PG_aug_2025_BIOCHEM_Question_8.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89902,
      "choices": [
        {
          "id": 358000,
          "text": "<p><span style=\"font-size:14.0pt;\">Personal management&nbsp;</span></p>"
        },
        {
          "id": 358001,
          "text": "<p><span style=\"font-size:14.0pt;\">System analysis&nbsp;</span></p>"
        },
        {
          "id": 358002,
          "text": "<p><span style=\"font-size:14.0pt;\">Management by objectives&nbsp;</span></p>"
        },
        {
          "id": 358003,
          "text": "<p><span style=\"font-size:14.0pt;\">Communication strategies</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following methods is not rooted in behavioral‐science principles for managing human behavior?&nbsp;</span></p>",
      "unique_key": "Q1415037",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>B) System analysis</strong>&nbsp;</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>System analysis</strong> originates from systems engineering and operations research.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It focuses on mapping, modeling, and optimizing organizational processes and structures rather than on psychological or behavioral techniques to shape individual attitudes, motivations, or skills.</span></li><li><span style=\"font-size:14.0pt;\">Quantitative methods</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Cost benefit analysis</span></li><li><span style=\"font-size:14.0pt;\">Cost effective analysis</span></li><li><span style=\"font-size:14.0pt;\">Input output analysis</span></li><li><span style=\"font-size:14.0pt;\">System analysis&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Network analysis (PERT and CPM)</span></li><li><span style=\"font-size:14.0pt;\">Model</span></li><li><span style=\"font-size:14.0pt;\">PPBS</span></li><li><span style=\"font-size:14.0pt;\">Cost accounting</span></li><li><span style=\"font-size:14.0pt;\">Work sampling&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Decision making</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Personal management:</strong> Draws on counseling, motivation theory, and interpersonal skills to guide and develop individual staff performance.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Management by objectives:</strong> Based on goal‑setting theory from organizational psychology; uses clear targets, participatory goal selection, and regular feedback to drive behavior change.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Communication strategies:</strong> Employ principles of persuasion, social marketing, and health‐behavior theory to influence attitudes and promote desired behaviors.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Behavioral‑science</strong> techniques—such as personal management, goal‑setting (management by objectives), and strategic communication—focus on influencing people’s motivations and actions, whereas <strong>system analysis</strong> optimizes workflows and is not a direct behavior‑change method.</span></p>",
      "correct_choice_id": 358001,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89902/NEET_PG_aug_2025_PSM_Question_16.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89902/NEET_PG_aug_2025_PSM_Question_16.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90493,
      "choices": [
        {
          "id": 360336,
          "text": "<p><span style=\"font-size:14.0pt;\">Acute epididymo-orchitis</span></p>"
        },
        {
          "id": 360337,
          "text": "<p><span style=\"font-size:14.0pt;\">Testicular torsion</span></p>"
        },
        {
          "id": 360338,
          "text": "<p><span style=\"font-size:14.0pt;\">Strangulated inguinal hernia</span></p>"
        },
        {
          "id": 360339,
          "text": "<p><span style=\"font-size:14.0pt;\">Hydrocele</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 2-month-old male infant presents with scrotal swelling that has been present since birth. Now the swelling has become suddenly painful, red, and irreducible. What is the most likely diagnosis?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q3491938",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Strangulated inguinal hernia</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">A long-standing reducible hernia that becomes <strong>painful, red, and irreducible</strong> suggests <strong>strangulation</strong> (vascular compromise of herniated contents).&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It is a surgical emergency.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Acute epididymo-orchitis:&nbsp;</strong>Incorrect. Rare in neonates and infants; it usually presents with pain but <strong>not</strong> irreducibility or sudden swelling. Also not associated with congenital hernias.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Testicular torsion:&nbsp;</strong>Incorrect. Presents with <strong>acute onset of pain</strong>, but there’s usually <strong>no prior scrotal swelling</strong> since birth. Seen in teenage boys</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Hydrocele:&nbsp;</strong>In a child with prior scrotal swelling now presenting with pain, redness, and irreducibility, suspect strangulated inguinal hernia.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Painful, red and irreducible swelling in an infant indicates strangulated inguinal hernia</span></p>",
      "correct_choice_id": 360338,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90493/NEET_PG_aug_2025_Surgery_Question_8.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90493/NEET_PG_aug_2025_Surgery_Question_8.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89987,
      "choices": [
        {
          "id": 358328,
          "text": "<p><span style=\"font-size:14.0pt;\">Substantia nigra</span></p>"
        },
        {
          "id": 358329,
          "text": "<p><span style=\"font-size:14.0pt;\">Medial lemniscus&nbsp;</span></p>"
        },
        {
          "id": 358330,
          "text": "<p><span style=\"font-size:14.0pt;\">Red nucleus</span></p>"
        },
        {
          "id": 358331,
          "text": "<p><span style=\"font-size:14.0pt;\">Edinger–Westphal nuclear fibers</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A middle-aged male experiences sudden onset of left-sided limb weakness and diplopia. Neurological examination reveals right-sided ptosis, a&nbsp;“down and out”&nbsp;eye position, and a dilated pupil. MRI confirms a lesion involving the ventral portion of the midbrain. Which of the following structures is most likely to remain unaffected?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q5703070",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;B) Medial lemniscus</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This clinical scenario describes a classic presentation of&nbsp;<strong>Weber syndrome</strong>, a brainstem stroke syndrome caused by infarction in the <strong>ventral midbrain</strong>.</span></li><li><span style=\"font-size:14.0pt;\">The hallmark findings include:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Contralateral hemiparesis</strong>: due to involvement of the&nbsp;<strong>corticospinal tract</strong> in the cerebral peduncle.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Ipsilateral third nerve palsy</strong>: due to damage to&nbsp;<strong>oculomotor nerve fascicles</strong>, resulting in ptosis, a&nbsp;“down and out”&nbsp;eye, and a dilated pupil from parasympathetic fiber involvement.</span></li></ul></li><li><span style=\"font-size:14.0pt;\">Among the structures listed, the <strong>medial lemniscus</strong> lies&nbsp;<strong>dorsal</strong> to the cerebral peduncles and is usually spared in such&nbsp;<strong>ventral</strong> midbrain lesions.</span></li><li><span style=\"font-size:14.0pt;\">Therefore, <strong>medial lemniscus</strong> is the correct answer.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Substantia nigra</strong>: Found in the ventral midbrain and located near the cerebral peduncles, making it susceptible in ventral midbrain infarcts. Thus, it is not typically spared.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Red nucleus</strong>: Positioned within the tegmentum of the midbrain, it may be affected depending on the size and extension of the lesion.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Edinger–Westphal nuclear fibers</strong>: These parasympathetic fibers contribute to pupillary constriction and travel with the oculomotor nerve. Because the fascicular part of the oculomotor nerve is involved in ventral lesions, these fibers are also likely to be compromised.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">In <strong>ventral midbrain infarction (Weber syndrome)</strong>,&nbsp;<strong>medial lemniscus is usually spared</strong> while corticospinal tracts and oculomotor fascicles are affected, leading to contralateral hemiparesis and ipsilateral cranial nerve III palsy.</span></p>",
      "correct_choice_id": 358329,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89987/NEET_PG_aug_2025_ANATOMY_Question_8.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        3
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89987/NEET_PG_aug_2025_ANATOMY_Question_8.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90535,
      "choices": [
        {
          "id": 360504,
          "text": "<p><span style=\"font-size:14.0pt;\">Central 10° of vision</span></p>"
        },
        {
          "id": 360505,
          "text": "<p><span style=\"font-size:14.0pt;\">Central 20° of vision</span></p>"
        },
        {
          "id": 360506,
          "text": "<p><span style=\"font-size:14.0pt;\">Peripheral vision</span></p>"
        },
        {
          "id": 360507,
          "text": "<p><span style=\"font-size:14.0pt;\">Lens opacity</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">The grid shown below is primarily used to evaluate which region of vision?&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_LnoMPOu.png\" width=\"514\" height=\"513\"></span></p>",
      "unique_key": "Q4397172",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Central 20° of vision</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The Amsler grid subtends approximately 20 degrees of visual angle around fixation, allowing assessment of the macula and parafoveal retina.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The test is called as Amsler’s test&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It is a home monitoring test&nbsp;</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">The patient must wear spectacles&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It is done with one eye at a time&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Patient has to look at the central dot&nbsp;</span></li></ul></li><li><span style=\"font-size:14.0pt;\">When a patient fixates the central dot, any distortion, waviness, or scotoma of the grid lines—known as metamorphopsia or central scotoma—will be confined to this central 20° field.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-08-20%20133236.jpeg\" width=\"1163\" height=\"461\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Seen in:</strong></span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">ARMD&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Posterior uveitis</span></li><li><span style=\"font-size:14.0pt;\">CSR</span></li><li><span style=\"font-size:14.0pt;\">Macular hole&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">CME&nbsp;</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Central 10° of vision:&nbsp;</strong>The 10° field is too small for an Amsler grid; that region is better tested by a 10-2 Humphrey visual field program.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Peripheral vision:&nbsp;</strong>Peripheral field defects (&gt;20°) require kinetic or automated perimetry with a larger field of view (e.g., Goldmann or Humphrey 30-2/60-4).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Lens opacity:&nbsp;</strong>Lens changes are detected by slit-lamp examination and glare testing, not by grid distortion.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Use the <strong>Amsler grid</strong> to monitor the <strong>central 20°</strong> of the visual field for macular diseases—patients report line waviness or missing areas indicating metamorphopsia or scotoma.</span></p>",
      "correct_choice_id": 360505,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90535/NEET_PG_aug_2025_OPTHALMOLOGY_Question_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        8
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90535/NEET_PG_aug_2025_OPTHALMOLOGY_Question_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90220,
      "choices": [
        {
          "id": 359252,
          "text": "<p><span style=\"font-size:14.0pt;\">EMACO regimen</span></p>"
        },
        {
          "id": 359253,
          "text": "<p><span style=\"font-size:14.0pt;\">Methotrexate with folinic acid</span></p>"
        },
        {
          "id": 359254,
          "text": "<p><span style=\"font-size:14.0pt;\">Methotrexate monotherapy</span></p>"
        },
        {
          "id": 359255,
          "text": "<p><span style=\"font-size:14.0pt;\">Hysterectomy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 28-year-old woman presents with lower abdominal distention and dull pain for the past month. She underwent a dilatation and curettage procedure for a molar pregnancy six months ago but has not followed up since. Her urine pregnancy test is strongly positive. Quantitative beta-hCG levels are elevated and remain persistently high on serial testing. A chest X-ray is ordered for further evaluation and is shown below. What is the most appropriate next step in management?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_YWIY19E.png\" width=\"400\" height=\"308\"></strong></span></p>",
      "unique_key": "Q9921281",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Methotrexate with folinic acid</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This is case of choriocarcinoma&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The patient’s history of molar pregnancy followed by persistently elevated beta-hCG levels and the presence of “cannonball” pulmonary metastases on chest X-ray is consistent with <strong>gestational trophoblastic neoplasia (GTN)</strong>.</span></li><li><span style=\"font-size:14.0pt;\">The choice between single-agent and multi-agent chemotherapy depends on the <strong>WHO risk score</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Patients with a <strong>low-risk metastatic GTN</strong> (score ≤ 6) — even if lung metastases are present — can be effectively treated with <strong>methotrexate plus folinic acid</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This regimen is preferred due to its high cure rates, fewer side effects compared to multi-drug regimens, and ability to preserve fertility.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">In this patient, the history and findings suggest low-risk metastatic disease, making methotrexate with folinic acid the appropriate first-line choice.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. EMACO regimen</strong>: Incorrect. This multi-agent chemotherapy (etoposide, methotrexate, actinomycin D, cyclophosphamide, vincristine) is reserved for <strong>high-risk metastatic GTN</strong> (WHO score ≥ 7). It is not necessary in low-risk metastatic disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Methotrexate monotherapy</strong>: Incorrect. Methotrexate alone can be used for low-risk disease, but when pulmonary metastases are present, folinic acid rescue is generally added to reduce toxicity and optimize efficacy.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Hysterectomy</strong>: Incorrect. Surgery may be used in selected cases (e.g., localized uterine disease in women who do not desire fertility), but it is not first-line for metastatic GTN and would not treat distant metastases.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">In gestational trophoblastic neoplasia with <strong>low-risk metastatic disease</strong> — including pulmonary metastases but with a WHO score ≤ 6 — the treatment of choice is <strong>methotrexate with folinic acid</strong>.</span></p>",
      "correct_choice_id": 359253,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90220/NEET_PG_aug_2025_OBG_Question_8.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90220/NEET_PG_aug_2025_OBG_Question_8.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90504,
      "choices": [
        {
          "id": 360380,
          "text": "<p><span style=\"font-size:14.0pt;\">Cricothyrotomy</span></p>"
        },
        {
          "id": 360381,
          "text": "<p><span style=\"font-size:14.0pt;\">Nasopharyngeal airway</span></p>"
        },
        {
          "id": 360382,
          "text": "<p><span style=\"font-size:14.0pt;\">ICD insertion</span></p>"
        },
        {
          "id": 360383,
          "text": "<p><span style=\"font-size:14.0pt;\">Do suction and again try intubation</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">After an RTA patient has severe maxillofacial trauma with SpO₂ 80% at room air and the patient cannot be intubated or ventilated, what should be your immediate step?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q2609160",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Cricothyrotomy</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In severe maxillofacial trauma, if both intubation and ventilation fail, securing the airway becomes the priority.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Cricothyrotomy is the preferred emergency airway procedure as it can be performed rapidly and does not require neck extension or extensive surgical exposure.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Tracheostomy is a more definitive airway but not the immediate step in acute emergencies.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Nasopharyngeal airway:&nbsp;</strong>Will not be possible in maxillofacial trauma</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. ICD insertion:</strong> Irrelevant here; used for pneumothorax or hemothorax.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.&nbsp;Do suction and again try intubation:</strong> Already tried and failed, hence not useful now.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">In trauma with failed intubation and ventilation, emergency cricothyrotomy is the immediate lifesaving airway intervention.</span></p>",
      "correct_choice_id": 360380,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90504/NEET_PG_aug_2025_Surgery_Question_10.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90504/NEET_PG_aug_2025_Surgery_Question_10.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89929,
      "choices": [
        {
          "id": 358108,
          "text": "<p><span style=\"font-size:14.0pt;\">a–2, b–3, c–4, d–1&nbsp;</span></p>"
        },
        {
          "id": 358109,
          "text": "<p><span style=\"font-size:14.0pt;\">a–3, b–4, c–1, d–2</span></p>"
        },
        {
          "id": 358110,
          "text": "<p><span style=\"font-size:14.0pt;\">a–1, b–2, c–3, d–4</span></p>"
        },
        {
          "id": 358111,
          "text": "<p><span style=\"font-size:14.0pt;\">a–4, b–1, c–2, d–3</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Match each renal condition with its characteristic histopathologic finding:<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-08-19%20171712.jpeg\" width=\"1159\" height=\"444\"></p>",
      "unique_key": "Q1299637",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) a–2, b–3, c–4, d–1</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>a. Chronic reflux nephropathy → 2 (Segmental sclerosis involving some glomeruli, often with hyaline deposition): </strong>Chronic reflux nephropathy results from repeated episodes of vesicoureteral reflux causing cortical scarring and loss of functional nephrons. The surviving nephrons undergo <strong>hyperfiltration injury</strong>, producing the <strong>focal segmental glomerulosclerosis (FSGS)</strong> pattern. Histologically, this is seen as <strong>segmental sclerosis</strong> in some glomeruli with frequent hyaline deposition.</span></li><li><span style=\"font-size:14.0pt;\"><strong>b. Diabetic nephropathy → 3 (Nodular glomerulosclerosis):</strong> Long-standing diabetes causes non-enzymatic glycosylation of the GBM and mesangial proteins, leading to increased permeability and mesangial matrix expansion. The hallmark lesion is <strong>Kimmelstiel–Wilson nodules</strong> (nodular glomerulosclerosis).</span></li><li><span style=\"font-size:14.0pt;\"><strong>c. Membranous nephropathy → 4 (Diffuse thickening of the glomerular basement membrane with subepithelial immune deposits):</strong> Membranous nephropathy is characterized by immune complex deposition on the <strong>subepithelial</strong> side of the GBM. This produces diffuse GBM thickening seen on light microscopy and <strong>spike and dome appearance</strong> on electron microscopy.</span></li><li><span style=\"font-size:14.0pt;\"><strong>d. Rapidly progressive glomerulonephritis (RPGN) → 1 (Crescents in Bowman’s space) :</strong> RPGN is a severe form of glomerulonephritis that progresses rapidly to renal failure. Histologically, <strong>crescents</strong> composed of proliferating parietal epithelial cells and infiltrating monocytes/macrophages fill Bowman’s space, compressing the glomerular tuft.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Chronic reflux nephropathy most often leads to secondary FSGS; diabetic nephropathy is characterized by Kimmelstiel–Wilson nodules; membranous nephropathy shows subepithelial immune deposits with diffuse GBM thickening; RPGN demonstrates crescents in Bowman’s space.</span></p>",
      "correct_choice_id": 358108,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89929/NEET_PG_aug_2025_PATHOLOGY_Question_9.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89929/NEET_PG_aug_2025_PATHOLOGY_Question_9.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90484,
      "choices": [
        {
          "id": 360300,
          "text": "<p><span style=\"font-size:14.0pt;\">Cooper’s ligament</span></p>"
        },
        {
          "id": 360301,
          "text": "<p><span style=\"font-size:14.0pt;\">Lactiferous duct</span></p>"
        },
        {
          "id": 360302,
          "text": "<p><span style=\"font-size:14.0pt;\">Dermal lymphatics</span></p>"
        },
        {
          "id": 360303,
          "text": "<p><span style=\"font-size:14.0pt;\">Suspensory fascia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Infiltration of which of the following structures causes this defect in the breast?</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-08-21%20110630.jpeg\" width=\"395\" height=\"501\"></p>",
      "unique_key": "Q3980903",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Cooper’s ligament</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The image shows <strong>dimpling of the skin over the breast</strong>, which is a classical sign seen in <strong>invasive breast carcinoma</strong>. This happens due to <strong>involvement of Cooper's ligaments</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Cooper’s ligaments</strong> (also known as <strong>suspensory ligaments of the breast</strong>) are fibrous connective tissue strands that anchor the breast tissue to the <strong>overlying skin</strong>.</span></li><li><span style=\"font-size:14.0pt;\">In <strong>invasive breast cancer</strong>, cancer cells <strong>infiltrate and shorten</strong> these ligaments.</span></li><li><span style=\"font-size:14.0pt;\">This leads to <strong>tethering</strong> of the skin over the involved area, causing visible <strong>dimpling</strong> or puckering of the skin, and sometimes <strong>fixation</strong>.</span></li><li><span style=\"font-size:14.0pt;\">This clinical sign is important for early suspicion of underlying <strong>malignancy</strong> even before a palpable lump becomes evident.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Lactiferous duct</strong>: Involved in milk secretion, and its blockage may cause nipple discharge or retraction, but not dimpling of the skin.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Dermal lymphatics</strong>: Obstruction here leads to <strong>peaud’orange appearance</strong> due to lymphatic edema, not dimpling due to tethering.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Suspensory fascia</strong>: A vague term and not anatomically distinct; Cooper's ligaments are the specific suspensory structures involved in this pathology.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Dimpling of breast skin in carcinoma is caused by cancer infiltration and shortening of Cooper’s ligaments, which tether the skin, leading to puckering or fixation.</span></p>",
      "correct_choice_id": 360300,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90484/NEET_PG_aug_2025_Surgery_Question_1.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90484/NEET_PG_aug_2025_Surgery_Question_1.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90827,
      "choices": [
        {
          "id": 361648,
          "text": "<p><span style=\"font-size:14.0pt;\">Point A</span></p>"
        },
        {
          "id": 361649,
          "text": "<p><span style=\"font-size:14.0pt;\">Point B</span></p>"
        },
        {
          "id": 361650,
          "text": "<p><span style=\"font-size:14.0pt;\">Point C</span></p>"
        },
        {
          "id": 361651,
          "text": "<p><span style=\"font-size:14.0pt;\">Point D</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">In a patient with pulmonary embolism causing complete obstruction of blood flow. Which of the following points on the V/Q curve corresponds with given condition?</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-08-19%20100324.jpeg\" width=\"725\" height=\"433\"></span></p>",
      "unique_key": "Q7315437",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Point D</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">A <strong>complete obstruction of pulmonary arterial blood flow</strong> means there is <strong>no perfusion to the affected alveolus</strong>.</span></li><li><span style=\"font-size:14.0pt;\">This results in a <strong>ventilation/perfusion (V/Q) ratio approaching infinity (∞)</strong>: ventilation is present, but perfusion is absent.</span></li><li><span style=\"font-size:14.0pt;\">On a V/Q diagram plotting <strong>alveolar PO₂ vs PCO₂</strong>, this situation corresponds to the <strong>dead space point</strong> — where alveolar gas composition approaches <strong>inspired air</strong>:</span></li><li><span style=\"font-size:14.0pt;\"><strong>PO₂ ≈ 150 mm Hg</strong> (humidified inspired air value at sea level)</span></li><li><span style=\"font-size:14.0pt;\"><strong>PCO₂ ≈ 0 mm Hg</strong></span></li><li><span style=\"font-size:14.0pt;\">Point <strong>D</strong> on the curve represents this extreme, and is therefore correct.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Point A:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Represents <strong>low V/Q</strong> close to <strong>zero</strong>, as in a <strong>shunt</strong> situation (e.g., complete airway obstruction).</span></li><li><span style=\"font-size:14.0pt;\">Perfusion is present, but ventilation is absent, causing alveolar gas to resemble <strong>mixed venous blood</strong> (low PO₂, high PCO₂).</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Point B:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Reflects <strong>normal V/Q ratio (~0.8)</strong> with normal alveolar gas values (PO₂ ~100 mm Hg, PCO₂ ~40 mm Hg).</span></li><li><span style=\"font-size:14.0pt;\">Seen in healthy, well-matched lung regions.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Point C:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Indicates <strong>moderately elevated V/Q ratio</strong> (e.g., apex of the lung in an upright person), where ventilation exceeds perfusion.</span></li><li><span style=\"font-size:14.0pt;\">Leads to alveolar gas PO₂ higher than normal, and PCO₂ lower than normal, but not to the extremes of dead space.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">On the alveolar V/Q curve, <strong>pulmonary embolism</strong> causing complete cessation of blood flow creates a <strong>dead space unit</strong> (V/Q → ∞). &nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Here, alveolar gas composition approaches that of inspired air (PO₂ ~150 mm Hg, PCO₂ ~0 mm Hg), corresponding to the <strong>dead space point</strong> on the diagram (Point D).</span></li></ul>",
      "correct_choice_id": 361651,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90827/NEET_PG_aug_2025_PHYSIOLOGY_Question_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        2
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90827/NEET_PG_aug_2025_PHYSIOLOGY_Question_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89926,
      "choices": [
        {
          "id": 358096,
          "text": "<p><span style=\"font-size:14.0pt;\">High frequency of EGFR mutations</span></p>"
        },
        {
          "id": 358097,
          "text": "<p><span style=\"font-size:14.0pt;\">Association with cavitary lesions due to central necrosis&nbsp;</span></p>"
        },
        {
          "id": 358098,
          "text": "<p><span style=\"font-size:14.0pt;\">Predilection for peripheral location in the lung</span></p>"
        },
        {
          "id": 358099,
          "text": "<p><span style=\"font-size:14.0pt;\">Increased incidence in non-smokers, especially women</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 65-year-old man with a 50-pack-year smoking history presents with persistent cough and weight loss. Chest X-ray reveals a hilar mass. Biopsy of the lesion is shown below. Which of the following features is most strongly associated with this condition?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_DmzqhMC.png\" width=\"306\" height=\"233\"></strong></span></p>",
      "unique_key": "Q5293405",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Association with cavitary lesions due to central necrosis</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The biopsy demonstrates <strong>keratin pearls</strong>, a hallmark of <strong>squamous cell carcinoma (SCC) of the lung</strong>.</span></li><li><span style=\"font-size:14.0pt;\">SCC is <strong>strongly associated with smoking</strong> and typically arises as a <strong>central hilar mass</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Due to its central necrosis and obstructive growth pattern, <strong>cavitation</strong> within the lesion is common.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. High frequency of EGFR mutations</strong>: Seen more in <strong>adenocarcinoma of the lung</strong>, particularly in nonsmokers.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Predilection for peripheral location in the lung</strong>: This describes <strong>adenocarcinoma</strong>, not squamous cell carcinoma.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Increased incidence in non-smokers, especially women</strong>: Again, this describes <strong>adenocarcinoma</strong>, not squamous cell carcinoma.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Squamous cell carcinoma of the lung is a smoking-related central tumor characterized by keratin pearls and cavitation due to central necrosis.</span></p>",
      "correct_choice_id": 358097,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89926/NEET_PG_aug_2025_PATHOLOGY_Question_7.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89926/NEET_PG_aug_2025_PATHOLOGY_Question_7.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90526,
      "choices": [
        {
          "id": 360468,
          "text": "<p><span style=\"font-size:14.0pt;\">1 and 2</span></p>"
        },
        {
          "id": 360469,
          "text": "<p><span style=\"font-size:14.0pt;\">2 and 5</span></p>"
        },
        {
          "id": 360470,
          "text": "<p><span style=\"font-size:14.0pt;\">3 and 4</span></p>"
        },
        {
          "id": 360471,
          "text": "<p><span style=\"font-size:14.0pt;\">4 and 5</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">During β-oxidation of palmitic acid (C₁₆), which of the following are produced?</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">Three molecules of acetyl-CoA</span></li><li><span style=\"font-size:14.0pt;\">A net yield of 106ATP</span></li><li><span style=\"font-size:14.0pt;\">A net yield of 108 ATP</span></li><li><span style=\"font-size:14.0pt;\">Sixteen molecules of acetyl-CoA</span></li><li><span style=\"font-size:14.0pt;\">Eighty ATP produced from the citric acid cycle per molecule of palmitoyl-CoA</span></li></ol>",
      "unique_key": "Q7744372",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) 2 and 5</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Step 1 – Understanding β-oxidation of palmitic acid (C₁₆)</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Palmitic acid has <strong>16 carbons</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>β-oxidation</strong> cleaves 2 carbons at a time → produces <strong>acetyl-CoA</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Number of acetyl-CoA formed:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Number&nbsp;of&nbsp;carbons = 16 /2 = 8&nbsp;acetyl-CoA</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">So <strong>16 acetyl-CoA</strong> in option 4 is <strong>wrong</strong> — it should be 8.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Step 2 – ATP yield from palmitic acid oxidation</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>1. β-oxidation cycles</strong>:</span></p><p><br><span style=\"font-size:14.0pt;\">Number of cycles = <strong>n/2 – 1 = 8 – 1 = 7 cycles</strong></span></p><p><br><span style=\"font-size:14.0pt;\">Each cycle gives:</span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">1 NADH → 2.5 ATP</span></li><li><span style=\"font-size:14.0pt;\">1 FADH₂ → 1.5 ATP</span></li></ul><p><span style=\"font-size:14.0pt;\">ATP from 7 cycles = 7 × (2.5+1.5) = 7×4 =28 ATP</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>2. TCA cycle from acetyl-CoA:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Each acetyl-CoA gives:</span></p><ul style=\"list-style-type:square;\"><li><span style=\"font-size:14.0pt;\">3 NADH → 7.5 ATP</span></li><li><span style=\"font-size:14.0pt;\">1 FADH₂ → 1.5 ATP</span></li><li><span style=\"font-size:14.0pt;\">1 GTP → 1 ATP</span><br><span style=\"font-size:14.0pt;\">Total = 10 ATP per acetyl-CoA</span></li></ul><p><span style=\"font-size:14.0pt;\">8 acetyl-CoA → 8×10=80 ATP (<strong>matches option 5</strong>)</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>3. Total ATP before activation cost:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">28 (from&nbsp;β-oxidation) + 80 (from&nbsp;TCA) = 108&nbsp;ATP</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>4. Subtract 2 ATP for fatty acid activation</strong>:</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">108 – 2 = 106&nbsp;ATP&nbsp;net&nbsp;yield&nbsp;<strong>(matches&nbsp;option&nbsp;2)</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Complete β-oxidation of palmitic acid yields 8 acetyl-CoA, which produce 80 ATP via the TCA cycle, plus additional ATP from NADH and FADH₂ generated during β-oxidation, for a net total of 106 ATP after subtracting the activation cost.</span></p>",
      "correct_choice_id": 360469,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90526/NEET_PG_aug_2025_BIOCHEM_Question_4.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        1
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90526/NEET_PG_aug_2025_BIOCHEM_Question_4.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89822,
      "choices": [
        {
          "id": 357680,
          "text": "<p><span style=\"font-size:14.0pt;\">Psychoanalysis</span></p>"
        },
        {
          "id": 357681,
          "text": "<p><span style=\"font-size:14.0pt;\">Systematic desensitization</span></p>"
        },
        {
          "id": 357682,
          "text": "<p><span style=\"font-size:14.0pt;\">Cognitive restructuring</span></p>"
        },
        {
          "id": 357683,
          "text": "<p><span style=\"font-size:14.0pt;\">Exposure and response prevention</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 22-year-old woman complains of persistent thoughts of contamination and compulsive handwashing. She recognizes the thoughts as irrational but cannot stop herself. What is the first-line psychotherapy for her condition?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q9342279",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Exposure and response prevention</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Exposure and Response Prevention (ERP)</strong> is the <strong>first-line psychotherapy for Obsessive-Compulsive Disorder (OCD)</strong>.</span></li><li><span style=\"font-size:14.0pt;\">ERP involves gradually <strong>exposing the patient to feared stimuli</strong> (e.g., dirt, germs) and <strong>preventing the usual compulsive response</strong> (e.g., handwashing).</span></li><li><span style=\"font-size:14.0pt;\">Over time, this reduces anxiety and the urge to perform compulsions through <strong>habituation</strong>.</span></li><li><span style=\"font-size:14.0pt;\">The key aspect in this case is that the patient is <strong>aware that her thoughts are irrational</strong> (ego-dystonic), yet is unable to stop the compulsions — a classic presentation of OCD, and ERP is specifically designed to address this pattern.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Psychoanalysis:&nbsp;</strong>An insight-oriented therapy focusing on unconscious conflicts; <strong>not effective for OCD</strong>, especially not as first-line treatment.</span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Systematic desensitization:&nbsp;</strong>A technique used for <strong>phobias</strong>, involving relaxation training and gradual exposure to a feared stimulus. It is <strong>less effective for OCD</strong>, which involves <strong>obsessions and compulsions</strong> rather than simple avoidance behaviors.</span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Cognitive restructuring:&nbsp;</strong>Part of <strong>CBT</strong>, useful for addressing maladaptive beliefs, but <strong>on its own</strong>, it is <strong>less effective</strong> than ERP in managing compulsions. ERP specifically targets the <strong>behavioral aspect</strong> of OCD.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">For OCD, Exposure and Response Prevention (ERP), a specialized form of CBT, is the evidence-based first-line treatment.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It involves exposing patients to their obsessional triggers while refraining from performing their compulsive rituals, gradually reducing the distress elicited by obsessions.</span></li></ul>",
      "correct_choice_id": 357683,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89822/NEET_PG_aug_2025_PSYCHIATRY_Question_3.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        16
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89822/NEET_PG_aug_2025_PSYCHIATRY_Question_3.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90238,
      "choices": [
        {
          "id": 359324,
          "text": "<p><span style=\"font-size:14.0pt;\">Yeast</span></p>"
        },
        {
          "id": 359325,
          "text": "<p><span style=\"font-size:14.0pt;\">Septate hyphae 4–5 μm</span></p>"
        },
        {
          "id": 359326,
          "text": "<p><span style=\"font-size:14.0pt;\">Dematiaceous fungi</span></p>"
        },
        {
          "id": 359327,
          "text": "<p><span style=\"font-size:14.0pt;\">Arthrospore</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A patient presents with irregular swelling over the foot, with multiple discharging sinuses and black granules in the discharge. A KOH mount is performed on the discharge. What is the most likely observation?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_YpmZ1Bt.png\" width=\"474\" height=\"355\"></strong></span></p>",
      "unique_key": "Q5412834",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Septate hyphae 4–5 μm</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The presentation is classical of <strong>mycetoma</strong>, specifically <strong>eumycetoma</strong> caused by fungi (vs. actinomycetoma caused by bacteria).&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The presence of <strong>black granules</strong> strongly suggests a <strong>fungal mycetoma</strong> (black-grain eumycetoma).</span></li></ul><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Key Diagnostic Clues:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Discharging sinuses + granules</strong>: Seen in mycetoma.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Black granules</strong>: Associated with <strong>eumycetoma</strong> (fungal origin), especially <strong>dematiaceous fungi</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>KOH mount</strong>: Helps visualize fungal elements.</span></li></ul></li><li><span style=\"font-size:14.0pt;\">Characteristic of <strong>fungal eumycetoma</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Especially <strong>Madurella mycetomatis</strong> and other dematiaceous fungi show <strong>septate branching hyphae</strong> in KOH.</span></li><li><span style=\"font-size:14.0pt;\">Right thickness (4–5 μm) and septation.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Yeast:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Seen in infections like candidiasis or cryptococcosis.</span></li><li><span style=\"font-size:14.0pt;\">Do <strong>not</strong> form granules or sinuses like in this case.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Incorrect</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Dematiaceous fungi:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This refers to the fungal group (pigmented fungi), not an <strong>observation</strong> on KOH mount.</span></li><li><span style=\"font-size:14.0pt;\">The <strong>KOH finding</strong> is the hyphal structure, not the fungal classification.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Incorrect as an observation</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Arthrospore:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Seen in infections like <strong>tinea</strong> (dermatophytes), <strong>Coccidioides</strong>, etc.</span></li><li><span style=\"font-size:14.0pt;\">Not typical in mycetoma presentation.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Incorrect</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In a patient with chronic discharging sinuses and <strong>black granules</strong>, <strong>eumycetoma</strong> should be suspected.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\"><strong>KOH mount</strong> reveals <strong>septate hyphae (4–5 μm)</strong>, distinguishing fungal mycetoma from actinomycetoma, which shows thin filamentous bacteria.</span></li></ul>",
      "correct_choice_id": 359325,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90238/NEET_PG_aug_2025_DERMA_Question_3.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        18
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90238/NEET_PG_aug_2025_DERMA_Question_3.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89903,
      "choices": [
        {
          "id": 358004,
          "text": "<p><span style=\"font-size:14.0pt;\">50%</span></p>"
        },
        {
          "id": 358005,
          "text": "<p><span style=\"font-size:14.0pt;\">66.7%</span></p>"
        },
        {
          "id": 358006,
          "text": "<p><span style=\"font-size:14.0pt;\">75%</span></p>"
        },
        {
          "id": 358007,
          "text": "<p><span style=\"font-size:14.0pt;\">100%</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A small clinic measures mean waiting time for its first five patients as 12 minutes. When a sixth patient experiences a 60-minute wait, the clinic director wants to quantify how dramatically the average increased. By approximately what percent did the mean waiting time increase after including the sixth patient’s 60-minute delay?</span></p>",
      "unique_key": "Q6023794",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;B) 66.7%</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The original total waiting time for five patients is&nbsp;</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">5 × 12 = 60&nbsp;minutes</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Adding the sixth patient’s 60 minutes gives a new total of&nbsp;</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">60 + 60 = 120&nbsp;minutes&nbsp;</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Dividing by six patients yields&nbsp;</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">120 ÷ 6 = 20&nbsp;minutes&nbsp;</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Absolute increase</strong> in mean: 20 − 12 = 8 min</span></li><li><span style=\"font-size:14.0pt;\"><strong>Percent increase</strong>:&nbsp;</span></li></ul><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-08-23%20123508.jpg\" width=\"672\" height=\"211\"></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">When a new data point alters the average, quantify its impact using:&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">(New Mean - Original Mean) &nbsp;÷ Original Mean × 100%</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">to express the relative change—recognizing that extreme values can dramatically skew the mean.</span></p>",
      "correct_choice_id": 358005,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89903/NEET_PG_aug_2025_PSM_Question_17.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89903/NEET_PG_aug_2025_PSM_Question_17.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89951,
      "choices": [
        {
          "id": 358188,
          "text": "<p><span style=\"font-size:14.0pt;\">Animal bite</span></p>"
        },
        {
          "id": 358189,
          "text": "<p><span style=\"font-size:14.0pt;\">Insect bite</span></p>"
        },
        {
          "id": 358190,
          "text": "<p><span style=\"font-size:14.0pt;\">Respiratory droplets</span></p>"
        },
        {
          "id": 358191,
          "text": "<p><span style=\"font-size:14.0pt;\">Sexual contact</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Pasteurella multocida infection in humans is most commonly acquired through which route?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q7311567",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Animal bite</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Pasteurella multocida</strong> is a gram-negative coccobacillus that is part of the normal oral and respiratory flora of many animals, especially <strong>cats and dogs</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Human infection typically follows <strong>bites or scratches</strong>, whereby the organism is inoculated directly into subcutaneous tissues.</span></li><li><span style=\"font-size:14.0pt;\">Clinical manifestations include <strong>cellulitis</strong>, abscess formation, and potential systemic spread (septic arthritis, osteomyelitis) if not treated promptly.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Insect bite:</strong> While various pathogens (e.g., Bartonella henselae) can be transmitted by arthropod vectors, <strong>Pasteurella</strong> is not insect-borne.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Respiratory droplets:</strong> P. multocida does not spread via the respiratory route; respiratory transmission is associated with organisms like Bordetella pertussis or Mycobacterium tuberculosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Sexual contact:</strong> This mode of transmission is not implicated in Pasteurella infections, which are zoonotic and linked to direct animal exposure.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">For any <strong>cat or dog bite</strong>, promptly irrigate the wound and consider antibiotic coverage (e.g., amoxicillin–clavulanate) to prevent <strong>Pasteurella multocida</strong>–associated cellulitis and deeper tissue infection.</span></p>",
      "correct_choice_id": 358188,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89951/NEET_PG_aug_2025_MICROBIOLOGY_Question_15.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        6
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89951/NEET_PG_aug_2025_MICROBIOLOGY_Question_15.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89850,
      "choices": [
        {
          "id": 357792,
          "text": "<p><span style=\"font-size:14.0pt;\">Breast abscess</span></p>"
        },
        {
          "id": 357793,
          "text": "<p><span style=\"font-size:14.0pt;\">Invasive ductal carcinoma</span></p>"
        },
        {
          "id": 357794,
          "text": "<p><span style=\"font-size:14.0pt;\">Fibroadenoma</span></p>"
        },
        {
          "id": 357795,
          "text": "<p><span style=\"font-size:14.0pt;\">Simple cyst</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 32‑year‑old woman discovers a firm, mobile lump in her right breast during self‑examination. She has no nipple changes, discharge, or systemic symptoms. A targeted ultrasound image is shown below. Which diagnosis is most consistent with these sonographic findings?&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_Uu5f6pY.png\" width=\"350\" height=\"276\"></span></p>",
      "unique_key": "Q6757899",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C)&nbsp;Fibroadenoma</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">A <strong>fibroadenoma</strong> typically appears on ultrasound as a <strong>solid</strong>, oval mass with uniform echotexture, smooth margins, and sometimes lateral (edge) shadowing caused by the benign lesion’s compressible, fibrous nature.</span></li><li><span style=\"font-size:14.0pt;\">These features contrast with the fluid‑filled, anechoic appearance of a cyst and the irregular, spiculated, vascular patterns seen in malignancy.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Breast abscess:</strong> Presents as a complex, often painful fluid collection with posterior enhancement and irregular walls—not a uniform, solid mass with edge shadowing.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Invasive ductal carcinoma:</strong> Usually appears <strong>taller‑than‑wide</strong>, spiculated or angular, and hypoechoic with internal vascular flow, lacking the smooth, benign profile of this lesion.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Simple cyst:</strong> Is entirely <strong>anechoic</strong> (black) with marked posterior acoustic enhancement rather than iso‑ to hypoechoic texture and edge shadow.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">An <strong>oval</strong>, well‑defined, iso‑ to hypoechoic breast lesion with <strong>edge shadowing</strong> in a young woman is highly suggestive of a <strong>fibroadenoma</strong> and typically managed with routine imaging follow‑up rather than immediate biopsy.</span></p>",
      "correct_choice_id": 357794,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89850/NEET_PG_aug_2025_RADIO_Question_5.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        17
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89850/NEET_PG_aug_2025_RADIO_Question_5.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89904,
      "choices": [
        {
          "id": 358008,
          "text": "<p><span style=\"font-size:14.0pt;\">Mann–Whitney U test</span></p>"
        },
        {
          "id": 358009,
          "text": "<p><span style=\"font-size:14.0pt;\">Wilcoxon signed‑rank test</span></p>"
        },
        {
          "id": 358010,
          "text": "<p><span style=\"font-size:14.0pt;\">Sign test</span></p>"
        },
        {
          "id": 358011,
          "text": "<p><span style=\"font-size:14.0pt;\">Chi‑square test</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Two independent groups of diabetic patients (n=12 each) rate their quality of life on a validated 5‑point ordinal scale. The distributions are skewed, and the data do not meet parametric assumptions. Which statistical test is most appropriate to compare the two groups?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q9945678",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>A) Mann–Whitney U test</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>Mann–Whitney U test</strong> (also called the Wilcoxon rank‑sum test) compares two <strong>independent</strong> samples on an <strong>ordinal</strong> (or non‑normal continuous) outcome by ranking all observations and assessing whether one group’s ranks tend to be higher than the other’s.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It does <strong>not</strong> require normality and is ideal for skewed distributions.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Wilcoxon signed‑rank test:</strong> Designed for <strong>paired</strong> or matched samples (e.g., before/after measurements in the same subjects), not independent groups.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Sign test:</strong> Compares binary or paired directional changes within the same subjects, not suitable for two independent samples or full ordinal scales. It is done for comparing before and after in 1 group&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Chi‑square test:</strong> Compares <strong>categorical</strong> frequencies across groups; ignores the ordinal nature and requires larger expected cell counts. It is done for comparing &nbsp;≥2 group of people.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Use the <strong>Mann–Whitney U test</strong> to compare two independent groups on an ordinal or non‑normal continuous outcome—reserve paired tests (Wilcoxon signed‑rank or sign test) for matched data and chi‑square for categorical counts.</span></p>",
      "correct_choice_id": 358008,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89904/NEET_PG_aug_2025_PSM_Question_18.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89904/NEET_PG_aug_2025_PSM_Question_18.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89818,
      "choices": [
        {
          "id": 357664,
          "text": "<p><span style=\"font-size:14.0pt;\">Delayed skeletal maturation is suggested</span></p>"
        },
        {
          "id": 357665,
          "text": "<p><span style=\"font-size:14.0pt;\">Pisiform normally appears later than other carpals</span></p>"
        },
        {
          "id": 357666,
          "text": "<p><span style=\"font-size:14.0pt;\">Early estrogen exposure accelerates pisiform ossification</span></p>"
        },
        {
          "id": 357667,
          "text": "<p><span style=\"font-size:14.0pt;\">Lunate should not yet be ossified at this age</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A pediatric endocrinologist reviews a wrist X-ray of an 11-year-old girl. All carpal centers except the pisiform are present. Which of the following best explains this finding?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q1586757",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;B) Pisiform normally appears later than other carpals</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Carpal bones&nbsp;</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">1<sup>st</sup> 2 carpal bones → 2 months&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">3<sup>rd</sup> – 7<sup>th</sup> carpal bone → 3 – 6 years&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">8<sup>th</sup> carpal bone (Pisiform) → 10 - 12 years</span></li></ul></li><li><span style=\"font-size:14.0pt;\">By age 11, all carpal ossification centers except the pisiform should be present.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The pisiform is the <strong>last</strong> carpal to ossify—typically between <strong>10 and 12 years</strong> of age—because it arises within the tendon of the flexor carpi ulnaris rather than directly from the general carpal ossification sequence.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Seeing all other centers (capitate, hamate, triquetral, lunate, scaphoid, trapezium, trapezoid) but <strong>no pisiform</strong> is therefore normal for an 11-year-old.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Delayed skeletal maturation is suggested:</strong> A “bone age” delay would involve missing ossification centers that should normally appear by this age (e.g., scaphoid or trapezoid). Here, only the pisiform is absent, which is expected—so maturation is on schedule.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Early estrogen exposure accelerates pisiform ossification:</strong> Hormonal influences can affect overall skeletal maturation, but the pisiform’s timing is highly consistent across genders and hormonal states. Early estrogen does <strong>not</strong> selectively advance only the pisiform.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Lunate should not yet be ossified at this age:</strong> The lunate ossifies by <strong>4 years</strong>—well before age 11—so its presence is entirely expected and would not argue against normal development.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The pisiform is the final carpal bone to ossify, appearing between 10 and 12 years; all other carpals are present by early childhood.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-08-19%20143805.jpeg\" width=\"796\" height=\"588\"></p>",
      "correct_choice_id": 357665,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89818/NEET_PG_Aug_FMT_Question_4.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        10
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89818/NEET_PG_Aug_FMT_Question_4.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90604,
      "choices": [
        {
          "id": 360776,
          "text": "<p><span style=\"font-size:14.0pt;\">Luc’s forceps</span></p>"
        },
        {
          "id": 360777,
          "text": "<p><span style=\"font-size:14.0pt;\">Walsham forceps</span></p>"
        },
        {
          "id": 360778,
          "text": "<p><span style=\"font-size:14.0pt;\">Killian’s forceps</span></p>"
        },
        {
          "id": 360779,
          "text": "<p><span style=\"font-size:14.0pt;\">Tilley’s forceps</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 28-year-old man presents to the emergency department after sustaining facial trauma in a road traffic accident. He reports nasal pain, swelling, and difficulty breathing through his nose. On examination, there is visible nasal deformity with tenderness over the nasal bridge and crepitus. There is no septal hematoma. A lateral X-ray of the nasal bones is as given below. Which of the following is the most appropriate instrument for reduction of this fracture?&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_4JBz6Y4.png\" width=\"290\" height=\"412\"></span></p>",
      "unique_key": "Q4019856",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Walsham forceps</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Walsham forceps are specifically designed for <strong>closed reduction of nasal bone fractures</strong>.</span></li><li><span style=\"font-size:14.0pt;\">They have a smooth surface to prevent mucosal trauma and are used to realign displaced nasal bones under local or general anesthesia.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">In lateral nasal bone fractures, these forceps are inserted intranasally to elevate and reposition the bone fragments to restore both airway patency and cosmetic contour.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-08-21%20110315.jpeg\" width=\"207\" height=\"602\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Luc’s forceps</strong>: Incorrect. Luc’s forceps are mainly used in <strong>endoscopic sinus surgery</strong> or <strong>Caldwell-Luc procedures</strong> to remove diseased mucosa, polyps, or bony fragments from the maxillary sinus. They are not intended for nasal bone fracture reduction.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Killian’s forceps</strong>: Incorrect. Killian’s nasal speculum (sometimes called forceps) is used for <strong>anterior rhinoscopy</strong> and <strong>nasal septal surgeries</strong>, particularly for exposing the septum. It is not a reduction tool for nasal fractures.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Tilley’s forceps</strong>: Incorrect. Tilley’s forceps are angled, toothed or untoothed forceps mainly used for <strong>packing removal</strong> or <strong>placing nasal packs</strong> in epistaxis. They are not designed for manipulating or reducing bone fractures.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Walsham forceps</strong> are the instrument of choice for <strong>closed reduction of nasal bone fractures</strong>, allowing atraumatic manipulation and realignment of displaced fragments to restore nasal structure and function.</span></p>",
      "correct_choice_id": 360777,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90604/NEET_PG_aug_2025_ENT_Question_1.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        9
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90604/NEET_PG_aug_2025_ENT_Question_1.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89908,
      "choices": [
        {
          "id": 358024,
          "text": "<p><span style=\"font-size:14.0pt;\">a–3, b–2, c–1, d–4&nbsp;</span></p>"
        },
        {
          "id": 358025,
          "text": "<p><span style=\"font-size:14.0pt;\">a–1, b–3, c–4, d–2</span></p>"
        },
        {
          "id": 358026,
          "text": "<p><span style=\"font-size:14.0pt;\">a–2, b–3, c–1, d–4</span></p>"
        },
        {
          "id": 358027,
          "text": "<p><span style=\"font-size:14.0pt;\">a–4, b–1, c–2, d–3</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Match the following transplant-related conditions with their correct immunological mechanism:<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_KzfILMO.png\" width=\"615\" height=\"312\"></strong></span></p>",
      "unique_key": "Q9461013",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) a–2, b–3, c–1, d–4</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>a. GVHD (Runt disease) → 2.</strong> <strong>Donor immunocompetent T lymphocytes recognize host alloantigens and attack recipient tissues:</strong> Donor T cells attack host tissues (skin, liver, GI tract).</span></li><li><span style=\"font-size:14.0pt;\"><strong>b. Hyperacute rejection → 3.</strong> <strong>Preformed recipient antibodies react with donor endothelium → complement activation and thrombosis:</strong> Mediated by <strong>preformed antibodies</strong> (eg, anti-ABO, anti-HLA) → immediate thrombosis and necrosis.</span></li><li><span style=\"font-size:14.0pt;\"><strong>c. Acute rejection → 1.</strong> <strong>Host T lymphocytes recognize alloantigens on donor tissue and activate cytokine-mediated cytotoxicity (CD8⁺ and CD4⁺ T cells):&nbsp;</strong>Host T cells recognize donor antigens → cytokine release, inflammation, and cytotoxic killing.</span></li><li><span style=\"font-size:14.0pt;\"><strong>d. Chronic rejection → 4.</strong> <strong>Host T cells and antibodies cause progressive fibrosis and narrowing of graft vessels:</strong> Long-term immune injury → smooth muscle proliferation, fibrosis, and vascular narrowing.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>GVHD (Runt disease):</strong> Donor T cells attack host tissues.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Hyperacute rejection:</strong> Preformed host antibodies cause complement-mediated necrosis.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Acute rejection:</strong> Host T cells mediate direct cytotoxicity.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Chronic rejection:</strong> Progressive fibrosis and vascular narrowing lead to long-term graft loss.</span></li></ul>",
      "correct_choice_id": 358026,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89908/NEET_PG_aug_2025_PATHOLOGY_Question_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89908/NEET_PG_aug_2025_PATHOLOGY_Question_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89938,
      "choices": [
        {
          "id": 358136,
          "text": "<p><span style=\"font-size:14.0pt;\">Hyperacute rejection; B cells</span></p>"
        },
        {
          "id": 358137,
          "text": "<p><span style=\"font-size:14.0pt;\">Acute rejection; T lymphocytes</span></p>"
        },
        {
          "id": 358138,
          "text": "<p><span style=\"font-size:14.0pt;\">Chronic rejection; macrophages</span></p>"
        },
        {
          "id": 358139,
          "text": "<p><span style=\"font-size:14.0pt;\">Late acute rejection; neutrophils</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 55-year-old man undergoes a liver transplant from an unrelated donor. Six weeks post–transplant, he develops fever and elevated liver enzymes. Biopsy reveals lymphocytic infiltration and endothelial damage. Which rejection type is most likely and what cell type mediates it?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q7486234",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Acute rejection; T lymphocytes</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Timing &amp; Histology:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Occurs <strong>weeks to months</strong> after transplant (here, 6 weeks).</span></li><li><span style=\"font-size:14.0pt;\">Histology shows <strong>dense lymphocytic infiltrates</strong> targeting graft endothelium and parenchyma.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Mechanism:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Host T lymphocytes</strong> (predominantly <strong>CD8+ cytotoxic T cells</strong>, aided by <strong>CD4+ helper T cells</strong>) recognize <strong>donor allo–MHC molecules</strong> on graft cells.</span></li><li><span style=\"font-size:14.0pt;\">This triggers <strong>cell-mediated cytotoxicity</strong>, release of perforin/granzymes, and cytokine-driven inflammation, resulting in graft injury.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Hyperacute rejection; B cells:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Hyperacute:</strong> Occurs <strong>minutes to hours</strong> post-transplant due to <strong>preformed antibodies</strong> (B-cell products) against donor antigens → complement activation and thrombosis.</span></li><li><span style=\"font-size:14.0pt;\">This patient’s presentation at 6 weeks and lymphocytic infiltrate are inconsistent.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Chronic rejection; macrophages:</strong>&nbsp;</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Chronic:</strong> Develops <strong>months to years</strong> later with <strong>vascular intimal fibrosis</strong>, smooth-muscle proliferation, and parenchymal fibrosis.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Macrophages and antibodies contribute, but timing and histology differ.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Late acute rejection; neutrophils:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Neutrophils are key in <strong>hyperacute</strong> (early) and ischemia–reperfusion injury, not in typical acute cellular rejection.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">There is no distinct “late acute” entity mediated by neutrophils.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Acute graft rejection</strong> occurs <strong>weeks to months</strong> post-transplant and is mediated by <strong>host T lymphocytes</strong> recognizing <strong>donor MHC</strong> on graft cells, leading to <strong>lymphocytic infiltration</strong> and <strong>endothelial injury</strong>.</span></li><li><span style=\"font-size:14.0pt;\">A transplant patient presenting <strong>4–12 weeks</strong> after surgery with <strong>fever</strong>, <strong>organ dysfunction</strong>, and <strong>lymphocytic infiltrates</strong> on biopsy is experiencing <strong>acute T cell–mediated rejection</strong>, which requires adjustment of immunosuppression to prevent permanent graft damage.</span></li></ul>",
      "correct_choice_id": 358137,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89938/NEET_PG_aug_2025_MICROBIOLOGY_Question_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        6
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89938/NEET_PG_aug_2025_MICROBIOLOGY_Question_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89821,
      "choices": [
        {
          "id": 357676,
          "text": "<p><span style=\"font-size:14.0pt;\">Prescribe SSRI and monitor</span></p>"
        },
        {
          "id": 357677,
          "text": "<p><span style=\"font-size:14.0pt;\">Admit and start antipsychotics</span></p>"
        },
        {
          "id": 357678,
          "text": "<p><span style=\"font-size:14.0pt;\">Start mood stabilizer at home</span></p>"
        },
        {
          "id": 357679,
          "text": "<p><span style=\"font-size:14.0pt;\">Reassure and schedule follow-up</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 26-year-old woman, 2 weeks postpartum, reports hearing voices commanding her to harm her baby. She is disorganized and has not been sleeping. What is the next best step?</span></p>",
      "unique_key": "Q3110312",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Admit and start antipsychotics</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This patient is presenting with <strong>postpartum psychosis</strong>, a <strong>psychiatric emergency</strong> that occurs within days to weeks after childbirth.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Hallucinations (especially <strong>command auditory hallucinations</strong> to harm the baby), <strong>disorganized behavior</strong>, and <strong>insomnia</strong> are red flags.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The <strong>next best step is immediate psychiatric hospitalization</strong> to ensure the safety of both mother and infant, and to initiate <strong>antipsychotic medication</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Prescribe SSRI and monitor:&nbsp;</strong>SSRIs are used for <strong>postpartum depression</strong>, not psychosis. Delaying appropriate treatment in psychosis is dangerous.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Start mood stabilizer at home:&nbsp;</strong>Mood stabilizers may be used <strong>in bipolar postpartum psychosis</strong>, but <strong>home treatment is unsafe</strong> given the risk of <strong>infanticide or self-harm</strong>. Hospitalization is necessary.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Reassure and schedule follow-up:&nbsp;</strong>Reassurance and outpatient management are <strong>inappropriate</strong> in <strong>acute postpartum psychosis</strong>, especially with <strong>command hallucinations</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Postpartum psychosis</strong> is a psychiatric emergency requiring <strong>immediate inpatient care and antipsychotic therapy</strong> to protect both mother and child.</span></p>",
      "correct_choice_id": 357677,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89821/NEET_PG_aug_2025_PSYCHIATRY_Question_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        16
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89821/NEET_PG_aug_2025_PSYCHIATRY_Question_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90879,
      "choices": [
        {
          "id": 361852,
          "text": "<p><span style=\"font-size:14.0pt;\">Rapid hydroxylation of isoniazid</span></p>"
        },
        {
          "id": 361853,
          "text": "<p><span style=\"font-size:14.0pt;\">Slow acetylation of isoniazid</span></p>"
        },
        {
          "id": 361854,
          "text": "<p><span style=\"font-size:14.0pt;\">Impaired renal clearance of isoniazid</span></p>"
        },
        {
          "id": 361855,
          "text": "<p><span style=\"font-size:14.0pt;\">Cytochrome P450 inhibition by isoniazid</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 44-year-old man is prescribed isoniazid as part of combination therapy for latent tuberculosis. After 4 weeks, he presents with numbness and tingling in both feet. Neurologic exam reveals decreased pinprick and vibration sensation in a stocking-glove distribution. Which of the following is the most likely mechanism predisposing this patient to the adverse effect?</span></p>",
      "unique_key": "Q5298293",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Slow acetylation of isoniazid</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Isoniazid</strong> is metabolized by <strong>N-acetyltransferase</strong>, and patients who are <strong>slow acetylators</strong> accumulate more of the parent drug.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This increases the risk of <strong>peripheral neuropathy</strong> due to pyridoxine (vitamin B6) depletion.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Genetic polymorphism in the acetylation pathway explains the variability in toxicity profiles among individuals.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.</strong> <strong>Rapid hydroxylation of isoniazid: Hydroxylation</strong> is not the primary metabolic route for isoniazid.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Impaired renal</strong> <strong>clearance of isoniazid:</strong> Isoniazid is mainly metabolized hepatically, not cleared renally.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.</strong> <strong>Cytochrome P450 inhibition by isoniazid:&nbsp;</strong>Though isoniazid can inhibit CYP enzymes, this is not the mechanism for neuropathy.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Slow acetylators are at increased risk of isoniazid-induced peripheral neuropathy due to impaired drug clearance and pyridoxine deficiency.</span></p>",
      "correct_choice_id": 361853,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90879/NEET_PG_aug_2025_PHARMACOLOGY_Question_4.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90879/NEET_PG_aug_2025_PHARMACOLOGY_Question_4.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90849,
      "choices": [
        {
          "id": 361736,
          "text": "<p><span style=\"font-size:14.0pt;\">Tafamidis</span></p>"
        },
        {
          "id": 361737,
          "text": "<p><span style=\"font-size:14.0pt;\">Nusinersen</span></p>"
        },
        {
          "id": 361738,
          "text": "<p><span style=\"font-size:14.0pt;\">Diflunisal</span></p>"
        },
        {
          "id": 361739,
          "text": "<p><span style=\"font-size:14.0pt;\">Vutisiran</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 65-year-old woman with known ATTR amyloidosis presents for follow-up. She has been suffering from HFpEF, and peripheral neuropathy for the last 6 months. Genetic testing confirms transthyretin gene mutation, and nuclear scans confirm amyloid deposition. Which of the following is not used in the treatment?</span></p>",
      "unique_key": "Q2321033",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Nusinersen</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>ATTR amyloidosis</strong> can be <strong>wild-type</strong> or <strong>hereditary</strong> and results from misfolded <strong>transthyretin (TTR) protein</strong>, depositing in the heart, nerves, or other organs.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Treatment approaches target different steps in TTR amyloidogenesis:</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Nusinersen</strong> is used in <strong>spinal muscular atrophy (SMA)</strong> and has <strong>no role in ATTR amyloidosis</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Tafamidis:</strong> FDA-approved for <strong>ATTR cardiomyopathy</strong>; stabilizes the TTR tetramer to prevent misfolding.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Diflunisal:</strong> NSAID shown to stabilize TTR; used off-label for <strong>ATTR polyneuropathy</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Vutisiran:</strong> siRNA therapy approved for <strong>hereditary ATTR amyloidosis with polyneuropathy</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Tafamidis</strong>, <strong>diflunisal</strong>, and <strong>vutisiran</strong> are approved or used off-label for <strong>ATTR amyloidosis</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Nusinersen</strong> is specific to <strong>SMA</strong> and has <strong>no therapeutic role</strong> in ATTR.</span></li><li><span style=\"font-size:14.0pt;\">Therapies target either <strong>TTR stabilization</strong> or <strong>reduction of TTR synthesis</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-08-23%20101705.jpg\" width=\"1293\" height=\"434\"></span></p>",
      "correct_choice_id": 361737,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90849/Neet_Pg_Aug_2025_Medicine_Question_15.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90849/Neet_Pg_Aug_2025_Medicine_Question_15.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89931,
      "choices": [
        {
          "id": 358116,
          "text": "<p><span style=\"font-size:14.0pt;\">Mutation of the CDKN2 gene</span></p>"
        },
        {
          "id": 358117,
          "text": "<p><span style=\"font-size:14.0pt;\">Mutation of the WT gene</span></p>"
        },
        {
          "id": 358118,
          "text": "<p><span style=\"font-size:14.0pt;\">Mutation of the NF2 gene&nbsp;</span></p>"
        },
        {
          "id": 358119,
          "text": "<p><span style=\"font-size:14.0pt;\">Mutation of the PTEN gene</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 39-year-old man presents with progressive hearing loss and unsteadiness while walking. MRI of the brain shows a mass at the cerebellopontine angle compressing the vestibulocochlear nerve. The mass is surgically excised and histology confirms a benign tumor. Several years later, follow-up imaging reveals multiple dural-based enhancing lesions consistent with meningiomas. Which of the following genetic mutations is most likely responsible for this patient’s presentation?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q6951456",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Mutation of the NF2 gene</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This presentation is most consistent with <strong>neurofibromatosis type 2 (NF2)</strong>, an <strong>autosomal dominant</strong> disorder.</span></li><li><span style=\"font-size:14.0pt;\">NF2 is caused by a <strong>mutation in the NF2 gene</strong> located on chromosome 22, which encodes the tumor suppressor protein <strong>merlin (schwannomin)</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Merlin regulates contact-dependent inhibition of cell proliferation. Loss of merlin allows uncontrolled proliferation of <strong>Schwann cells</strong>, <strong>meningothelial cells</strong>, and <strong>ependymal cells</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Key features of NF2:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Bilateral vestibular schwannomas</strong> (or unilateral schwannoma in young patients) involving the cerebellopontine angle and CN VIII → hearing loss, tinnitus, imbalance</span></li><li><span style=\"font-size:14.0pt;\">Multiple <strong>meningiomas</strong> and <strong>ependymomas</strong> of the spinal cord</span></li></ul></li><li><span style=\"font-size:14.0pt;\">The combination of a vestibular schwannoma and later multiple meningiomas is classic for NF2.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Mutation of the CDKN2 gene</strong>: CDKN2A mutations are linked to <strong>familial melanoma</strong> and <strong>pancreatic cancer</strong>, not schwannomas or meningiomas.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Mutation of the WT gene</strong>: WT1 and WT2 gene mutations are associated with <strong>Wilms tumor</strong>, a pediatric renal malignancy, and do not cause CNS tumors.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Mutation of the PTEN gene</strong>: PTEN mutations cause <strong>Cowden syndrome</strong>, which is associated with multiple hamartomas and increased risk of breast, thyroid, and endometrial cancers — not vestibular schwannomas or meningiomas.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Neurofibromatosis type 2</strong> is an <strong>autosomal dominant</strong> disorder caused by a mutation in the <strong>NF2 tumor suppressor gene</strong> on chromosome 22.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It presents with <strong>bilateral vestibular schwannomas</strong>, multiple meningiomas, and spinal ependymomas.</span></li></ul>",
      "correct_choice_id": 358118,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89931/NEET_PG_aug_2025_PATHOLOGY_Question_12.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89931/NEET_PG_aug_2025_PATHOLOGY_Question_12.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89937,
      "choices": [
        {
          "id": 358132,
          "text": "<p><span style=\"font-size:14.0pt;\">Cell-mediated immunity</span></p>"
        },
        {
          "id": 358133,
          "text": "<p><span style=\"font-size:14.0pt;\">Innate immunity</span></p>"
        },
        {
          "id": 358134,
          "text": "<p><span style=\"font-size:14.0pt;\">Complement-mediated immunity</span></p>"
        },
        {
          "id": 358135,
          "text": "<p><span style=\"font-size:14.0pt;\">Humoral immunity</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 3-month-old infant is brought to the clinic with a history of recurrent bacterial infections, including otitis media and pneumonia. On examination, the infant has absent tonsils and lymph nodes, and laboratory investigations show very low levels of all immunoglobulin classes (IgG, IgA, IgM). Flow cytometry reveals absent CD19+ B cells but normal T-cell counts. Which of the following best describes the type of immunity that is defective in this patient?</span></p>",
      "unique_key": "Q3150380",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Humoral immunity</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The clinical picture is consistent with <strong>Bruton’s agammaglobulinemia</strong> (X-linked agammaglobulinemia).</span></li><li><span style=\"font-size:14.0pt;\">There is a defect in <strong>B-cell maturation</strong> → <strong>absent B cells (CD19+)</strong> → <strong>no antibody production</strong> → defective <strong>humoral immunity</strong>.</span></li><li><span style=\"font-size:14.0pt;\">This leads to recurrent infections with <strong>encapsulated bacteria</strong> (e.g., Streptococcus pneumoniae, Haemophilus influenzae).</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Cell-mediated immunity:</strong> <strong>Incorrect</strong> because,</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Cell-mediated immunity is mediated by <strong>T cells</strong>, especially <strong>CD4+ and CD8+ T cells</strong>.</span></li><li><span style=\"font-size:14.0pt;\">In this case, <strong>T-cell count is normal</strong>, and the infections are predominantly <strong>bacterial</strong>, not viral or fungal (which are typical in T-cell defects like DiGeorge syndrome).</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option</strong> <strong>B. Innate immunity: Incorrect</strong> because,</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Innate immunity involves <strong>neutrophils, macrophages, NK cells, and barriers</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Defects here often present with <strong>severe, early-onset infections</strong> (e.g., in CGD, LAD).</span></li><li><span style=\"font-size:14.0pt;\">This child specifically has <strong>absent B cells and low immunoglobulins</strong>, which points to <strong>adaptive immunity (humoral)</strong>, not innate.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Complement-mediated immunity: Incorrect</strong> because,</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Complement deficiencies (like C3, C5-C9) lead to issues like <strong>recurrent Neisseria infections</strong>, or <strong>increased susceptibility to pyogenic infections</strong>.</span></li><li><span style=\"font-size:14.0pt;\">But complement defects usually show <strong>normal immunoglobulin levels</strong> and <strong>normal B-cell counts</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Here, the absence of <strong>B cells and all Ig classes</strong> is key.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:&nbsp;</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Humoral immunity</strong> is the part of adaptive immunity mediated by <strong>B cells and antibodies (IgG, IgA, IgM, etc.)</strong>.</span></li><li><span style=\"font-size:14.0pt;\">It protects against <strong>extracellular bacteria, viruses, and toxins</strong> by neutralization and opsonization.</span></li><li><span style=\"font-size:14.0pt;\">Deficiency leads to <strong>recurrent bacterial infections</strong>, especially with <strong>encapsulated organisms</strong>, due to impaired antibody production.</span></li></ul>",
      "correct_choice_id": 358135,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89937/NEET_PG_aug_2025_MICROBIOLOGY_Question_1.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        6
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89937/NEET_PG_aug_2025_MICROBIOLOGY_Question_1.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90881,
      "choices": [
        {
          "id": 361860,
          "text": "<p><span style=\"font-size:14.0pt;\">Nilotinib</span></p>"
        },
        {
          "id": 361861,
          "text": "<p><span style=\"font-size:14.0pt;\">Methotrexate</span></p>"
        },
        {
          "id": 361862,
          "text": "<p><span style=\"font-size:14.0pt;\">Pertuzumab</span></p>"
        },
        {
          "id": 361863,
          "text": "<p><span style=\"font-size:14.0pt;\">Cisplatin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Identify the drug which works by the mechanism shown in the image?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-08-20%20111711.jpeg\" width=\"819\" height=\"627\"></strong></span></p>",
      "unique_key": "Q5776559",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Nilotinib</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Nilotinib</strong> is a <strong>second-generation tyrosine kinase inhibitor (TKI)</strong> that specifically targets the <strong>BCR-ABL fusion protein</strong>, which is characteristic of <strong>chronic myeloid leukemia (CML)</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It binds to the <strong>ATP-binding site</strong>, blocking phosphorylation of tyrosine residues on downstream substrates, thereby <strong>inhibiting intracellular signaling and proliferation</strong> of leukemic cells.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This is exactly what's illustrated in the image: the left side shows ATP enabling phosphorylation, and the right side shows a drug (Z) preventing ATP binding and thereby blocking signal transduction.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Methotrexate</strong>: A folate antagonist that inhibits <strong>dihydrofolate reductase</strong>, used in cancer and autoimmune diseases; does not affect tyrosine kinases.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Pertuzumab</strong>: A monoclonal antibody against <strong>HER2</strong>, preventing <strong>dimerization</strong> of the receptor in breast cancer; it does not target BCR-ABL or block ATP binding.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Cisplatin</strong>: A <strong>platinum-based chemotherapy</strong> that forms DNA crosslinks; its action is unrelated to kinase activity.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Nilotinib inhibits the BCR-ABL tyrosine kinase by binding to its ATP-binding site, thereby blocking phosphorylation and downstream leukemic signaling in CML.</span></p>",
      "correct_choice_id": 361860,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90881/NEET_PG_aug_2025_PHARMACOLOGY_Question_5.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90881/NEET_PG_aug_2025_PHARMACOLOGY_Question_5.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90448,
      "choices": [
        {
          "id": 360160,
          "text": "<p><span style=\"font-size:14.0pt;\">Letter A</span></p>"
        },
        {
          "id": 360161,
          "text": "<p><span style=\"font-size:14.0pt;\">Letter B</span></p>"
        },
        {
          "id": 360162,
          "text": "<p><span style=\"font-size:14.0pt;\">Letter C</span></p>"
        },
        {
          "id": 360163,
          "text": "<p><span style=\"font-size:14.0pt;\">Letter E</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">In the figure below, which letter designates a reaction that may be catalyzed by different enzymes in different tissues, playing an important role in regulation of serum glucose levels?&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_3CiejQu.png\" width=\"549\" height=\"336\"></span></p>",
      "unique_key": "Q3188439",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Letter A</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Letter A</strong> represents the reaction: <strong>Glucose → Glucose-6-phosphate</strong></span></li><li><span style=\"font-size:14.0pt;\">This phosphorylation step is catalyzed by <strong>different enzymes in different tissues</strong>:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Hexokinase</strong> (in most tissues) — low Km, high affinity, inhibited by glucose-6-phosphate.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Glucokinase</strong> (in liver and pancreatic β-cells) — high Km, high capacity, <strong>not inhibited</strong> by glucose-6-phosphate; active mainly when blood glucose is high.</span></li></ul></li><li><span style=\"font-size:14.0pt;\">This difference is important in <strong>regulation of serum glucose</strong>:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Liver glucokinase helps remove excess glucose after a meal.</span></li><li><span style=\"font-size:14.0pt;\">Hexokinase ensures constant glucose trapping in peripheral tissues even at low blood glucose.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Letter B:</strong> <strong>Glucose-6-phosphate → Fructose-6-phosphate</strong> via phosphohexose isomerase</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Same enzyme in all tissues, not a key point of hormonal control of blood glucose.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Letter C:</strong> <strong>Fructose-6-phosphate → Fructose-1,6-bisphosphate</strong> via PFK-1</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This is the rate-limiting step of glycolysis, but catalyzed by the same enzyme everywhere; regulation here is more about metabolic flux, not directly serum glucose control.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Letter E:</strong> &nbsp;Letter E is triose phosphate isomerase , Same enzyme in all tissues, not a key point of hormonal control of blood glucose</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The phosphorylation of glucose to glucose-6-phosphate is catalyzed by hexokinase in most tissues and glucokinase in the liver and pancreatic β-cells. These isoenzymes have different kinetic properties, enabling tissue-specific regulation of glucose utilization and serum glucose levels.</span></p>",
      "correct_choice_id": 360160,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90448/NEET_PG_aug_2025_BIOCHEM_Question_1.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        1
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90448/NEET_PG_aug_2025_BIOCHEM_Question_1.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89925,
      "choices": [
        {
          "id": 358092,
          "text": "<p><span style=\"font-size:14.0pt;\">PTEN loss with EGFR amplification</span></p>"
        },
        {
          "id": 358093,
          "text": "<p><span style=\"font-size:14.0pt;\">IDH mutation with 1p/19q co-deletion&nbsp;</span></p>"
        },
        {
          "id": 358094,
          "text": "<p><span style=\"font-size:14.0pt;\">NF2 mutation on chromosome 22q</span></p>"
        },
        {
          "id": 358095,
          "text": "<p><span style=\"font-size:14.0pt;\">BRAF V600E mutation</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 44-year-old man presents with several months of headaches and new-onset seizures. MRI reveals a well-circumscribed lesion in the frontal lobe with calcifications. Histopathology of the lesion is shown in the image below. Which of the following molecular alterations is most commonly associated with this tumor and predicts better prognosis?</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_iS6DyJv.png\" width=\"397\" height=\"255\"></span></p>",
      "unique_key": "Q6979163",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) IDH mutation with 1p/19q co-deletion</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Oligodendrogliomas</strong> are <strong>slow-growing primary brain tumors</strong> that often present in adults with <strong>seizures</strong>.</span></li><li><span style=\"font-size:14.0pt;\">They typically occur in the <strong>frontal lobe</strong> and frequently show <strong>calcifications</strong> on imaging.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Histology:</strong> “Fried egg” cells with clear perinuclear halos and “chicken-wire” capillary vasculature.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Molecular hallmark:</strong> <strong>IDH mutation with 1p/19q co-deletion</strong>, which not only confirms the diagnosis but also indicates <strong>better prognosis</strong> and response to therapy.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. PTEN loss with EGFR amplification</strong>: Found in <strong>glioblastoma </strong>not oligodendroglioma.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. NF2 mutation on chromosome 22q</strong>: Associated with acoustic neuroma, <strong>meningiomas</strong> and <strong>schwannomas</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. BRAF V600E mutation</strong>: Seen in <strong>juvenile</strong> <strong>pilocytic astrocytomas</strong> and some <strong>gangliogliomas</strong>, not oligodendrogliomas.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Oligodendrogliomas present with calcified frontal lobe tumors and seizures. Histology shows “fried egg” cells and chicken-wire vasculature.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The key molecular alteration is IDH mutation with 1p/19q co-deletion, predicting favorable prognosis.</span></li></ul>",
      "correct_choice_id": 358093,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89925/NEET_PG_aug_2025_PATHOLOGY_Question_6.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89925/NEET_PG_aug_2025_PATHOLOGY_Question_6.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89940,
      "choices": [
        {
          "id": 358144,
          "text": "<p><span style=\"font-size:14.0pt;\">Increased intrinsic resistance to antibiotics</span></p>"
        },
        {
          "id": 358145,
          "text": "<p><span style=\"font-size:14.0pt;\">Formation of organized bacterial communities on surfaces</span></p>"
        },
        {
          "id": 358146,
          "text": "<p><span style=\"font-size:14.0pt;\">Enhanced secretion of exotoxin A</span></p>"
        },
        {
          "id": 358147,
          "text": "<p><span style=\"font-size:14.0pt;\">Elevated production of bacteriocins</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 19-year-old patient with cystic fibrosis has a respiratory culture that grows a slimy, mucoid strain of Pseudomonas aeruginosa. Which feature is most directly enabled by this mucoid phenotype?</span></p>",
      "unique_key": "Q3977543",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Formation of organized bacterial communities on surfaces</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The mucoid appearance of P. aeruginosa colonies is caused by <strong>alginate overproduction</strong>, an exopolysaccharide that is a key component of <strong>biofilms</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Biofilms are <strong>structured multicellular communities</strong> of bacteria embedded in a self-produced matrix.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Within a biofilm, bacteria:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Adhere tightly to respiratory epithelium or indwelling devices.</span></li><li><span style=\"font-size:14.0pt;\">Are protected from mechanical clearance and immune cells.</span></li><li><span style=\"font-size:14.0pt;\">Exhibit markedly <strong>reduced susceptibility</strong> to antibiotics and disinfectants because the matrix and altered metabolic state limit drug penetration and efficacy.</span></li></ul></li><li><span style=\"font-size:14.0pt;\">Thus, the mucoid strain’s primary clinical significance is its ability to <strong>produce biofilms</strong>, which underlies chronic, difficult-to-treat infections in cystic fibrosis patients.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Increased intrinsic resistance to antibiotics:</strong> While biofilm formation <strong>indirectly</strong> confers antibiotic tolerance, mucoid does <strong>not</strong> change the bacterial cell’s inherent drug-resistance mechanisms (e.g., efflux pumps, β-lactamases).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Enhanced secretion of exotoxin A:</strong> Exotoxin A production is regulated independently of alginate synthesis; mucoid strains do <strong>not</strong> secrete more exotoxin than nonmucoid strains.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Elevated production of bacteriocins:</strong> Bacteriocins are antimicrobial peptides targeting other bacteria; their production is <strong>not</strong> linked to the mucoid, alginate-overproducing phenotype.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The mucoid phenotype of P. aeruginosa reflects <strong>biofilm formation</strong>, not an inherent increase in toxin or bacteriocin production, and is the cornerstone of its persistence in chronic lung infections.</span></p>",
      "correct_choice_id": 358145,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89940/NEET_PG_aug_2025_MICROBIOLOGY_Question_4.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        6
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89940/NEET_PG_aug_2025_MICROBIOLOGY_Question_4.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90888,
      "choices": [
        {
          "id": 361888,
          "text": "<p><span style=\"font-size:14.0pt;\">It is administered intramuscularly once a month</span></p>"
        },
        {
          "id": 361889,
          "text": "<p><span style=\"font-size:14.0pt;\">It acts as a selective estrogen receptor downregulator without agonist effects</span></p>"
        },
        {
          "id": 361890,
          "text": "<p><span style=\"font-size:14.0pt;\">It acts rapidly and is considered safer and more potent than SERMs</span></p>"
        },
        {
          "id": 361891,
          "text": "<p><span style=\"font-size:14.0pt;\">It is used in the treatment of hormone receptor–positive advanced breast cancer</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following statements regarding fulvestrant is incorrect?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q7722056",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>C) It acts rapidly and is considered safer and more potent than SERMs</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Fulvestrant is a&nbsp;<strong>Selective Estrogen Receptor Downregulator (SERD)</strong>. Unlike SERMs (e.g., tamoxifen), it has&nbsp;<strong>pure antagonist activity with no agonist effects</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It is administered&nbsp;<strong>intramuscularly once a month</strong>&nbsp;and is used in&nbsp;<strong>postmenopausal women with hormone receptor–positive advanced breast cancer</strong>, often after progression on SERMs or aromatase inhibitors.</span></li><li><span style=\"font-size:14.0pt;\">However, fulvestrant&nbsp;<strong>does not act rapidly</strong>; its onset is relatively slow (full effects can take weeks to months), and it is&nbsp;<strong>not considered inherently safer or more potent than SERMs</strong>—it is simply used in a different clinical context.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. It is administered intramuscularly once a month</strong>: Correct. Standard dosing is monthly IM injection.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. It acts as a selective estrogen receptor downregulator without agonist effects</strong>: Correct. Unlike tamoxifen, fulvestrant has no partial agonist action.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. It is used in the treatment of hormone receptor–positive advanced breast cancer</strong>: Correct. Approved for ER+ advanced or metastatic breast cancer, especially in postmenopausal women.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Fulvestrant</strong> is a SERD used in hormone receptor–positive advanced breast cancer.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It acts by degrading estrogen receptors without partial agonist effects.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It is slower acting and <strong>not considered safer or more potent</strong> than SERMs like tamoxifen.</span></li></ul>",
      "correct_choice_id": 361890,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90888/NEET_PG_aug_2025_PHARMACOLOGY_Question_11.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90888/NEET_PG_aug_2025_PHARMACOLOGY_Question_11.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90212,
      "choices": [
        {
          "id": 359220,
          "text": "<p><span style=\"font-size:14.0pt;\">Pemphigus vulgaris</span></p>"
        },
        {
          "id": 359221,
          "text": "<p><span style=\"font-size:14.0pt;\">Bullous pemphigoid</span></p>"
        },
        {
          "id": 359222,
          "text": "<p><span style=\"font-size:14.0pt;\">Psoriasis</span></p>"
        },
        {
          "id": 359223,
          "text": "<p><span style=\"font-size:14.0pt;\">Dermatitis herpetiformis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A woman presents with a pruritic papulovesicular rash on the elbows and buttocks. She has a recent diagnosis of gluten-sensitive enteropathy. Direct immunofluorescence of a skin biopsy shows granular IgA deposition at the dermoepidermal junction. What is the most likely diagnosis?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-08-11%20115113.jpeg\" width=\"597\" height=\"382\"></strong></span></p>",
      "unique_key": "Q1553576",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Dermatitis herpetiformis</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Pruritic papulovesicular rash on extensor surfaces</strong> (elbows, buttocks) is classic.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Association with gluten-sensitive enteropathy (celiac disease)</strong> is a hallmark feature.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Immunofluorescence</strong> shows <strong>granular IgA deposits</strong> in the <strong>dermal papillae</strong>—highly characteristic.</span></li><li><span style=\"font-size:14.0pt;\">These features are diagnostic of <strong>Dermatitis Herpetiformis</strong>, a chronic autoimmune blistering disorder.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Pemphigus vulgaris:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Involves mucosa and skin.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Flaccid blisters</strong>, positive <strong>Nikolsky sign</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>IgG antibodies</strong> against desmoglein 3 and 1.</span></li><li><span style=\"font-size:14.0pt;\">Immunofluorescence shows <strong>intercellular IgG (\"chicken wire\" pattern)</strong>, <strong>not granular IgA</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Bullous pemphigoid:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Tense bullae in the elderly, <strong>less itchy</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Immunofluorescence shows <strong>linear IgG and C3</strong> along the <strong>basement membrane zone</strong>.</span></li><li><span style=\"font-size:14.0pt;\">No association with celiac disease.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Psoriasis:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Chronic scaly plaques on extensor surfaces.</span></li><li><span style=\"font-size:14.0pt;\">No vesicles or IgA deposition.</span></li><li><span style=\"font-size:14.0pt;\">Not associated with celiac disease or pruritic vesicles.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Dermatitis herpetiformis</strong> is an autoimmune blistering disease associated with <strong>celiac disease</strong>, showing <strong>pruritic vesicular eruptions on extensor surfaces</strong> and <strong>granular IgA deposits in dermal papillae</strong> on direct immunofluorescence.</span></p>",
      "correct_choice_id": 359223,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90212/NEET_PG_aug_2025_DERMA_Question_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        18
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90212/NEET_PG_aug_2025_DERMA_Question_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90848,
      "choices": [
        {
          "id": 361732,
          "text": "<p><span style=\"font-size:14.0pt;\">Congestive heart failure</span></p>"
        },
        {
          "id": 361733,
          "text": "<p><span style=\"font-size:14.0pt;\">Pneumonia</span></p>"
        },
        {
          "id": 361734,
          "text": "<p><span style=\"font-size:14.0pt;\">Pulmonary embolism</span></p>"
        },
        {
          "id": 361735,
          "text": "<p><span style=\"font-size:14.0pt;\">Recurrence of lung cancer</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 72-year-old man with type 2 diabetes presents with dyspnea and pitting pedal edema. CXR shows B/L pleural effusions. Thoracentesis removes 700 mL straw-colored fluid (LDH 77 units/L, protein 2.1 g/dL, cholesterol 35 mg/dL, glucose 100 mg/dL, pH 7.4, no WBCs/RBCs, unremarkable cytology). Serum LDH 187 units/L, protein 7.2 g/dL, glucose 110 mg/dL. What is the most likely cause of this effusion?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q2167604",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;A) Congestive heart failure</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">CHF causes transudative bilateral effusions.</span></li><li><span style=\"font-size:14.0pt;\">Fluid analysis (low LDH/protein) confirms transudative etiology.</span></li><li><span style=\"font-size:14.0pt;\">No WBCs or malignant cells rule out infection or cancer.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Pneumonia:</strong> Exudative with WBCs/fever.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Pulmonary embolism:</strong> Small, unilateral effusions. Mostly exudative (bloody effusion).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Recurrence of lung cancer:</strong> Exudative with malignant cells.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">CHF causes transudative effusions.</span></li><li><span style=\"font-size:14.0pt;\">Low LDH/protein confirms transudative fluid.</span></li><li><span style=\"font-size:14.0pt;\">Thoracentesis can be done for persistent effusions.</span></li></ul>",
      "correct_choice_id": 361732,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90848/NEET_PG_aug_2025_MEDICINE_Question_14.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90848/NEET_PG_aug_2025_MEDICINE_Question_14.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90815,
      "choices": [
        {
          "id": 361600,
          "text": "<p><span style=\"font-size:14.0pt;\">Administer octreotide</span></p>"
        },
        {
          "id": 361601,
          "text": "<p><span style=\"font-size:14.0pt;\">Start IV antibiotics</span></p>"
        },
        {
          "id": 361602,
          "text": "<p><span style=\"font-size:14.0pt;\">IV fluids and start feeding</span></p>"
        },
        {
          "id": 361603,
          "text": "<p><span style=\"font-size:14.0pt;\">Nil per oral and IV fluids</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 47-year-old man presents with epigastric pain, nausea, vomiting, and loss of appetite for 3 days. He has been on a 10-day binge drinking. On examination, he has epigastric tenderness. Lab results:</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_c7X9u9f.png\" width=\"362\" height=\"291\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">What is the most appropriate initial management?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q3842779",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;D) Nil per oral and IV fluids</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Epigastric pain, nausea, vomiting, and elevated lipase (800 U/L) and amylase (1200 U/L) confirm acute pancreatitis, likely alcohol-induced.</span></li><li><span style=\"font-size:14.0pt;\">Initial management includes bowel rest (NPO) to reduce pancreatic stimulation and IV fluids for hydration.</span></li><li><span style=\"font-size:14.0pt;\">IV fluids are given initially to prevent hypovolemic shock.</span></li><li><span style=\"font-size:14.0pt;\">Pain control and monitoring for complications (e.g., necrosis) are key.</span></li><li><span style=\"font-size:14.0pt;\">Alcohol cessation prevents recurrence.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Administer octreotide:</strong> Not standard for acute pancreatitis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Start IV antibiotics:</strong> Only for confirmed infective necrosis in pancreas, not routine.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. IV fluids and start feeding:</strong> While IV fluids are correct, starting feeding is premature. The patient's symptoms (nausea, vomiting, loss of appetite, and significant epigastric pain) indicate that the pancreas is actively inflamed. Early feeding, especially with solid food, would stimulate the pancreas and worsen the condition. The transition to oral feeding is a gradual process, usually starting with a clear liquid diet once the patient is pain-free and has a return of appetite.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Acute pancreatitis requires bowel rest and IV fluids.</span></li><li><span style=\"font-size:14.0pt;\">Alcohol is a common etiology; cessation is critical.</span></li><li><span style=\"font-size:14.0pt;\">Monitor for complications like necrosis.</span></li></ul>",
      "correct_choice_id": 361603,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90815/Neet_Pg_Aug_2025_Medicine_Question_3.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90815/Neet_Pg_Aug_2025_Medicine_Question_3.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89943,
      "choices": [
        {
          "id": 358156,
          "text": "<p><span style=\"font-size:14.0pt;\">Type I only</span></p>"
        },
        {
          "id": 358157,
          "text": "<p><span style=\"font-size:14.0pt;\">Types I and II</span></p>"
        },
        {
          "id": 358158,
          "text": "<p><span style=\"font-size:14.0pt;\">Types I and IV</span></p>"
        },
        {
          "id": 358159,
          "text": "<p><span style=\"font-size:14.0pt;\">Types III and IV</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which hypersensitivity mechanisms are evaluated by skin testing procedures?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q5704392",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Types I and IV</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Allergen skin prick tests</strong> assess <strong>Type I (immediate) hypersensitivity</strong>. In this test, small amounts of allergen are introduced into the skin, where they cross-link preformed <strong>IgE</strong> bound to mast cells. This triggers <strong>rapid degranulation</strong>, releasing histamine and other mediators that produce a <strong>wheal-and-flare</strong> reaction within minutes.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Purified protein derivative (PPD) tests</strong> assess <strong>Type IV (delayed) hypersensitivity</strong>. Here, protein antigens (e.g., mycobacterial proteins) are injected intradermally and processed by local antigen-presenting cells. <strong>Th1 CD4⁺ T cells</strong> recognize these antigens, secrete <strong>IFN-γ</strong>, and recruit macrophages over <strong>48–72 hours</strong>, causing induration and erythema.</span></li><li><span style=\"font-size:14.0pt;\">Thus, skin testing simultaneously probes an <strong>immediate (Type I)</strong> and a <strong>delayed (Type IV)</strong> immune response.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Type I only:</strong> Fails to account for the PPD reaction, which is <strong>T cell–mediated</strong> and delayed (Type IV).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Types I and II:</strong> <strong>Type II</strong> hypersensitivity involves <strong>antibody-mediated cytotoxicity</strong> (e.g., hemolytic anemia, Goodpasture syndrome), not evaluated by skin testing.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Types III and IV:</strong> <strong>Type III</strong> reactions involve <strong>immune complexes</strong> (e.g., Arthus reaction), which can be assessed by specific skin tests but are <strong>not</strong> routinely tested clinically with PPD or allergen prick tests.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Skin testing</strong> can evaluate two distinct hypersensitivity mechanisms: <strong>immediate IgE-mediated (Type I)</strong> and <strong>delayed T cell–mediated (Type IV)</strong> responses.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Neither Type II nor routine Type III reactions are assessed by standard allergy or PPD skin tests.</span></li></ul>",
      "correct_choice_id": 358158,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89943/NEET_PG_aug_2025_MICROBIOLOGY_Question_7.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        6
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89943/NEET_PG_aug_2025_MICROBIOLOGY_Question_7.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89922,
      "choices": [
        {
          "id": 358080,
          "text": "<p><span style=\"font-size:14.0pt;\">RB1</span></p>"
        },
        {
          "id": 358081,
          "text": "<p><span style=\"font-size:14.0pt;\">APC</span></p>"
        },
        {
          "id": 358082,
          "text": "<p><span style=\"font-size:14.0pt;\">VHL&nbsp;</span></p>"
        },
        {
          "id": 358083,
          "text": "<p><span style=\"font-size:14.0pt;\">TP53</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 64-year-old man presents with painless hematuria and unintended weight loss. CT abdomen reveals a solid mass in the upper pole of the left kidney. Biopsy of the mass is given below. Which genetic mutation is most strongly associated with this malignancy?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-08-22%20135539.jpg\" width=\"538\" height=\"358\"></p>",
      "unique_key": "Q2574682",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) VHL</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The clinical features — <strong>hematuria, renal mass, and histology showing clear cytoplasm</strong> — are classic for <strong>clear cell renal cell carcinoma (RCC)</strong>.</span></li><li><span style=\"font-size:14.0pt;\">The tumor originates from the <strong>proximal tubular epithelial cells</strong> of the kidney.</span></li><li><span style=\"font-size:14.0pt;\"><strong>VHL (Von Hippel–Lindau) tumor suppressor gene mutations</strong> on <strong>chromosome 3p</strong> are strongly associated with clear cell RCC.</span></li><li><span style=\"font-size:14.0pt;\">VHL inactivation leads to increased levels of <strong>hypoxia-inducible factor (HIF)</strong>, which upregulates <strong>VEGF and PDGF</strong>, promoting angiogenesis and tumor growth.</span></li><li><span style=\"font-size:14.0pt;\">These tumors may occur sporadically or as part of <strong>Von Hippel–Lindau syndrome</strong>, where bilateral renal cell carcinomas are seen along with hemangioblastomas and pheochromocytomas.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. RB1</strong>: RB1 gene mutations are associated with <strong>retinoblastoma</strong> and <strong>osteosarcoma</strong>, not with renal cell carcinoma.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. APC</strong>: APC gene mutations are linked to <strong>familial adenomatous polyposis (FAP)</strong> and <strong>colorectal carcinoma</strong>, not to RCC.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. TP53</strong>: TP53 mutations are implicated in a wide range of malignancies, including <strong>Li-Fraumeni syndrome</strong>, breast carcinoma, and many solid tumors, but they are <strong>not specifically associated with clear cell RCC</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Clear cell renal cell carcinoma</strong> arises from the proximal tubular epithelium and is strongly associated with <strong>VHL gene inactivation on chromosome 3p</strong>, leading to dysregulated angiogenesis.</span></p>",
      "correct_choice_id": 358082,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89922/NEET_PG_aug_2025_PATHOLOGY_Question_3.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89922/NEET_PG_aug_2025_PATHOLOGY_Question_3.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89816,
      "choices": [
        {
          "id": 357656,
          "text": "<p><span style=\"font-size:14.0pt;\">No inquest is required, as the death was caused by a natural illness.&nbsp;</span></p>"
        },
        {
          "id": 357657,
          "text": "<p><span style=\"font-size:14.0pt;\">A police inquest is required to investigate the cause of death.&nbsp;</span></p>"
        },
        {
          "id": 357658,
          "text": "<p><span style=\"font-size:14.0pt;\">A Magistrate must hold an inquest into the cause of death.&nbsp;</span></p>"
        },
        {
          "id": 357659,
          "text": "<p><span style=\"font-size:14.0pt;\">An inquest is not required, but the body should be forwarded for post mortem examination.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A woman dies after 5 years of marriage due to tuberculosis, following prolonged hospital admission in Mumbai, India. There are no allegation of dowry or suspicious foul play from anyone. The attending physician is confused regarding who will be doing the inquest. Which of the following is the correct in this context?&nbsp;</span></p>",
      "unique_key": "Q2480728",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) No inquest is required, as the death was caused by a natural illness.</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Under&nbsp;<strong>Section 194 BNSS</strong>, a&nbsp;<strong>police inquest</strong>&nbsp;is required only in cases of suicide, homicide, accidents, or deaths under suspicious circumstances.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\"><strong>Section 196 BNSS</strong>&nbsp;mandates a&nbsp;<strong>Magistrate’s inquest</strong>&nbsp;for special cases like custodial deaths or suspicious deaths of women within 7 years of marriage.</span></li><li><span style=\"font-size:14.0pt;\">In this case, the woman died from&nbsp;<strong>tuberculosis</strong>&nbsp;(a natural illness) after&nbsp;<strong>5 years of marriage</strong>, with&nbsp;<strong>no suspicion or foul play</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Since the death is natural and not suspicious,&nbsp;<strong>no inquest—police or magistrate—is required</strong>&nbsp;under either section.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. A police inquest is required to investigate the cause of death</strong>: No police inquest is needed — the death was natural.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C.</strong> <strong>A Magistrate must hold an inquest into the cause of death:</strong> A Magistrate's inquest is only mandatory if the death is unnatural or suspicious (especially within 7 years of marriage). Not applicable here.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.</strong> <strong>An inquest is not required, but the body should be forwarded for post mortem examination:</strong> A post-mortem isn’t mandatory unless there’s doubt about the cause of death. Since it's clearly natural, neither inquest nor post-mortem is required.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Natural deaths</strong> from known illnesses (e.g., tuberculosis) <strong>do not</strong> trigger police or magistrate inquests, nor mandatory post-mortems—these are reserved for <strong>unnatural</strong> or <strong>suspicious</strong> circumstances.</span></p>",
      "correct_choice_id": 357656,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89816/NEET_PG_Aug_FMT_Question_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        10
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89816/NEET_PG_Aug_FMT_Question_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90549,
      "choices": [
        {
          "id": 360560,
          "text": "<p><span style=\"font-size:14.0pt;\">Both bone forearm fractures</span></p>"
        },
        {
          "id": 360561,
          "text": "<p><span style=\"font-size:14.0pt;\">Crush syndrome</span></p>"
        },
        {
          "id": 360562,
          "text": "<p><span style=\"font-size:14.0pt;\">Compartment syndrome</span></p>"
        },
        {
          "id": 360563,
          "text": "<p><span style=\"font-size:14.0pt;\">Deep vein thrombosis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 30-year-old illiterate patient after sustaining injury to Right Upper Limb went for Native treatment, where she was given inappropriate tight bandaging. Now she has presented with severe pain with numbness of hand. On examination pulse felt to be feeble, stretch pain present. What can be the diagnosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_i7IlHwv.png\" width=\"492\" height=\"340\"></strong></span></p>",
      "unique_key": "Q5649187",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Compartment syndrome</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Compartment syndrome occurs when pressure within a closed fascial compartment (in this case, in the forearm) increases, compromising the blood supply and nerve function in the area.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The classic signs and symptoms align perfectly with the patient's presentation:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Severe pain:</strong> The pain is often disproportionate to the injury.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Numbness (Paresthesia):</strong> Caused by nerve compression.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Feeble pulse:</strong> Indicates compromised arterial blood flow.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Stretch pain:</strong> Severe pain when the muscles in the compartment are stretched, which is a key diagnostic sign.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Tight bandaging:</strong> The application of a tight bandage is a common precipitating factor for compartment syndrome, as it restricts the expansion of the muscle compartment.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Both bone forearm fractures:</strong>&nbsp;</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">While a forearm fracture may have been the initial injury, the described progression of symptoms—severe pain, numbness, feeble pulse, and stretch pain after tight bandaging—is not a direct diagnosis of the fracture itself but rather a complication of it.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The diagnosis should reflect the current, life-threatening condition.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Crush syndrome:</strong>&nbsp;</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This is a systemic complication of muscle necrosis caused by severe crushing injuries.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It involves the release of muscle breakdown products (e.g., myoglobin) into the bloodstream, which can lead to kidney failure and other systemic issues.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">While a severe injury could potentially lead to this, the immediate presentation with localized signs like numbness, feeble pulse, and stretch pain points more directly to a localized pressure issue.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Deep vein thrombosis (DVT):</strong>&nbsp;</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">DVT is a blood clot in a deep vein, typically in the legs.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">While it can cause pain and swelling, it does not typically present with the classic signs of compartment syndrome in the upper limb, such as stretch pain and a feeble pulse.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The educational objective is to enable learners to identify and recognize the critical signs and symptoms of <strong>compartment syndrome</strong>, a surgical emergency.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">One should be able to correlate the classic triad of symptoms—disproportionate pain, paresthesia (numbness), and pain on passive stretching—with the patient's history and precipitating factors (like tight bandaging) to make an accurate and timely diagnosis.</span></li></ul>",
      "correct_choice_id": 360562,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90549/NEET_PG_aug_2025_ORTHO_Question_3.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        15
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90549/NEET_PG_aug_2025_ORTHO_Question_3.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90512,
      "choices": [
        {
          "id": 360412,
          "text": "<p><span style=\"font-size:14.0pt;\">Mammography</span></p>"
        },
        {
          "id": 360413,
          "text": "<p><span style=\"font-size:14.0pt;\">X-ray Breast</span></p>"
        },
        {
          "id": 360414,
          "text": "<p><span style=\"font-size:14.0pt;\">USG Breast</span></p>"
        },
        {
          "id": 360415,
          "text": "<p><span style=\"font-size:14.0pt;\">CT Chest</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Identify the modality shown in the image.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-08-14%20141019.jpeg\" width=\"452\" height=\"339\"></span></p>",
      "unique_key": "Q9671628",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Mammography</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The image is a classic mediolateral oblique (MLO) view from a mammogram showing breast parenchyma and calcifications.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Mammography is a specialized low-dose X-ray imaging technique for breast tissue.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. X-ray Breast:&nbsp;</strong>Incorrect. This term is vague and not a standard diagnostic modality. Standard breast X-ray imaging is called <strong>mammography</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. USG Breast:&nbsp;</strong>Incorrect. Ultrasonography shows the breast in grayscale soft tissue imaging, not the radiopaque appearance seen in this image.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. CT Chest:&nbsp;</strong>Incorrect. CT of the chest includes the lungs and mediastinum, not a detailed view of the breast alone, and appears with axial slices, not this projection.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Mammography is the gold standard imaging modality for breast cancer screening and shows detailed internal architecture and calcifications in breast tissue.</span></p>",
      "correct_choice_id": 360412,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90512/NEET_PG_aug_2025_Surgery_Question_14.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90512/NEET_PG_aug_2025_Surgery_Question_14.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90235,
      "choices": [
        {
          "id": 359312,
          "text": "<p><span style=\"font-size:14.0pt;\">Inhibin B</span></p>"
        },
        {
          "id": 359313,
          "text": "<p><span style=\"font-size:14.0pt;\">hCG</span></p>"
        },
        {
          "id": 359314,
          "text": "<p><span style=\"font-size:14.0pt;\">AFP</span></p>"
        },
        {
          "id": 359315,
          "text": "<p><span style=\"font-size:14.0pt;\">Unconjugated Estriol (E3)</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 29-year-old woman, currently 16 weeks pregnant, visits the antenatal clinic for her routine second-trimester evaluation. Her obstetrician recommends maternal serum screening to assess the risk of fetal chromosomal anomalies and quadruple test is ordered. Which of the following analytes is not measured in this screening panel?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q7049306",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Inhibin B</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>quadruple screen</strong> is a maternal blood test performed typically between <strong>15–22 weeks gestation</strong>, most often around <strong>16–18 weeks</strong>, to screen for fetal chromosomal abnormalities like <strong>Down syndrome (Trisomy 21)</strong> and <strong>neural tube defects</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It measures four biomarkers:</span></li></ul><ol><li><span style=\"font-size:14.0pt;\"><strong>Alpha-fetoprotein (AFP)</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Human chorionic gonadotropin (hCG)</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Unconjugated estriol (uE3)</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Inhibin A</strong></span></li></ol><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Inhibin B</strong> is <strong>not part of the quadruple screen</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">While it is a hormone involved in gonadal feedback mechanisms and can be used in reproductive endocrinology, <strong>it has no role in prenatal screening protocols</strong> such as the quadruple test.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. hCG:&nbsp;</strong>Correct component. Elevated in pregnancies affected by Down syndrome. Lowered in Trisomy 18.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. AFP (Alpha-fetoprotein):</strong> Correct component. Produced by the fetal liver; elevated in open neural tube defects and decreased in some chromosomal abnormalities.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Unconjugated Estriol (E3):</strong> Correct component. A marker of fetal well-being and placental function; typically decreased in Down syndrome.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>The quadruple screening test includes AFP, hCG, unconjugated estriol (E3), and inhibin A.&nbsp;</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Inhibin B is not part of this panel.</strong>&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This test is vital for assessing the risk of fetal aneuploidy during the second trimester.</span></li></ul>",
      "correct_choice_id": 359312,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90235/NEET_PG_aug_2025_OBG_Question_19.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90235/NEET_PG_aug_2025_OBG_Question_19.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90895,
      "choices": [
        {
          "id": 361916,
          "text": "<p><span style=\"font-size:14.0pt;\">Rofecoxib</span></p>"
        },
        {
          "id": 361917,
          "text": "<p><span style=\"font-size:14.0pt;\">Nicorandil</span></p>"
        },
        {
          "id": 361918,
          "text": "<p><span style=\"font-size:14.0pt;\">Losartan</span></p>"
        },
        {
          "id": 361919,
          "text": "<p><span style=\"font-size:14.0pt;\">Metoprolol</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following medications has been associated with the adverse cardiac outcomes, including increased cardiac mortality?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q3637845",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Rofecoxib</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Rofecoxib</strong>, a selective COX-2 inhibitor, was withdrawn from the market due to its association with a <strong>significantly increased risk of myocardial infarction and stroke</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The inhibition of prostacyclin (a vasodilator and inhibitor of platelet aggregation) without affecting thromboxane A2 (a vasoconstrictor and promoter of platelet aggregation) creates a <strong>pro-thrombotic state</strong>, leading to cardiovascular events.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Nicorandil</strong>: A nitrate-like drug used in angina; not associated with increased cardiac mortality.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Losartan</strong>: An angiotensin receptor blocker (ARB) with cardiovascular <strong>protective effects</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Metoprolol</strong>: A β1-selective blocker that <strong>reduces mortality</strong> in heart failure and post-MI patients.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Rofecoxib, a COX-2 inhibitor, was linked to increased cardiovascular risk and was withdrawn due to elevated rates of myocardial infarction and cardiac mortality.</span></p>",
      "correct_choice_id": 361916,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90895/NEET_PG_aug_2025_PHARMACOLOGY_Question_18.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90895/NEET_PG_aug_2025_PHARMACOLOGY_Question_18.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89924,
      "choices": [
        {
          "id": 358088,
          "text": "<p><span style=\"font-size:14.0pt;\">Promotes cell cycle progression from G1 to S phase&nbsp;</span></p>"
        },
        {
          "id": 358089,
          "text": "<p><span style=\"font-size:14.0pt;\">Acts as a transcription factor for epidermal growth factor signalling</span></p>"
        },
        {
          "id": 358090,
          "text": "<p><span style=\"font-size:14.0pt;\">Facilitates homologous recombination–mediated repair of DNA double-strand breaks</span></p>"
        },
        {
          "id": 358091,
          "text": "<p><span style=\"font-size:14.0pt;\">Stimulates vascular endothelial growth factor expression</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following best describes the primary function of the BRCA1 gene product?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q4199158",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Facilitates homologous recombination–mediated repair of DNA double-strand breaks</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>BRCA1</strong> is a tumor suppressor gene that encodes a protein involved in the <strong>repair of double-strand DNA breaks</strong> via <strong>homologous recombination</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Mutations in BRCA1 (and BRCA2) increase the risk of <strong>breast, ovarian, prostate, and pancreatic cancers</strong> because defective DNA repair leads to genomic instability.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Promotes cell cycle progression from G1 to S phase</strong>: This role is associated with <strong>cyclins/CDKs</strong>, not BRCA1, which functions as a tumor suppressor, not an oncogene.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Acts as a transcription factor for epidermal growth factor signalling</strong>: Growth factor signaling is mediated by receptors like <strong>HER2/neu (ERBB2)</strong>, not BRCA1.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Stimulates vascular endothelial growth factor expression</strong>: Angiogenesis is promoted by <strong>VEGF and HIF-1α</strong>, not BRCA1.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">BRCA1 is a tumor suppressor gene that repairs double-strand DNA breaks via homologous recombination.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Loss of BRCA1 function predisposes to breast and ovarian cancers due to defective DNA repair.</span></li></ul>",
      "correct_choice_id": 358090,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89924/NEET_PG_aug_2025_PATHOLOGY_Question_5.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89924/NEET_PG_aug_2025_PATHOLOGY_Question_5.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90836,
      "choices": [
        {
          "id": 361684,
          "text": "<p><span style=\"font-size:14.0pt;\">Metabolic acidosis</span></p>"
        },
        {
          "id": 361685,
          "text": "<p><span style=\"font-size:14.0pt;\">Metabolic alkalosis</span></p>"
        },
        {
          "id": 361686,
          "text": "<p><span style=\"font-size:14.0pt;\">Respiratory acidosis</span></p>"
        },
        {
          "id": 361687,
          "text": "<p><span style=\"font-size:14.0pt;\">Respiratory alkalosis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A man went for trekking on a high mountain. Which of the following primary acid–base abnormality is most likely to occur based on his physiological response to high altitude?&nbsp;</span></p>",
      "unique_key": "Q9923183",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Respiratory alkalosis</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">At high altitude, the reduced atmospheric oxygen pressure lowers alveolar and arterial PO₂, leading to hypoxaemia.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This is detected by peripheral chemoreceptors in the carotid and aortic bodies, which stimulate the respiratory centre to increase ventilation.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The resulting hyperventilation causes excessive CO₂ washout, lowering PaCO₂ and shifting the bicarbonate buffer equilibrium toward a higher pH, producing acute respiratory alkalosis.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">If the exposure is prolonged over two to three days, the kidneys respond by excreting more bicarbonate, which partially normalizes the pH.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Metabolic acidosis:</strong> Would require primary ↓ HCO₃⁻ (e.g., diarrhoea, lactic acidosis); not the first change at altitude.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Metabolic alkalosis:</strong> Seen with H⁺ loss or excess HCO₃⁻; opposite of what occurs initially.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Respiratory acidosis:</strong> Results from hypoventilation &amp; CO₂ retention, not hyperventilation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">At high altitude, hypoxic stimulation of peripheral chemoreceptors causes <strong>hyperventilation</strong>, leading to <strong>primary respiratory alkalosis</strong> (↓ PaCO₂, ↑ pH).&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">With time, renal bicarbonate loss provides partial metabolic compensation.</span></li></ul>",
      "correct_choice_id": 361687,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90836/NEET_PG_aug_2025_PHYSIOLOGY_Question_7.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        2
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90836/NEET_PG_aug_2025_PHYSIOLOGY_Question_7.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90487,
      "choices": [
        {
          "id": 360312,
          "text": "<p><span style=\"font-size:14.0pt;\">Re-explore laparoscopically</span></p>"
        },
        {
          "id": 360313,
          "text": "<p><span style=\"font-size:14.0pt;\">Higher antibiotics</span></p>"
        },
        {
          "id": 360314,
          "text": "<p><span style=\"font-size:14.0pt;\">MRCP</span></p>"
        },
        {
          "id": 360315,
          "text": "<p><span style=\"font-size:14.0pt;\">USG-guided aspiration of content</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 30-year-old female presented with pain in the right upper quadrant of the abdomen after 4 days of cholecystectomy. On USG, it showed a significant collection of 200 cc in the RUQ. What will you do further?</span></p>",
      "unique_key": "Q6708856",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) USG-guided aspiration of content</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The patient presents with a post-cholecystectomy fluid collection, most likely a biloma or infected collection.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The next best step is <strong>ultrasound-guided aspiration</strong> for diagnostic and therapeutic purposes.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It helps assess the nature of the fluid and may relieve symptoms.</span></li><li><span style=\"font-size:14.0pt;\">After USG guided aspiration of content, insert pig tail catheter.&nbsp;</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Re-explore laparoscopically:&nbsp;</strong>It is more invasive and reserved for peritonitis or failed conservative management.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Higher antibiotics:&nbsp;</strong>May be used adjunctively but not as a sole intervention.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. MRCP:&nbsp;</strong>It is diagnostic but not immediately therapeutic.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">In post-cholecystectomy patients with localized fluid collection, USG-guided aspiration is the initial therapeutic and diagnostic step.</span></p>",
      "correct_choice_id": 360315,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90487/NEET_PG_aug_2025_Surgery_Question_3.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90487/NEET_PG_aug_2025_Surgery_Question_3.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89817,
      "choices": [
        {
          "id": 357660,
          "text": "<p><span style=\"font-size:14.0pt;\">Contact shot</span></p>"
        },
        {
          "id": 357661,
          "text": "<p><span style=\"font-size:14.0pt;\">Close shot&nbsp;</span></p>"
        },
        {
          "id": 357662,
          "text": "<p><span style=\"font-size:14.0pt;\">Intermediate range&nbsp;</span></p>"
        },
        {
          "id": 357663,
          "text": "<p><span style=\"font-size:14.0pt;\">Distant shot&nbsp;</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 28-year-old man arrives unconscious after being found near a spent-­shell casing. On exam, there is a 1 cm circular wound on his right chest. The margin is surrounded by a broad, sooty, blackened zone but no soot is found in the central defect. Which firing distance best explains these findings?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q2048374",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>B) Close shot</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In a <strong>close shot</strong>, the muzzle is held just slightly away from the skin (typically within about 1 ft), allowing hot gases and soot-laden powder to spray out in a broad halo around the entry wound.</span></li><li><span style=\"font-size:14.0pt;\">These hot gases blacken and burn the skin over an area surrounding the defect—but without the tight gas seal required to drive soot or gas into the wound tract itself.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Hence, you see a <strong>broad, sooty blackened zone</strong> encircling the 1 cm entry wound, with <strong>no soot deposited in the central defect</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Contact shot:</strong> A contact shot yields a muzzle seal against the skin, forcefully driving gases and soot <strong>into</strong> the tissues. Externally, you’ll see a <strong>narrow soot ring</strong> confined exactly to the wound margin, often with muzzle imprint or concentric abrasion. You <strong>would not</strong> get a broad halo of blackening.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Intermediate range:</strong> At about 1–3 ft, the propellant gases have cooled too much to blacken the skin. What remains are <strong>unburned powder particles</strong> that embed as pinpoint abrasions (“stippling” or “tattooing”) around the wound—<strong>no soot or burning</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Distant shot:</strong> Beyond roughly 3 ft, both soot and powder particles disperse and never reach the target. An entry wound from a distant shot appears as a clean defect with <strong>no blackening, burning, or stippling</strong> on the surrounding skin.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Entry Wound features<strong>:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Contact Shot:&nbsp;</strong>Burning, blackening and tattooing present just on the margin; not around the wound. Very minimally visible.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\"><strong>Close Shot:&nbsp;</strong>Burning, blackening and tattooing present in large amount around the wound (esp. blackening is prominent)&nbsp;</span></li><li><span style=\"font-size:14.0pt;\"><strong>Intermediate Range:</strong> Only Tattooing present around the wound</span></li><li><span style=\"font-size:14.0pt;\"><strong>Distant range:</strong> None of these present around the wound.</span></li></ul>",
      "correct_choice_id": 357661,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89817/NEET_PG_Aug_FMT_Question_3.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        10
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89817/NEET_PG_Aug_FMT_Question_3.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89949,
      "choices": [
        {
          "id": 358180,
          "text": "<p><span style=\"font-size:14.0pt;\">Influenza A</span></p>"
        },
        {
          "id": 358181,
          "text": "<p><span style=\"font-size:14.0pt;\">Parainfluenza virus</span></p>"
        },
        {
          "id": 358182,
          "text": "<p><span style=\"font-size:14.0pt;\">Respiratory syncytial virus (RSV)</span></p>"
        },
        {
          "id": 358183,
          "text": "<p><span style=\"font-size:14.0pt;\">SARS coronavirus</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Study the viral replication cycle shown in the given image. Which virus is depicted?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_tJTgqur.png\" width=\"831\" height=\"510\"></strong></span></p>",
      "unique_key": "Q3565783",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Influenza A</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Key features identifying Influenza A:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Segmented (–) sense RNA genome:</strong> Influenza possesses eight RNA segments that require nuclear import for transcription, unlike most other RNA viruses that replicate entirely in the cytoplasm.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Nuclear replication:</strong> The image shows viral RNA (vRNA) and mRNA synthesis within the host cell nucleus, a hallmark of Orthomyxoviruses.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Surface glycoproteins HA and NA:</strong> Influenza’s hemagglutinin (HA) mediates attachment and fusion, while neuraminidase (NA) cleaves sialic acid to facilitate viral release. These are unique to influenza among the listed respiratory viruses.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Budding from the plasma membrane:</strong> Mature influenza virions bud through the host cell membrane, acquiring their envelope studded with HA, NA, and M2 proteins.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Parainfluenza virus:</strong> A Paramyxovirus with a <strong>nonsegmented</strong> (–) sense RNA genome that replicates in the <strong>cytoplasm</strong>, not the nucleus. Its surface proteins include hemagglutinin–neuraminidase (HN) but lack separate NA and the segmented genome.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Respiratory syncytial virus (RSV):</strong> Also a Paramyxovirus, RSV has a <strong>nonsegmented</strong> genome and <strong>fusion (F) proteins</strong> but no neuraminidase. It replicates in the cytoplasm and forms syncytia rather than budding via HA/NA.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. SARS coronavirus:</strong> A positive-sense, <strong>nonsegmented</strong> RNA virus of the Coronaviridae family that replicates entirely in the cytoplasm and uses spike (S) proteins for entry, without HA/NA.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Orthomyxoviruses like <strong>Influenza A</strong> replicate their <strong>segmented (–) sense RNA</strong> within the <strong>nucleus</strong> and bud from the plasma membrane using distinct <strong>hemagglutinin</strong> and <strong>neuraminidase</strong> surface glycoproteins.</span></p>",
      "correct_choice_id": 358180,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89949/NEET_PG_aug_2025_MICROBIOLOGY_Question_13.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        6
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89949/NEET_PG_aug_2025_MICROBIOLOGY_Question_13.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90875,
      "choices": [
        {
          "id": 361836,
          "text": "<p><span style=\"font-size:14.0pt;\">Fidaxomicin</span></p>"
        },
        {
          "id": 361837,
          "text": "<p><span style=\"font-size:14.0pt;\">IV ceftriaxone</span></p>"
        },
        {
          "id": 361838,
          "text": "<p><span style=\"font-size:14.0pt;\">Bezlotoxumab</span></p>"
        },
        {
          "id": 361839,
          "text": "<p><span style=\"font-size:14.0pt;\">Oral metronidazole</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 62-year-old patient is diagnosed with C. difficile colitis after receiving levofloxacin post-surgery. He has had 2 prior episodes in the last 6 months; both treated with oral vancomycin. Which of the following agents can be added now to reduce recurrence risk?</span></p>",
      "unique_key": "Q1465621",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>C) Bezlotoxumab</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This patient has&nbsp;<strong>recurrent C. difficile infection (≥2 relapses within 6 months)</strong>&nbsp;despite standard therapy with oral vancomycin.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">In such patients, adding&nbsp;<strong>bezlotoxumab</strong>, a monoclonal antibody against C. difficile toxin B, reduces recurrence risk.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It is given IV along with standard antibiotics and is particularly recommended in patients at high risk of recurrence.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Fidaxomicin</strong>: Effective for&nbsp;treatment&nbsp;of C. difficile (pseudomembranous colitis) and has a slightly lower recurrence rate compared to vancomycin, but this patient has already had multiple recurrences. Fidaxomicin could be considered as an alternative regimen, but the specific agent shown to&nbsp;reduce recurrence risk when added&nbsp;is bezlotoxumab.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. IV ceftriaxone</strong>: Incorrect. This broad-spectrum antibiotic could actually predispose further to C. difficile by disrupting gut flora. It has no role in treatment or prevention of C. difficile.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Oral metronidazole</strong>: Used in&nbsp;mild initial episodes&nbsp;of C. difficile, but not recommended for recurrent cases (especially after vancomycin failures). Recurrent infections require stronger regimens (fidaxomicin, vancomycin taper, or adjunctive bezlotoxumab).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Bezlotoxumab is a monoclonal antibody targeting C. difficile toxin B and is used adjunctively to reduce the risk of recurrence in high-risk patients.</span></p>",
      "correct_choice_id": 361838,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90875/NEET_PG_aug_2025_PHARMACOLOGY_Question_3.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90875/NEET_PG_aug_2025_PHARMACOLOGY_Question_3.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90485,
      "choices": [
        {
          "id": 360304,
          "text": "<p><span style=\"font-size:14.0pt;\">2, 3 and 4</span></p>"
        },
        {
          "id": 360305,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 2 &amp; 3</span></p>"
        },
        {
          "id": 360306,
          "text": "<p><span style=\"font-size:14.0pt;\">5, 6, 7 &amp; 8</span></p>"
        },
        {
          "id": 360307,
          "text": "<p><span style=\"font-size:14.0pt;\">2, 3, 4 &amp; 5</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 46-year-old male had a tumor in the left lobe of his liver. A left hemi-hepatectomy was planned. Which of the following segments of the liver will be resected in this procedure?</span></p>",
      "unique_key": "Q9938868",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) 2, 3 and 4</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The liver is divided into 8 functional segments based on Couinaud’s classification.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">A <strong>left hemihepatectomy</strong> involves the removal of segments <strong>II, III, and IV</strong> (which form the functional left liver).&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Segment I (caudate lobe) is usually preserved unless specifically indicated.</span></li><li><span style=\"font-size:14.0pt;\">This surgical procedure is performed for tumors localized to the left lobe and ensures oncologic clearance.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/WhatsApp%20Image%202025-08-20%20at%2015.42.41.jpeg\" width=\"597\" height=\"427\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. 1, 2 &amp; 3</strong>: Segment 1 is the caudate lobe and is not routinely removed in left hemihepatectomy.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. 5, 6, 7 &amp; 8</strong>: These belong to the <strong>right</strong> lobe of the liver.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. 2, 3, 4 &amp; 5</strong>: Segment 5 is part of the right lobe.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Left hemihepatectomy includes resection of segments II, III, and IV, which correspond to the functional left liver, crucial for managing tumors in the left hepatic lobe.</span></p>",
      "correct_choice_id": 360304,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90485/NEET_PG_aug_2025_Surgery_Question_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90485/NEET_PG_aug_2025_Surgery_Question_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90229,
      "choices": [
        {
          "id": 359288,
          "text": "<p><span style=\"font-size:14.0pt;\">Decidua basalis</span></p>"
        },
        {
          "id": 359289,
          "text": "<p><span style=\"font-size:14.0pt;\">Trophoblastic shell</span></p>"
        },
        {
          "id": 359290,
          "text": "<p><span style=\"font-size:14.0pt;\">Nitabuch’s layer</span></p>"
        },
        {
          "id": 359291,
          "text": "<p><span style=\"font-size:14.0pt;\">Chorionic villi</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 32-year-old gravida 3 para 2 woman presents at 34 weeks of gestation for routine evaluation. She has had two prior cesarean deliveries. Recent sonographic evaluation reveals findings highly suspicious for abnormal placental adherence with loss of the normal uteroplacental interface and placental lacunae. The invasive pathology is most likely associated with absence of which of the following histological barriers?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q5316847",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Nitabuch’s layer</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This patient presents with signs of <strong>placenta accreta spectrum (PAS)</strong>, a condition characterized by <strong>abnormal placental adherence to or invasion into the myometrium</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It is commonly associated with <strong>prior uterine surgeries</strong> such as <strong>cesarean sections</strong>, particularly in the presence of <strong>placenta previa</strong>.</span></li><li><span style=\"font-size:14.0pt;\">In a normal pregnancy, the <strong>Nitabuch’s layer</strong>, a <strong>fibrinoid layer within the decidua basalis</strong>, acts as a protective boundary that prevents chorionic villi from invading the myometrium.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">In <strong>placenta accreta spectrum disorders</strong>, <strong>this Nitabuch’s layer is absent</strong>, leading to <strong>direct attachment</strong> of placental villi to the myometrium (<strong>accreta</strong>), <strong>invasion into</strong> the myometrium (<strong>increta</strong>), or <strong>penetration through</strong> the uterine wall (<strong>percreta</strong>).</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Decidua basalis</strong>: While the decidua basalis is the maternal component of the placenta, its mere presence or absence is not the specific issue in PAS. The <strong>Nitabuch’s layer within the decidua basalis</strong> is the structural barrier that becomes deficient.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Trophoblastic shell</strong>: This structure helps in initial implantation and anchoring of the placenta but <strong>does not function as a barrier</strong> to prevent deep invasion into the uterus. It is not implicated in the pathogenesis of placenta accreta spectrum.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Chorionic villi</strong>: These are normal fetal structures that participate in nutrient exchange. In PAS, the <strong>problem is not the chorionic villi themselves</strong>, but the <strong>absence of the structural layer (Nitabuch’s layer)</strong> that limits their depth of invasion.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Absence of Nitabuch’s layer</strong> is the key pathological feature leading to abnormal placental invasion (placenta accreta spectrum), particularly in women with previous cesarean deliveries.</span></p>",
      "correct_choice_id": 359290,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90229/NEET_PG_aug_2025_OBG_Question_15.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90229/NEET_PG_aug_2025_OBG_Question_15.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89959,
      "choices": [
        {
          "id": 358220,
          "text": "<p><span style=\"font-size:14.0pt;\">Inferior surface of the right ventricle</span></p>"
        },
        {
          "id": 358221,
          "text": "<p><span style=\"font-size:14.0pt;\">Lateral part of the heart</span></p>"
        },
        {
          "id": 358222,
          "text": "<p><span style=\"font-size:14.0pt;\">Posterior part of the interventricular septum</span></p>"
        },
        {
          "id": 358223,
          "text": "<p><span style=\"font-size:14.0pt;\">Anterior wall of the left ventricle</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 64-year-old man presents with chest pain and shortness of breath. ECG shows ST-segment elevations in leads II, III, and aVF. Coronary angiography confirms a right coronary artery (RCA) occlusion. Which of the following myocardial regions is most likely affected in this patient?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q8453608",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Posterior part of the interventricular septum</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>right coronary artery (RCA)</strong> supplies several important structures in the heart, including:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Inferior wall of the left ventricle</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Posterior part of the interventricular septum</strong> (via the <strong>posterior descending artery</strong>, which typically arises from the RCA in a right-dominant circulation, the most common type)</span></li><li><span style=\"font-size:14.0pt;\"><strong>Inferior part of the right ventricle</strong></span></li></ul></li><li><span style=\"font-size:14.0pt;\">When the <strong>RCA is occluded</strong>, as in this clinical scenario (ST elevation in II, III, aVF), the <strong>posterior part of the interventricular septum</strong> is frequently involved.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This area is critically affected due to its vascular supply from the <strong>posterior descending artery</strong>, which branches from the RCA in ~85% of individuals.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_7usDcDW.png\" width=\"362\" height=\"286\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Inferior surface of the right ventricle:</strong>&nbsp;While the RCA does supply this area, it is <strong>less commonly the main contributor</strong> to infarction in ST-elevation MI compared to the posterior septum. Also, ECG signs and wall motion abnormalities point more strongly toward septal involvement.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Lateral part of the heart:</strong>&nbsp;This region is typically supplied by the <strong>left circumflex artery</strong>, not the RCA. It is not implicated in RCA-related infarcts.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Anterior wall of the left ventricle:</strong>&nbsp;This is supplied by the <strong>left anterior descending (LAD) artery</strong>. Infarction of this region would show ECG changes in <strong>precordial leads (V1–V4)</strong>, not inferior leads.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">In right-dominant coronary circulation (most common), occlusion of the right coronary artery can lead to infarction of the posterior part of the interventricular septum via its branch, the posterior descending artery.</span></p>",
      "correct_choice_id": 358222,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89959/NEET_PG_aug_2025_ANATOMY_Question_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        3
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89959/NEET_PG_aug_2025_ANATOMY_Question_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89899,
      "choices": [
        {
          "id": 357988,
          "text": "<p><span style=\"font-size:14.0pt;\">1 and 2</span></p>"
        },
        {
          "id": 357989,
          "text": "<p><span style=\"font-size:14.0pt;\">2 and 3</span></p>"
        },
        {
          "id": 357990,
          "text": "<p><span style=\"font-size:14.0pt;\">3 and 4</span></p>"
        },
        {
          "id": 357991,
          "text": "<p><span style=\"font-size:14.0pt;\">1 and 4</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which statements correctly contrast egg‐laying patterns of hard vs. soft ticks?&nbsp;</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">Hard ticks lay eggs only once, in very large batches (hundreds–thousands).</span></li><li><span style=\"font-size:14.0pt;\">Soft ticks lay eggs in small batches (20–100) repeatedly over time.</span></li><li><span style=\"font-size:14.0pt;\">Hard ticks deposit eggs in multiple small batches throughout their life.</span></li><li><span style=\"font-size:14.0pt;\">Soft ticks deposit a single, massive egg batch and then die.</span></li></ol>",
      "unique_key": "Q2840928",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) 1 and 2</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 1.</strong> <strong>Hard ticks lay eggs only once, in very large batches (hundreds–thousands):&nbsp;</strong>True<strong>.&nbsp;</strong>Hard ticks lay a single, very large batch of eggs (hundreds to thousands) after engorgement.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 2.&nbsp;Soft ticks lay eggs in small batches (20–100) repeatedly over time:&nbsp;</strong>True<strong>.</strong> Soft ticks lay smaller clutches of eggs (20–100) repeatedly over their lifespan.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Incorrect Statements:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 3.</strong> <strong>Hard ticks deposit eggs in multiple small batches throughout their life:&nbsp;</strong>False<strong>.</strong> Hard ticks do <strong>not</strong> lay multiple small batches; they oviposit once in one large batch.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 4</strong>. <strong>Soft ticks deposit a single, massive egg batch and then die:&nbsp;</strong>False<strong>.&nbsp;</strong>Soft ticks do <strong>not</strong> lay a single massive batch; they deposit eggs in several small batches over time.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Hard Ticks vs. Soft Ticks:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_KgLAXhK.png\" width=\"678\" height=\"518\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-08-19%20161314.jpeg\" width=\"1035\" height=\"443\"></strong></span></p>",
      "correct_choice_id": 357988,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89899/NEET_PG_aug_2025_PSM_Question_13.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89899/NEET_PG_aug_2025_PSM_Question_13.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89815,
      "choices": [
        {
          "id": 357652,
          "text": "<p><span style=\"font-size:14.0pt;\">Arsenic</span></p>"
        },
        {
          "id": 357653,
          "text": "<p><span style=\"font-size:14.0pt;\">Organophosphate</span></p>"
        },
        {
          "id": 357654,
          "text": "<p><span style=\"font-size:14.0pt;\">Lead</span></p>"
        },
        {
          "id": 357655,
          "text": "<p><span style=\"font-size:14.0pt;\">Iron overdose</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 34-year-old male presents to the emergency department with profuse vomiting, severe abdominal cramping, and profuse watery diarrhea. On examination, his breath has a faint garlicky odor. His blood pressure is 90/60 mm Hg, and his heart rate is 110 bpm. He reports working in a pesticide factory and thinks he may have ingested a small amount of a contaminant. A stool sample is noted to be dark greenish in color. Which of the following toxins is the most likely culprit?&nbsp;</span></p>",
      "unique_key": "Q5322969",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;A) Arsenic</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Garlicky odor is seen in TOPA (<strong>Mnemonic</strong>)→ Thallium, organophosphate, phosphorus and arsenic&nbsp;&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Arsenic poisoning classically presents with acute gastrointestinal distress—severe abdominal pain, vomiting, and profuse diarrhea—often accompanied by a garlic-like odor on the breath.</span></li><li><span style=\"font-size:14.0pt;\">In arsenic poisoning dark coloured diarrhea which later becomes rice watery</span></li><li><span style=\"font-size:14.0pt;\">Arsenic reacts with sulfhydryl groups and, when reduced in the gut, can yield colored compounds that may impart a greenish or blackish hue to the stool.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The hypotension and tachycardia further reflect arsenic’s profound fluid shifts and vasodilatory effects.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Organophosphate:</strong> In case of organophosphate cholinergic symptoms occur. These inhibit acetylcholinesterase, causing muscarinic signs (excessive salivation, bronchospasm, diarrhea) and nicotinic effects (muscle twitching), plus pinpoint pupils. They do not produce a garlic odor or dark-green stools.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Lead:</strong> Chronic lead toxicity features abdominal pain (“lead colic”), constipation, headache, and a bluish gingival line, with stools often dark or tarry from gastrointestinal bleeding. Lead does not cause vomiting with garlic odor or acute secretory diarrhea.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Iron overdose:</strong> Excess iron causes nausea, vomiting, and abdominal pain early and, later, metabolic acidosis and hepatic injury. Black or dark-green stools from iron sulfide can occur, but there is no characteristic garlicky breath odor.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Comparison of Poisoning Types:</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-08-22%20110758.jpeg\" width=\"604\" height=\"756\"></p>",
      "correct_choice_id": 357652,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89815/NEET_PG_Aug_FMT_Question_1.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        10
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89815/NEET_PG_Aug_FMT_Question_1.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90543,
      "choices": [
        {
          "id": 360536,
          "text": "<p><span style=\"font-size:14.0pt;\">Retinitis punctata albescens</span></p>"
        },
        {
          "id": 360537,
          "text": "<p><span style=\"font-size:14.0pt;\">Fundus albipunctatus</span></p>"
        },
        {
          "id": 360538,
          "text": "<p><span style=\"font-size:14.0pt;\">Best disease</span></p>"
        },
        {
          "id": 360539,
          "text": "<p><span style=\"font-size:14.0pt;\">Stargardt macular dystrophy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 22-year-old woman complains of lifelong difficulty seeing in dim light but has perfect daytime vision. Examination shows numerous tiny white dots scattered throughout her mid-peripheral retina, as in the image below. Which inherited condition is most likely?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_MgvPR5l.png\" width=\"416\" height=\"274\"></strong></span></p>",
      "unique_key": "Q3169508",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Fundus albipunctatus</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Fundus albipunctatus</strong> is a form of stationary congenital night blindness characterized by:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Numerous small, round, yellow-white dots</strong> in the mid-peripheral retina (“salt-and-pepper” appearance).</span></li><li><span style=\"font-size:14.0pt;\"><strong>Congenital nyctalopia</strong> (night blindness from birth) with normal daytime (cone-mediated) vision.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Delayed rod dark adaptation</strong> on electroretinogram that improves after prolonged (&gt;2–3 hours) dark adaptation.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">This condition arises from <strong>autosomal recessive</strong> mutations in the <strong>RDH5</strong> gene, which encodes 11-cis-retinol dehydrogenase in the visual cycle.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-08-20%20164039.jpeg\" width=\"393\" height=\"262\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Retinitis punctata albescens:&nbsp;</strong>Also features white retinal flecks but causes a <strong>progressive</strong> rod-cone dystrophy. There is <strong>no recovery</strong> of rod function with prolonged dark adaptation, and patients gradually lose both night and day vision.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-08-20%20133257.jpeg\" width=\"384\" height=\"375\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Best disease</strong> (vitelliform macular dystrophy): Presents with a <strong>“egg-yolk”</strong> lesion in the <strong>macula</strong>, not widespread flecks. Central vision and color discrimination are affected early. EOG is the IOC and used to measure Arden ratio.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-08-20%20164051.jpeg\" width=\"371\" height=\"280\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Stargardt macular dystrophy:&nbsp;</strong>Characterized by <strong>flecks at the posterior pole</strong> and a <strong>“beaten-bronze”</strong> macular appearance, leading to central vision loss in childhood or adolescence. It does <strong>not</strong> cause congenital night blindness.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-08-20%20164104.jpeg\" width=\"302\" height=\"257\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">In a patient with lifelong night blindness, <strong>normal daytime vision</strong>, and <strong>mid-peripheral retinal flecks</strong>, think <strong>fundus albipunctatus</strong>—verify with delayed-but-recoverable rod ERG and genetic testing for <strong>RDH5</strong> mutations.&nbsp;</span></p>",
      "correct_choice_id": 360537,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90543/Neet_Pg_Aug_2025_Opthalmology_Question_3.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        8
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90543/Neet_Pg_Aug_2025_Opthalmology_Question_3.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90814,
      "choices": [
        {
          "id": 361596,
          "text": "<p><span style=\"font-size:14.0pt;\">Checking growth hormone after an oral glucose load</span></p>"
        },
        {
          "id": 361597,
          "text": "<p><span style=\"font-size:14.0pt;\">Fasting morning growth hormone level</span></p>"
        },
        {
          "id": 361598,
          "text": "<p><span style=\"font-size:14.0pt;\">Glucagon stimulation test</span></p>"
        },
        {
          "id": 361599,
          "text": "<p><span style=\"font-size:14.0pt;\">Measurement of serum IGF-1</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 40-year-old man presents with a 2-year history of increasing knee and shoulder stiffness and swelling in his hands and feet. His snoring got worsened as per his wife, and he has the following features on examination. What is the next best step?&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_chpOZNq.png\" width=\"230\" height=\"332\"></span></p>",
      "unique_key": "Q5460832",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;D) Measurement of serum IGF-1</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Enlarged hands/feet, joint stiffness, snoring, and facial changes suggest acromegaly from growth hormone (GH) excess.</span></li><li><span style=\"font-size:14.0pt;\">Serum IGF-1, reflecting long-term GH activity, is the best initial screening test due to GH’s pulsatile secretion.</span></li><li><span style=\"font-size:14.0pt;\">Elevated IGF-1 prompts confirmatory glucose suppression testing.</span></li><li><span style=\"font-size:14.0pt;\">Acromegaly may cause sleep apnea (snoring due to macroglossia), diabetes, or hypertension.</span></li><li><span style=\"font-size:14.0pt;\">Facial features include frontal bossing, coarse facial features, prognathism, squaring of mandible, prominent zygoma, etc.&nbsp;</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Checking growth hormone after an oral glucose load:</strong> Confirmatory, not initial test. Giving a glucose load decreases serum growth hormone levels to an undetectable range.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Fasting morning growth hormone level:</strong> Unreliable due to pulsatile GH secretion.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Glucagon stimulation test:</strong> Used for testing GH deficiency, not acromegaly.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Acromegaly is screened with serum IGF-1.</span></li><li><span style=\"font-size:14.0pt;\">Features include enlarged extremities and snoring.</span></li><li><span style=\"font-size:14.0pt;\">Confirm with glucose suppression if IGF-1 elevated.</span></li></ul>",
      "correct_choice_id": 361599,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90814/Neet_Pg_Aug_2025_Medicine_Question_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90814/Neet_Pg_Aug_2025_Medicine_Question_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89898,
      "choices": [
        {
          "id": 357984,
          "text": "<p><span style=\"font-size:14.0pt;\">They survive longer than many waterborne pathogens</span></p>"
        },
        {
          "id": 357985,
          "text": "<p><span style=\"font-size:14.0pt;\">They are abundant in the human intestine</span></p>"
        },
        {
          "id": 357986,
          "text": "<p><span style=\"font-size:14.0pt;\">They require specialized, hard‑to‑obtain culture media</span></p>"
        },
        {
          "id": 357987,
          "text": "<p><span style=\"font-size:14.0pt;\">They are easily detected by simple culture methods</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A municipal laboratory assesses fecal contamination in drinking water. Which property least justifies using coliforms (especially E. coli) as the primary bacterial indicator?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q1174141",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) They require specialized, hard‑to‑obtain culture media</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Coliforms like E. coli are selected because they are common in fecal matter, persist longer than many pathogens in the environment, and can be reliably identified on standard, widely available media using straightforward acid‑and‑gas tests.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The notion that they need rare or expensive culture systems is incorrect and does not support their role as practical indicators of fecal pollution.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.</strong> <strong>They survive longer than many waterborne pathogens:</strong> Survival advantage: Coliforms’ ability to endure environmental stresses longer than many pathogens makes them a conservative marker of past contamination.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B.</strong> <strong>They are abundant in the human intestine:</strong> Abundance. Their high concentration in human intestines ensures that even small fecal inputs yield detectable coliform counts.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.</strong> <strong>They are easily detected by simple culture methods:</strong> Ease of detection. Routine laboratory media (e.g., Acid gas formation test) allow simple, low‑cost confirmation of coliform presence.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Coliforms are chosen as fecal indicators because they are <strong>widespread</strong>, <strong>resilient</strong>, and <strong>detectable</strong> with basic microbiological methods—not because they demand complex or rare media.</span></p>",
      "correct_choice_id": 357986,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89898/NEET_PG_aug_2025_PSM_Question_12.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89898/NEET_PG_aug_2025_PSM_Question_12.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89863,
      "choices": [
        {
          "id": 357844,
          "text": "<p><span style=\"font-size:14.0pt;\">Malaria surveillance</span></p>"
        },
        {
          "id": 357845,
          "text": "<p><span style=\"font-size:14.0pt;\">Distribution of condoms</span></p>"
        },
        {
          "id": 357846,
          "text": "<p><span style=\"font-size:14.0pt;\">Immunization</span></p>"
        },
        {
          "id": 357847,
          "text": "<p><span style=\"font-size:14.0pt;\">DOTS activities</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A regional health administrator is reviewing the scope of work for Female Multipurpose Health Workers (F‑MPHWs) under India’s National Rural Health Mission. Which of the following activities is not typically assigned to F‑MPHWs?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q1859848",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;A) Malaria surveillance</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Female Multipurpose Health Workers (F‑MPHWs, also known as Auxiliary Nurse Midwives) focus primarily on maternal and child health, family planning, NIS, communicable diseases and non-communicable diseases, basic disease control at the village level, nutrition, MTP and Dai training</span></li><li><span style=\"font-size:14.0pt;\">Their responsibilities include:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Providing antenatal/postnatal care and health education</span></li><li><span style=\"font-size:14.0pt;\">Conducting routine immunization sessions</span></li><li><span style=\"font-size:14.0pt;\">Distributing contraceptives (e.g., condoms) as part of family planning services</span></li><li><span style=\"font-size:14.0pt;\">Supporting DOTS (Directly Observed Treatment, Short-course) for tuberculosis under the Revised National Tuberculosis Control Programme</span></li></ul></li><li><span style=\"font-size:14.0pt;\">They do <strong>not</strong> conduct malaria surveillance, which is handled by the Male Multipurpose Health Workers (M‑MPHWs) and specialized vector‑control teams under the National Vector Borne Disease Control Programme.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Female Multipurpose Health Workers</strong> are responsible for <strong>immunization</strong>, <strong>family planning</strong> (including condom distribution), and <strong>DOTS support</strong>, but <strong>malaria surveillance</strong> is conducted by male health workers or dedicated vector‑control staff.</span></p>",
      "correct_choice_id": 357844,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89863/NEET_PG_aug_2025_PSM_Question_4.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89863/NEET_PG_aug_2025_PSM_Question_4.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89844,
      "choices": [
        {
          "id": 357768,
          "text": "<p><span style=\"font-size:14.0pt;\">Carotid artery; compressible structure best avoided for central access</span></p>"
        },
        {
          "id": 357769,
          "text": "<p><span style=\"font-size:14.0pt;\">Internal jugular vein; preferred site for central venous catheter placement</span></p>"
        },
        {
          "id": 357770,
          "text": "<p><span style=\"font-size:14.0pt;\">Subclavian vein; difficult to visualize above the clavicle</span></p>"
        },
        {
          "id": 357771,
          "text": "<p><span style=\"font-size:14.0pt;\">External jugular vein; not suitable for ultrasound-guided central line</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">What is the most appropriate identification of the structure marked in the image and its clinical relevance?</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/WhatsApp%20Image%202025-08-05%20at%2011.31.12.jpeg\" width=\"500\" height=\"404\"></p>",
      "unique_key": "Q7366682",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Internal jugular vein; preferred site for central venous catheter placement</strong></span></p><p><br><span style=\"font-size:14.0pt;\">The <strong>internal jugular vein (IJV)</strong> lies <strong>lateral and superficial</strong> to the <strong>carotid artery</strong>, is <strong>non-pulsatile and compressible</strong>, and is the <strong>preferred site for central venous catheterization</strong> due to its straight course and accessibility under ultrasound.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.</strong> <strong>Carotid artery; compressible structure best avoided for central access:</strong> Carotid artery is deeper, <strong>pulsatile and non-compressible</strong> — it must be <strong>avoided</strong> to prevent arterial puncture.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Subclavian vein; difficult to visualize above the clavicle:</strong> Subclavian vein is not typically visualized in this <strong>transverse neck view</strong>, as it lies <strong>beneath the clavicle</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.</strong> <strong>External jugular vein; not suitable for ultrasound-guided central line:</strong> External jugular is more superficial and variable; it is not the standard target for central venous access.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Under ultrasound, the internal jugular vein appears as a superficial, compressible, non-pulsatile structure lateral to the carotid artery, making it the ideal site for central venous catheter insertion.</span></p>",
      "correct_choice_id": 357769,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89844/NEET_PG_Aug_ANESTHESIA_Question_4.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        19
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89844/NEET_PG_Aug_ANESTHESIA_Question_4.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89865,
      "choices": [
        {
          "id": 357852,
          "text": "<p><span style=\"font-size:14.0pt;\">25</span></p>"
        },
        {
          "id": 357853,
          "text": "<p><span style=\"font-size:14.0pt;\">30</span></p>"
        },
        {
          "id": 357854,
          "text": "<p><span style=\"font-size:14.0pt;\">35</span></p>"
        },
        {
          "id": 357855,
          "text": "<p><span style=\"font-size:14.0pt;\">40</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A district health officer reviews annual birth records and finds that, over the past year, there were 12,000 total births, of which 360 were stillbirths.&nbsp;What is the stillbirth rate in this district?&nbsp;</span></p>",
      "unique_key": "Q2651121",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;B) 30</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>stillbirth rate</strong> is calculated as the number of stillbirths divided by the total number of births (live births + stillbirths), multiplied by 1,000:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Total births</strong> = 12,000</span></li><li><span style=\"font-size:14.0pt;\"><strong>Stillbirths</strong> = 360</span></li><li><span style=\"font-size:14.0pt;\"><strong>Stillbirth rate</strong> = (360 / 12,000) × 1,000 = <strong>30 per 1,000 total births</strong></span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">To determine the stillbirth rate,&nbsp;</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/WhatsApp%20Image%202025-08-19%20at%2012.16.38.jpeg\" width=\"1131\" height=\"210\"></p>",
      "correct_choice_id": 357853,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89865/NEET_PG_aug_2025_PSM_Question_5.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89865/NEET_PG_aug_2025_PSM_Question_5.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90841,
      "choices": [
        {
          "id": 361704,
          "text": "<p><span style=\"font-size:14.0pt;\">Patient with known epilepsy</span></p>"
        },
        {
          "id": 361705,
          "text": "<p><span style=\"font-size:14.0pt;\">Focal neurologic findings</span></p>"
        },
        {
          "id": 361706,
          "text": "<p><span style=\"font-size:14.0pt;\">New-onset seizure</span></p>"
        },
        {
          "id": 361707,
          "text": "<p><span style=\"font-size:14.0pt;\">Papilledema</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following scenarios does not require head imaging prior to lumbar puncture?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q2998346",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;A) Patient with known epilepsy</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Known epilepsy with typical seizures doesn’t require pre-LP imaging unless atypical features present.</span></li><li><span style=\"font-size:14.0pt;\">Focal neurologic findings (e.g., weakness) suggest structural lesions, needing imaging.</span></li><li><span style=\"font-size:14.0pt;\">New-onset seizures may indicate pathology (e.g., tumor), requiring imaging.</span></li><li><span style=\"font-size:14.0pt;\">Papilledema indicates increased intracranial pressure, risking herniation without imaging.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Focal neurologic findings:</strong> Imaging needed for possible lesions.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. New-onset seizure:</strong> Requires imaging for underlying causes.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Papilledema:</strong> Mandates imaging to prevent herniation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Focal signs or new seizures require imaging.</span></li><li><span style=\"font-size:14.0pt;\">Avoid LP in increased pressure without imaging.</span></li></ul>",
      "correct_choice_id": 361704,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90841/NEET_PG_aug_2025_MEDICINE_Question_7.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90841/NEET_PG_aug_2025_MEDICINE_Question_7.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89939,
      "choices": [
        {
          "id": 358140,
          "text": "<p><span style=\"font-size:14.0pt;\">B. pseudomallei</span></p>"
        },
        {
          "id": 358141,
          "text": "<p><span style=\"font-size:14.0pt;\">B. mallei</span></p>"
        },
        {
          "id": 358142,
          "text": "<p><span style=\"font-size:14.0pt;\">B. cepacia</span></p>"
        },
        {
          "id": 358143,
          "text": "<p><span style=\"font-size:14.0pt;\">B. thailandensis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A laboratory technologist inoculates a specimen with an unknown Burkholderia species into guinea pigs and observes testicular swelling (Strauss reaction) within 3 days. The isolate is nonmotile and oxidase negative. Which Burkholderia species is most likely the culprit?</span></p>",
      "unique_key": "Q7879123",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) B. mallei</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Burkholderia mallei is the causative agent of <strong>glanders</strong>, primarily infecting horses but also transmissible to humans.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Key distinguishing features include:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Nonmotile</strong>: Unlike B. pseudomallei and B. cepacia, B. mallei lacks flagella.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Oxidase negative</strong>: Differentiates it from most other Burkholderia spp., which are oxidase positive.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Strauss reaction</strong>: Inoculation into guinea pigs produces <strong>testicular swelling</strong> within 2–4 days, a classic diagnostic sign for B. mallei.</span></li></ul></li><li><span style=\"font-size:14.0pt;\">These characteristics together confirm B. mallei as the organism.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. B. pseudomallei</strong>: <strong>Motile</strong> and <strong>oxidase positive</strong>. Causes melioidosis, not glanders, and does <strong>not</strong> produce a Strauss reaction.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. B. cepacia</strong>: <strong>Motile</strong>, <strong>oxidase positive</strong>, and primarily a pathogen in cystic fibrosis or ICU settings. No Strauss reaction.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. B. thailandensis</strong>: Closely related to B. pseudomallei and <strong>oxidase positive</strong>, but generally nonpathogenic in humans and does <strong>not</strong> cause glanders or Strauss reaction.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Burkholderia mallei:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Nonmotile</strong>, <strong>oxidase negative</strong> gram-negative bacillus</span></li><li><span style=\"font-size:14.0pt;\">Causes <strong>glanders</strong>; guinea-pig <strong>Strauss reaction</strong> (testicular swelling) is pathognomonic</span></li></ul>",
      "correct_choice_id": 358141,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89939/NEET_PG_aug_2025_MICROBIOLOGY_Question_3.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        6
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89939/NEET_PG_aug_2025_MICROBIOLOGY_Question_3.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89983,
      "choices": [
        {
          "id": 358312,
          "text": "<p><span style=\"font-size:14.0pt;\">Aorta</span></p>"
        },
        {
          "id": 358313,
          "text": "<p><span style=\"font-size:14.0pt;\">Thoracic duct</span></p>"
        },
        {
          "id": 358314,
          "text": "<p><span style=\"font-size:14.0pt;\">Esophagus&nbsp;</span></p>"
        },
        {
          "id": 358315,
          "text": "<p><span style=\"font-size:14.0pt;\">Vagus nerve</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 36-year-old man sustains a stab wound. Imaging confirms that the stab wound tracks just anterior to the T10 vertebral body. Which of the following structures is most likely to be injured as it traverses the diaphragm at this level?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q8891450",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Esophagus</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The&nbsp;<strong>esophagus</strong> passes through the <strong>esophageal hiatus</strong> of the diaphragm at the level of&nbsp;<strong>T10</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">A stab wound just <strong>anterior to the T10 vertebral body</strong> would most likely injure this structure as it lies immediately anterior to the vertebra at this level.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The esophageal hiatus also allows passage of the <strong>vagal trunks</strong>, but the esophagus remains the central and largest structure through this opening.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option&nbsp;A. Aorta:</strong> Incorrect. The aorta enters the abdomen through the&nbsp;<strong>aortic hiatus</strong> at the&nbsp;<strong>T12</strong> level, posterior to the diaphragm.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option&nbsp;B. Thoracic duct:</strong> Incorrect. It also traverses the&nbsp;<strong>aortic hiatus</strong> at&nbsp;<strong>T12</strong>, not T10.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option&nbsp;D. Vagus nerve:</strong> Incorrect. Although the <strong>anterior and posterior vagal trunks</strong> pass through the <strong>esophageal hiatus</strong> with the esophagus, they are smaller structures and less likely to be directly injured in isolation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The&nbsp;<strong>esophagus</strong> traverses the diaphragm at the <strong>T10 level</strong>, making it the structure most likely to be injured in a stab wound just <strong>anterior to the T10 vertebral body</strong>.</span></p>",
      "correct_choice_id": 358314,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89983/NEET_PG_aug_2025_ANATOMY_Question_5.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        3
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89983/NEET_PG_aug_2025_ANATOMY_Question_5.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89845,
      "choices": [
        {
          "id": 357772,
          "text": "<p><span style=\"font-size:14.0pt;\">Hemorrhagic stroke</span></p>"
        },
        {
          "id": 357773,
          "text": "<p><span style=\"font-size:14.0pt;\">Hyperacute ischemic stroke</span></p>"
        },
        {
          "id": 357774,
          "text": "<p><span style=\"font-size:14.0pt;\">Vanishing bone disease</span></p>"
        },
        {
          "id": 357775,
          "text": "<p><span style=\"font-size:14.0pt;\">Marchiafava‑Bignami disease</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 68‑year‑old man presents 1 hour after sudden onset right‑sided weakness and aphasia. Diffusion‑weighted MRI of the brain shows a focal area of markedly increased signal intensity in the left middle cerebral artery territory referred to as the “light‑bulb” sign. Which condition is this finding most characteristic of?&nbsp;</span></p>",
      "unique_key": "Q7566330",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;B) Hyperacute ischemic stroke</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In <strong>hyperacute ischemic stroke</strong> (within minutes to a few hours of arterial occlusion), cytotoxic edema causes <strong>restricted diffusion of water</strong>, producing a very bright (“light‑bulb”) signal on diffusion‑weighted imaging (DWI).&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This change precedes alterations on other MRI sequences or CT and is highly specific for acute infarction.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Hemorrhagic stroke:</strong> Would show blood products with variable signal intensity on diffusion-weighted imaging, often associated with susceptibility artifact on gradient-echo sequences, not a uniform bright “light bulb” restricted diffusion. NCCT hyper density will be seen</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Vanishing bone disease:</strong> A skeletal disorder (Gorham’s disease) unrelated to intracranial DWI findings.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Marchiafava‑Bignami disease:</strong> Involves demyelination of the corpus callosum and may show diffusion abnormalities, but lesions are less focal and not described as “light‑bulb” brightness.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">In suspected acute stroke presenting within the first few hours, obtain <strong>DWI MRI</strong>: a <strong>“light‑bulb” bright</strong> focus of restricted diffusion confirms <strong>hyperacute ischemia</strong> and guides urgent reperfusion therapy.</span></p>",
      "correct_choice_id": 357773,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89845/NEET_PG_aug_2025_RADIO_Question_1.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        17
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89845/NEET_PG_aug_2025_RADIO_Question_1.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89861,
      "choices": [
        {
          "id": 357836,
          "text": "<p><span style=\"font-size:14.0pt;\">Device A</span></p>"
        },
        {
          "id": 357837,
          "text": "<p><span style=\"font-size:14.0pt;\">Device B</span></p>"
        },
        {
          "id": 357838,
          "text": "<p><span style=\"font-size:14.0pt;\">Device C</span></p>"
        },
        {
          "id": 357839,
          "text": "<p><span style=\"font-size:14.0pt;\">Device D</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A laboratory is comparing four new point‑of‑care devices (A–D) for measuring serum creatinine. The true serum creatinine concentration is 1.0 mg/dL. Each device is tested repeatedly under identical conditions, and the results are plotted on target diagrams A to D, as given below. If a perfect recalibration procedure could eliminate all systematic bias in each device (so their mean equals 1.0 mg/dL), which device would still fail to provide reliable, reproducible results?&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_WM8lc9I.png\" width=\"940\" height=\"271\"></span></p>",
      "unique_key": "Q7771349",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;D) Device D</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Device D shows poor precision (large random scatter) as well as bias.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Neither precise nor accurate; and even after recalibration (shifting its mean onto 1.0 mg/dL), its wide spread of readings means it cannot reliably reproduce the same measurement.</span></li><li><span style=\"font-size:14.0pt;\">Precision—reflected by tight clustering—is essential for reproducibility, and Device D lacks it.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Device A:</strong> High precision/reliable (tight cluster) <strong>and</strong> high accuracy/validity; recalibration isn’t needed—already reliable.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Device B:</strong> High precision but low accuracy (clustered away from the target); after recalibration (shifting its cluster onto 1.0 mg/dL), it becomes both accurate and precise.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Device C:</strong> &nbsp;Accurate but not precise. After recalibration, its mean remains at 1.0 mg/dL and its moderate spread makes it acceptably reproducible.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Recalibration</strong> can correct <strong>systematic error</strong> (bias) but <strong>cannot</strong> reduce <strong>random error</strong>—devices with high scatter remain <strong>unreliable</strong>, even if their average reading is correct.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_XmURxzF.png\" width=\"750\" height=\"338\"></span></p>",
      "correct_choice_id": 357839,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89861/NEET_PG_aug_2025_PSM_Question_3.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89861/NEET_PG_aug_2025_PSM_Question_3.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90883,
      "choices": [
        {
          "id": 361868,
          "text": "<p><span style=\"font-size:14.0pt;\">CD25</span></p>"
        },
        {
          "id": 361869,
          "text": "<p><span style=\"font-size:14.0pt;\">LFA1</span></p>"
        },
        {
          "id": 361870,
          "text": "<p><span style=\"font-size:14.0pt;\">TNF</span></p>"
        },
        {
          "id": 361871,
          "text": "<p><span style=\"font-size:14.0pt;\">IL-2</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Basiliximab is an immunosuppressive monoclonal antibody used in renal transplantation. Its action is mediated by antagonism against which of the following targets?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q6045786",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) CD25</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Basiliximab</strong> is a chimeric monoclonal antibody that specifically binds to <strong>CD25</strong>, the <strong>alpha subunit of the IL-2 receptor</strong> on activated T cells.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">By blocking IL-2 from binding to its receptor, basiliximab prevents <strong>T-cell activation and proliferation</strong>, thus reducing the risk of transplant rejection.</span></li><li><span style=\"font-size:14.0pt;\">It is used as part of <strong>induction therapy in organ transplantation</strong>, especially renal transplants.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. LFA1</strong>: Targeted by <strong>efalizumab</strong> (withdrawn), involved in adhesion; not the target of basiliximab.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. TNF</strong>: Targeted by drugs like <strong>infliximab</strong>, <strong>etanercept</strong>, and <strong>adalimumab</strong> for autoimmune diseases; basiliximab does not affect TNF.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. IL-2</strong>: Basiliximab does <strong>not bind directly to IL-2</strong>, but rather to its receptor (<strong>CD25</strong>), thereby preventing IL-2 signaling.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Basiliximab is an IL-2 receptor (CD25) antagonist that prevents T-cell proliferation, making it useful in preventing acute transplant rejection.</span></p>",
      "correct_choice_id": 361868,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90883/NEET_PG_aug_2025_PHARMACOLOGY_Question_6.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90883/NEET_PG_aug_2025_PHARMACOLOGY_Question_6.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90490,
      "choices": [
        {
          "id": 360324,
          "text": "<p><span style=\"font-size:14.0pt;\">An immediate surgical correction</span></p>"
        },
        {
          "id": 360325,
          "text": "<p><span style=\"font-size:14.0pt;\">Conservative management with higher antibiotics</span></p>"
        },
        {
          "id": 360326,
          "text": "<p><span style=\"font-size:14.0pt;\">Cover the content with a silo bag and shift to the NICU</span></p>"
        },
        {
          "id": 360327,
          "text": "<p><span style=\"font-size:14.0pt;\">Cover with saline soaked gauze and wait for it to self-resolve</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A neonate has intestines protruding from the abdomen without any external covering. What will be your immediate next line of management?</span></p>",
      "unique_key": "Q3206961",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Cover the content with silo bag and shift to the NICU</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This describes <strong>gastroschisis</strong>—a congenital defect where intestines protrude <strong>without a covering sac</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Initial management involves placing the exposed bowel in a <strong>silo bag</strong> to allow gradual reduction before definitive surgical repair.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.&nbsp;An Immediate</strong> <strong>surgical correction:&nbsp;</strong>Incorrect<strong>.</strong> Immediate surgical correction may not be feasible if the bowel is edematous or distended. Attempting this without stabilization increases risk of complications like abdominal compartment syndrome.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Conservative management with higher antibiotics:&nbsp;</strong>Incorrect<strong>.</strong> Antibiotics are supportive but not sufficient alone. The priority is protecting the bowel and managing fluid loss.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.&nbsp;Cover with saline soaked gauze and wait for it to self-resolve:&nbsp;</strong>Incorrect. NS gauze can help temporarily, but it’s not as effective or protective as a silo bag. It also risks bowel injury or infection.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">In gastroschisis, the first step is to protect bowel loops by covering them with a silo bag for staged reduction.</span></p>",
      "correct_choice_id": 360326,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90490/NEET_PG_aug_2025_Surgery_Question_6.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90490/NEET_PG_aug_2025_Surgery_Question_6.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90608,
      "choices": [
        {
          "id": 360792,
          "text": "<p><span style=\"font-size:14.0pt;\">Ligation of anterior ethmoidal artery</span></p>"
        },
        {
          "id": 360793,
          "text": "<p><span style=\"font-size:14.0pt;\">Ligation of external carotid artery</span></p>"
        },
        {
          "id": 360794,
          "text": "<p><span style=\"font-size:14.0pt;\">Ligation of sphenopalatine artery via endoscopic approach</span></p>"
        },
        {
          "id": 360795,
          "text": "<p><span style=\"font-size:14.0pt;\">Ligation of facial artery</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 60-year-old man with a history of poorly controlled hypertension and diabetes presents with severe epistaxis. Initial measures, including anterior and posterior nasal packing, have failed to control the bleeding. Endoscopic examination suggests the bleeding source is in the posterior nasal cavity. Which of the following is the next best step in management?&nbsp;</span></p>",
      "unique_key": "Q9947929",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Ligation of sphenopalatine artery via endoscopic approach</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In <strong>refractory posterior epistaxis</strong>, after failure of conservative measures (packing, cautery), the <strong>standard next step</strong> is <strong>endoscopic sphenopalatine artery ligation (SPAL)</strong>.</span></li><li><span style=\"font-size:14.0pt;\">The sphenopalatine artery is the <strong>terminal branch of the maxillary artery</strong> and the main supply to the posterior nasal cavity.</span></li><li><span style=\"font-size:14.0pt;\">Endoscopic ligation directly targets the bleeding source while minimizing morbidity compared to more proximal vessel ligations.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/WhatsApp%20Image%202025-08-20%20at%2017.54.44.jpeg\" width=\"850\" height=\"765\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Ligation of anterior ethmoidal artery</strong>: Incorrect. The anterior ethmoidal artery is a branch of the ophthalmic artery supplying the anterior-superior nasal septum and lateral wall. It is not the main source in posterior epistaxis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Ligation of external carotid artery:</strong> Incorrect. Ligation of the external carotid is rarely performed now because it is more invasive and less targeted, with higher morbidity.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Ligation of facial artery</strong>: Incorrect. The facial artery supplies mainly the anterior part of the nasal cavity and external nose, not the posterior nasal cavity.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">For <strong>refractory posterior epistaxis</strong> unresponsive to nasal packing, <strong>endoscopic sphenopalatine artery ligation</strong> is the treatment of choice, as it directly addresses the main posterior nasal blood supply.</span></p>",
      "correct_choice_id": 360794,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90608/NEET_PG_aug_2025_ENT_Question_4.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        9
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90608/NEET_PG_aug_2025_ENT_Question_4.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89842,
      "choices": [
        {
          "id": 357760,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 2, 3</span></p>"
        },
        {
          "id": 357761,
          "text": "<p><span style=\"font-size:14.0pt;\">2, 3, 4</span></p>"
        },
        {
          "id": 357762,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 2, 4</span></p>"
        },
        {
          "id": 357763,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 2, 3, 4</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following are true regarding adult cardiac arrest and CPR?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">Pulse check should be for no more than 10 seconds.</span></li><li><span style=\"font-size:14.0pt;\">High-quality chest compressions must achieve a depth of 5–6 cm.</span></li><li><span style=\"font-size:14.0pt;\">Bag-mask ventilation with room air is acceptable in early CPR.</span></li><li><span style=\"font-size:14.0pt;\">Chest compression to ventilation ratio is 15:2 in adults.</span></li></ol>",
      "unique_key": "Q2514071",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>A) 1, 2, 3</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 1.</strong> <strong>Pulse check should be for no more than 10 seconds:</strong> True. Limit pulse check to 10 seconds.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 2. High-quality chest compressions must achieve a depth of 5–6 cm:</strong> True. Depth should be 5–6 cm.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 3.</strong> <strong>Bag-mask ventilation with room air is acceptable in early CPR:</strong> True. If oxygen unavailable, room air can be used.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Incorrect Statement:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 4.</strong> <strong>Chest compression to ventilation ratio is 15:2 in adults:</strong> False. In adults, compression: ventilation = <strong>30:2</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Adult CPR begins with checking pulse &lt;10s, with 30:2 compression: ventilation ratio and compressions 5–6 cm deep.</span></p>",
      "correct_choice_id": 357760,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89842/NEET_PG_Aug_ANESTHESIA_Question_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        19
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89842/NEET_PG_Aug_ANESTHESIA_Question_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90233,
      "choices": [
        {
          "id": 359304,
          "text": "<p><span style=\"font-size:14.0pt;\">Danazol</span></p>"
        },
        {
          "id": 359305,
          "text": "<p><span style=\"font-size:14.0pt;\">Combined high dose estrogen-progestin pills</span></p>"
        },
        {
          "id": 359306,
          "text": "<p><span style=\"font-size:14.0pt;\">CuT200</span></p>"
        },
        {
          "id": 359307,
          "text": "<p><span style=\"font-size:14.0pt;\">RU486</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 27-year-old woman presents to a pharmacy within 24 hours after an episode of unprotected sexual intercourse. She is not currently on any form of contraception and seeks an immediate intervention to prevent pregnancy. Which of the following is not recommended as a method of emergency contraception?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q5220160",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Danazol</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Danazol</strong> is a synthetic androgen and <strong>is not used as a method of emergency contraception</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It is primarily used in the treatment of <strong>endometriosis</strong>, <strong>fibrocystic breast disease</strong>, and <strong>hereditary angioedema</strong> due to its suppressive effect on gonadotropin secretion.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Danazol lacks both the mechanism and approval to be used for post-coital pregnancy prevention.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Therefore, among the listed options, <strong>Danazol is the only one not recommended for emergency contraception</strong>, making it the correct answer.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Combined high dose estrogen-progestin pills:</strong> This method, known as the <strong>Yuzpe regimen</strong>, involves using high-dose <strong>ethinyl estradiol + levonorgestrel</strong> and is <strong>an accepted emergency contraceptive method</strong> when used within 72 hours of intercourse.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. CuT200 (Copper-T 200 IUD):</strong> Copper-containing intrauterine devices such as CuT 380A or 375 but can be <strong>CuT200</strong> can be used for emergency contraception <strong>within 5 days</strong> post-coitus. Copper ions are spermicidal and prevent fertilization or implantation, making this method both <strong>highly effective and reversible</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. RU486 (Mifepristone):</strong> Mifepristone is a <strong>progesterone receptor antagonist</strong>, and in low doses, it can prevent pregnancy by inhibiting ovulation or implantation. It is <strong>used as an emergency contraceptive</strong> and is effective if taken <strong>within 5 days</strong> of unprotected intercourse.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Danazol is not used for emergency contraception.</strong> Emergency contraceptive methods include <strong>CuT IUD</strong>, <strong>combined estrogen-progestin pills</strong>, <strong>levonorgestrel-only pills</strong>, and <strong>mifepristone (RU486)</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Note – LNG and Ulipristal, Yuzpe regime, IUDs – primarily used as emergency contraceptives.&nbsp;</strong></span></p>",
      "correct_choice_id": 359304,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90233/NEET_PG_aug_2025_OBG_Question_16.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90233/NEET_PG_aug_2025_OBG_Question_16.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89819,
      "choices": [
        {
          "id": 357668,
          "text": "<p><span style=\"font-size:14.0pt;\">Oleandrin</span></p>"
        },
        {
          "id": 357669,
          "text": "<p><span style=\"font-size:14.0pt;\">Thevetoxin</span></p>"
        },
        {
          "id": 357670,
          "text": "<p><span style=\"font-size:14.0pt;\">Cerberin</span></p>"
        },
        {
          "id": 357671,
          "text": "<p><span style=\"font-size:14.0pt;\">Neriumin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 45-year-old gardener presents with nausea, vomiting, visual disturbances (yellow halos), and bradycardia two hours after chewing on an ornamental shrub leaf. His ECG shows peaked T waves and a bidirectional ventricular tachycardia. Which toxin is most likely responsible?</span></p>",
      "unique_key": "Q8909747",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;A) Oleandrin</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Cardiac glycosides:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">White oleander (oleandrin, Nerin)</span></li><li><span style=\"font-size:14.0pt;\">Yellow oleander (Thevetin, Thevatoxin, Cerberin)</span></li><li><span style=\"font-size:14.0pt;\">Cerebra odollum (Cerberin)</span></li></ul></li><li><span style=\"font-size:14.0pt;\">Oleandrin is the principal cardiac glycoside in <strong>Nerium odorum</strong> (white oleander).&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Like digoxin, it inhibits Na⁺/K⁺-ATPase in myocytes, causing hyperkalemia (peaked T waves), increased intracellular calcium (afterdepolarizations), and characteristic arrhythmias such as bidirectional VT.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Visual disturbances (xanthopsia) are classic for cardiac glycoside toxicity.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_Oqz36jF.png\" width=\"394\" height=\"394\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Thevetoxin</strong>: Found in <strong>Cascabela thevetia</strong>, but the more abundant glycoside there is <strong>cerberin</strong>, and thevetoxin is less clinically described; presentation is identical, but naming convention favors cerberin.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_ufl5Pz2.png\" width=\"352\" height=\"352\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Cerberin</strong>: The chief toxin of yellow oleander and Cerebra odollum; also causes digoxin‐like toxicity, but oleandrin is the more common culprit in white oleander exposures.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Neriumin</strong>: Not a recognized cardiac glycoside name (the true second glycoside in Nerium is nerin).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Oleandrin is the main cardiac glycoside of white oleander—presenting like digoxin overdose with hyperkalemia and bidirectional VT.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Additional Information:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Oleander Plant</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">There are two oleander plants: Nerium odorum and Cascabela Thevetia</span></li><li><span style=\"font-size:14.0pt;\">Both are cardiac poisons</span></li><li><span style=\"font-size:14.0pt;\">Both have digoxin like toxicity:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Heart failure (Fall in BP, arrhythmias, weak pulse, circulatory collapse).&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Similar to digitalis.</span></li><li><span style=\"font-size:14.0pt;\">Muscle spasm like that seen in strychnine poisoning.&nbsp;</span></li></ul></li><li><span style=\"font-size:14.0pt;\"><strong>Treatment of Both Oleander poisoning:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Atropine&nbsp;</strong>for sinus bradycardia and AV block</span></li><li><span style=\"font-size:14.0pt;\"><strong>Antiarrhythmics: lignocaine&nbsp;</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Digoxin-specific antibodies&nbsp;</strong>for severe arrhythmias&nbsp;</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_0xyUpu4.png\" width=\"676\" height=\"352\"></span></p>",
      "correct_choice_id": 357668,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89819/NEET_PG_Aug_FMT_Question_5.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        10
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89819/NEET_PG_Aug_FMT_Question_5.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90829,
      "choices": [
        {
          "id": 361656,
          "text": "<p><span style=\"font-size:14.0pt;\">Estrogen and progesterone increase, FSH &amp; LH decrease</span></p>"
        },
        {
          "id": 361657,
          "text": "<p><span style=\"font-size:14.0pt;\">Estrogen increases, progesterone decreases, FSH increases LH decrease</span></p>"
        },
        {
          "id": 361658,
          "text": "<p><span style=\"font-size:14.0pt;\">Estrogen decreases progesterone increases, FSH decreases &amp; LH increases</span></p>"
        },
        {
          "id": 361659,
          "text": "<p><span style=\"font-size:14.0pt;\">Estrogen increases and progesterone decreases, LH &amp; FSH decrease</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">In a regular 28‑day menstrual cycle, which hormonal levels are typically observed between days 21 and 25?</span></p>",
      "unique_key": "Q5139933",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Estrogen and progesterone increase, FSH &amp; LH decrease</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Days 21–25 correspond to the mid‑ to late‑luteal phase.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The corpus luteum actively secretes progesterone (peak around day ~21) and a moderate second rise of estrogen.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">These ovarian steroids exert negative feedback on the hypothalamus and pituitary, so FSH and LH remain suppressed during this interval.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Estrogen increases, progesterone decreases, FSH increases LH decrease:&nbsp;</strong>Progesterone does not decrease yet in the mid‑luteal phase; it is still high. Its fall occurs closer to the end of the luteal phase (around days 26–28) if no implantation occurs.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Estrogen decreases progesterone increases, FSH decreases &amp; LH increases:&nbsp;</strong>LH does not increase in the luteal phase; it remains low after the ovulatory surge due to negative feedback from high progesterone/estrogen.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Estrogen increases and progesterone decreases, LH &amp; FSH decrease:&nbsp;</strong>Again, progesterone is not decreasing between days 21–25; it is elevated. (FSH is low, but this partial truth doesn’t make the overall statement correct.)</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">During the mid‑luteal phase (days 21–25) of a 28‑day cycle, progesterone is high (with a moderate estrogen rise) from corpus luteum secretion, producing negative feedback that keeps FSH and LH low.</span></p>",
      "correct_choice_id": 361656,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90829/NEET_PG_aug_2025_PHYSIOLOGY_Question_3.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        2
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90829/NEET_PG_aug_2025_PHYSIOLOGY_Question_3.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89851,
      "choices": [
        {
          "id": 357796,
          "text": "<p><span style=\"font-size:14.0pt;\">Strength of association</span></p>"
        },
        {
          "id": 357797,
          "text": "<p><span style=\"font-size:14.0pt;\">Consistency of association</span></p>"
        },
        {
          "id": 357798,
          "text": "<p><span style=\"font-size:14.0pt;\">Sensitivity of association</span></p>"
        },
        {
          "id": 357799,
          "text": "<p><span style=\"font-size:14.0pt;\">Coherence of association</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A public health researcher is reviewing several epidemiological studies that investigate the link between a new industrial pollutant and increased rates of a rare cancer. To determine whether a causal relationship exists, the researcher evaluates various criteria used in epidemiology for causal inference. Which of the following is not considered a standard criterion for establishing causality?&nbsp;</span></p>",
      "unique_key": "Q7663427",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Sensitivity of association</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Causal inference in epidemiology is guided by a set of principles known as the <strong>Bradford Hill criteria</strong>, which are used to assess whether an observed association is likely to be causal rather than due to chance, bias, or confounding.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">These criteria include <strong>temporality, specificity, coherence, consistency, strength of association, bio plausibility, dose response and cessation</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Sensitivity of association</strong>, however, is <strong>not</strong> one of these criteria.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Sensitivity is a statistical measure used to assess the performance of diagnostic tests—it refers to a test’s ability to correctly identify those with a disease (true positives).</span></li><li><span style=\"font-size:14.0pt;\">&nbsp;It has no relevance in evaluating whether an exposure causes an outcome.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Strength of association:</strong> This refers to the magnitude of the relationship between exposure and outcome. A strong association (e.g., high relative risk or odds ratio) provides greater support for causality, as it is less likely to be explained by confounding or bias.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Consistency of association:</strong> If the same association is observed in different studies, populations, or settings, it reinforces the likelihood of a causal relationship, making it a key component of causal inference.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Coherence of association:</strong> Coherence means the observed association does not conflict with the known biology or natural history of the disease. A coherent finding fits within the broader framework of scientific understanding, which strengthens causal reasoning.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Bradford Hill criteria</strong>, used to assess causality in epidemiological research, include strength, consistency, specificity, temporality, biological gradient, plausibility, coherence, experiment, and analogy — but <strong>do not include \"sensitivity of association.\"</strong></span></p>",
      "correct_choice_id": 357798,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89851/NEET_PG_aug_2025_PSM_Question_1.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89851/NEET_PG_aug_2025_PSM_Question_1.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90222,
      "choices": [
        {
          "id": 359260,
          "text": "<p><span style=\"font-size:14.0pt;\">Decidual transformation</span></p>"
        },
        {
          "id": 359261,
          "text": "<p><span style=\"font-size:14.0pt;\">Arias-Stella reaction</span></p>"
        },
        {
          "id": 359262,
          "text": "<p><span style=\"font-size:14.0pt;\">Chronic endometrial inflammation</span></p>"
        },
        {
          "id": 359263,
          "text": "<p><span style=\"font-size:14.0pt;\">Endometritis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 32-year-old woman arrives at the emergency department with complaints of vaginal bleeding and lower abdominal pain. Her urine pregnancy test is positive, but transvaginal ultrasonography reveals an empty uterine cavity. A subsequent endometrial biopsy is performed, and shown below. Which of the following is the most likely histologic diagnosis?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-08-23%20103307.jpg\" width=\"667\" height=\"513\"></p>",
      "unique_key": "Q3010496",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Arias-Stella reaction</strong></span></p><p><span style=\"font-size:14.0pt;\"><strong>&nbsp;</strong></span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>Arias-Stella reaction</strong> is a benign, hormone-induced change in endometrial glandular epithelium, most commonly seen in the setting of <strong>ectopic pregnancy</strong>, <strong>molar pregnancy</strong>, or <strong>elevated β-hCG states</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Histologically, it is marked by:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Nuclear enlargement</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Hyperchromasia</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Cellular crowding and pseudostratification</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Eosinophilic cytoplasm</strong></span></li><li><span style=\"font-size:14.0pt;\">Often occurs in a background of secretory endometrium</span></li></ul></li><li><span style=\"font-size:14.0pt;\">In this clinical scenario, a <strong>positive pregnancy test</strong> with <strong>no intrauterine pregnancy</strong> on ultrasound and the <strong>described biopsy findings</strong> strongly support the diagnosis of an <strong>Arias-Stella reaction</strong>, most likely in the setting of <strong>ectopic pregnancy</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Decidual transformation:</strong> Incorrect. This refers to changes in the endometrial stroma, not glandular epithelium. Decidualized stromal cells appear large, polygonal, with eosinophilic cytoplasm, and are not associated with nuclear atypia or hyperchromasia like Arias-Stella reaction.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Chronic endometrial inflammation:</strong> Incorrect. Chronic endometrial inflammation (chronic endometritis) is characterized histologically by <strong>plasma cells</strong> in the endometrial stroma and sometimes lymphoid aggregates, not glandular nuclear atypia or eosinophilic cytoplasm.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Endometritis:</strong> Incorrect. Refers to acute inflammation of the endometrium and typically shows <strong>neutrophilic infiltration</strong> in the stroma and glands, often associated with infection, fever, and uterine tenderness — none of which are indicated here.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>Arias-Stella reaction</strong> is a <strong>non-neoplastic</strong>, <strong>hormone-induced endometrial change</strong> seen in the setting of <strong>high β-hCG levels</strong>, most notably in <strong>ectopic pregnancy</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It is characterized by <strong>glandular nuclear atypia</strong> with <strong>enlarged, hyperchromatic nuclei</strong> and <strong>eosinophilic cytoplasm</strong>.</span></li></ul>",
      "correct_choice_id": 359261,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90222/NEET_PG_aug_2025_OBG_Question_10.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90222/NEET_PG_aug_2025_OBG_Question_10.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89936,
      "choices": [
        {
          "id": 358128,
          "text": "<p><span style=\"font-size:14.0pt;\">Immune-mediated destruction of acinar cells</span></p>"
        },
        {
          "id": 358129,
          "text": "<p><span style=\"font-size:14.0pt;\">Ischemic injury due to thrombosis of the splenic artery</span></p>"
        },
        {
          "id": 358130,
          "text": "<p><span style=\"font-size:14.0pt;\">Autodigestion of pancreatic tissue by activated enzymes&nbsp;</span></p>"
        },
        {
          "id": 358131,
          "text": "<p><span style=\"font-size:14.0pt;\">Direct bacterial invasion of pancreatic parenchyma</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 48-year-old man presents to the emergency department with sudden onset severe epigastric pain radiating to the back, nausea, and repeated vomiting for the past 12 hours. He has a history of heavy alcohol use. On examination, he is hypotensive and febrile. Laboratory studies show:</span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Serum amylase: 1,250 U/L (normal: 30–110 U/L)</span></li><li><span style=\"font-size:14.0pt;\">Serum lipase: 2,600 U/L (normal: 0–160 U/L)</span></li><li><span style=\"font-size:14.0pt;\">Calcium: 7.2 mg/dL (normal: 8.5–10.5 mg/dL)</span></li></ul><p><span style=\"font-size:14.0pt;\">Despite resuscitation, he developed multi-organ failure and died within 48 hours. At autopsy, the gross specimen of pancreas is obtained and shown below. Which of the following best explains the mechanism of the tissue injury seen in this specimen?</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_PYbTbkk.png\" alt=\"A piece of meat with a blue background\r\n\r\nAI-generated content may be incorrect.\" width=\"445\" height=\"259\"></span></p>",
      "unique_key": "Q1587724",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>C) Autodigestion of pancreatic tissue by activated enzymes</strong>&nbsp;</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The gross image shows <strong>acute necrotizing pancreatitis</strong>, with diffuse <strong>stippled pale areas</strong> corresponding to <strong>fat necrosis</strong> and <strong>parenchymal destruction</strong>.</span></li><li><span style=\"font-size:14.0pt;\">In acute necrotizing pancreatitis, premature activation of pancreatic proenzymes (especially <strong>trypsinogen to trypsin</strong>) within the pancreas triggers activation of other zymogens, including <strong>phospholipase A₂</strong> and <strong>elastase</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Lipase</strong> → breaks down triglycerides in adipose tissue, releasing fatty acids. These bind calcium, forming <strong>chalky white calcium soaps</strong> (<strong>fat saponification</strong>) seen grossly.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Proteases</strong> → cause autodigestion and necrosis of pancreatic acinar cells.</span></li><li><span style=\"font-size:14.0pt;\">The process results in <strong>parenchymal necrosis</strong> and <strong>extensive peripancreatic fat necrosis</strong>, as seen in the specimen.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Hypocalcemia</strong> occurs because calcium is sequestered in these fatty acid soaps.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Immune-mediated destruction of acinar cells:</strong> Seen in autoimmune pancreatitis, not in acute necrotizing pancreatitis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Ischemic injury due to thrombosis of the splenic artery:</strong> Can cause segmental pancreatic necrosis but would not produce diffuse fat saponification as seen here.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Direct bacterial invasion</strong> <strong>of pancreatic parenchyma:</strong> Usually a late complication of pancreatitis (infected necrosis), not the initial cause.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Acute necrotizing pancreatitis results from <strong>inappropriate intrapancreatic activation of digestive enzymes</strong>, leading to <strong>autodigestion</strong> of pancreatic parenchyma and peripancreatic fat.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Grossly, this appears as pale, chalky foci of fat necrosis interspersed with hemorrhagic areas, and histologically, necrotic adipocytes with basophilic calcium deposits.</span></li></ul>",
      "correct_choice_id": 358130,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89936/NEET_PG_aug_2025_PATHOLOGY_Question_15.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89936/NEET_PG_aug_2025_PATHOLOGY_Question_15.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90534,
      "choices": [
        {
          "id": 360500,
          "text": "<p><span style=\"font-size:14.0pt;\">Homonymous hemianopia</span></p>"
        },
        {
          "id": 360501,
          "text": "<p><span style=\"font-size:14.0pt;\">Early primary open-angle glaucoma</span></p>"
        },
        {
          "id": 360502,
          "text": "<p><span style=\"font-size:14.0pt;\">Optic neuritis</span></p>"
        },
        {
          "id": 360503,
          "text": "<p><span style=\"font-size:14.0pt;\">Pituitary macroadenoma</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 58-year-old woman comes for routine ophthalmologic screening. She is asymptomatic. Automated perimetry of the right eye is shown below. What is the most likely diagnosis?&nbsp;</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_UXkNu9X.png\" width=\"911\" height=\"555\"></p>",
      "unique_key": "Q3639181",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Early primary open-angle glaucoma</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In primary open-angle glaucoma, initial visual-field loss often appears as a small arcuate scotoma adjacent to the nasal field that respects the horizontal midline.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This defect arises from focal damage to the <strong>temporal retinal nerve-fiber layer</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Elevated intraocular pressure in one eye with a corresponding nasal step on perimetry, in an otherwise asymptomatic patient, would be diagnostic for early glaucoma.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Homonymous hemianopia:&nbsp;</strong>Homonymous defects respect the <strong>vertical</strong> meridian and affect both eyes in corresponding fields, not an isolated nasal step in one eye.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Optic neuritis:&nbsp;</strong>Optic neuritis typically produces <strong>central</strong> or diffuse scotomas and is accompanied by pain on eye movement and reduced visual acuity; it does not produce a horizontal-meridian–respecting nasal step.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-08-20%20163647.jpeg\" width=\"486\" height=\"266\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Pituitary macroadenoma:&nbsp;</strong>Compression of the optic chiasm causes <strong>bitemporal</strong> hemianopic field loss, not a unilateral nasal step.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-08-20%20133144.jpeg\" width=\"570\" height=\"305\"></p><p><span style=\"font-size:14.0pt;\"><strong>Heteronymous field defect.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">A sharply demarcated <strong>nasal step</strong> on perimetry in an eye with elevated IOP—but no other symptoms—strongly suggests <strong>early glaucomatous optic neuropathy</strong>, warranting prompt treatment to prevent progression.</span></p>",
      "correct_choice_id": 360501,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90534/Neet_Pg_Aug_2025_Opthalmology_Question_1.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        8
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90534/Neet_Pg_Aug_2025_Opthalmology_Question_1.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90892,
      "choices": [
        {
          "id": 361904,
          "text": "<p><span style=\"font-size:14.0pt;\">Tiagabine</span></p>"
        },
        {
          "id": 361905,
          "text": "<p><span style=\"font-size:14.0pt;\">Retigabine</span></p>"
        },
        {
          "id": 361906,
          "text": "<p><span style=\"font-size:14.0pt;\">Gabapentin</span></p>"
        },
        {
          "id": 361907,
          "text": "<p><span style=\"font-size:14.0pt;\">Levetiracetam</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which antiepileptic drug does not act at the presynaptic terminal, but exerts its effect directly on postsynaptic ion channels?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q7399317",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Retigabine</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Retigabine (Ezogabine)</strong> is unique among antiepileptic drugs because it acts <strong>postsynaptically</strong> by opening <strong>KCNQ (Kv7) potassium channels</strong> on the <strong>postsynaptic neuron</strong>.</span></li><li><span style=\"font-size:14.0pt;\">This leads to <strong>membrane hyperpolarization</strong>, making it less excitable and reducing neuronal firing.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It does <strong>not act presynaptically</strong> to alter neurotransmitter release.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Tiagabine</strong>: Acts <strong>presynaptically</strong> by inhibiting <strong>GABA reuptake</strong> via the <strong>GAT-1 transporter</strong>, increasing synaptic GABA levels.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Gabapentin</strong>: Binds to the <strong>α2δ subunit of presynaptic voltage-gated Ca²⁺ channels</strong>, inhibiting calcium influx and thus <strong>reducing excitatory neurotransmitter release</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Levetiracetam</strong>: Binds to <strong>SV2A</strong>, a presynaptic vesicular protein involved in neurotransmitter release, particularly glutamate.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Retigabine is a unique antiepileptic drug that acts on postsynaptic KCNQ potassium channels to hyperpolarize neurons, rather than modulating presynaptic neurotransmitter release.</span></p>",
      "correct_choice_id": 361905,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90892/NEET_PG_aug_2025_PHARMACOLOGY_Question_15.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90892/NEET_PG_aug_2025_PHARMACOLOGY_Question_15.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89901,
      "choices": [
        {
          "id": 357996,
          "text": "<p><span style=\"font-size:14.0pt;\">1 and 3</span></p>"
        },
        {
          "id": 357997,
          "text": "<p><span style=\"font-size:14.0pt;\">2 and 4</span></p>"
        },
        {
          "id": 357998,
          "text": "<p><span style=\"font-size:14.0pt;\">1 and 2</span></p>"
        },
        {
          "id": 357999,
          "text": "<p><span style=\"font-size:14.0pt;\">3 and 4</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following statements about how health education and health propaganda shape individuals are correct?&nbsp;</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">Health education develops individuality and personality.</span></li><li><span style=\"font-size:14.0pt;\">Health education sets attitudes and directs behavior.</span></li><li><span style=\"font-size:14.0pt;\">Health propaganda sets attitudes and directs behavior.</span></li><li><span style=\"font-size:14.0pt;\">Health propaganda develops individuality and personal growth.</span></li></ol>",
      "unique_key": "Q6246990",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans</strong>. <strong>A) 1 and 3</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 1. Health education develops individuality and personality:</strong> Through self‑reliant learning and reflective behavior, health education empowers individuals to form their own values, critical thinking, and unique personal growth—fostering true individuality.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 3. Health propaganda sets attitudes and directs behaviour:</strong> By appealing to emotion and employing passive information delivery, propaganda is designed to shape public attitudes and trigger reflexive actions, guiding people’s behavior in a predetermined direction.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Incorrect statements:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 2. Health education sets attitudes and directs behavior.</strong> False. Health education promotes reflective decision‑making rather than prescribing specific attitudes or actions.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 4. Health propaganda develops individuality and personal growth.</strong> False. Propaganda discourages independent thought and personal development, focusing instead on uniform attitudes and behaviors.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Health education <strong>builds individuality</strong> and encourages <strong>critical thinking</strong>, whereas health propaganda <strong>manipulates attitudes</strong> and enforces <strong>uniform behavior</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Health Education vs. Health Propaganda:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_aOXaPRK.png\" width=\"677\" height=\"449\"></strong></span></p>",
      "correct_choice_id": 357996,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89901/NEET_PG_aug_2025_PSM_Question_15.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89901/NEET_PG_aug_2025_PSM_Question_15.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90529,
      "choices": [
        {
          "id": 360480,
          "text": "<p><span style=\"font-size:14.0pt;\">Gaucher’s disease</span></p>"
        },
        {
          "id": 360481,
          "text": "<p><span style=\"font-size:14.0pt;\">Niemann pick disease</span></p>"
        },
        {
          "id": 360482,
          "text": "<p><span style=\"font-size:14.0pt;\">Tay Sachs’ disease</span></p>"
        },
        {
          "id": 360483,
          "text": "<p><span style=\"font-size:14.0pt;\">Metachromatic leukodystrophy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following storage disorder is most consistent with the finding shown in the image given below?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-08-16%20122542.jpeg\" width=\"617\" height=\"461\"></p>",
      "unique_key": "Q1164159",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Niemann pick disease</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The image shows <strong>foamy macrophages</strong> (arrows) with cytoplasm packed with lipid droplets.</span></li><li><span style=\"font-size:14.0pt;\">This is characteristic of <strong>Niemann–Pick disease types A and B</strong>, which are caused by <strong>sphingomyelinase deficiency</strong> → accumulation of <strong>sphingomyelin</strong> in macrophages.</span></li><li><span style=\"font-size:14.0pt;\">These lipid-laden macrophages are called <strong>foam cells</strong> and are found in liver, spleen, bone marrow, lymph nodes.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Gaucher’s disease:&nbsp;</strong>Incorrect.<strong>&nbsp;</strong>Gaucher cells have <strong>crumpled tissue paper</strong> cytoplasm due to glucocerebroside accumulation, not foamy cytoplasm.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Tay–Sachs disease:&nbsp;</strong>Incorrect.<strong>&nbsp;</strong>Shows ballooned neurons with GM2 ganglioside accumulation; <strong>no foam cells</strong> in reticuloendothelial system; also <strong>no hepatosplenomegaly</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Metachromatic leukodystrophy:&nbsp;</strong>Incorrect<strong>. </strong>Due to arylsulfatase A deficiency → sulfatide accumulation in myelin → demyelination. No foamy macrophages in systemic organs.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Niemann–Pick disease —</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Enzyme deficiency:</strong> Sphingomyelinase</span></li><li><span style=\"font-size:14.0pt;\"><strong>Accumulated substrate:</strong> Sphingomyelin</span></li><li><span style=\"font-size:14.0pt;\"><strong>Histology:</strong> Foamy macrophages (foam cells)</span></li><li><span style=\"font-size:14.0pt;\"><strong>Clinical:</strong> Hepatosplenomegaly, neurodegeneration, cherry-red macula.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-08-23%20104645.jpg\" width=\"1282\" height=\"365\"></span></p>",
      "correct_choice_id": 360481,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90529/NEET_PG_aug_2025_BIOCHEM_Question_7.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        1
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90529/NEET_PG_aug_2025_BIOCHEM_Question_7.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90846,
      "choices": [
        {
          "id": 361724,
          "text": "<p><span style=\"font-size:14.0pt;\">Amiodarone</span></p>"
        },
        {
          "id": 361725,
          "text": "<p><span style=\"font-size:14.0pt;\">Aspirin alone</span></p>"
        },
        {
          "id": 361726,
          "text": "<p><span style=\"font-size:14.0pt;\">Half-dose apixaban</span></p>"
        },
        {
          "id": 361727,
          "text": "<p><span style=\"font-size:14.0pt;\">Percutaneous left atrial appendage occlusion</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 70-year-old woman with long-standing permanent atrial fibrillation is evaluated for stroke prevention. She has a history of cerebral amyloid angiopathy and a large intracerebral hemorrhage in the past. What option should be considered?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q2034423",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;D) Percutaneous left atrial appendage occlusion</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">AF increases stroke risk; ICH and amyloid angiopathy contraindicate anticoagulation.</span></li><li><span style=\"font-size:14.0pt;\">LAA occlusion (e.g., Watchman) reduces stroke risk without anticoagulation.</span></li><li><span style=\"font-size:14.0pt;\">Ideal for high bleeding risk patients.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Amiodarone:</strong> Antiarrhythmic, not for stroke prevention.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Aspirin alone:</strong> Ineffective for high-risk AF.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Half-dose apixaban:</strong> High ICH risk remains.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">LAA occlusion for AF with anticoagulation contraindications.</span></li><li><span style=\"font-size:14.0pt;\">Aspirin insufficient for AF stroke prevention.</span></li><li><span style=\"font-size:14.0pt;\">ICH history guides safer options.</span></li></ul>",
      "correct_choice_id": 361727,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90846/NEET_PG_aug_2025_MEDICINE_Question_12.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90846/NEET_PG_aug_2025_MEDICINE_Question_12.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89947,
      "choices": [
        {
          "id": 358172,
          "text": "<p><span style=\"font-size:14.0pt;\">Candida albicans</span></p>"
        },
        {
          "id": 358173,
          "text": "<p><span style=\"font-size:14.0pt;\">Dermatophytes (e.g., Trichophyton spp.)</span></p>"
        },
        {
          "id": 358174,
          "text": "<p><span style=\"font-size:14.0pt;\">Cryptococcus neoformans</span></p>"
        },
        {
          "id": 358175,
          "text": "<p><span style=\"font-size:14.0pt;\">Malassezia furfur</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following fungi is notably challenging to grow in laboratory culture due to its specialized lipid requirements and slow, fastidious growth?&nbsp;</span></p>",
      "unique_key": "Q2313104",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Malassezia furfur</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Malassezia furfur</strong> is a lipophilic yeast that requires <strong>long-chain fatty acids</strong> (e.g., in olive oil–enriched media) for growth.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Standard laboratory media lacking these lipids will fail to support its multiplication, making isolation and culture particularly difficult.</span></li><li><span style=\"font-size:14.0pt;\">Colonies, when they do appear on specialized media, grow <strong>slowly</strong> and may take <strong>up to 2 weeks</strong> to become visible.</span></li><li><span style=\"font-size:14.0pt;\">The colonies gives a <strong>fried egg appearance</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Malassezia furfur causes <strong>pityriasis versicolor</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Candida albicans:&nbsp;</strong>Grows readily on routine fungal media (e.g., Sabouraud dextrose agar) within <strong>24–48 hours</strong>, forming characteristic creamy, budding yeast colonies.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Dermatophytes (e.g., Trichophyton spp.):</strong> While somewhat slower-growing than Candida, dermatophytes reliably grow on standard Sabouraud agar within <strong>1–2 weeks</strong> without special lipid supplementation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Cryptococcus neoformans:</strong> Grows well on routine SDA media, often within <strong>48–72 hours</strong>, producing mucoid colonies. Its <strong>polysaccharide capsule</strong> can be visualized with India ink but does not impede culture.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Malassezia furfur requires <strong>lipid‐enriched media</strong> and extended incubation for successful isolation, unlike more easily cultured yeasts such as Candida and Cryptococcus or dermatophytes.</span></p>",
      "correct_choice_id": 358175,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89947/NEET_PG_aug_2025_MICROBIOLOGY_Question_11.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        6
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89947/NEET_PG_aug_2025_MICROBIOLOGY_Question_11.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89896,
      "choices": [
        {
          "id": 357976,
          "text": "<p><span style=\"font-size:14.0pt;\">That 3.2 % of all collected fleas were Xenopsylla cheopis</span></p>"
        },
        {
          "id": 357977,
          "text": "<p><span style=\"font-size:14.0pt;\">An average of 3.2 X. cheopis fleas per rat</span></p>"
        },
        {
          "id": 357978,
          "text": "<p><span style=\"font-size:14.0pt;\">An average of 3.2 fleas per rodent burrow</span></p>"
        },
        {
          "id": 357979,
          "text": "<p><span style=\"font-size:14.0pt;\">That X. cheopis comprised 32 % of the total flea population</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">In a plague outbreak investigation, field teams report a Cheopsis index of 3.2. What does this index value represent?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q2096005",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;B) An average of 3.2 X. cheopis fleas per rat</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>Cheopsis index</strong> specifically quantifies the <strong>mean number of Xenopsylla cheopis fleas found on each captured rat</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Threshold of Cheopsis = 1. If rate is &gt;1 means high transmission risk &nbsp;</span></li><li><span style=\"font-size:14.0pt;\">A value of 3.2 means that, on average, each rat carried 3.2 individual X. cheopis—the primary vector for plague in India—indicating a high potential for transmission.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.&nbsp;That 3.2 % of all collected fleas were Xenopsylla cheopis:&nbsp;</strong>This describes the <strong>specific percentage</strong> index (species’ proportion), not the Cheopsis index.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C.&nbsp;An average of 3.2 fleas per rodent burrow:&nbsp;</strong>This would be the <strong>burrow index</strong>, which measures average fleas per rodent burrow, not per rat.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.&nbsp;That X. cheopis comprised 32 % of the total flea population:&nbsp;</strong>Misinterprets the absolute mean as a percentage of total fleas.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">A <strong>Cheopsis index</strong> value reflects the <strong>average count</strong> of Xenopsylla cheopis on each rat; values &gt; 1 warn of increased plague transmission risk due to abundant primary vectors.</span></p>",
      "correct_choice_id": 357977,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89896/NEET_PG_aug_2025_PSM_Question_10.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89896/NEET_PG_aug_2025_PSM_Question_10.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90842,
      "choices": [
        {
          "id": 361708,
          "text": "<p><span style=\"font-size:14.0pt;\">Central diabetes insipidus</span></p>"
        },
        {
          "id": 361709,
          "text": "<p><span style=\"font-size:14.0pt;\">Gestational diabetes insipidus</span></p>"
        },
        {
          "id": 361710,
          "text": "<p><span style=\"font-size:14.0pt;\">Primary polydipsia</span></p>"
        },
        {
          "id": 361711,
          "text": "<p><span style=\"font-size:14.0pt;\">Preeclampsia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 26-year-old pregnant woman at 32 weeks of gestation is admitted for evaluation of suspected preeclampsia. She reports excessive thirst, frequent urination, and has a past history of bipolar disorder treated with lithium (now discontinued). Her BP is 155/80 mmHg, and her physical exam, blood counts, and liver function tests are normal. Polyuria persists despite fluid restriction. A DDAVP challenge test is done. Lab findings:</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_ExJMI6l.png\" width=\"674\" height=\"210\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">What is the most likely diagnosis?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q5459661",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Gestational diabetes insipidus</strong></span></p><p><span style=\"font-size:14.0pt;\"><strong>&nbsp;</strong></span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This woman is in her <strong>third trimester</strong> and presents with <strong>polyuria, polydipsia</strong>, and a <strong>markedly dilute urine</strong> despite fluid restriction.</span></li><li><span style=\"font-size:14.0pt;\">Her urine osmolality <strong>remains low with water deprivation</strong> but shows a <strong>dramatic increase after DDAVP</strong>, indicating <strong>intact renal response to ADH</strong>.</span></li><li><span style=\"font-size:14.0pt;\">In <strong>gestational diabetes insipidus</strong>, <strong>placental vasopressinase</strong> degrades endogenous vasopressin (ADH), especially in the <strong>third trimester</strong>, leading to <strong>transient central DI</strong>.</span></li><li><span style=\"font-size:14.0pt;\">The <strong>normalization of urine osmolality and reduction in volume after DDAVP</strong> confirms <strong>vasopressin deficiency</strong>, not resistance.</span></li><li><span style=\"font-size:14.0pt;\">Although she has a <strong>past history of lithium use</strong>, the <strong>current pregnancy context</strong> and <strong>full DDAVP response</strong> are classic for <strong>gestational DI</strong>, not nephrogenic or primary central DI.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Central diabetes insipidus:</strong> Presents similarly but is typically <strong>non-transient</strong> and unrelated to pregnancy. Gestational DI is more likely here.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Primary polydipsia:</strong> Would show <strong>improvement in urine osmolality with water restriction</strong>, which is absent here.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Preeclampsia:</strong> May coexist, but <strong>does not cause polyuria or dilute urine</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Gestational DI</strong> is due to <strong>vasopressinase from the placenta degrading ADH</strong>, leading to <strong>transient central DI</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>DDAVP</strong> (resistant to vasopressinase) corrects the urine concentrating defect.</span></li><li><span style=\"font-size:14.0pt;\">Suspect gestational DI in <strong>pregnant women in third trimester</strong> with <strong>polyuria</strong>, <strong>polydipsia</strong>, and <strong>low urine osmolality</strong>.</span></li></ul>",
      "correct_choice_id": 361709,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90842/Neet_Pg_Aug_2025_Medicine_Question_8.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90842/Neet_Pg_Aug_2025_Medicine_Question_8.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90553,
      "choices": [
        {
          "id": 360576,
          "text": "<p><span style=\"font-size:14.0pt;\">Down Syndrome</span></p>"
        },
        {
          "id": 360577,
          "text": "<p><span style=\"font-size:14.0pt;\">Patau Syndrome</span></p>"
        },
        {
          "id": 360578,
          "text": "<p><span style=\"font-size:14.0pt;\">Edward Syndrome</span></p>"
        },
        {
          "id": 360579,
          "text": "<p><span style=\"font-size:14.0pt;\">Fragile X Syndrome</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A young boy is brought to the clinic for developmental assessment. On examination he has a prominent epicanthal fold, a single transverse palmar crease, hypotonia, and intellectual disability. Facial features appear flat with upslanting palpebral fissures. What is the most likely diagnosis?&nbsp;</span></p>",
      "unique_key": "Q1690358",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Down syndrome</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Down syndrome</strong> (Trisomy 21) is the most common chromosomal disorder and is characterized by a <strong>nondisjunction</strong> leading to an extra chromosome 21.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Classic clinical features include:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Upslanting palpebral fissures</span></li><li><span style=\"font-size:14.0pt;\">Epicanthal folds</span></li><li><span style=\"font-size:14.0pt;\">Flat facial profile</span></li><li><span style=\"font-size:14.0pt;\">Single transverse palmar crease (Simian crease)</span></li><li><span style=\"font-size:14.0pt;\">Generalized hypotonia</span></li><li><span style=\"font-size:14.0pt;\">Intellectual disability</span></li><li><span style=\"font-size:14.0pt;\">Congenital heart defects (especially atrioventricular septal defects)</span></li><li><span style=\"font-size:14.0pt;\">Duodenal atresia, Hirschsprung disease</span></li><li><span style=\"font-size:14.0pt;\">Increased risk of leukemia (especially ALL and AML) and early-onset Alzheimer’s</span></li></ul></li><li><span style=\"font-size:14.0pt;\">The constellation of findings in the question strongly supports this diagnosis.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Patau syndrome:&nbsp;</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Patau syndrome (Trisomy 13)&nbsp;</strong>is presents with <strong>holoprosencephaly</strong>, <strong>cleft lip/palate</strong>, <strong>polydactyly</strong>, <strong>microphthalmia</strong>, <strong>scalp defects (cutis aplasia)</strong>, and severe developmental delay.</span></li><li><span style=\"font-size:14.0pt;\">Facial features are not flat and the hallmark signs of Down syndrome are absent.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Edward syndrome:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Edward syndrome (Trisomy 18) is&nbsp;</strong>characterized by <strong>micrognathia</strong>, <strong>low-set ears</strong>, <strong>clenched fists with overlapping fingers</strong>, <strong>rocker-bottom feet</strong>, and <strong>severe intellectual disability</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Palmar creases and facial features differ from those seen in Down syndrome.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Fragile X syndrome:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">X-linked disorder caused by <strong>CGG repeat expansion</strong> in the <strong>FMR1 gene</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Presents with <strong>macroorchidism</strong>, <strong>long face with large ears</strong>, <strong>high-arched palate</strong>, and <strong>behavioral problems like autism</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Palmar crease and facial features described here do not match Fragile X.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Down syndrome (Trisomy 21) is characterized by hypotonia, a single palmar crease, epicanthal folds, and upslanting palpebral fissures along with intellectual disability and other congenital anomalies.</span></p>",
      "correct_choice_id": 360576,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90553/NEET_PG_Aug_PEDIATRICS_Question_4.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        13
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90553/NEET_PG_Aug_PEDIATRICS_Question_4.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90213,
      "choices": [
        {
          "id": 359224,
          "text": "<p><span style=\"font-size:14.0pt;\">Elevated serum androgens</span></p>"
        },
        {
          "id": 359225,
          "text": "<p><span style=\"font-size:14.0pt;\">Decreased estrogen production</span></p>"
        },
        {
          "id": 359226,
          "text": "<p><span style=\"font-size:14.0pt;\">Hyperprolactinemia</span></p>"
        },
        {
          "id": 359227,
          "text": "<p><span style=\"font-size:14.0pt;\">Increased progesterone activity</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 52-year-old woman presents to the clinic with complaints of persistent night sweats, vaginal dryness, and a recent history of two low-impact vertebral fractures. She is not on any hormone therapy. Her menstrual periods ceased 2 years ago. Which of the following is the most likely underlying pathophysiological mechanism responsible for her current symptoms?&nbsp;</span></p>",
      "unique_key": "Q3471113",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Decreased estrogen production</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This patient presents with classic features of <strong>hypo-estrogenism</strong> post-menopause, including:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Vaginal dryness</strong> (due to atrophy of vaginal epithelium)</span></li><li><span style=\"font-size:14.0pt;\"><strong>Vasomotor symptoms</strong> such as <strong>hot flushes and night sweats</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Osteoporosis</strong>, evidenced by low-impact fractures</span></li><li><span style=\"font-size:14.0pt;\"><strong>Increased cardiovascular risk</strong> (though not directly seen here, it's a known long-term consequence)</span></li></ul></li><li><span style=\"font-size:14.0pt;\">All of these are consequences of <strong>reduced ovarian estrogen production</strong> after menopause. Estrogen plays critical roles in thermoregulation, maintaining bone mineral density, and vascular health.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Elevated serum androgens:</strong> Incorrect. Elevated androgens are more often associated with conditions like polycystic ovary syndrome (PCOS), not the hypo-estrogenic state typical of postmenopause.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Hyperprolactinemia:</strong> Incorrect. While hyperprolactinemia can cause amenorrhea, it is not associated with <strong>vasomotor symptoms, osteoporosis, or increased cardiovascular risk</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Increased progesterone activity:</strong> Incorrect. Progesterone levels also decline after menopause and are not the primary driver of these symptoms.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Estrogen deficiency</strong> following menopause leads to <strong>vasomotor symptoms, vaginal dryness, osteoporosis, and increased cardiovascular risk-&nbsp;</strong>key clinical markers of a hypo-estrogenic state.</span></p>",
      "correct_choice_id": 359225,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90213/NEET_PG_aug_2025_OBG_Question_1.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90213/NEET_PG_aug_2025_OBG_Question_1.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89823,
      "choices": [
        {
          "id": 357684,
          "text": "<p><span style=\"font-size:14.0pt;\">Increase olanzapine dose gradually and monitor response</span></p>"
        },
        {
          "id": 357685,
          "text": "<p><span style=\"font-size:14.0pt;\">Switch to risperidone</span></p>"
        },
        {
          "id": 357686,
          "text": "<p><span style=\"font-size:14.0pt;\">Add valproate as adjunctive therapy</span></p>"
        },
        {
          "id": 357687,
          "text": "<p><span style=\"font-size:14.0pt;\">Initiate clozapine therapy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 28-year-old man with schizophrenia has had persistent delusions and hallucinations for 2 years. He was previously on haloperidol at maximum tolerated doses without significant improvement. He is currently on olanzapine 5 mg/day for the last 6 weeks, but remains symptomatic. What is the next best step in management?</span></p>",
      "unique_key": "Q1916764",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Increase olanzapine dose gradually and monitor response</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The patient has been on <strong>olanzapine 5 mg/day for 6 weeks</strong>, which is considered a <strong>subtherapeutic dose</strong> for schizophrenia.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Before labeling the patient as having <strong>treatment-resistant schizophrenia</strong>, it is necessary to ensure an <strong>adequate trial</strong> of the current antipsychotic.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This includes using a <strong>therapeutic dose for an adequate duration</strong> (usually ≥6 weeks).&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The next appropriate step is to <strong>titrate olanzapine to at least 10 mg/day</strong> and monitor for clinical improvement.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Switch to risperidone</strong>: Not indicated yet, since the patient has not had an adequate trial of olanzapine at therapeutic doses.</span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Add valproate as adjunctive therapy</strong>: Valproate is not indicated for persistent positive symptoms of schizophrenia unless there is a comorbid mood or aggression issue.</span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Initiate clozapine therapy</strong>: Clozapine is reserved for <strong>treatment-resistant schizophrenia</strong>, defined as failure of <strong>at least two adequate trials of antipsychotics</strong> at therapeutic doses. Since olanzapine was used at a subtherapeutic dose, TRS criteria are not yet met.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Before diagnosing <strong>treatment-resistant schizophrenia</strong>, ensure the patient has had <strong>at least two adequate trials</strong> of antipsychotics at <strong>therapeutic doses and durations</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\"><strong>Olanzapine</strong> should be titrated to an appropriate dose (typically <strong>10–20 mg/day</strong>) and assessed for response before considering a switch or clozapine initiation.</span></li></ul>",
      "correct_choice_id": 357684,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89823/NEET_PG_aug_2025_PSYCHIATRY_Question_4.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        16
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89823/NEET_PG_aug_2025_PSYCHIATRY_Question_4.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90887,
      "choices": [
        {
          "id": 361884,
          "text": "<p><span style=\"font-size:14.0pt;\">Short half-life with high fibrin specificity</span></p>"
        },
        {
          "id": 361885,
          "text": "<p><span style=\"font-size:14.0pt;\">Immunogenic protein structure derived from bacterial sources</span></p>"
        },
        {
          "id": 361886,
          "text": "<p><span style=\"font-size:14.0pt;\">Extended half-life</span></p>"
        },
        {
          "id": 361887,
          "text": "<p><span style=\"font-size:14.0pt;\">Prodrug that must be converted by hepatic enzymes</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 63-year-old man with an acute ST-elevation myocardial infarction is given Reteplase as two intravenous bolus doses. What pharmacologic feature of this drug allows for bolus-only delivery?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q5732672",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Extended half-life&nbsp;</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Reteplase</strong> is a <strong>modified recombinant tissue plasminogen activator (tPA)</strong> engineered by deleting specific fibrin-binding domains.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This modification <strong>reduces its fibrin affinity</strong> but significantly <strong>prolongs its plasma half-life</strong>, allowing for <strong>bolus administration</strong> rather than a continuous infusion, as required with alteplase.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This makes it more practical in emergency or prehospital settings, particularly where rapid administration is critical.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Short half-life with high fibrin specificity</strong>: Describes <strong>alteplase (tPA)</strong>, which requires intravenous infusion due to rapid clearance.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Immunogenic protein structure derived from bacterial sources</strong>: Applies to <strong>streptokinase</strong>, which can cause allergic reactions due to its streptococcal origin.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Prodrug that must be converted by hepatic enzymes</strong>: Incorrect. Reteplase is <strong>active upon administration</strong> and does not rely on hepatic metabolism.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Reteplase</strong> is a genetically modified tPA analog with an extended half-life that allows for <strong>bolus-only dosing</strong> in acute myocardial infarction, improving ease of administration in emergency settings.</span></p>",
      "correct_choice_id": 361886,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90887/NEET_PG_aug_2025_PHARMACOLOGY_Question_10.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90887/NEET_PG_aug_2025_PHARMACOLOGY_Question_10.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90812,
      "choices": [
        {
          "id": 361588,
          "text": "<p><span style=\"font-size:14.0pt;\">Adrenal hyperplasia</span></p>"
        },
        {
          "id": 361589,
          "text": "<p><span style=\"font-size:14.0pt;\">Ovarian tumor</span></p>"
        },
        {
          "id": 361590,
          "text": "<p><span style=\"font-size:14.0pt;\">Pituitary mass</span></p>"
        },
        {
          "id": 361591,
          "text": "<p><span style=\"font-size:14.0pt;\">Medication related</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 30-year-old woman presents with a 6-month history of amenorrhea, occasional breast tenderness, milky discharge from both breasts. She takes over the counter medications for dyspepsia but otherwise has no significant past history. UPT is negative. What is the most likely source of her symptoms?</span></p>",
      "unique_key": "Q9432551",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>D) Medication related</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Amenorrhea, galactorrhea, and breast tenderness suggest hyperprolactinemia, driven by elevated prolactin levels.</span></li><li><span style=\"font-size:14.0pt;\">Dyspepsia medications like metoclopramide or domperidone, dopamine antagonists, increase prolactin by blocking inhibition.</span></li><li><span style=\"font-size:14.0pt;\">This causes galactorrhea, amenorrhea (via gonadotropin suppression), and mild headaches.</span></li><li><span style=\"font-size:14.0pt;\">No visual defects or severe headaches reduce pituitary mass likelihood.</span></li><li><span style=\"font-size:14.0pt;\">Negative pregnancy test rules out pregnancy-related causes.</span></li><li><span style=\"font-size:14.0pt;\">Medication-induced hyperprolactinemia is reversible by stopping the offending drug.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Adrenal hyperplasia:</strong> Leads to cortisol or androgen excess, not galactorrhea or amenorrhea.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Ovarian tumor:</strong> Disrupts menses but rarely elevates prolactin for galactorrhea.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C.</strong> <strong>Pituitary mass:</strong> Can cause similar symptoms but one have to rule out secondary causes of hyper-prolactinemia first (and pituitary tumours often have visual field defects).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Dopamine antagonists (e.g., metoclopramide) cause hyperprolactinemia.</span></li><li><span style=\"font-size:14.0pt;\">Hyperprolactinemia presents with amenorrhea and galactorrhea.</span></li><li><span style=\"font-size:14.0pt;\">Check medication history before pituitary evaluation.</span></li></ul>",
      "correct_choice_id": 361591,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90812/Neet_Pg_Aug_2025_Medicine_Question_1.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90812/Neet_Pg_Aug_2025_Medicine_Question_1.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90488,
      "choices": [
        {
          "id": 360316,
          "text": "<p><span style=\"font-size:14.0pt;\">Gastrin</span></p>"
        },
        {
          "id": 360317,
          "text": "<p><span style=\"font-size:14.0pt;\">Insulin</span></p>"
        },
        {
          "id": 360318,
          "text": "<p><span style=\"font-size:14.0pt;\">VIP</span></p>"
        },
        {
          "id": 360319,
          "text": "<p><span style=\"font-size:14.0pt;\">Glucagon</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A follow-up patient of long-standing GERD on endoscopy was found to have a nodule in the 2nd part of the duodenum. Which hormone are you suspecting to be raised?</span></p>",
      "unique_key": "Q8214099",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Gastrin</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">A duodenal nodule in a patient with GERD raises suspicion of a <strong>gastrinoma (Zollinger-Ellison syndrome)</strong>, especially in the 2nd part of the duodenum—a classic location.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Gastrin-producing &nbsp;tumors increase gastric acid secretion, which worsens GERD and causes ulcers.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Insulin:</strong> Suggestive of insulinoma, presents with hypoglycemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. VIP:</strong> Seen in VIPoma, presents with watery diarrhea.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Glucagon:</strong> Seen in glucagonoma, presents with necrolytic migratory erythema and hyperglycemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">A duodenal mass in a patient with GERD should raise suspicion of gastrinoma, associated with elevated gastrin levels and Zollinger-Ellison syndrome.</span></p>",
      "correct_choice_id": 360316,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90488/NEET_PG_aug_2025_Surgery_Question_4.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90488/NEET_PG_aug_2025_Surgery_Question_4.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90561,
      "choices": [
        {
          "id": 360604,
          "text": "<p><span style=\"font-size:14.0pt;\">Behavioral modification</span></p>"
        },
        {
          "id": 360605,
          "text": "<p><span style=\"font-size:14.0pt;\">Start anticholinergic drugs</span></p>"
        },
        {
          "id": 360606,
          "text": "<p><span style=\"font-size:14.0pt;\">Prescribe oxybutynin</span></p>"
        },
        {
          "id": 360607,
          "text": "<p><span style=\"font-size:14.0pt;\">Start desmopressin therapy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">An 8-year-old child presents with enuresis. The parents mention the child had a fall from the bed once but has no other significant medical history. There are no signs of urinary tract infection or neurological deficits. What is the best next step in management?&nbsp;</span></p>",
      "unique_key": "Q4098530",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Behavioral modification</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Behavioral modification</strong> is the first-line approach in managing <strong>primary monosymptomatic nocturnal enuresis</strong> (PMNE), especially when the child has no underlying neurological or urological pathology.</span></li><li><span style=\"font-size:14.0pt;\">Behavioral techniques include:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Positive reinforcement (praise for dry nights)</span></li><li><span style=\"font-size:14.0pt;\">Alarm therapy</span></li><li><span style=\"font-size:14.0pt;\">Timed voiding before sleep</span></li><li><span style=\"font-size:14.0pt;\">Limiting fluid intake in the evening</span></li><li><span style=\"font-size:14.0pt;\">These interventions are non-invasive, cost-effective, and address the behavioral root of the issue in many cases.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Start anticholinergic drugs:&nbsp;</strong>Anticholinergics are <strong>not first-line</strong> for uncomplicated PMNE. They are used in children with daytime symptoms or detrusor overactivity, not in a child with no neurological or voiding issues.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Prescribe oxybutynin:&nbsp;</strong>Oxybutynin is an <strong>anticholinergic agent</strong>, primarily indicated for <strong>urge incontinence</strong> or <strong>overactive bladder</strong>, not primary bedwetting in an otherwise healthy child.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Start desmopressin therapy:&nbsp;</strong>Desmopressin, a synthetic analog of vasopressin, is effective in <strong>reducing nighttime urine production</strong> and is <strong>used when behavioral modifications fail</strong> or in cases requiring <strong>short-term control</strong> (e.g., sleepovers). However, it is <strong>not first-line therapy</strong> due to the risk of <strong>hyponatremia</strong> and relapse after discontinuation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Behavioral therapy is the initial and preferred management for monosymptomatic nocturnal enuresis in children without signs of neurological or urinary tract pathology.</span></p>",
      "correct_choice_id": 360604,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90561/NEET_PG_Aug_PEDIATRICS_Question_6.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        13
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90561/NEET_PG_Aug_PEDIATRICS_Question_6.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90513,
      "choices": [
        {
          "id": 360416,
          "text": "<p><span style=\"font-size:14.0pt;\">Familial Adenomatous Polyposis</span></p>"
        },
        {
          "id": 360417,
          "text": "<p><span style=\"font-size:14.0pt;\">Peutz-Jeghers Syndrome</span></p>"
        },
        {
          "id": 360418,
          "text": "<p><span style=\"font-size:14.0pt;\">Juvenile Polyposis Syndrome</span></p>"
        },
        {
          "id": 360419,
          "text": "<p><span style=\"font-size:14.0pt;\">Cronkhite-Canada Syndrome</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 16-year-old boy presents with multiple episodes of abdominal pain and a history of passing blood in stools. On examination, he has dark pigmented spots on his lips and oral mucosa. Endoscopy reveals multiple hamartomatous polyps in the small intestine. What is the most likely diagnosis?</span></p>",
      "unique_key": "Q1240611",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Peutz-Jeghers Syndrome</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Peutz-Jeghers Syndrome (PJS) is an <strong>autosomal dominant</strong> disorder characterized by:</span></li><li><span style=\"font-size:14.0pt;\"><strong>Hamartomatous polyps</strong> in the gastrointestinal tract, especially the <strong>small intestine</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Mucocutaneous pigmentation</strong>, most prominently around the <strong>lips, oral mucosa, and fingers</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Symptoms like <strong>abdominal pain</strong>, <strong>GI bleeding</strong>, and <strong>intussusception</strong>.</span></li><li><span style=\"font-size:14.0pt;\">It is associated with <strong>mutation in the STK11 (LKB1)</strong> tumor suppressor gene.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Familial Adenomatous Polyposis:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Involves <strong>hundreds to thousands of adenomatous polyps</strong>, especially in the <strong>colon</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Associated with mutations in the <strong>APC gene</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Mucocutaneous pigmentation is <strong>not a feature</strong>.</span></li><li><span style=\"font-size:14.0pt;\">The polyps are <strong>adenomatous</strong>, not hamartomatous.</span></li></ul><p style=\"text-align:center;\">&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Juvenile Polyposis Syndrome:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Presents in childhood with <strong>multiple hamartomatous polyps</strong>, mainly in the <strong>colon</strong> and rectum.</span></li><li><span style=\"font-size:14.0pt;\">Lacks the <strong>pigmented mucocutaneous lesions</strong>.</span></li><li><span style=\"font-size:14.0pt;\">May present with anemia, bleeding, or intussusception.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Cronkhite-Canada Syndrome:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">A <strong>non-inherited</strong> disorder occurring in adults.</span></li><li><span style=\"font-size:14.0pt;\">Presents with <strong>diarrhea, weight loss</strong>, alopecia, and nail changes.</span></li><li><span style=\"font-size:14.0pt;\">Also has hamartomatous polyps, but no <strong>mucocutaneous pigmentation</strong> and occurs later in life.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Peutz-Jeghers Syndrome is identified by the presence of mucocutaneous pigmentation and hamartomatous polyps in the small intestine, often in adolescents with GI symptoms and STK11 gene mutation.</span></p>",
      "correct_choice_id": 360417,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90513/NEET_PG_aug_2025_Surgery_Question_15.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90513/NEET_PG_aug_2025_Surgery_Question_15.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90854,
      "choices": [
        {
          "id": 361756,
          "text": "<p><span style=\"font-size:14.0pt;\">Quantify urine albumin to creatinine ratio</span></p>"
        },
        {
          "id": 361757,
          "text": "<p><span style=\"font-size:14.0pt;\">Renal biopsy</span></p>"
        },
        {
          "id": 361758,
          "text": "<p><span style=\"font-size:14.0pt;\">Empiric treatment with IV steroids</span></p>"
        },
        {
          "id": 361759,
          "text": "<p><span style=\"font-size:14.0pt;\">Continue supportive measures</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 68-year-old man with type 2 diabetes mellitus and hypertension is admitted to the ICU for septic shock secondary to streptococcus bacteremia, managed with IV antibiotics and vasopressors. Laboratory results show Hb 9 g/dL, WBC 12,000/µL, platelets 100,000/µL, AKI with creatinine 1.7 mg/dL (baseline 1.0 mg/dL), Urinalysis finding is shown below and urine protein to creatinine ratio of 1700 mg/g. What is the best course of action?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_A1K3tuz.png\" width=\"444\" height=\"346\"></strong></span></p>",
      "unique_key": "Q9800809",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;D) Continue supportive measures</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Septic shock with AKI, oliguria, and muddy brown casts indicate acute tubular necrosis (ATN) from sepsis and hypoperfusion.</span></li><li><span style=\"font-size:14.0pt;\">Proteinuria (1700 mg/g) is non-specific and not of much value in the setting of AKI. In this case, it is likely to be tubular (not glomerular).&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Supportive care (fluids, sepsis treatment) is key, as ATN often resolves with underlying cause correction.</span></li><li><span style=\"font-size:14.0pt;\">Avoid nephrotoxic agents and monitor renal function.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Quantify urine albumin to creatinine ratio:</strong> Indicated if there is suspicion of glomerular injury, not indicated with ATN.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Renal biopsy:</strong> Unnecessary with a clear etiology for AKI.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Empiric treatment with IV steroids:</strong> No role without autoimmune evidence or refractory septic shock.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Muddy brown casts and proteinuria indicate ATN in sepsis.</span></li><li><span style=\"font-size:14.0pt;\">Supportive care is primary for AKI management.</span></li><li><span style=\"font-size:14.0pt;\">Avoid invasive tests when etiology is clear.</span></li></ul>",
      "correct_choice_id": 361759,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90854/Neet_Pg_Aug_2025_Medicine_Question_20.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90854/Neet_Pg_Aug_2025_Medicine_Question_20.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90847,
      "choices": [
        {
          "id": 361728,
          "text": "<p><span style=\"font-size:14.0pt;\">A biphasic reaction may occur 8 to 72 hours after anaphylaxis</span></p>"
        },
        {
          "id": 361729,
          "text": "<p><span style=\"font-size:14.0pt;\">Penicillin allergy is more common in patients with history of allergic reactions</span></p>"
        },
        {
          "id": 361730,
          "text": "<p><span style=\"font-size:14.0pt;\">Observation for 6 to 12 hours is appropriate for urticaria</span></p>"
        },
        {
          "id": 361731,
          "text": "<p><span style=\"font-size:14.0pt;\">Patients should be prescribed epinephrine autoinjectors on discharge</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">23-year-old man with a known peanut allergy presents to the ED after accidental exposure at a restaurant. He has urticaria over the chest and upper back, but no dyspnea, throat tightness, or facial swelling. Vitals are stable. He reports having had similar reactions in the past. Which of the following statements is false?</span></p>",
      "unique_key": "Q9785869",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Penicillin allergy is more common in patients with history of allergic reactions</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Anaphylaxis and allergic reactions</strong> can recur in a <strong>biphasic manner</strong>, typically within <strong>8–72 hours</strong> after the initial reaction — so statement A is <strong>true</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Patients with <strong>anaphylaxis or urticaria</strong> should be <strong>observed for at least 6–12 hours</strong>, especially if there's a history of severe reaction — statement C is <strong>true</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Epinephrine autoinjectors</strong> are appropriate for all patients with a history of <strong>IgE-mediated food allergy</strong>, even if the current reaction is mild — statement D is <strong>true</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Penicillin allergy is not necessarily more common</strong> in patients with other allergic reactions. While atopy (e.g., eczema, allergic rhinitis) is associated with increased general allergic tendencies, <strong>penicillin allergy is independent and may be overreported</strong> — so statement B is <strong>false</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. A biphasic reaction</strong> <strong>may occur 8 to 72 hours after anaphylaxis: </strong>These are well-documented and can occur hours after the initial resolution of symptoms, especially in anaphylaxis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Observation for 6 to 12 hours is appropriate for urticaria:</strong> Appropriate for <strong>moderate allergic reactions</strong>, even if airway or cardiovascular compromise is absent.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.&nbsp;Patients should be prescribed epinephrine autoinjectors on discharge:</strong> Recommended for all patients with <strong>IgE-mediated food allergy</strong>, regardless of severity of current episode. Delay in epinephrine injection increases the risk of death.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Penicillin allergy is often overreported</strong> and not more common solely due to a general allergic history.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Biphasic reactions</strong> may occur up to <strong>72 hours after initial symptoms</strong>, especially in anaphylaxis.</span></li><li><span style=\"font-size:14.0pt;\">Patients with any <strong>IgE-mediated food allergy</strong> should be <strong>prescribed epinephrine autoinjectors</strong> even if their current episode is mild.</span></li></ul>",
      "correct_choice_id": 361729,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90847/NEET_PG_aug_2025_MEDICINE_Question_13.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90847/NEET_PG_aug_2025_MEDICINE_Question_13.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89984,
      "choices": [
        {
          "id": 358316,
          "text": "<p><span style=\"font-size:14.0pt;\">Deep peroneal nerve</span></p>"
        },
        {
          "id": 358317,
          "text": "<p><span style=\"font-size:14.0pt;\">Common peroneal nerve</span></p>"
        },
        {
          "id": 358318,
          "text": "<p><span style=\"font-size:14.0pt;\">Saphenous nerve</span></p>"
        },
        {
          "id": 358319,
          "text": "<p><span style=\"font-size:14.0pt;\">Superficial peroneal nerve&nbsp;</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 37-year old male presents after a traumatic knee dislocation. On neurological examination, there is sensory loss over most of the dorsum of the foot, except the first web space, and dorsiflexion is preserved. Which of the following nerves is most likely affected?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q2213756",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;D) Superficial peroneal nerve</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The&nbsp;<strong>superficial peroneal nerve</strong> provides <strong>sensory innervation to the dorsum of the foot</strong> except the <strong>first web space</strong>, which is supplied by the&nbsp;<strong>deep peroneal nerve</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Because <strong>dorsiflexion (a motor function of the deep peroneal nerve)</strong> is preserved, the motor component is intact, pointing to <strong>isolated superficial peroneal nerve involvement</strong>, typically affected in trauma near the fibular neck or with stretch injuries.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_insdCvr.png\" width=\"275\" height=\"548\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option&nbsp;A. Deep peroneal nerve:</strong> Incorrect. Damage would result in <strong>loss of dorsiflexion</strong> and <strong>sensory loss in the first web space</strong>. This is not consistent with preserved dorsiflexion and spared first web space.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option&nbsp;B. Common peroneal nerve:</strong> Incorrect. Injury would cause <strong>loss of both superficial and deep peroneal functions</strong>, leading to <strong>foot drop and widespread sensory loss</strong> on the dorsum. Here, dorsiflexion is preserved.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option&nbsp;C. Saphenous nerve:</strong> Incorrect. It is a <strong>purely sensory branch</strong> of the&nbsp;<strong>femoral nerve</strong> and provides <strong>sensation to the medial leg</strong>, not the dorsum of the foot.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Injury to the&nbsp;<strong>superficial peroneal nerve</strong> causes <strong>sensory loss over the dorsum of the foot except the first web space</strong>, with <strong>preserved dorsiflexion</strong>, distinguishing it from deep or common peroneal nerve injury.</span></p>",
      "correct_choice_id": 358319,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89984/NEET_PG_aug_2025_ANATOMY_Question_6.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        3
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89984/NEET_PG_aug_2025_ANATOMY_Question_6.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90236,
      "choices": [
        {
          "id": 359316,
          "text": "<p>&nbsp;<span style=\"font-size:14.0pt;\">Testicular biopsy</span></p>"
        },
        {
          "id": 359317,
          "text": "<p><span style=\"font-size:14.0pt;\">Serum testosterone levels</span></p>"
        },
        {
          "id": 359318,
          "text": "<p><span style=\"font-size:14.0pt;\">Serum FSH levels</span></p>"
        },
        {
          "id": 359319,
          "text": "<p><span style=\"font-size:14.0pt;\">Serum LH levels</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 32-year-old male presents to a reproductive endocrinology clinic due to primary infertility. He and his partner have been unable to conceive after 12 months of unprotected intercourse. His partner’s gynecologic evaluation, including hysterosalpingography, is unremarkable. Semen analysis reveals azoospermia. The next step involves distinguishing between a testicular and an obstructive etiology. Which of the following tests would be most useful to determine the underlying cause?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q7600974",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Testicular biopsy</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">A <strong>testicular biopsy</strong> is the most definitive method to distinguish between <strong>obstructive</strong> and <strong>non-obstructive</strong> (testicular) causes of <strong>azoospermia</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">If spermatogenesis is found to be normal on biopsy, an <strong>obstructive</strong> pathology (e.g., congenital absence of the vas deferens, ejaculatory duct obstruction) is more likely.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">If the biopsy reveals absent or defective spermatogenesis, the etiology is <strong>testicular failure</strong> (non-obstructive azoospermia).</span></li><li><span style=\"font-size:14.0pt;\">While hormone assays such as FSH and testosterone can provide <strong>indirect information</strong>, they <strong>cannot conclusively establish</strong> the cause. Biopsy offers direct histological evidence.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Serum testosterone levels:</strong> Incorrect. While testosterone reflects <strong>Leydig cell function</strong>, it is not diagnostic of the <strong>type of azoospermia</strong>. Testosterone may be normal in both obstructive and non-obstructive causes.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Serum FSH levels:</strong> Incorrect. Elevated FSH levels suggest <strong>testicular damage</strong>, but <strong>normal levels do not rule out</strong> a testicular cause. Thus, FSH is a useful screening tool but <strong>not definitive</strong> for diagnosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Serum LH levels:</strong> Incorrect. LH primarily reflects <strong>Leydig cell stimulation</strong> and has a <strong>limited role</strong> in distinguishing obstructive from testicular azoospermia. It is more useful in evaluating <strong>hypogonadotropic hypogonadism</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Testicular biopsy</strong> is the most definitive test to distinguish obstructive from testicular causes of <strong>azoospermia</strong> when semen analysis confirms absence of sperm.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Hormonal tests may support the evaluation but cannot replace histological confirmation.</span></li></ul>",
      "correct_choice_id": 359316,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90236/NEET_PG_aug_2025_OBG_Question_20.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90236/NEET_PG_aug_2025_OBG_Question_20.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90515,
      "choices": [
        {
          "id": 360424,
          "text": "<p><span style=\"font-size:14.0pt;\">Myositis Ossificans</span></p>"
        },
        {
          "id": 360425,
          "text": "<p><span style=\"font-size:14.0pt;\">Osteogenic Sarcoma</span></p>"
        },
        {
          "id": 360426,
          "text": "<p><span style=\"font-size:14.0pt;\">Ewings Sarcoma</span></p>"
        },
        {
          "id": 360427,
          "text": "<p><span style=\"font-size:14.0pt;\">Osteoclastoma</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 25-year-old executive had an insidious onset right knee pain. On examination there was severe tenderness over the right knee. No gross swelling. X-ray showed the following finding. Diagnosis please.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-08-14%20141104.jpeg\" width=\"447\" height=\"334\"></span></p>",
      "unique_key": "Q4744681",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Osteogenic Sarcoma</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This is the most common primary malignant bone tumor.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It typically presents in adolescents and young adults (10-25 years old), with a peak incidence in the second decade of life.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The most common location is the metaphysis of long bones, particularly around the knee (distal femur, proximal tibia).</span></li><li><span style=\"font-size:14.0pt;\">The clinical presentation of insidious onset pain, swelling, and tenderness in this age group is classic.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">X-rays typically show an aggressive lesion with a mixed lytic (bone-destroying) and sclerotic (bone-forming) pattern, ill-defined margins, and classic signs of periosteal reaction like \"Codman's triangle\" or a \"sunburst\" appearance.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This diagnosis perfectly fits the patient's age and symptoms, and the X-ray findings must have been indicative of this aggressive tumor.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p style=\"margin-left:0cm;\">&nbsp;</p><p style=\"margin-left:0cm;\"><span style=\"font-size:14.0pt;\"><strong>Option A. Myositis Ossificans:</strong>&nbsp;</span></p><p style=\"margin-left:0cm;\">&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This is a benign condition characterized by the formation of bone tissue within muscle or other soft tissue, usually following a trauma.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">On X-ray, it typically shows a characteristic \"zonal\" pattern of calcification with a dense, well-defined periphery and a less dense center.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">While it can cause pain and a mass, the insidious onset without a clear traumatic event and the characteristic radiographic findings of an aggressive tumor (as implied by the correct answer) make this diagnosis unlikely.</span></li></ul><p>&nbsp;</p><p style=\"margin-left:0cm;\"><span style=\"font-size:14.0pt;\"><strong>Option C. Ewing's Sarcoma:</strong></span></p><p style=\"margin-left:0cm;\">&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This is another highly malignant bone tumor of childhood and early adulthood (typically 5-20 years).&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">While it can also occur in the knee region and cause similar symptoms, its classic presentation is an \"onion-skin\" periosteal reaction on X-ray and a preference for the diaphysis (shaft) of long bones.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The patient's age range slightly overlaps, but the specific radiographic findings implied by the correct answer point more strongly to osteosarcoma.</span></li></ul><p>&nbsp;</p><p style=\"margin-left:0cm;\"><span style=\"font-size:14.0pt;\"><strong>Option D. Osteoclastoma (Giant Cell Tumor):</strong>&nbsp;</span></p><p style=\"margin-left:0cm;\">&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This is a benign but locally aggressive bone tumor that typically affects young adults (20-40 years old).&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It characteristically presents as an eccentric, lytic lesion in the epiphysis (end of the bone), extending to the articular surface. On X-ray, it often has a \"soap-bubble\" appearance.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">While the age and location (around the knee) are a good fit, the specific radiographic features (lytic, epiphyseal location) differ from the aggressive, mixed-pattern, metaphyseal lesion typical of osteosarcoma.</span></li></ul><p>&nbsp;</p><p style=\"margin-left:0cm;\"><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p style=\"margin-left:0cm;\">&nbsp;</p><p><span style=\"font-size:14.0pt;\">The learner should be able to differentiate common bone tumors in young adults by integrating clinical presentation (age, onset, location of pain) with characteristic radiographic findings to arrive at the most probable diagnosis.</span></p>",
      "correct_choice_id": 360425,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90515/NEET_PG_aug_2025_ORTHO_Question_5.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        15
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90515/NEET_PG_aug_2025_ORTHO_Question_5.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89991,
      "choices": [
        {
          "id": 358344,
          "text": "<p><span style=\"font-size:14.0pt;\">Ventral spinocerebellar tract</span></p>"
        },
        {
          "id": 358345,
          "text": "<p><span style=\"font-size:14.0pt;\">Lateral corticospinal tract</span></p>"
        },
        {
          "id": 358346,
          "text": "<p><span style=\"font-size:14.0pt;\">Dorsal columns and dorsal roots&nbsp;</span></p>"
        },
        {
          "id": 358347,
          "text": "<p><span style=\"font-size:14.0pt;\">Nucleus proprius</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 43-year-old male with a long-standing history of untreated sexually transmitted infection reports progressive difficulty with balance and sharp shooting pain in his legs. Neurologic examination shows a wide-based gait, reduced joint position sensation, absent lower limb reflexes, and preserved muscle strength. Which of the following spinal cord structures is most likely involved in this condition?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q5202060",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Dorsal columns and dorsal roots</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This patient exhibits classic signs of&nbsp;<strong>tabes dorsalis</strong>, a form of&nbsp;<strong>tertiary neurosyphilis</strong> that involves the <strong>dorsal columns and dorsal roots</strong>. The symptoms:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Wide-based gait</strong> and <strong>proprioception loss</strong> reflect dorsal column involvement.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Lightning-like leg pain</strong> and <strong>absent deep tendon reflexes</strong> are due to dorsal root degeneration.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Preserved motor strength</strong> confirms sparing of motor tracts.</span></li></ul></li><li><span style=\"font-size:14.0pt;\">This degeneration disrupts fine touch, vibration, and proprioceptive sensation, especially in the lower limbs.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option&nbsp;A. Ventral spinocerebellar tract:</strong> Involved in unconscious proprioception but not classically affected in neurosyphilis. Lesions here wouldn't explain the absent reflexes or stabbing pain.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option&nbsp;B. Lateral corticospinal tract:</strong> Carries motor fibers. Damage would cause weakness, spasticity, and increased reflexes—opposite to findings here.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option&nbsp;D. Nucleus proprius:</strong> Located in the dorsal horn and involved in processing pain and temperature. While it relays sensory info, its damage doesn’t produce the specific proprioceptive deficits and reflex loss seen in tabes dorsalis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Tabes dorsalis</strong>, seen in late <strong>untreated syphilis</strong>, primarily affects the <strong>dorsal columns and dorsal roots</strong>, leading to sensory ataxia, stabbing leg pain, and areflexia without motor weakness.</span></p>",
      "correct_choice_id": 358346,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89991/NEET_PG_aug_2025_ANATOMY_Question_10.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        3
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89991/NEET_PG_aug_2025_ANATOMY_Question_10.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89946,
      "choices": [
        {
          "id": 358168,
          "text": "<p><span style=\"font-size:14.0pt;\">Kerion; Trichophyton verrucosum</span></p>"
        },
        {
          "id": 358169,
          "text": "<p><span style=\"font-size:14.0pt;\">Favus; Microsporum audouinii</span></p>"
        },
        {
          "id": 358170,
          "text": "<p><span style=\"font-size:14.0pt;\">Ectothrix; Trichophyton tonsurans</span></p>"
        },
        {
          "id": 358171,
          "text": "<p><span style=\"font-size:14.0pt;\">Endothrix; Microsporum canis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 12-year-old boy presents with an intensely pruritic, boggy, erythematous plaque on his scalp. The lesion exudes pus, and several hairs break off at the skin surface. KOH prep of plucked hairs shows arthroconidia around the hair shaft. Which clinical variant of tinea capitis does this most likely represent, and which organism is the usual culprit?&nbsp;</span></p>",
      "unique_key": "Q1857531",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;A) Kerion; Trichophyton verrucosum</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Kerion</strong> is an inflammatory, boggy form of tinea capitis characterized by tender, pustular plaques and hair loss.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-08-19%20172153.jpeg\" width=\"519\" height=\"484\"></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">It often results from a robust host immune response to <strong>zoophilic</strong> dermatophytes, especially T. verrucosum (from cattle).</span></li><li><span style=\"font-size:14.0pt;\">Arthroconidia and hyphae invade the <strong>deeper dermis</strong>, provoking intense inflammation.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_RRKHG2a.png\" width=\"456\" height=\"271\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Favus;&nbsp;Microsporum audouinii:</strong> Produces yellow “scutula” crusts with minimal inflammation, not boggy plaques.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-08-19%20172500.jpeg\" width=\"491\" height=\"322\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Ectothrix;&nbsp;Trichophyton tonsurans:</strong> Arthroconidia form on hair surface—less inflammatory, more patchy scaling.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Endothrix; Microsporum canis:</strong> Arthroconidia fill the hair shaft—typically noninflammatory alopecia (“black dot”) rather than kerion.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-08-19%20172305.jpeg\" width=\"465\" height=\"441\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Inflammatory scalp lesions (kerion) with boggy plaques and pustules in tinea capitis are most often caused by <strong>zoophilic</strong> species like T. verrucosum.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Remember: Kerion</strong> = painful, purulent scalp mass in kids; key pathogen = <strong>zoophilic T. verrucosum</strong>.</span></p>",
      "correct_choice_id": 358168,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89946/NEET_PG_aug_2025_MICROBIOLOGY_Question_10.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        6
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89946/NEET_PG_aug_2025_MICROBIOLOGY_Question_10.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90851,
      "choices": [
        {
          "id": 361744,
          "text": "<p><span style=\"font-size:14.0pt;\">Increase the dose of omeprazole to 40 mg daily</span></p>"
        },
        {
          "id": 361745,
          "text": "<p><span style=\"font-size:14.0pt;\">Do an EGD</span></p>"
        },
        {
          "id": 361746,
          "text": "<p><span style=\"font-size:14.0pt;\">Do a barium swallow</span></p>"
        },
        {
          "id": 361747,
          "text": "<p><span style=\"font-size:14.0pt;\">Encourage the patient not to miss any doses of omeprazole</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 55-year-old man with a history of diabetes, hypertension, obesity, tobacco use, and GERD presents with a new onset of dysphagia, describing a sensation of solid food getting stuck in the mid-chest. He has been taking omeprazole 20 mg daily for 3 years, with occasional missed doses. What is the most appropriate next step in management?</span></p>",
      "unique_key": "Q9281413",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Do an EGD</strong></span></p><p><span style=\"font-size:14.0pt;\"><strong>&nbsp;</strong></span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This patient has <strong>new-onset solid food dysphagia</strong>, a <strong>red flag symptom</strong> that requires <strong>prompt evaluation</strong> for <strong>esophageal structural or malignant lesions</strong>.</span></li><li><span style=\"font-size:14.0pt;\">His risk factors (age &gt;50, tobacco use, obesity, chronic GERD) increase the concern for <strong>Barrett’s esophagus</strong> or <strong>esophageal cancer</strong>.</span></li><li><span style=\"font-size:14.0pt;\">The <strong>appropriate next step is esophagogastroduodenoscopy (EGD)</strong>, which allows direct visualization and biopsy if needed.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Empiric acid suppression (omeprazole adjustments)</strong> is <strong>not sufficient</strong> when <strong>alarm symptoms</strong> like dysphagia are present.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Barium swallow</strong> may be useful in evaluating structural abnormalities or motility issues but is <strong>not first-line when endoscopy is accessible</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Increase the dose of omeprazole</strong> <strong>to 40 mg daily:</strong> Not appropriate as first step in a patient with <strong>new solid food dysphagia</strong>, which may indicate a structural lesion.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Do a barium swallow:</strong> Less sensitive than EGD and <strong>not preferred</strong> as the initial diagnostic test when endoscopy is available.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Encourage&nbsp;the patient not to miss any doses of</strong> <strong>omeprazole: </strong>Good long-term GERD strategy, but <strong>not appropriate</strong> in the setting of new-onset dysphagia.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>New-onset dysphagia</strong>, especially to solids, requires <strong>prompt endoscopic evaluation</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>EGD</strong> is the first-line test for assessing <strong>esophageal structural abnormalities and malignancy</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Acid suppression should <strong>not delay investigation</strong> when alarm symptoms like dysphagia are present.</span></li></ul>",
      "correct_choice_id": 361745,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90851/NEET_PG_aug_2025_MEDICINE_Question_17.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90851/NEET_PG_aug_2025_MEDICINE_Question_17.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89853,
      "choices": [
        {
          "id": 357804,
          "text": "<p><span style=\"font-size:14.0pt;\">Bias</span></p>"
        },
        {
          "id": 357805,
          "text": "<p><span style=\"font-size:14.0pt;\">Known confounding</span></p>"
        },
        {
          "id": 357806,
          "text": "<p><span style=\"font-size:14.0pt;\">Unknown confounding</span></p>"
        },
        {
          "id": 357807,
          "text": "<p><span style=\"font-size:14.0pt;\">Known + Unknown confounding</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A team of researchers is designing a case-control study to evaluate the association between long-term exposure to air pollution and the risk of developing chronic bronchitis. To minimize the influence of differences in age and smoking status between cases and controls, they decide to use matching. Here, the matching is done for removal of?&nbsp;</span></p>",
      "unique_key": "Q8578156",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;B) Known confounding</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Matching is a technique used during the design phase of observational studies — especially <strong>case-control studies</strong> — to ensure that the distribution of <strong>known confounding variables</strong> is balanced between the case and control groups.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This helps reduce the confounding effect of those variables on the observed relationship between exposure and outcome.</span></li><li><span style=\"font-size:14.0pt;\">For example, since both age and smoking are known to influence the risk of chronic bronchitis and may also be associated with air pollution exposure, matching on these variables helps isolate the true effect of air pollution.</span></li><li><span style=\"font-size:14.0pt;\">However, matching is only effective for variables that are known and measurable at the time of study design.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Bias:</strong> Bias refers to systematic errors in the study process, such as selection bias or information bias. Matching does not eliminate bias; methods like blinding, using standardized data collection tools, or random sampling are more appropriate for that purpose.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Unknown confounding:</strong> By definition, matching cannot address variables that are not known or identified at the time of study design. Unknown confounders may still distort results despite matching.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Known + Unknown confounding:</strong> Matching does not handle unknown confounding. It is limited to variables that are specifically identified and selected during study planning. Randomization removes both known and unknown confounding</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Matching is used in observational study design to control for <strong>known confounding variables</strong>, improving the validity of the association between exposure and outcome.</span></p>",
      "correct_choice_id": 357805,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89853/NEET_PG_aug_2025_PSM_Question_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89853/NEET_PG_aug_2025_PSM_Question_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90565,
      "choices": [
        {
          "id": 360620,
          "text": "<p><span style=\"font-size:14.0pt;\">Cleaning the eyes with a wet sterile swab</span></p>"
        },
        {
          "id": 360621,
          "text": "<p><span style=\"font-size:14.0pt;\">Giving a bath immediately after birth</span></p>"
        },
        {
          "id": 360622,
          "text": "<p><span style=\"font-size:14.0pt;\">Initiating breastfeeding within 1 hour</span></p>"
        },
        {
          "id": 360623,
          "text": "<p><span style=\"font-size:14.0pt;\">Placing the baby on the mother’s chest</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following is considered harmful to a newborn in the immediate postnatal period?&nbsp;</span></p>",
      "unique_key": "Q6497991",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Giving a bath immediately after birth</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Giving a bath to a newborn immediately after birth is harmful because it can lead to:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Hypothermia</strong>: Newborns lose heat rapidly due to a large surface area-to-body weight ratio. Bathing removes the vernix caseosa (a white, creamy, protective layer), and the exposure to cold water/air can drop the baby's core temperature significantly.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Respiratory distress</strong>: Due to cold stress, babies may exhibit increased respiratory effort or apnea.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Hypoglycemia</strong>: The stress response and cold environment increase glucose consumption, risking hypoglycemia.</span></li></ul></li><li><span style=\"font-size:14.0pt;\">WHO and national newborn care guidelines recommend <strong>delaying the first bath for at least 24 hours</strong>, or at minimum 6 hours if 24 is not feasible.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Cleaning the eyes with a wet sterile swab:&nbsp;</strong>This is a standard preventive measure to clean debris and reduce the risk of neonatal conjunctivitis (ophthalmia neonatorum), especially in high-risk deliveries. This practice does <strong>not harm</strong> the baby.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Initiating breastfeeding within 1 hour:&nbsp;</strong>Known as <strong>early initiation of breastfeeding</strong>, this is highly beneficial. It provides the baby with colostrum—rich in immunoglobulins—and promotes bonding, temperature regulation, and glucose stability.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Placing the baby on the mother’s chest:&nbsp;</strong>This is <strong>skin-to-skin contact</strong> or <strong>Kangaroo Mother Care</strong>, and is strongly recommended immediately after birth. It helps maintain the newborn’s body temperature, heart rate, and breathing, and also encourages early breastfeeding initiation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In the immediate postnatal period, harmful practices such as early bathing must be avoided due to the risk of hypothermia and related complications.</span></li><li><span style=\"font-size:14.0pt;\">WHO recommends delaying the first bath to preserve warmth and promote neonatal stability.</span></li></ul>",
      "correct_choice_id": 360621,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90565/NEET_PG_Aug_PEDIATRICS_Question_9.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        13
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90565/NEET_PG_Aug_PEDIATRICS_Question_9.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89944,
      "choices": [
        {
          "id": 358160,
          "text": "<p><span style=\"font-size:14.0pt;\">Fasciola gigantica</span></p>"
        },
        {
          "id": 358161,
          "text": "<p><span style=\"font-size:14.0pt;\">Ancylostoma braziliense</span></p>"
        },
        {
          "id": 358162,
          "text": "<p><span style=\"font-size:14.0pt;\">Ancylostoma caninum</span></p>"
        },
        {
          "id": 358163,
          "text": "<p><span style=\"font-size:14.0pt;\">Opisthorchis viverrini</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 15-year-old boy has experienced intermittent abdominal cramps and diarrhea for over a year. A stool wet mount reveals numerous large, operculated trematode eggs measuring approximately 160–190 µm in length. Which parasite is most likely responsible?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q1959108",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Fasciola gigantica</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Egg morphology and size:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Fasciola gigantica is a trematode whose eggs are <strong>oval, bile-stained, operculated</strong>, and notably <strong>large</strong> (160–190 µm × 70–90 µm).</span></li><li><span style=\"font-size:14.0pt;\">The chronic intermittent GI symptoms reflect the parasite’s migration through the biliary tree and subsequent fibrosis rather than an acute intestinal illness.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Clinical course:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Acute phase (1–2 weeks after ingestion):</strong> Larval migration through liver parenchyma causes <strong>fever</strong>, <strong>right-upper-quadrant pain</strong>, <strong>hepatomegaly</strong>, and <strong>eosinophilia</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Chronic phase:</strong> Adults in bile ducts produce eggs that pass into the intestine, leading to <strong>biliary colic</strong>, intermittent diarrhea, and malabsorption.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Ancylostoma braziliense :&nbsp;</strong>A canine hookworm; humans harbor only the <strong>larval</strong> stage (cutaneous larva migrans). No eggs are produced in human stool, and egg size (~60–75 µm) is much smaller.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Ancylostoma caninum</strong>: A canine hookworm; humans harbor only the <strong>larval</strong> stage (cutaneous larva migrans). No eggs are produced in human stool, and egg size (~60–75 µm) is much smaller.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Opisthorchis viverrini</strong>: A small liver fluke; eggs are <strong>~27 µm × 15 µm</strong>, operculated with a small shoulder. Infection leads to cholangitis and increased cholangiocarcinoma risk, but egg size and shape differ greatly.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Large, operculated trematode eggs (&gt;150 µm) in a patient with biliary-type abdominal pain and chronic diarrhea point to <strong>Fasciola gigantica</strong>, a liver fluke that matures in bile ducts.</span></p>",
      "correct_choice_id": 358160,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89944/NEET_PG_aug_2025_MICROBIOLOGY_Question_8.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        6
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89944/NEET_PG_aug_2025_MICROBIOLOGY_Question_8.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89930,
      "choices": [
        {
          "id": 358112,
          "text": "<p><span style=\"font-size:14.0pt;\">Mutation in surfactant protein genes</span></p>"
        },
        {
          "id": 358113,
          "text": "<p><span style=\"font-size:14.0pt;\">Reduced anti-elastase activity&nbsp;</span></p>"
        },
        {
          "id": 358114,
          "text": "<p><span style=\"font-size:14.0pt;\">Chronic hypersensitivity reaction to inhaled antigens</span></p>"
        },
        {
          "id": 358115,
          "text": "<p><span style=\"font-size:14.0pt;\">CFTR gene mutation</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 42-year-old man reports gradually worsening shortness of breath over the past several years. He has no history of smoking. Physical examination reveals hyperresonant lung fields with diminished breath sounds. A chest radiograph demonstrates flattened diaphragms and diffuse hyperlucency of both lungs. Pulmonary function testing shows a decreased FEV₁/FVC ratio. His younger sibling has been diagnosed with a similar lung condition. Which of the following is the most likely underlying mechanism for this patient’s pulmonary disease?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q5692800",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Reduced anti-elastase activity</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This patient’s presentation — <strong>progressive dyspnea in a young, nonsmoking adult</strong>, family history, imaging with <strong>hyperinflation and flattened diaphragms</strong>, and <strong>obstructive spirometry pattern</strong> — is consistent with <strong>panacinar emphysema</strong> from <strong>alpha-1 antitrypsin (AAT) deficiency</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>AAT</strong> is a protease inhibitor that primarily blocks <strong>neutrophil elastase</strong>.</span></li><li><span style=\"font-size:14.0pt;\">In AAT deficiency, <strong>reduced anti-elastase activity</strong> leads to unopposed elastase-mediated destruction of alveolar walls.</span></li><li><span style=\"font-size:14.0pt;\">This results in loss of elastic recoil, air trapping, and diffuse emphysema, classically involving the <strong>lower lobes</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Mutation in surfactant protein genes</strong>: Seen in neonatal respiratory distress syndrome and some interstitial lung diseases, not emphysema due to protease-antiprotease imbalance.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Chronic hypersensitivity reaction to inhaled antigens</strong>: Causes hypersensitivity pneumonitis, an interstitial lung disease with granulomatous inflammation, not panacinar emphysema.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. CFTR gene mutation</strong>: CFTR defects cause cystic fibrosis, which presents with recurrent lung infections, bronchiectasis, and pancreatic insufficiency — not isolated emphysema with family history of early-onset disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Alpha-1 antitrypsin deficiency</strong> leads to early-onset panacinar emphysema due to <strong>reduced anti-elastase activity</strong>, causing unopposed elastase-mediated alveolar wall destruction, especially in the lower lobes.</span></p>",
      "correct_choice_id": 358113,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89930/NEET_PG_aug_2025_PATHOLOGY_Question_11.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89930/NEET_PG_aug_2025_PATHOLOGY_Question_11.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90225,
      "choices": [
        {
          "id": 359272,
          "text": "<p><span style=\"font-size:14.0pt;\">Concurrent chemoradiation</span></p>"
        },
        {
          "id": 359273,
          "text": "<p><span style=\"font-size:14.0pt;\">Chemotherapy</span></p>"
        },
        {
          "id": 359274,
          "text": "<p><span style=\"font-size:14.0pt;\">Brachytherapy</span></p>"
        },
        {
          "id": 359275,
          "text": "<p><span style=\"font-size:14.0pt;\">Surgery</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 56-year-old postmenopausal woman presents with persistent, foul-smelling vaginal discharge and occasional blood-tinged mucus for several weeks. On pelvic examination, an ulcerated necrotic lesion is noted on the cervix with evidence of extension into the surrounding parametrium. There is no evidence of distant metastasis or palpable lymphadenopathy. Which of the following is the most appropriate next step in management?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q5393504",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Concurrent chemoradiation</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The clinical presentation—<strong>postmenopausal woman</strong> with <strong>necrotic cervical lesion</strong> that has <strong>extended into the parametrium</strong>—is characteristic of <strong>locally advanced cervical cancer</strong>, likely <strong>Stage IIB</strong>.</span></li><li><span style=\"font-size:14.0pt;\">According to <strong>FIGO staging</strong>, involvement of the <strong>parametrium without extension to the pelvic sidewall</strong> falls under Stage IIB.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">At this stage, the standard of care is <strong>concurrent chemoradiation</strong>, which includes:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>External beam radiotherapy (EBRT)</strong> targeting the pelvic region.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Cisplatin-based chemotherapy</strong> given concurrently to sensitize tumor cells to radiation.</span></li></ul></li><li><span style=\"font-size:14.0pt;\">Surgery (e.g., radical hysterectomy) is <strong>not preferred</strong> once the disease involves the <strong>parametrium</strong>, as this significantly increases morbidity without improving outcomes.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Early-stage cervical cancers (Stage IA–IB1) are typically managed surgically.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Chemotherapy:</strong> Systemic chemotherapy alone is <strong>not sufficient</strong> for treating locally advanced cervical cancer. It is typically reserved for <strong>metastatic or recurrent disease</strong> or used as <strong>part of concurrent chemoradiation</strong>, not as a standalone initial treatment in Stage IIB.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Brachytherapy:</strong> While <strong>brachytherapy</strong> (internal radiation) is an important component of treatment, it is <strong>not used alone</strong> in Stage IIB disease. It is generally added <strong>after</strong> external beam radiation as part of the full chemoradiation regimen.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Surgery:</strong> <strong>Radical hysterectomy</strong> is not recommended once there is <strong>parametrial invasion</strong>. At this point, the tumor is considered <strong>inoperable</strong>, and surgery would carry <strong>greater risks and no additional benefit</strong> compared to chemoradiation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">In <strong>Stage IIB cervical cancer</strong>, where there is <strong>parametrial involvement without distant metastasis</strong>, the <strong>standard treatment is concurrent chemoradiation</strong>, combining <strong>external beam radiation and cisplatin-based chemotherapy</strong> for optimal tumor control.</span></p>",
      "correct_choice_id": 359272,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90225/NEET_PG_aug_2025_OBG_Question_12.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90225/NEET_PG_aug_2025_OBG_Question_12.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90217,
      "choices": [
        {
          "id": 359240,
          "text": "<p><span style=\"font-size:14.0pt;\">Reassure and observe</span></p>"
        },
        {
          "id": 359241,
          "text": "<p><span style=\"font-size:14.0pt;\">Start hormonal therapy</span></p>"
        },
        {
          "id": 359242,
          "text": "<p><span style=\"font-size:14.0pt;\">Schedule endometrial biopsy</span></p>"
        },
        {
          "id": 359243,
          "text": "<p><span style=\"font-size:14.0pt;\">Repeat ultrasound in 6 months</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 54-year-old postmenopausal woman undergoes pelvic ultrasound as part of her evaluation for abnormal uterine bleeding. The report shows an endometrial thickness of 15–16 mm, with heterogeneous echotexture, few cysts, and no internal vascularity on Doppler imaging. What is the next best step in management?</span></p>",
      "unique_key": "Q5028458",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Schedule endometrial biopsy</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">An endometrial thickness 5 mm in a <strong>postmenopausal</strong> woman is concerning, especially when associated with heterogeneous echotexture, cysts, or other abnormal features.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">In this case, the <strong>thickness of 15–16 mm</strong> is markedly abnormal.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Even though the Doppler study shows <strong>no internal vascularity</strong>, this does <strong>not exclude endometrial hyperplasia or malignancy</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Therefore, <strong>endometrial biopsy</strong> is warranted to evaluate for <strong>endometrial hyperplasia or carcinoma</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Reassure and Observe:</strong> Not appropriate given the endometrial thickness far exceeds the normal postmenopausal cutoff of 4 mm. Observation could delay diagnosis of a potentially serious pathology.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Start hormonal therapy:</strong> Empirical treatment is not recommended without histological confirmation, especially when malignancy is on the differential.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Repeat ultrasound in 6 months:</strong> Delayed evaluation is inappropriate in this context. Prompt biopsy is necessary to rule out serious conditions like carcinoma.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">In postmenopausal women, an endometrial thickness &gt;4 mm with heterogeneous echotexture and/or cysts requires further evaluation with endometrial biopsy to rule out hyperplasia or carcinoma.</span></p>",
      "correct_choice_id": 359242,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90217/NEET_PG_aug_2025_OBG_Question_5.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90217/NEET_PG_aug_2025_OBG_Question_5.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89941,
      "choices": [
        {
          "id": 358148,
          "text": "<p><span style=\"font-size:14.0pt;\">Toxoplasma gondii</span></p>"
        },
        {
          "id": 358149,
          "text": "<p><span style=\"font-size:14.0pt;\">Rubella virus</span></p>"
        },
        {
          "id": 358150,
          "text": "<p><span style=\"font-size:14.0pt;\">Cytomegalovirus (CMV)</span></p>"
        },
        {
          "id": 358151,
          "text": "<p><span style=\"font-size:14.0pt;\">Herpes simplex virus (HSV)</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 2-week-old newborn presents with jaundice, hepatosplenomegaly, microcephaly, and periventricular calcifications on cranial imaging. The mother had a mild, flu-like illness during her second trimester. Which of the following is the most likely cause of this newborn’s condition?</span></p>",
      "unique_key": "Q3353045",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>&nbsp;Ans. C) Cytomegalovirus (CMV)</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">CMV is the <strong>most common congenital viral infection</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Classic features:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Periventricular calcifications</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Sensorineural hearing loss</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Microcephaly</strong>, <strong>jaundice</strong>, <strong>hepatosplenomegaly</strong>, <strong>thrombocytopenia (blueberry muffin rash)</strong></span></li></ul></li><li><span style=\"font-size:14.0pt;\">Transmitted <strong>transplacentally</strong>, especially if the mother has a <strong>primary infection during pregnancy</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Toxoplasma gondii:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Causes <strong>diffuse intracranial calcifications</strong> (not periventricular) and <strong>chorioretinitis</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Often associated with <strong>severe hydrocephalus</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Rubella virus:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Causes <strong>congenital rubella syndrome</strong>: <strong>cataracts</strong>, <strong>sensorineural deafness</strong>, <strong>PDA</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Calcifications are <strong>not typical</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Herpes simplex virus (HSV):</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Usually acquired <strong>during delivery</strong>, not transplacentally.</span></li><li><span style=\"font-size:14.0pt;\">Presents with <strong>vesicular skin lesions</strong>, <strong>seizures</strong>, and <strong>temporal lobe encephalitis</strong>, not periventricular calcifications.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Congenital CMV</strong> is the most common cause of <strong>periventricular calcifications</strong> in neonates, associated with <strong>hearing loss</strong>, <strong>microcephaly</strong>, and <strong>jaundice</strong>, especially following a <strong>maternal flu-like illness during pregnancy</strong>.</span></p>",
      "correct_choice_id": 358150,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89941/NEET_PG_aug_2025_MICROBIOLOGY_Question_5.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        6
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89941/NEET_PG_aug_2025_MICROBIOLOGY_Question_5.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89927,
      "choices": [
        {
          "id": 358100,
          "text": "<p><span style=\"font-size:14.0pt;\">Production of aflatoxin leading to p53 gene mutation</span></p>"
        },
        {
          "id": 358101,
          "text": "<p><span style=\"font-size:14.0pt;\">High rate of hepatocyte proliferation with genomic instability&nbsp;</span></p>"
        },
        {
          "id": 358102,
          "text": "<p><span style=\"font-size:14.0pt;\">Increased risk of hepatic iron deposition with DNA damage</span></p>"
        },
        {
          "id": 358103,
          "text": "<p><span style=\"font-size:14.0pt;\">Chronic alcohol use leading to acetaldehyde-induced DNA breaks</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 45-year-old man is being followed for chronic hepatitis B virus (HBV) infection. He has no history of alcohol use. Laboratory studies reveal persistently elevated ALT and AST levels. Abdominal ultrasound shows evidence of cirrhosis. Which of the following mechanisms best explains his increased risk of developing hepatocellular carcinoma (HCC)?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q2674815",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) High rate of hepatocyte proliferation with genomic instability</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>HBV is a DNA virus</strong> that causes chronic hepatocyte injury and regeneration.</span></li><li><span style=\"font-size:14.0pt;\">The <strong>increased hepatocyte turnover and proliferation</strong> raise the chance of accumulating genetic mutations.</span></li><li><span style=\"font-size:14.0pt;\">In addition, <strong>HBV DNA integrates into the host genome</strong>, leading to <strong>genomic instability</strong> and potential inactivation of tumor suppressor genes.</span></li><li><span style=\"font-size:14.0pt;\">These combined effects markedly increase the risk of <strong>hepatocellular carcinoma (HCC)</strong>, even in the absence of cirrhosis.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Production of aflatoxin leading to p53 gene mutation</strong>: This mechanism is seen in <strong>aflatoxin B1 exposure</strong> (e.g., from Aspergillus-contaminated grains), not HBV.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Increased risk of hepatic iron deposition with DNA damage</strong>: Refers to <strong>hereditary hemochromatosis</strong>, which can cause HCC, but is unrelated to HBV infection.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Chronic alcohol use leading to acetaldehyde-induced DNA breaks</strong>: Alcohol is an independent risk factor for HCC, but the patient has <strong>no alcohol use history</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Chronic HBV infection increases the risk of hepatocellular carcinoma through ongoing hepatocyte proliferation and HBV DNA integration into the host genome, leading to genetic instability and oncogenesis.</span></p>",
      "correct_choice_id": 358101,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89927/NEET_PG_aug_2025_PATHOLOGY_Question_8.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89927/NEET_PG_aug_2025_PATHOLOGY_Question_8.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90451,
      "choices": [
        {
          "id": 360168,
          "text": "<p><span style=\"font-size:14.0pt;\">Statement 1 only</span></p>"
        },
        {
          "id": 360169,
          "text": "<p><span style=\"font-size:14.0pt;\">Statement 2 only</span></p>"
        },
        {
          "id": 360170,
          "text": "<p><span style=\"font-size:14.0pt;\">Statement 3 only</span></p>"
        },
        {
          "id": 360171,
          "text": "<p><span style=\"font-size:14.0pt;\">Statement 4 only</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">During a biochemistry review session, a student makes the following claims about the citric acid cycle:</span></p><ol><li><span style=\"font-size:14.0pt;\">Pyruvate directly condenses with oxaloacetate to form citrate.</span></li><li><span style=\"font-size:14.0pt;\">α-Ketoglutarate is a five-carbon intermediate.</span></li><li><span style=\"font-size:14.0pt;\">Oxidative phosphorylation takes place in the cytoplasm.</span></li><li><span style=\"font-size:14.0pt;\">The citric acid cycle can operate under anaerobic conditions.</span></li></ol><p><span style=\"font-size:14.0pt;\">Which statement is true?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q5811814",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Statement 2 only</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 2. α-Ketoglutarate is a five-carbon intermediate:</strong> True<strong>.</strong> α-Ketoglutarate contains <strong>five carbons</strong> and is produced by oxidative decarboxylation of isocitrate.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Incorrect Statements:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 1. Pyruvate directly condenses with oxaloacetate to form citrate:&nbsp;</strong>False. Pyruvate is first converted to <strong>acetyl-CoA</strong> by the pyruvate dehydrogenase complex; acetyl-CoA (2 carbons) then combines with oxaloacetate (4 carbons) to form citrate.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 3. Oxidative phosphorylation takes place in the cytoplasm:&nbsp;</strong>False. Oxidative phosphorylation occurs on the <strong>inner mitochondrial membrane</strong>, not in the cytoplasm.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 4. The citric acid cycle can operate under anaerobic conditions:&nbsp;</strong>False. The cycle requires regeneration of NAD⁺ and FAD via the electron transport chain, which depends on oxygen as the final electron acceptor; thus it cannot function anaerobically.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The citric acid cycle’s <strong>α-ketoglutarate</strong> intermediate has <strong>five carbons</strong>, acetyl-CoA must form first to condense with oxaloacetate, and the cycle’s continuous operation relies on <strong>mitochondrial</strong> oxidative phosphorylation under <strong>aerobic</strong> conditions.</span></p>",
      "correct_choice_id": 360169,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90451/NEET_PG_aug_2025_BIOCHEM_Question_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        1
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90451/NEET_PG_aug_2025_BIOCHEM_Question_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89900,
      "choices": [
        {
          "id": 357992,
          "text": "<p><span style=\"font-size:14.0pt;\">Encapsulation in plastic foam only</span></p>"
        },
        {
          "id": 357993,
          "text": "<p><span style=\"font-size:14.0pt;\">Inertization with cement and simultaneous encapsulation</span></p>"
        },
        {
          "id": 357994,
          "text": "<p><span style=\"font-size:14.0pt;\">Direct disposal in a sanitary landfill</span></p>"
        },
        {
          "id": 357995,
          "text": "<p><span style=\"font-size:14.0pt;\">Shredding followed by compacting</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A hospital needs to dispose off, expired pharmaceuticals and metal‑rich incinerator ash in a way that both immobilizes hazardous constituents and permits safe landfilling. Which approach is most appropriate?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q6971903",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Inertization with cement and simultaneous encapsulation</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Inertization</strong> mixes waste (pharmaceuticals, metal‑laden ash) with cement 15% and lime 15%, chemically stabilizing and immobilizing soluble toxins.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Encapsulation</strong> then seals the mixture within a durable matrix (e.g., cement mortar), preventing leachate generation.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Together, these steps ensure that hazardous chemicals and heavy metals remain locked in and do not contaminate groundwater when landfilled.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.&nbsp;Encapsulation in plastic foam only:</strong> Seals waste but does <strong>not</strong> chemically bind heavy metals or soluble pharmaceuticals, risking future leaching.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C</strong>.&nbsp;<strong>Direct disposal in a sanitary landfill:</strong> Bypasses any stabilization—hazardous constituents can readily migrate into soil and groundwater.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.&nbsp;Shredding followed by compacting:</strong> Reduces volume but neither stabilizes toxins nor prevents leaching.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">For hazardous wastes with soluble toxins or heavy metals, <strong>combine inertization</strong> (chemical binding) with <strong>encapsulation</strong> (physical sealing) to achieve immobilization and safe landfill disposal.</span></p>",
      "correct_choice_id": 357993,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89900/NEET_PG_aug_2025_PSM_Question_14.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89900/NEET_PG_aug_2025_PSM_Question_14.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90817,
      "choices": [
        {
          "id": 361608,
          "text": "<p><span style=\"font-size:14.0pt;\">Electromyography</span></p>"
        },
        {
          "id": 361609,
          "text": "<p><span style=\"font-size:14.0pt;\">Serum protein electrophoresis</span></p>"
        },
        {
          "id": 361610,
          "text": "<p><span style=\"font-size:14.0pt;\">Hepatitis B serology</span></p>"
        },
        {
          "id": 361611,
          "text": "<p><span style=\"font-size:14.0pt;\">Liver biopsy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 65-year-old woman presents with stress urinary incontinence, weight loss and tingling in her feet for 3 months. On examination she has hepatosplenomegaly and bruising in her arms. On examination, Phalen’s sign is positive and urinalysis reveals a 3+ proteinuria. Labs: Hb is 12 g/dL, and S. creatinine is 1.6 mg/dL. What is the next best step?</span></p>",
      "unique_key": "Q4223398",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;B) Serum protein electrophoresis</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Proteinuria, peripheral&nbsp;neuropathy (pain, tingling), hepatosplenomegaly, bruising, carpal tunnel syndrome, and weight loss suggest amyloidosis.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Given her age and renal failure – multiple myeloma is highly likely.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Serum protein electrophoresis (SPEP) with immunofixation detects monoclonal proteins or light chains, key for diagnosing plasma cell disorders.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Amyloidosis causes organ infiltration (liver, spleen, nerves) and carpal tunnel from tissue deposition.</span></li><li><span style=\"font-size:14.0pt;\">Elevated creatinine indicates renal involvement, common in these conditions.</span></li><li><span style=\"font-size:14.0pt;\">SPEP is non-invasive, guiding further workup (e.g., bone marrow biopsy).</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Electromyography:</strong> Assesses neuropathy but not systemic cause.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Hepatitis B serology:</strong> Unrelated to proteinuria or systemic symptoms.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Liver biopsy:</strong> Invasive, not first-line for suspected amyloidosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Amyloidosis presents with proteinuria, neuropathy, and organomegaly.</span></li><li><span style=\"font-size:14.0pt;\">SPEP is the initial test for plasma cell disorders.</span></li><li><span style=\"font-size:14.0pt;\">Non-invasive tests precede biopsy.</span></li></ul>",
      "correct_choice_id": 361609,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90817/Neet_Pg_Aug_2025_Medicine_Question_5.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90817/Neet_Pg_Aug_2025_Medicine_Question_5.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90837,
      "choices": [
        {
          "id": 361688,
          "text": "<p><span style=\"font-size:14.0pt;\">Hypoxia causing cerebral vasodilation</span></p>"
        },
        {
          "id": 361689,
          "text": "<p><span style=\"font-size:14.0pt;\">Metabolic acidosis leading to edema&nbsp;</span></p>"
        },
        {
          "id": 361690,
          "text": "<p><span style=\"font-size:14.0pt;\">Hypoxia causing cerebral vasoconstriction&nbsp;</span></p>"
        },
        {
          "id": 361691,
          "text": "<p><span style=\"font-size:14.0pt;\">High PCO₂ causing cerebral vasoconstriction</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A man is flying on 3,400 m. He develops confusion, headache, and cerebral edema. Which of the following mechanisms best describes high altitude cerebral edema?</span></p>",
      "unique_key": "Q9697971",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Hypoxia causing cerebral vasodilation</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">At high altitude, the reduced atmospheric oxygen pressure lowers alveolar PO₂, resulting in hypoxaemia.</span></li><li><span style=\"font-size:14.0pt;\">This hypoxic state causes direct vasodilation of cerebral vessels, increasing cerebral blood flow in an effort to maintain oxygen delivery to brain tissue.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">However, excessive vasodilation, coupled with increased capillary permeability, leads to vasogenic cerebral edema.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The accumulation of fluid within the brain raises intracranial pressure, producing symptoms such as headache, confusion, ataxia, and altered mental status — the hallmark features of high‑altitude cerebral edema (HACE).</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Metabolic acidosis leading to edema:</strong> Initial response to hypoxia is respiratory alkalosis from hyperventilation, not metabolic acidosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Hypoxia causing cerebral vasoconstriction:</strong> Hypoxia causes pulmonary vasoconstriction, but cerebral vessels respond with vasodilation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. High PCO₂ causing cerebral vasoconstriction:</strong> High PCO₂ (hypercapnia) causes vasodilation, not vasoconstriction, in cerebral circulation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">High‑altitude cerebral edema is caused by <strong>hypoxia‑induced cerebral vasodilation</strong> and increased permeability of the blood–brain barrier, leading to vasogenic edema.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It’s a potentially fatal complication of rapid ascent and requires prompt descent and oxygen therapy.</span></li></ul>",
      "correct_choice_id": 361688,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90837/NEET_PG_aug_2025_PHYSIOLOGY_Question_8.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        2
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90837/NEET_PG_aug_2025_PHYSIOLOGY_Question_8.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90890,
      "choices": [
        {
          "id": 361896,
          "text": "<p><span style=\"font-size:14.0pt;\">Adenosine</span></p>"
        },
        {
          "id": 361897,
          "text": "<p><span style=\"font-size:14.0pt;\">Amiodarone</span></p>"
        },
        {
          "id": 361898,
          "text": "<p><span style=\"font-size:14.0pt;\">Propranolol</span></p>"
        },
        {
          "id": 361899,
          "text": "<p><span style=\"font-size:14.0pt;\">Quinidine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 16-year-old girl presents with sudden-onset palpitations and dizziness. ECG shows a narrow-complex regular tachycardia at 180 bpm, consistent with paroxysmal supraventricular tachycardia (PSVT). She is hemodynamically stable. Which of the following is the most appropriate initial pharmacologic treatment?</span></p>",
      "unique_key": "Q6594933",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Adenosine</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Adenosine</strong> is the <strong>drug of choice</strong> for acute termination of <strong>AV nodal reentrant tachycardia (AVNRT)</strong>, the most common form of PSVT.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It acts by <strong>transiently blocking AV nodal conduction</strong>, interrupting the reentry circuit and restoring sinus rhythm.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Its action is extremely short-lived (half-life &lt;10 seconds), making it ideal for acute use.</span></li><li><span style=\"font-size:14.0pt;\">Dose in adults – IV first dose of 6 mg → (if not controlled) 12 mg second dose&nbsp;→ (if not controlled) 12 mg third dose. 3 doses can be used.</span></li><li><span style=\"font-size:14.0pt;\">Dose in children – IV 0.1 mg/kg first dose&nbsp;→ (if not controlled) 0.2 mg/kg second dose&nbsp;→ (if not controlled) 0.2 mg/kg third dose.&nbsp;</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Amiodarone</strong>: Used for <strong>ventricular arrhythmias</strong> or atrial fibrillation; not first-line for PSVT due to slower onset and more toxic profile.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Propranolol</strong>: A beta-blocker that can slow AV nodal conduction, but it is not as rapid-acting as adenosine in acute PSVT.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Quinidine</strong>: A class IA antiarrhythmic used historically for atrial or ventricular arrhythmias; <strong>not effective for AVNRT</strong> and associated with significant side effects.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Adenosine</strong> is the first-line drug for <strong>acute management of stable AV nodal–dependent supraventricular tachycardias</strong>, due to its rapid AV nodal blockade and ultra-short half-life.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Prophylaxis for PSVT – DOC is Verapamil</strong></span></p>",
      "correct_choice_id": 361896,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90890/NEET_PG_aug_2025_PHARMACOLOGY_Question_13.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90890/NEET_PG_aug_2025_PHARMACOLOGY_Question_13.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90563,
      "choices": [
        {
          "id": 360612,
          "text": "<p><span style=\"font-size:14.0pt;\">Coxsackie Virus</span></p>"
        },
        {
          "id": 360613,
          "text": "<p><span style=\"font-size:14.0pt;\">Epstein–Barr Virus (EBV)</span></p>"
        },
        {
          "id": 360614,
          "text": "<p><span style=\"font-size:14.0pt;\">Herpes simplex Virus (HSV)</span></p>"
        },
        {
          "id": 360615,
          "text": "<p><span style=\"font-size:14.0pt;\">Varicella–zoster Virus (VZV)</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 4-year-old child is brought to the clinic with low-grade fever, sore mouth, and painful vesicular rash on the hands, feet, and inside the mouth. The child attends daycare, and similar cases have been reported. What is the most likely causative organism?&nbsp;</span></p>",
      "unique_key": "Q6094048",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Coxsackie virus</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Coxsackie A16 virus is the most common cause of <strong>Hand-Foot-Mouth Disease (HFMD)</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It presents with mild fever, oral ulcers, and vesicular rash on hands and feet.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It is highly contagious in daycare settings.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Epstein–Barr Virus (EBV):&nbsp;</strong>Typically causes infectious mononucleosis with fever, sore throat, lymphadenopathy, and hepatosplenomegaly—not vesicular rash on extremities.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Herpes simplex Virus (HSV):&nbsp;</strong>Causes gingivostomatitis in children but does not involve hands and feet typically.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Varicella–zoster Virus (VZV):&nbsp;</strong>Causes chickenpox or shingles, usually with generalized vesicular rash starting on the trunk.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Coxsackie virus, particularly A16, is the most common cause of HFMD in children, presenting with oral ulcers and vesicles on hands and feet, often in outbreaks in daycare centers.</span></p>",
      "correct_choice_id": 360612,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90563/NEET_PG_Aug_PEDIATRICS_Question_8.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        13
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90563/NEET_PG_Aug_PEDIATRICS_Question_8.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90527,
      "choices": [
        {
          "id": 360472,
          "text": "<p><span style=\"font-size:14.0pt;\">Liver</span></p>"
        },
        {
          "id": 360473,
          "text": "<p><span style=\"font-size:14.0pt;\">Brain</span></p>"
        },
        {
          "id": 360474,
          "text": "<p><span style=\"font-size:14.0pt;\">Skeletal Muscle</span></p>"
        },
        {
          "id": 360475,
          "text": "<p><span style=\"font-size:14.0pt;\">RBC</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Organ which can utilize glucose, fatty acids and ketone bodies, is:<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q1825578",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Skeletal Muscle</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Skeletal muscle</strong> is metabolically flexible and can use multiple fuel sources depending on the situation:</span><ol><li><span style=\"font-size:14.0pt;\"><strong>Glucose</strong> – During fed state and high-intensity exercise (via glycolysis)</span></li><li><span style=\"font-size:14.0pt;\"><strong>Fatty acids</strong> – During fasting and prolonged low-intensity exercise (via β-oxidation)</span></li><li><span style=\"font-size:14.0pt;\"><strong>Ketone bodies</strong> – During prolonged fasting or starvation (via ketolysis)</span></li></ol></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-08-20%20132953.jpeg\" width=\"1193\" height=\"463\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Liver:&nbsp;</strong>Can use glucose and fatty acids, but <strong>does not use ketone bodies</strong> (it produces them but lacks the enzyme thiophorase for ketone utilization).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Brain:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Normally uses only glucose; during prolonged fasting, it can adapt to use ketone bodies.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Does not use fatty acids</strong> directly because they cannot cross the blood–brain barrier.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. RBC:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Can only use glucose (anaerobic glycolysis) because they lack mitochondria;</span></li><li><span style=\"font-size:14.0pt;\">Cannot use fatty acids or ketones.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Skeletal muscle can oxidize glucose, fatty acids, and ketone bodies, allowing metabolic flexibility across fed, fasting, and exercise states. The liver does not use ketones, the brain cannot use fatty acids, and RBCs rely only on glucose due to absence of mitochondria.</span></p>",
      "correct_choice_id": 360474,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90527/NEET_PG_aug_2025_BIOCHEM_Question_5.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        1
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90527/NEET_PG_aug_2025_BIOCHEM_Question_5.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90546,
      "choices": [
        {
          "id": 360548,
          "text": "<p><span style=\"font-size:14.0pt;\">Pleomorphic adenoma of the lacrimal gland</span></p>"
        },
        {
          "id": 360549,
          "text": "<p><span style=\"font-size:14.0pt;\">Adenoid cystic carcinoma of the lacrimal gland</span></p>"
        },
        {
          "id": 360550,
          "text": "<p><span style=\"font-size:14.0pt;\">Oncocytoma of the lacrimal gland</span></p>"
        },
        {
          "id": 360551,
          "text": "<p><span style=\"font-size:14.0pt;\">Lacrimal gland dacryoadenitis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 45-year-old patient presents with a painless, slowly enlarging mass in the superotemporal orbit. Examination reveals downward and inward displacement of the globe. Which of the following is the most likely diagnosis?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q2892565",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Pleomorphic adenoma of the lacrimal gland</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Key point in question:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Painless, slowly enlarging superotemporal orbital mass</span></li><li><span style=\"font-size:14.0pt;\">Downward and inward globe displacement → suggests lesion in lacrimal gland region (superotemporal orbit)</span></li><li><span style=\"font-size:14.0pt;\">Benign, slow growth → pleomorphic adenoma is most likely.</span></li><li><span style=\"font-size:14.0pt;\">Most common benign epithelial tumor of lacrimal gland.</span></li><li><span style=\"font-size:14.0pt;\">Typically affects middle-aged adults.</span></li><li><span style=\"font-size:14.0pt;\">Presents as a slowly progressive, painless swelling in superotemporal orbit.</span></li><li><span style=\"font-size:14.0pt;\">Displaces the globe downward and inward.</span></li><li><span style=\"font-size:14.0pt;\">No bone destruction on imaging (may cause smooth fossa expansion).</span></li><li><span style=\"font-size:14.0pt;\">Complete excision without biopsy is recommended (biopsy may seed tumor cells and cause recurrence).</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-08-20%20133410.jpeg\" width=\"787\" height=\"277\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/WhatsApp%20Image%202025-08-20%20at%2012.48.37.jpeg\" width=\"1599\" height=\"1192\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Adenoid cystic carcinoma of the lacrimal gland:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Most common malignant epithelial tumor of lacrimal gland.</span></li><li><span style=\"font-size:14.0pt;\">Pain is a key feature (due to perineural invasion).</span></li><li><span style=\"font-size:14.0pt;\">Rapid progression.</span></li><li><span style=\"font-size:14.0pt;\">May cause bone destruction and irregular margins on imaging.</span></li><li><span style=\"font-size:14.0pt;\">Displaces globe downward and inward, but more aggressive clinical course.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Oncocytoma of the lacrimal gland:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Rare, benign epithelial tumor of lacrimal gland.</span></li><li><span style=\"font-size:14.0pt;\">Usually affects older adults, often asymptomatic until large.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Lacrimal gland dacryoadenitis:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Inflammatory swelling of lacrimal gland.</span></li><li><span style=\"font-size:14.0pt;\">Usually acute onset, painful, often associated with redness and tenderness.</span></li><li><span style=\"font-size:14.0pt;\">May be caused by viral (mumps, EBV) or bacterial infections.</span></li><li><span style=\"font-size:14.0pt;\">Resolves with treatment of underlying infection/inflammation.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">In orbital mass evaluation, note the globe’s displacement: a <strong>down-and-in</strong> shift is highly suggestive of a <strong>superotemporal</strong> lesion such as a pleomorphic adenoma of the lacrimal gland.</span></p>",
      "correct_choice_id": 360548,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90546/NEET_PG_aug_2025_OPTHALMOLOGY_Question_5.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        8
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90546/NEET_PG_aug_2025_OPTHALMOLOGY_Question_5.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89820,
      "choices": [
        {
          "id": 357672,
          "text": "<p><span style=\"font-size:14.0pt;\">D2 receptor antagonism in the mesolimbic pathway</span></p>"
        },
        {
          "id": 357673,
          "text": "<p><span style=\"font-size:14.0pt;\">5-HT2A receptor antagonism in the prefrontal cortex</span></p>"
        },
        {
          "id": 357674,
          "text": "<p><span style=\"font-size:14.0pt;\">H1 and 5-HT2C receptor antagonism in the hypothalamus</span></p>"
        },
        {
          "id": 357675,
          "text": "<p><span style=\"font-size:14.0pt;\">NMDA receptor antagonism in the limbic system</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 28-year-old woman with schizophrenia started on olanzapine reports rapid weight gain within 3 months. Which of the following receptor mechanisms is most implicated in the pathophysiology of antipsychotic-induced weight gain?</span></p>",
      "unique_key": "Q9499194",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) H1 and 5-HT2C receptor antagonism in the hypothalamus</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Olanzapine</strong>, like clozapine, is well-known for causing significant <strong>weight gain and metabolic syndrome</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The key mechanism behind this is <strong>antagonism at the histamine H1 receptors and serotonin 5-HT2C receptors in the hypothalamus</strong>, which leads to <strong>increased appetite and decreased satiety</strong>, contributing to <strong>hyperphagia and weight gain</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">These receptors play a central role in regulating feeding behavior and energy homeostasis.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. D2 receptor antagonism in the mesolimbic pathway:&nbsp;</strong>This mechanism is central to <strong>antipsychotic efficacy</strong> (especially for positive symptoms), but <strong>not primarily responsible for weight gain</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. 5-HT2A receptor antagonism in the prefrontal cortex:&nbsp;</strong>While 5-HT2A antagonism contributes to <strong>antipsychotic effects and improved cognition</strong>, it does <strong>not explain weight gain</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. NMDA receptor antagonism in the limbic system:&nbsp;</strong>NMDA antagonism is <strong>not a primary action</strong> of most antipsychotics (except perhaps ketamine-like agents) and is <strong>not involved in weight gain</strong> related to antipsychotics.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Pathophysiology of antipsychotic induced weight gain:</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_yhLwUIz.png\" width=\"500\" height=\"301\"></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Aripiprazole and ziprasidone are two antipsychotics with a relatively lower risk of weight gain compared to others.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Olanzapine and clozapine are most associated with weight gain.</span></li></ul>",
      "correct_choice_id": 357674,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89820/NEET_PG_aug_2025_PSYCHIATRY_Question_1.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        16
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89820/NEET_PG_aug_2025_PSYCHIATRY_Question_1.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90453,
      "choices": [
        {
          "id": 360176,
          "text": "<p><span style=\"font-size:14.0pt;\">1 and 5</span></p>"
        },
        {
          "id": 360177,
          "text": "<p><span style=\"font-size:14.0pt;\">2, 3 and 4</span></p>"
        },
        {
          "id": 360178,
          "text": "<p><span style=\"font-size:14.0pt;\">1 and 4</span></p>"
        },
        {
          "id": 360179,
          "text": "<p><span style=\"font-size:14.0pt;\">3 and 5</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A single-base change in a gene converts the codon GAC (encoding aspartic acid) to GAG (encoding glutamic acid). Which of the following descriptors best classify this mutation?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">Point mutation</span></li><li><span style=\"font-size:14.0pt;\">Silent mutation</span></li><li><span style=\"font-size:14.0pt;\">Nonsense mutation</span></li><li><span style=\"font-size:14.0pt;\">Conservative amino acid change</span></li><li><span style=\"font-size:14.0pt;\">Non-conservative amino acid change</span></li></ol>",
      "unique_key": "Q9484887",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) 1 and 4</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>1. Point mutation:</strong> A point mutation is a single‐nucleotide substitution. Here, guanine replaces cytosine in the third base of the codon.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>4. Conservative amino acid change:</strong> Aspartic acid and glutamic acid are both acidic, negatively charged amino acids with similar structures. Replacing one with the other typically preserves protein function conservative change.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Incorrect Statements:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>2. Silent mutation:</strong> Would require the codon change not alter the encoded amino acid (e.g.,UCA replace by UCU both code for Serine).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>3. Nonsense mutation:</strong> Changes a sense codon to a stop codon, prematurely truncating translation. If a codon is replaced by stop codon&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>5. Non-conservative change:</strong> Occurs when the new amino acid has very different properties (e.g., a polar to a nonpolar residue), which is not the case here.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Point mutations</strong> can change protein sequence; when they swap amino acids with similar properties (acidic to acidic), they are termed <strong>conservative</strong> substitutions, usually less disruptive to protein function.</span></p>",
      "correct_choice_id": 360178,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90453/NEET_PG_aug_2025_BIOCHEM_Question_3.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        1
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90453/NEET_PG_aug_2025_BIOCHEM_Question_3.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90853,
      "choices": [
        {
          "id": 361752,
          "text": "<p><span style=\"font-size:14.0pt;\">Iron 132 μg/dL, TIBC 299 μg/dL, ferritin 204 ng/mL</span></p>"
        },
        {
          "id": 361753,
          "text": "<p><span style=\"font-size:14.0pt;\">Iron 210 μg/dL, TIBC 350 μg/dL, ferritin 375 ng/mL</span></p>"
        },
        {
          "id": 361754,
          "text": "<p><span style=\"font-size:14.0pt;\">Iron/TIBC &lt;18%, ferritin 5 ng/mL</span></p>"
        },
        {
          "id": 361755,
          "text": "<p><span style=\"font-size:14.0pt;\">Iron/TIBC &gt;18%, ferritin 314 ng/mL</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 66-year-old man presents with fatigue and dyspnea. His wife is concerned with him eating excessive ice in the recent times. On examination, he has angular cheilitis and atrophic glossitis. Labs: Hemoglobin: 9.2 g/dL, MCV: 75 fL. What will his iron studies most likely reveal?<strong>&nbsp;</strong></span></p><p><span style=\"font-size:14.0pt;\">(Normal: iron 60-170 μg/dL, TIBC 240-450 μg/dL, ferritin 12-250 ng/mL)&nbsp;</span></p>",
      "unique_key": "Q2382967",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Iron/TIBC &lt;18%, ferritin 5 ng/mL</strong></span></p><p><span style=\"font-size:14.0pt;\"><strong>&nbsp;</strong></span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This patient has classic signs of <strong>iron deficiency anemia</strong>, including:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Fatigue, dyspnea</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Pica (ice chewing)</strong> — highly specific for iron deficiency</span></li><li><span style=\"font-size:14.0pt;\"><strong>Angular cheilitis</strong> and <strong>atrophic glossitis</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Guaiac-positive stool</strong> — suggesting <strong>chronic GI blood loss</strong> (most likely cause in older men)</span></li><li><span style=\"font-size:14.0pt;\"><strong>Microcytic anemia</strong> (MCV 75 fL)</span></li></ul></li><li><span style=\"font-size:14.0pt;\">Iron studies in iron deficiency anemia typically show:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Low serum iron</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Increased TIBC</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Low ferritin</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Transferrin saturation &lt;18%</strong></span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Iron 132 μg/dL, TIBC 299 μg/dL, ferritin 204 ng/mL:</strong> These values are <strong>within normal limits</strong>, not compatible with iron deficiency.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Iron 210 μg/dL, TIBC 350 μg/dL, ferritin 375 ng/mL:</strong> Suggestive of <strong>iron overload</strong>; not consistent with clinical and hematologic features.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Iron/TIBC &gt;18%, ferritin 314 ng/mL:Ferritin is elevated</strong> and transferrin saturation normal/high — not consistent with iron deficiency.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Pica, glossitis, and angular cheilitis</strong> are hallmark signs of <strong>iron deficiency anemia</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Guaiac-positive stool</strong> indicates <strong>chronic GI bleeding</strong>, the most common source of iron loss in elderly males.</span></li><li><span style=\"font-size:14.0pt;\">Iron deficiency labs: <strong>low serum iron</strong>, <strong>low ferritin</strong>, <strong>high TIBC</strong>, and <strong>low transferrin saturation (&lt;18%)</strong>.</span></li></ul>",
      "correct_choice_id": 361754,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90853/NEET_PG_aug_2025_MEDICINE_Question_19.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90853/NEET_PG_aug_2025_MEDICINE_Question_19.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90223,
      "choices": [
        {
          "id": 359264,
          "text": "<p><span style=\"font-size:14.0pt;\">Oxytocin</span></p>"
        },
        {
          "id": 359265,
          "text": "<p><span style=\"font-size:14.0pt;\">Dinoprostone</span></p>"
        },
        {
          "id": 359266,
          "text": "<p><span style=\"font-size:14.0pt;\">Ethacridine lactate</span></p>"
        },
        {
          "id": 359267,
          "text": "<p><span style=\"font-size:14.0pt;\">Carboprost</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 22-year-old woman in her second trimester of pregnancy at 17 weeks’ gestation presents requesting a pregnancy termination. The clinician decides to proceed with an intrauterine method involving extra-amniotic instillation. Which of the following pharmacologic agents is most appropriately administered via this route?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q7708878",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Ethacridine lactate</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Ethacridine lactate</strong> is an antiseptic agent commonly used in <strong>second-trimester pregnancy termination</strong>, especially between <strong>12–20 weeks gestation</strong>, via the <strong>extra-amniotic route</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The procedure involves insertion of a Foley catheter through the cervix and instillation of <strong>ethacridine lactate into the extra-amniotic space</strong>.</span></li><li><span style=\"font-size:14.0pt;\">It is safe, inexpensive, and widely used in resource-limited settings.</span></li><li><span style=\"font-size:14.0pt;\">This agent induces abortion by stimulating uterine contractions and separation of the placenta.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It is preferred in specific gestational windows when <strong>medical induction is indicated but systemic agents are either contraindicated or avoided</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Oxytocin:&nbsp;</strong>Oxytocin is used in the <strong>induction of labor</strong>, particularly in the third trimester, or for <strong>postpartum uterine atony</strong>. It is <strong>not administered via extra-amniotic route</strong> and is <strong>less effective for mid-trimester abortion</strong> due to lower sensitivity of the uterus to oxytocin at that stage.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Dinoprostone:</strong> Dinoprostone (PGE2) is typically used for <strong>cervical ripening and labor induction</strong>, often via <strong>vaginal or intracervical routes</strong>. It is <strong>not the agent of choice for extra-amniotic instillation</strong>, making it an incorrect option here.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Carboprost:</strong> Carboprost is a <strong>15-methyl prostaglandin F2-alpha</strong> analog used intramuscularly for <strong>second-trimester abortion</strong> and <strong>postpartum hemorrhage</strong>. However, it is <strong>not administered via extra-amniotic route</strong>, and its systemic side effects (nausea, vomiting, diarrhea) can be limiting.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Ethacridine lactate</strong> is the agent of choice for <strong>extra-amniotic instillation</strong> during <strong>second-trimester pregnancy termination</strong>, typically between <strong>12–20 weeks gestation</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It provides a localized method of induction with minimal systemic side effects.</span></li></ul>",
      "correct_choice_id": 359266,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90223/NEET_PG_aug_2025_OBG_Question_11.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90223/NEET_PG_aug_2025_OBG_Question_11.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90555,
      "choices": [
        {
          "id": 360580,
          "text": "<p><span style=\"font-size:14.0pt;\">Mature pincer grasp</span></p>"
        },
        {
          "id": 360581,
          "text": "<p><span style=\"font-size:14.0pt;\">Creeps well on hands and knees</span></p>"
        },
        {
          "id": 360582,
          "text": "<p><span style=\"font-size:14.0pt;\">Can hop on one foot</span></p>"
        },
        {
          "id": 360583,
          "text": "<p><span style=\"font-size:14.0pt;\">Runs steadily</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 9-month-old infant is brought for a routine check-up. Which of the following developmental milestones is most likely to be present at this age?&nbsp;</span></p>",
      "unique_key": "Q6240322",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Creeps well on hands and knees</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">At 9 months of age, an infant typically achieves important gross motor and fine motor milestones.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Among the <strong>gross motor milestones</strong>, <strong>creeping on hands and knees</strong> is expected and reflects developing strength and coordination of the upper and lower limbs.</span></li><li><span style=\"font-size:14.0pt;\">This behavior involves a cross-pattern movement where the opposite hand and knee move together, a significant neuromotor advancement from earlier belly crawling.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Mature pincer grasp:&nbsp;</strong>This fine motor milestone (using the tips of the thumb and index finger to pick up small objects) usually develops <strong>around 10 to 12 months</strong>. At 9 months, the infant may exhibit an <strong>inferior pincer grasp</strong> but not yet the mature form.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Can hop on one foot:&nbsp;</strong>This is a much <strong>later developmental milestone</strong>, typically achieved by <strong>3.5 to 4 years of age</strong>. It requires substantial balance and lower limb strength not seen in infancy.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Runs steadily:&nbsp;</strong>This occurs around <strong>18 months of age</strong>, once the child is confidently walking. At 9 months, most infants are either crawling or cruising (holding onto furniture to walk).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">At 9 months, normal gross motor milestones include creeping on hands and knees, sitting without support, and pulling to stand; mature pincer grasp and more advanced locomotor skills occur at later developmental stages.</span></p>",
      "correct_choice_id": 360581,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90555/NEET_PG_Aug_PEDIATRICS_Question_5.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        13
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90555/NEET_PG_Aug_PEDIATRICS_Question_5.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90896,
      "choices": [
        {
          "id": 361920,
          "text": "<p><span style=\"font-size:14.0pt;\">Quinidine</span></p>"
        },
        {
          "id": 361921,
          "text": "<p><span style=\"font-size:14.0pt;\">Amiodarone</span></p>"
        },
        {
          "id": 361922,
          "text": "<p><span style=\"font-size:14.0pt;\">Lignocaine</span></p>"
        },
        {
          "id": 361923,
          "text": "<p><span style=\"font-size:14.0pt;\">Flecainide</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">The figure shows the ventricular action potential in control (red) and after administration of Drug A (dashed line). Which of the following drugs is most likely responsible for the observed changes?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-08-20%20111823.jpeg\" width=\"602\" height=\"461\"></strong></span></p>",
      "unique_key": "Q5087995",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Lignocaine</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The graph demonstrates a <strong>shortening of the action potential duration</strong> after administration of <strong>Drug A</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This effect is characteristic of <strong>class IB antiarrhythmic drugs</strong> like <strong>lignocaine (lidocaine)</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">These drugs preferentially bind to <strong>inactivated sodium channels</strong>, especially in <strong>ischemic or depolarized tissue</strong>, and <strong>accelerate repolarization</strong> by <strong>shortening phase 3</strong> of the action potential.</span></li><li><span style=\"font-size:14.0pt;\">This is particularly useful in <strong>ventricular arrhythmias</strong>, especially post-myocardial infarction.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Quinidine</strong>: A <strong>class IA</strong> agent that <strong>prolongs the action potential duration</strong> and QT interval.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Amiodarone</strong>: A <strong>class III</strong> drug that markedly <strong>prolongs repolarization</strong> and <strong>action potential duration</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Flecainide</strong>: A <strong>class IC</strong> agent with <strong>minimal effect on repolarization</strong>; it significantly slows conduction without shortening the AP duration.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Class IB antiarrhythmic drugs like lignocaine shorten the ventricular action potential duration, especially in depolarized or ischemic tissue.</span></p>",
      "correct_choice_id": 361922,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90896/NEET_PG_aug_2025_PHARMACOLOGY_Question_19.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90896/NEET_PG_aug_2025_PHARMACOLOGY_Question_19.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90891,
      "choices": [
        {
          "id": 361900,
          "text": "<p><span style=\"font-size:14.0pt;\">Benztropine</span></p>"
        },
        {
          "id": 361901,
          "text": "<p><span style=\"font-size:14.0pt;\">Promethazine</span></p>"
        },
        {
          "id": 361902,
          "text": "<p><span style=\"font-size:14.0pt;\">Selegiline</span></p>"
        },
        {
          "id": 361903,
          "text": "<p><span style=\"font-size:14.0pt;\">Trihexyphenidyl</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 28-year-old man on high-dose risperidone develops tremor, rigidity, and mask-like facies. Drug-induced Parkinsonism is diagnosed. Which of the following medications would be least effective in treating his condition?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q3228947",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Selegiline</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Selegiline</strong> is a <strong>monoamine oxidase B inhibitor</strong> used in idiopathic Parkinson’s disease to reduce central dopamine metabolism.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">However, in <strong>drug-induced Parkinsonism</strong>, dopamine receptors are <strong>blocked by antipsychotics</strong>, so increasing dopamine levels is <strong>not helpful</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Thus, selegiline is <strong>ineffective</strong> in this context.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Benztropine:</strong> An anticholinergic agent similar to trihexyphenidyl, <strong>effective in treating DIP</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Promethazine:</strong> An antihistamine with <strong>anticholinergic properties</strong>, often used acutely for EPS.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Trihexyphenidyl:</strong> The <strong>first-line agent</strong> for DIP due to its central anticholinergic action.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Selegiline is not effective for drug-induced Parkinsonism because it requires intact dopaminergic pathways and does not overcome D2 receptor blockade. Anticholinergics remain the mainstay treatment.</span></p>",
      "correct_choice_id": 361902,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90891/NEET_PG_aug_2025_PHARMACOLOGY_Question_14.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90891/NEET_PG_aug_2025_PHARMACOLOGY_Question_14.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90215,
      "choices": [
        {
          "id": 359232,
          "text": "<p><span style=\"font-size:14.0pt;\">Ovarian cyst</span></p>"
        },
        {
          "id": 359233,
          "text": "<p><span style=\"font-size:14.0pt;\">Leiomyoma&nbsp;</span></p>"
        },
        {
          "id": 359234,
          "text": "<p><span style=\"font-size:14.0pt;\">Endometriosis</span></p>"
        },
        {
          "id": 359235,
          "text": "<p><span style=\"font-size:14.0pt;\">Adenomyosis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 38-year-old woman presents with abdominal distension and heavy menstrual bleeding. On physical examination, a smooth, firm, non-tender, and mobile abdominal mass is palpated, extending from the symphysis pubis to midway between the umbilicus and xiphisternum. Speculum examination reveals a normal cervix. Laboratory evaluation reveals microcytic anemia. What is the most likely underlying diagnosis?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q8201823",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Leiomyoma</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The patient’s presentation of <strong>progressive abdominal distension</strong>, <strong>heavy menstrual bleeding (menorrhagia)</strong>, and <strong>microcytic anemia</strong> in association with a <strong>firm, smooth, non-tender, and mobile abdominal mass</strong> extending well above the symphysis pubis is most consistent with <strong>uterine leiomyomas (fibroids)</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Fibroids are benign smooth muscle tumors of the myometrium that can grow to large sizes, causing a palpable abdominal mass.</span></li><li><span style=\"font-size:14.0pt;\">Heavy menstrual bleeding from fibroids can lead to <strong>iron deficiency anemia</strong>, which explains her microcytic indices.</span></li><li><span style=\"font-size:14.0pt;\">The <strong>normal cervix on speculum examination</strong> further supports a uterine (rather than cervical) pathology.</span></li><li><span style=\"font-size:14.0pt;\">The mass's <strong>mobility</strong> and smooth contour are also classic features of fibroids, differentiating them from fixed or irregular adnexal masses.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_NEzsDu1.png\" width=\"626\" height=\"630\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Ovarian cyst:</strong> While large ovarian cysts may cause abdominal fullness or mass effect, they are typically <strong>not associated with menorrhagia or microcytic anemia</strong>, and are often <strong>cystic and fluctuant</strong>, unlike the <strong>firm</strong> consistency noted here.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Endometriosis:</strong> Presents with <strong>pelvic pain</strong>, <strong>dysmenorrhea</strong>, and <strong>infertility</strong>, but <strong>not</strong> with a <strong>palpable abdominal mass</strong> or such profound uterine enlargement. The absence of chronic pelvic pain and tenderness argues against this.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Adenomyosis:</strong> Usually affects <strong>multiparous women</strong> and causes <strong>dysmenorrhea</strong>, <strong>menorrhagia</strong>, and a <strong>diffusely enlarged, boggy uterus</strong>, not a <strong>well-defined, large, mobile mass</strong> as seen here.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Uterine leiomyomas (fibroids)</strong> are the most common benign tumors of the female reproductive tract.</span></li><li><span style=\"font-size:14.0pt;\">Large fibroids can cause <strong>heavy menstrual bleeding, iron deficiency anemia, and a firm, smooth, enlarged uterus palpable on abdominal examination</strong>.</span></li></ul>",
      "correct_choice_id": 359233,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90215/NEET_PG_aug_2025_OBG_Question_3.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90215/NEET_PG_aug_2025_OBG_Question_3.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90550,
      "choices": [
        {
          "id": 360564,
          "text": "<p><span style=\"font-size:14.0pt;\">Prostaglandin E1</span></p>"
        },
        {
          "id": 360565,
          "text": "<p><span style=\"font-size:14.0pt;\">Indomethacin</span></p>"
        },
        {
          "id": 360566,
          "text": "<p><span style=\"font-size:14.0pt;\">Furosemide</span></p>"
        },
        {
          "id": 360567,
          "text": "<p><span style=\"font-size:14.0pt;\">Dopamine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 28-week preterm newborn has a continuous murmur, bounding pulses, and wide pulse pressure. CXR shows pulmonary plethora. Which drug can close the defect?&nbsp;</span></p>",
      "unique_key": "Q7213911",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Indomethacin</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The vignette describes a patent ductus arteriosus (PDA) in a preterm neonate (continuous murmur, bounding pulses, wide pulse pressure, pulmonary plethora).</span></li><li><span style=\"font-size:14.0pt;\">In premature infants, the ductus arteriosus remains open due to immaturity and increased prostaglandin E2 levels.</span></li><li><span style=\"font-size:14.0pt;\">Indomethacin (or ibuprofen) is a prostaglandin synthesis inhibitor (NSAID) that promotes closure of the ductus arteriosus by reducing prostaglandin E2 levels.</span></li><li><span style=\"font-size:14.0pt;\">Hence, Indomethacin is the drug of choice to close PDA in preterm neonates.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Prostaglandin E1:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Prostaglandin E1 is given to maintain ductal patency in cases where systemic or pulmonary blood flow depends on PDA (e.g., transposition of great arteries, hypoplastic left heart syndrome, pulmonary atresia).</span></li><li><span style=\"font-size:14.0pt;\">It is used to keep the duct open until surgical or catheter intervention can be performed.</span></li><li><span style=\"font-size:14.0pt;\">Here, the goal is closure, not patency, so this is incorrect.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Furosemide:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Furosemide is a loop diuretic that can be used to treat symptomatic heart failure from left-to-right shunts, as it reduces pulmonary congestion.</span></li><li><span style=\"font-size:14.0pt;\">However, it does not close PDA. In fact, it may increase prostaglandin E2 production and worsen ductal patency.</span></li><li><span style=\"font-size:14.0pt;\">Thus, it is supportive but not curative.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Dopamine:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Dopamine is an inotrope and vasopressor used for shock and hypotension in neonates.</span></li><li><span style=\"font-size:14.0pt;\">It has no role in closure of PDA.</span></li><li><span style=\"font-size:14.0pt;\">Hence, incorrect in this scenario.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In preterm infants, patent ductus arteriosus (PDA) commonly presents with a continuous murmur, bounding pulses, wide pulse pressure, and pulmonary overcirculation on chest X-ray.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Closure of PDA is achieved pharmacologically using Indomethacin or Ibuprofen (both prostaglandin synthesis&nbsp;inhibitors)</span></li></ul>",
      "correct_choice_id": 360565,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90550/NEET_PG_Aug_PEDIATRICS_Question_1.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        13
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90550/NEET_PG_Aug_PEDIATRICS_Question_1.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90552,
      "choices": [
        {
          "id": 360572,
          "text": "<p><span style=\"font-size:14.0pt;\">Edward syndrome</span></p>"
        },
        {
          "id": 360573,
          "text": "<p><span style=\"font-size:14.0pt;\">Patau syndrome</span></p>"
        },
        {
          "id": 360574,
          "text": "<p><span style=\"font-size:14.0pt;\">Cri-du-chat syndrome</span></p>"
        },
        {
          "id": 360575,
          "text": "<p><span style=\"font-size:14.0pt;\">Turner syndrome</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which genetic syndrome is caused by a deletion of the short arm of chromosome 5 (5p deletion)?&nbsp;</span></p>",
      "unique_key": "Q7064272",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Cri-du-chat syndrome</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Cri-du-chat syndrome</strong> (French for “cry of the cat”) is a chromosomal deletion syndrome caused by a <strong>partial deletion of the short arm (p) of chromosome 5</strong> — specifically <strong>5p15.2</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Characteristic high-pitched <strong>cat-like cry</strong> in infants is due to abnormal laryngeal development.</span></li><li><span style=\"font-size:14.0pt;\">Other features include <strong>microcephaly</strong>, <strong>intellectual disability</strong>, <strong>hypertelorism</strong>, <strong>low birth weight</strong>, and <strong>hypotonia</strong>.</span></li><li><span style=\"font-size:14.0pt;\">It is a classic example of a <strong>structural chromosomal abnormality</strong> and is diagnosed via <strong>karyotyping</strong> or FISH.</span></li><li><span style=\"font-size:14.0pt;\">Incidence is approximately 1 in 20,000 to 50,000 live births.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Edward Syndrome:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Also known as <strong>Trisomy 18</strong> (presence of an extra chromosome 18).</span></li><li><span style=\"font-size:14.0pt;\">Not caused by a deletion, but by a <strong>nondisjunction event</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Features include <strong>clenched fists with overlapping fingers</strong>, <strong>rocker-bottom feet</strong>, <strong>micrognathia</strong>, and <strong>cardiac defects</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Incompatible with long-term survival.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Patau Syndrome:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Also known as <strong>Trisomy 13</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Caused by a full extra copy of chromosome 13.</span></li><li><span style=\"font-size:14.0pt;\">Clinical signs include <strong>cleft lip/palate</strong>, <strong>polydactyly</strong>, <strong>holoprosencephaly</strong>, and <strong>congenital heart defects</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Again, not a deletion syndrome.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Turner Syndrome:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Genotype is <strong>45, XO</strong>, due to complete or partial <strong>monosomy of the X chromosome</strong>, not chromosome 5.</span></li><li><span style=\"font-size:14.0pt;\">Presents with <strong>short stature</strong>, <strong>webbed neck</strong>, <strong>streak ovaries</strong>, <strong>primary amenorrhea</strong>, and <strong>cardiac anomalies (e.g., coarctation of aorta)</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Cri-du-chat syndrome is a chromosomal disorder caused by a deletion of the short arm of chromosome 5 (5p−), classically presenting with a high-pitched cat-like cry, microcephaly, and developmental delay.</span></p>",
      "correct_choice_id": 360574,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90552/NEET_PG_Aug_PEDIATRICS_Question_3.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        13
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90552/NEET_PG_Aug_PEDIATRICS_Question_3.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90501,
      "choices": [
        {
          "id": 360368,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 4, 2, 3</span></p>"
        },
        {
          "id": 360369,
          "text": "<p><span style=\"font-size:14.0pt;\">2, 1, 4, 3</span></p>"
        },
        {
          "id": 360370,
          "text": "<p><span style=\"font-size:14.0pt;\">4, 1, 2, 3</span></p>"
        },
        {
          "id": 360371,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 3, 2, 4</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">From the steps below, what is the correct sequence of Damage Control Surgery?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">1. Patient selection</span></p><p><span style=\"font-size:14.0pt;\">2. Resuscitation in ICU</span></p><p><span style=\"font-size:14.0pt;\">3. Abdomen closure</span></p><p><span style=\"font-size:14.0pt;\">4. Control of hemorrhage</span></p>",
      "unique_key": "Q2429900",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) 1, 4, 2, 3</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Damage Control Surgery (DCS)</strong> is a strategy in trauma management where the priority is stabilization rather than definitive repair, especially in critically ill patients.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The sequence is crucial and follows this step-wise progression:</span><ol style=\"list-style-type:decimal;\"><li><span style=\"font-size:14.0pt;\"><strong>Patient Selection</strong>: Identifying patients who would benefit from DCS—typically those with acidosis, hypothermia, and coagulopathy.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Primary Exploration</strong>: A quick initial surgery to control bleeding and contamination.</span></li><li><span style=\"font-size:14.0pt;\"><strong>ICU Care</strong>: The patient is shifted to the ICU for resuscitation, correction of hypothermia, acidosis, and coagulopathy.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Secondary Exploration</strong>: After physiological stabilization, a second surgery is performed to reassess and plan for definitive care.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Abdominal Closure</strong>: Only done once the patient is stable and definitive repair is complete.</span></li></ol></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Understand the stepwise approach to damage control surgery: Initial patient selection, control of bleeding/contamination, ICU resuscitation, re-exploration, and eventual closure.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-08-14%20140807.jpeg\" width=\"983\" height=\"415\"></span></p>",
      "correct_choice_id": 360368,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90501/NEET_PG_aug_2025_Surgery_Question_9.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90501/NEET_PG_aug_2025_Surgery_Question_9.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90852,
      "choices": [
        {
          "id": 361748,
          "text": "<p><span style=\"font-size:14.0pt;\">Acute CMV</span></p>"
        },
        {
          "id": 361749,
          "text": "<p><span style=\"font-size:14.0pt;\">Stage 4 chronic lymphocytic leukemia</span></p>"
        },
        {
          "id": 361750,
          "text": "<p><span style=\"font-size:14.0pt;\">Acute myeloid leukemia</span></p>"
        },
        {
          "id": 361751,
          "text": "<p><span style=\"font-size:14.0pt;\">Diffuse large B-cell lymphoma</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 73-year-old woman with chronic lymphocytic leukemia (CLL) on daily ibrutinib presents with fever, unintentional weight loss, and progressive lymphadenopathy. Labs reveal the following:</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_LqCATzA.png\" width=\"386\" height=\"331\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">What is the most likely diagnosis?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q1794344",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Diffuse large B-cell lymphoma</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This patient with <strong>known CLL</strong> now presents with:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Constitutional symptoms</strong> (fever, weight loss)</span></li><li><span style=\"font-size:14.0pt;\"><strong>Rapidly enlarging lymphadenopathy</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Markedly elevated LDH</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Laboratory features of tumor lysis syndrome</strong> (hyperuricemia, hyperphosphatemia, hyperkalemia, hypocalcemia, and acute kidney injury)</span></li></ul></li><li><span style=\"font-size:14.0pt;\">These findings strongly suggest <strong>Richter transformation</strong> — the transformation of CLL into an aggressive <strong>high-grade lymphoma</strong>, most commonly <strong>diffuse large B-cell lymphoma (DLBCL)</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Richter transformation</strong> occurs in ~2–10% of CLL patients and is associated with:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Worsening lymphadenopathy</span></li><li><span style=\"font-size:14.0pt;\">Elevated LDH</span></li><li><span style=\"font-size:14.0pt;\">“B” symptoms</span></li><li><span style=\"font-size:14.0pt;\">Poor prognosis</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Acute CMV:</strong> CMV can cause fever in immunocompromised hosts but <strong>does not explain tumor lysis features or lymphadenopathy</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Stage 4 chronic lymphocytic leukemia:</strong> This is not a formal term used in CLL staging. The clinical deterioration and biochemical markers suggest <strong>transformation</strong>, not stable or progressive CLL alone.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Acute myeloid leukemia:</strong> No evidence of <strong>myeloid blast crisis</strong>; CLL rarely transforms into AML. The cytopenias and tumor lysis picture fit better with <strong>Richter transformation</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Richter transformation</strong> of CLL into <strong>diffuse large B-cell lymphoma</strong> presents with:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Rapid clinical decline, B symptoms, elevated LDH</span></li><li><span style=\"font-size:14.0pt;\">Tumor lysis labs (↑ K⁺, ↑ uric acid, ↑ phosphate, ↓ calcium, ↑ creatinine)</span></li></ul></li><li><span style=\"font-size:14.0pt;\">It should be suspected in CLL patients with new <strong>systemic symptoms and aggressive disease features</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Tumor lysis syndrome</strong> can occur spontaneously in high-grade lymphomas.</span></li></ul>",
      "correct_choice_id": 361751,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90852/NEET_PG_aug_2025_MEDICINE_Question_18.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90852/NEET_PG_aug_2025_MEDICINE_Question_18.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90234,
      "choices": [
        {
          "id": 359308,
          "text": "<p><span style=\"font-size:14.0pt;\">Ovarian implantation</span></p>"
        },
        {
          "id": 359309,
          "text": "<p><span style=\"font-size:14.0pt;\">Tubal implantation</span></p>"
        },
        {
          "id": 359310,
          "text": "<p><span style=\"font-size:14.0pt;\">Placental attachment over the internal cervical os</span></p>"
        },
        {
          "id": 359311,
          "text": "<p><span style=\"font-size:14.0pt;\">Abdominal implantation</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 24-year-old woman at 22 weeks of gestation presents to the emergency department with sudden-onset, painless, heavy vaginal bleeding. She is hemodynamically stable, and fetal heart tones are present. Which of the following implantation sites is most likely responsible for her current symptoms?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q3689547",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Placental attachment over the internal cervical os</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The clinical scenario describes <strong>placenta previa</strong>, a condition where the placenta partially or completely covers the <strong>internal cervical os</strong>.</span></li><li><span style=\"font-size:14.0pt;\">It typically presents in the <strong>second or third trimester</strong> with <strong>painless vaginal bleeding</strong> and no abdominal pain or uterine tenderness.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This diagnosis is supported by the <strong>presence of fetal heart tones</strong>, ruling out fetal demise, and the <strong>absence of trauma</strong> or infection.</span></li><li><span style=\"font-size:14.0pt;\">Placenta previa is most common in women with prior uterine surgery or multiple pregnancies but can occur de novo.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It requires close obstetric monitoring and usually necessitates <strong>cesarean delivery</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Ovarian implantation:</strong> This is a rare type of <strong>ectopic pregnancy</strong> typically presenting <strong>earlier in gestation</strong> with <strong>abdominal pain and signs of rupture</strong>, not painless bleeding at 22 weeks.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Tubal implantation:</strong> Tubal pregnancies usually rupture in the <strong>first trimester</strong>, leading to <strong>acute abdominal pain and hemodynamic instability</strong>, which is not consistent with this patient's stable presentation and gestational age.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Abdominal implantation:</strong> An abdominal pregnancy is <strong>extremely rare</strong>, often results in <strong>poor fetal outcomes</strong>, and does not classically present with <strong>painless vaginal bleeding</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Placenta previa</strong> should be suspected in any pregnant patient beyond <strong>20 weeks</strong> presenting with <strong>painless vaginal bleeding</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The bleeding results from placental separation as the lower uterine segment thins and stretches.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The condition is due to <strong>placental attachment over the internal os</strong>.</span></li></ul>",
      "correct_choice_id": 359310,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90234/NEET_PG_aug_2025_OBG_Question_17.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90234/NEET_PG_aug_2025_OBG_Question_17.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90885,
      "choices": [
        {
          "id": 361876,
          "text": "<p><span style=\"font-size:14.0pt;\">Site A</span></p>"
        },
        {
          "id": 361877,
          "text": "<p><span style=\"font-size:14.0pt;\">Site B</span></p>"
        },
        {
          "id": 361878,
          "text": "<p><span style=\"font-size:14.0pt;\">Site C</span></p>"
        },
        {
          "id": 361879,
          "text": "<p><span style=\"font-size:14.0pt;\">Site D</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">The image shows a β-lactam ring structure found in penicillins. At which labeled site does penicillinase (β-lactamase) exert its action, leading to antibiotic resistance?</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-08-20%20111737.jpeg\" width=\"656\" height=\"470\"></strong></span></p>",
      "unique_key": "Q9561302",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Site A</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Penicillinase (a type of β-lactamase)</strong> hydrolyzes the <strong>β-lactam ring</strong>, which is essential for the antibacterial activity of penicillins.</span></li><li><span style=\"font-size:14.0pt;\">Site <strong>A</strong> in the image represents the <strong>β-lactam carbonyl group</strong>, a critical part of the four-membered β-lactam ring.</span></li><li><span style=\"font-size:14.0pt;\">Cleavage at this site opens the ring and renders the molecule <strong>inactive</strong>, preventing its ability to inhibit bacterial cell wall synthesis.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Options B. Site B</strong>: Refers to a side-chain substitution; not the active site for β-lactamase.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Options C. Site C</strong>: Part of the carboxylic acid group in the side chain, not involved in β-lactamase interaction.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Options D. Site D</strong>: Represents a sulfur-linked moiety; not the cleavage site for penicillinase.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Penicillinase (β-lactamase) inactivates penicillins by cleaving the β-lactam ring at<strong>&nbsp;</strong>its carbonyl group, disabling its antibacterial activity.</span></p>",
      "correct_choice_id": 361876,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90885/NEET_PG_aug_2025_PHARMACOLOGY_Question_8.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90885/NEET_PG_aug_2025_PHARMACOLOGY_Question_8.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90893,
      "choices": [
        {
          "id": 361908,
          "text": "<p><span style=\"font-size:14.0pt;\">Desmopressin</span></p>"
        },
        {
          "id": 361909,
          "text": "<p><span style=\"font-size:14.0pt;\">Carbamazepine</span></p>"
        },
        {
          "id": 361910,
          "text": "<p><span style=\"font-size:14.0pt;\">Octreotide</span></p>"
        },
        {
          "id": 361911,
          "text": "<p><span style=\"font-size:14.0pt;\">Human chorionic gonadotropin (hCG)</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 35-year-old man presents with persistent, profuse watery diarrhea, hypokalemia, and achlorhydria. Imaging reveals a mass in the pancreas. Which of the following medications is most appropriate for symptomatic control?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q9824958",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Octreotide</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The clinical picture is suggestive of a <strong>VIPoma</strong>, a rare pancreatic neuroendocrine tumor that secretes <strong>vasoactive intestinal peptide (VIP)</strong>, leading to <strong>secretory diarrhea, hypokalemia, and achlorhydria</strong>—also known as <strong>WDHA syndrome</strong> (Watery Diarrhea, Hypokalemia, Achlorhydria).</span></li><li><span style=\"font-size:14.0pt;\"><strong>Octreotide</strong>, a long-acting <strong>somatostatin analog</strong>, inhibits the release of VIP and is the <strong>drug of choice</strong> for controlling symptoms related to hormone-secreting tumors such as <strong>VIPoma</strong> and <strong>carcinoid syndrome</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Desmopressin</strong>: A synthetic ADH analog used for <strong>central diabetes insipidus</strong> and <strong>mild hemophilia A</strong>; it has no role in VIPoma.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Carbamazepine</strong>: An antiepileptic that stimulates <strong>ADH release</strong>; used in <strong>central diabetes insipidus</strong>, not in secretory diarrhea or tumors.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.</strong> <strong>Human chorionic gonadotropin (hCG)</strong>: Used in <strong>male infertility</strong> and <strong>induction of ovulation</strong>; unrelated to neuroendocrine tumors or GI symptom control.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Octreotide is used to manage secretory diarrhea associated with VIPomas and carcinoid syndrome by inhibiting the release of gastrointestinal hormones.</span></p>",
      "correct_choice_id": 361910,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90893/NEET_PG_aug_2025_PHARMACOLOGY_Question_16.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90893/NEET_PG_aug_2025_PHARMACOLOGY_Question_16.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90834,
      "choices": [
        {
          "id": 361676,
          "text": "<p><span style=\"font-size:14.0pt;\">ACTH</span></p>"
        },
        {
          "id": 361677,
          "text": "<p><span style=\"font-size:14.0pt;\">Aldosterone</span></p>"
        },
        {
          "id": 361678,
          "text": "<p><span style=\"font-size:14.0pt;\">ADH</span></p>"
        },
        {
          "id": 361679,
          "text": "<p><span style=\"font-size:14.0pt;\">Cortisol</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Increase in which of the following hormones is responsible for the hyperpigmentation seen in Addison’s disease?&nbsp;</span></p>",
      "unique_key": "Q3080894",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) ACTH</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Pathophysiology of Addison’s disease</strong></span></li><li><span style=\"font-size:14.0pt;\">Primary adrenal insufficiency → destruction of adrenal cortex → ↓ cortisol, ↓ aldosterone.</span></li><li><span style=\"font-size:14.0pt;\">Lack of cortisol → loss of negative feedback on the pituitary → <strong>↑ ACTH secretion</strong>.</span></li><li><span style=\"font-size:14.0pt;\">ACTH is derived from <strong>pro‑opiomelanocortin (POMC)</strong>, the same precursor that produces <strong>α‑melanocyte‑stimulating hormone (α‑MSH)</strong>.</span></li><li><span style=\"font-size:14.0pt;\">High ACTH → increased α‑MSH → stimulates melanocytes → <strong>diffuse hyperpigmentation</strong>, especially in sun‑exposed areas, palmar creases, and mucous membranes.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Aldosterone:&nbsp;</strong>Low in Addison’s; deficiency leads to hypotension, hyperkalaemia, metabolic acidosis but <strong>not</strong> hyperpigmentation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. ADH:</strong>&nbsp;Unrelated to pigmentation; regulates water reabsorption in the kidney.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Cortisol:&nbsp;</strong>&nbsp;Deficient in Addison’s; loss of feedback causes ACTH to rise, but cortisol itself does not cause pigmentation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In primary adrenal insufficiency, <strong>loss of cortisol feedback</strong> on the pituitary leads to excess ACTH production.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Because ACTH and α‑MSH share the POMC precursor, ACTH overproduction causes <strong>skin and mucosal hyperpigmentation</strong>.</span></li><li><span style=\"font-size:14.0pt;\">This feature is <strong>specific to primary</strong>, not secondary, adrenal insufficiency.</span></li></ul>",
      "correct_choice_id": 361676,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90834/NEET_PG_aug_2025_PHYSIOLOGY_Question_6.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        2
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90834/NEET_PG_aug_2025_PHYSIOLOGY_Question_6.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89895,
      "choices": [
        {
          "id": 357972,
          "text": "<p><span style=\"font-size:14.0pt;\">1,&nbsp;3</span></p>"
        },
        {
          "id": 357973,
          "text": "<p><span style=\"font-size:14.0pt;\">1,&nbsp;2,&nbsp;3</span></p>"
        },
        {
          "id": 357974,
          "text": "<p><span style=\"font-size:14.0pt;\">1,&nbsp;3,&nbsp;4</span></p>"
        },
        {
          "id": 357975,
          "text": "<p><span style=\"font-size:14.0pt;\">2,&nbsp;4</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following combinations includes only correct statements about preventive measures for Kyasanur Forest Disease (KFD)?</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">Control of tick populations is a key preventive measure against KFD.</span></li><li><span style=\"font-size:14.0pt;\">Restriction of cattle movement in endemic areas has no impact on KFD transmission.</span></li><li><span style=\"font-size:14.0pt;\">Personal protection using repellents reduces human infection risk.</span></li><li><span style=\"font-size:14.0pt;\">There is no effective animal vaccination program against KFD.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Which of the following combinations is correct?</span></p>",
      "unique_key": "Q1210896",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;C)&nbsp;1,&nbsp;3,&nbsp;4</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Kyasanur forest disease is also called as monkey’s disease</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement&nbsp;1.</strong> <strong>Control of tick populations is a key preventive measure against KFD:&nbsp;</strong>True<strong>.</strong> Because KFD virus is transmitted by ticks (Hemaphysalis spp.), <strong>tick control</strong> (e.g., habitat management, acaricides) is fundamental to preventing human and animal infections.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement&nbsp;3.</strong> <strong>Personal protection using repellents reduces human infection risk:&nbsp;</strong>True<strong>.</strong> Use of <strong>personal protective measures</strong>—such as tick‑repellent clothing, topical repellents, and avoiding undergrowth—significantly <strong>decreases the chance</strong> of infective tick bites.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement&nbsp;4.</strong> <strong>There is no effective animal vaccination program against KFD:&nbsp;</strong>True<strong>.</strong> Although a <strong>killed vaccine</strong> exists for humans, <strong>no licensed vaccine</strong> is available for animal hosts (monkeys or rodents) to interrupt the enzootic cycle.<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-08-19%20145216.jpeg\" width=\"509\" height=\"504\"></strong></span></p><p><span style=\"font-size:14.0pt;\"><strong>Hard tick/ Haemaphysalis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Incorrect statement:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement&nbsp;2.</strong> <strong>Restriction of cattle movement in endemic areas has no impact on KFD transmission:&nbsp;</strong>False. Restricting the movement of <strong>cattle and other livestock</strong> in forest‑edge villages actually <strong>reduces tick dispersal</strong> and lowers human exposure risk.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Effective KFD prevention relies on <strong>tick control</strong> and <strong>personal repellents</strong>, and although a human vaccine exists, <strong>no animal vaccine</strong> is available to disrupt the enzootic cycle.</span></p>",
      "correct_choice_id": 357974,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89895/NEET_PG_aug_2025_PSM_Question_9.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89895/NEET_PG_aug_2025_PSM_Question_9.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90491,
      "choices": [
        {
          "id": 360328,
          "text": "<p><span style=\"font-size:14.0pt;\">Antibiotics</span></p>"
        },
        {
          "id": 360329,
          "text": "<p><span style=\"font-size:14.0pt;\">NSAIDs</span></p>"
        },
        {
          "id": 360330,
          "text": "<p><span style=\"font-size:14.0pt;\">USG venous doppler</span></p>"
        },
        {
          "id": 360331,
          "text": "<p><span style=\"font-size:14.0pt;\">Surgical exploration</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 13-year-old male presents with right testicular pain for 2 hours. On examination, there is severe testicular tenderness and an absent cremasteric reflex. What is the next step?</span></p>",
      "unique_key": "Q8138686",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Surgical exploration</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">Urgent scrotal exploration and untwisting is mandated in torsion of testes.</span></li><li><span style=\"font-size:14.0pt;\">Chances of salvage are maximum if we are doing it &lt;6 hrs of Torsion syndrome&nbsp;&nbsp;</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Antibiotics:&nbsp;</strong>Antibiotics have no role in the management of suspected torsion of testes.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. NSAIDs:&nbsp;</strong>Incorrect<strong>.</strong> NSAIDs may be used in cases like epididymitis or trauma-related pain, but not appropriate when torsion is suspected.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. USG venous doppler:&nbsp;</strong>Incorrect. Venous flow is less reliable for torsion diagnosis. Arterial flow is key to assess viability.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">USG arterial Doppler is the diagnostic test of choice in suspected testicular torsion; however, it is not a must prior to proceeding to surgical intervention.</span></p>",
      "correct_choice_id": 360331,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90491/NEET_PG_aug_2025_Surgery_Question_7.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90491/NEET_PG_aug_2025_Surgery_Question_7.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89866,
      "choices": [
        {
          "id": 357856,
          "text": "<p><span style=\"font-size:14.0pt;\">Niacin (vitamin B₃)</span></p>"
        },
        {
          "id": 357857,
          "text": "<p><span style=\"font-size:14.0pt;\">Riboflavin (vitamin B₂)</span></p>"
        },
        {
          "id": 357858,
          "text": "<p><span style=\"font-size:14.0pt;\">Pyridoxine (vitamin B₆)</span></p>"
        },
        {
          "id": 357859,
          "text": "<p><span style=\"font-size:14.0pt;\">Ascorbic acid (vitamin C)</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 3‑year‑old child presents with signs as shown in the image. There is no history of recent antibiotic use or known autoimmune disease. Laboratory studies are pending. Based on the clinical findings, which vitamin deficiency is most likely responsible for these mucocutaneous changes?&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_om62URz.png\" width=\"410\" height=\"268\"></span></p>",
      "unique_key": "Q2687898",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;B) Riboflavin (vitamin&nbsp;B₂)</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Ariboflavinosis triad is characterized by</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Glossitis (Geographic tongue)</span></li><li><span style=\"font-size:14.0pt;\">Cheilosis</span></li><li><span style=\"font-size:14.0pt;\">Angular stomatitis&nbsp;</span></li></ul></li><li><span style=\"font-size:14.0pt;\">Riboflavin deficiency classically causes <strong>angular cheilitis</strong> (fissuring and erythema at the mouth corners) and <strong>glossitis</strong> characterized by a smooth, magenta‑colored tongue.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Riboflavin is essential for epithelial maintenance; its absence leads to mucosal breakdown and atrophy of papillae on the tongue.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Niacin (vitamin B₃):</strong> Deficiency causes pellagra—dermatitis (photosensitive rash), diarrhea, and dementia. It does not typically produce angular cheilitis or smooth tongue.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Pyridoxine (vitamin B₆):</strong> Deficiency can lead to cheilosis and glossitis, but lesions are often more vesicular or ulcerative, and angular cheilitis is less prominent.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Ascorbic acid (vitamin C):</strong> Deficiency causes scurvy, marked by gum bleeding, petechiae, and poor wound healing—not smooth, beefy tongue or angular fissures.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Angular cheilitis combined with a smooth, beefy‑red tongue is indicative of <strong>vitamin&nbsp;B₂ deficiency</strong>.</span></p>",
      "correct_choice_id": 357857,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89866/NEET_PG_aug_2025_PSM_Question_6.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89866/NEET_PG_aug_2025_PSM_Question_6.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90547,
      "choices": [
        {
          "id": 360552,
          "text": "<p><span style=\"font-size:14.0pt;\">Femoral nerve</span></p>"
        },
        {
          "id": 360553,
          "text": "<p><span style=\"font-size:14.0pt;\">Obturator nerve</span></p>"
        },
        {
          "id": 360554,
          "text": "<p><span style=\"font-size:14.0pt;\">Genitofemoral nerve</span></p>"
        },
        {
          "id": 360555,
          "text": "<p><span style=\"font-size:14.0pt;\">Superior gluteal nerve</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 64-year-old female has the immediate onset of right hip pain after sustaining a blunt trauma to the hip. Radiograph is shown below. The muscle originating at the injured structure is innervated by which of the following nerves?&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_D0ueCMv.png\" width=\"784\" height=\"607\"></span></p>",
      "unique_key": "Q8789210",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Superior gluteal nerve</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The X-ray shows a fracture of the <strong>greater trochanter</strong> of the right femur.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The greater trochanter is a bony prominence on the upper part of the femur.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The muscles that attach to this structure are the <strong>gluteus medius</strong> and <strong>gluteus minimus</strong>.</span></li><li><span style=\"font-size:14.0pt;\">These muscles are the primary abductors of the hip and are crucial for stabilizing the pelvis during walking.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Both the gluteus medius and gluteus minimus muscles are innervated by the <strong>superior gluteal nerve</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Therefore, the muscle originating at the injured structure is innervated by the superior gluteal nerve.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_b6Lz2Za.png\" width=\"529\" height=\"380\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Femoral nerve:</strong>&nbsp;</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The femoral nerve innervates the muscles in the anterior compartment of the thigh, such as the quadriceps femoris (rectus femoris, vastus lateralis, vastus medialis, vastus intermedius) and the sartorius.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">These muscles are primarily responsible for knee extension and hip flexion. They do not originate from the greater trochanter.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Obturator nerve:</strong>&nbsp;</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The obturator nerve innervates the muscles of the medial compartment of the thigh, which are the adductor muscles (adductor longus, adductor brevis, adductor magnus, gracilis, and obturator externus).&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">These muscles are responsible for adducting the hip (bringing the leg toward the midline).&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">They also do not originate from the greater trochanter.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Genitofemoral nerve:</strong>&nbsp;</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The genitofemoral nerve is a sensory and motor nerve that innervates the skin of the groin and the cremasteric muscle in males.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It is not involved in the innervation of the major hip muscles.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The objective is to correlate the anatomy of the hip joint with clinical findings. This includes identifying a <strong>fracture of the greater trochanter</strong> on a radiograph, knowing which muscles originate from this structure (<strong>gluteus medius</strong> and <strong>gluteus minimus</strong>), and recalling the nerve that innervates them (<strong>superior gluteal nerve</strong>).&nbsp;</span></p>",
      "correct_choice_id": 360555,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90547/NEET_PG_aug_2025_ORTHO_Question_1.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        15
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90547/NEET_PG_aug_2025_ORTHO_Question_1.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90237,
      "choices": [
        {
          "id": 359320,
          "text": "<p><span style=\"font-size:14.0pt;\">Fetal demise</span></p>"
        },
        {
          "id": 359321,
          "text": "<p><span style=\"font-size:14.0pt;\">Rh isoimmunisation</span></p>"
        },
        {
          "id": 359322,
          "text": "<p><span style=\"font-size:14.0pt;\">Post maturity</span></p>"
        },
        {
          "id": 359323,
          "text": "<p><span style=\"font-size:14.0pt;\">Fetal distress</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 33-year-old primigravida at 37 weeks gestation is in active labor. During labor monitoring, amniotomy is performed at 5 cm cervical dilation. The clinician observes that the amniotic fluid is golden-yellow in color. Which of the following is the most likely underlying condition?</span></p>",
      "unique_key": "Q2706731",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Rh isoimmunization</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Golden or yellow-stained amniotic fluid is most <strong>characteristically associated with Rh isoimmunization</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">In this condition, <strong>maternal anti-D antibodies cross the placenta</strong> and destroy fetal red blood cells, leading to <strong>hemolysis</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The breakdown of red blood cells releases <strong>bilirubin</strong>, which discolors the amniotic fluid, giving it a <strong>golden appearance</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This finding is a key feature of <strong>hemolytic disease of the fetus and newborn (HDFN)</strong> due to <strong>alloimmune response</strong> in a Rh-negative mother sensitized during a previous pregnancy.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Fetal demise:</strong> Fetal death may result in <strong>dark brown (\"port wine\")</strong> amniotic fluid due to breakdown of hemoglobin, but <strong>not golden</strong> coloration.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Post maturity:</strong> This condition is often associated with <strong>meconium-stained (green)</strong> amniotic fluid due to fetal stress or aging placenta, not <strong>golden fluid</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Fetal distress:</strong> Acute distress may cause <strong>passage of meconium</strong>, also resulting in green-stained fluid. It is <strong>not associated</strong> with hemolysis or bilirubin discoloration.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Golden-stained amniotic fluid is a classic finding in Rh isoimmunization</strong>, reflecting high bilirubin levels due to immune-mediated fetal hemolysis.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This condition requires close fetal surveillance and appropriate perinatal management.</span></li></ul>",
      "correct_choice_id": 359321,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90237/NEET_PG_aug_2025_OBG_Question_18.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90237/NEET_PG_aug_2025_OBG_Question_18.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90219,
      "choices": [
        {
          "id": 359248,
          "text": "<p><span style=\"font-size:14.0pt;\">Placenta previa</span></p>"
        },
        {
          "id": 359249,
          "text": "<p><span style=\"font-size:14.0pt;\">Vasa previa</span></p>"
        },
        {
          "id": 359250,
          "text": "<p><span style=\"font-size:14.0pt;\">Placental abruption</span></p>"
        },
        {
          "id": 359251,
          "text": "<p><span style=\"font-size:14.0pt;\">Bloody show due to labor</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 27-year-old primigravida woman at 39 weeks + 5 days gestation presents with vaginal bleeding. She reports a small gush of bright red blood earlier in the evening, followed by intermittent lower abdominal discomfort. On examination, her blood pressure is 158/87 mmHg, fetal lie is cephalic, uterus is soft but has moderate uterine tenderness, and moderate vaginal bleeding with a closed cervical os on speculum. The fetus is alive with ongoing movements. What is the most likely diagnosis?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q2088551",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Placental abruption</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This patient presents with several key findings suggesting <strong>placental abruption</strong>:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Third-trimester bright red vaginal bleeding</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Uterine tenderness</strong> (a hallmark of abruption)</span></li><li><span style=\"font-size:14.0pt;\"><strong>Intermittent uterine tightenings</strong> without regular labor</span></li><li><span style=\"font-size:14.0pt;\"><strong>Elevated blood pressure</strong> (158/87 mmHg), possibly indicating underlying <strong>preeclampsia</strong>, a known risk factor</span></li><li><span style=\"font-size:14.0pt;\"><strong>Fetus alive and cephalic with normal movements</strong></span></li></ul></li><li><span style=\"font-size:14.0pt;\">Placental abruption involves <strong>premature separation of the placenta</strong> from the uterine wall, leading to bleeding and uterine irritability.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">While the bleeding can be concealed, visible vaginal bleeding, especially when coupled with <strong>uterine tenderness</strong>, is highly suggestive.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Placenta previa</strong>: Placenta previa typically presents with <strong>painless vaginal bleeding</strong> and <strong>non-tender uterus</strong>. This patient has <strong>uterine tenderness and tightenings</strong>, which go against previa. Also, previa would have likely been identified on prior ultrasounds.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Vasa previa</strong>: Vasa previa causes <strong>painless bleeding</strong> after rupture of membranes, and usually results in <strong>fetal distress</strong> or <strong>fetal demise</strong> due to fetal vessel rupture. This patient’s membranes are intact and fetal movements are normal.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Bloody show due to labor</strong>: A bloody show is usually <strong>small, mucous-streaked</strong>, and associated with <strong>cervical dilation</strong>. This patient’s <strong>cervical os is closed</strong>, and bleeding is <strong>moderate</strong>, which is atypical for a simple show.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Placental abruption</strong> should be suspected in any third-trimester pregnant patient presenting with <strong>vaginal bleeding</strong>, <strong>uterine tenderness</strong>, and <strong>hypertension</strong>, even in the absence of significant abdominal pain or fetal distress.</span></p>",
      "correct_choice_id": 359250,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90219/NEET_PG_aug_2025_OBG_Question_7.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90219/NEET_PG_aug_2025_OBG_Question_7.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90884,
      "choices": [
        {
          "id": 361872,
          "text": "<p><span style=\"font-size:14.0pt;\">Azithromycin</span></p>"
        },
        {
          "id": 361873,
          "text": "<p><span style=\"font-size:14.0pt;\">Ceftriaxone</span></p>"
        },
        {
          "id": 361874,
          "text": "<p><span style=\"font-size:14.0pt;\">Spectinomycin</span></p>"
        },
        {
          "id": 361875,
          "text": "<p><span style=\"font-size:14.0pt;\">Doxycycline</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 27-year-old man presents with purulent urethral discharge and dysuria. NAAT confirms Neisseria gonorrhoeae infection. He reports a severe allergy to cephalosporins and macrolide resistance is prevalent in the region. Which of the following is the most appropriate single dose treatment of gonorrhea in this patient?</span></p>",
      "unique_key": "Q2072026",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Spectinomycin</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">For&nbsp;<strong>Neisseria gonorrhoeae</strong>, the first-line drug is&nbsp;<strong>ceftriaxone</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">However, this patient has a&nbsp;<strong>severe cephalosporin allergy&nbsp;</strong>and the region has&nbsp;<strong>high macrolide resistance</strong>, eliminating ceftriaxone and azithromycin.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\"><strong>Doxycycline</strong>&nbsp;is effective against&nbsp;Chlamydia trachomatis&nbsp;but not reliable against gonorrhea.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">In such cases,&nbsp;<strong>spectinomycin</strong>, an aminocyclitol antibiotic that inhibits protein synthesis, is the best alternative for gonorrhea treatment.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Do not get distracted by single dose, all the drugs i.e, ceftriaxone, azithromycin as well as spectinomycin are used as single dose treatment of gonorrhea.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Azithromycin</strong>: Incorrect. Macrolide resistance is high in this region, making azithromycin ineffective. It was previously used in dual therapy with ceftriaxone.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Ceftriaxone</strong>: Incorrect here due to the patient’s&nbsp;<strong>severe allergy</strong>&nbsp;to cephalosporins, even though it is the first-line standard therapy.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Doxycycline</strong>: Incorrect. Used for&nbsp;Chlamydia trachomatis&nbsp;co-infection, but not effective as monotherapy for gonorrhea.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Spectinomycin is an alternative treatment for gonorrhea in patients with cephalosporin allergy and where resistance to macrolides is prevalent.</span></p>",
      "correct_choice_id": 361874,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90884/NEET_PG_aug_2025_PHARMACOLOGY_Question_7.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/90884/NEET_PG_aug_2025_PHARMACOLOGY_Question_7.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89942,
      "choices": [
        {
          "id": 358152,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 2 and 5</span></p>"
        },
        {
          "id": 358153,
          "text": "<p><span style=\"font-size:14.0pt;\">2, 3, 4 and 5</span></p>"
        },
        {
          "id": 358154,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 3, 4 and 5</span></p>"
        },
        {
          "id": 358155,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 2, 3, 4 and 5</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following organisms are recognized causes of Community acquired pneumonia (CAP)?<strong>&nbsp;</strong></span></p><p><br><span style=\"font-size:14.0pt;\">1. Staphylococcus aureus</span><br><span style=\"font-size:14.0pt;\">2. Streptococcus pyogenes</span><br><span style=\"font-size:14.0pt;\">3. Mycoplasma pneumoniae</span><br><span style=\"font-size:14.0pt;\">4. Chlamydia pneumoniae</span><br><span style=\"font-size:14.0pt;\">5. Legionella pneumophila</span></p>",
      "unique_key": "Q6421053",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) 1, 3, 4 and 5</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 1. Staphylococcus aureus</strong>: An important cause of <strong>post-influenza</strong> or <strong>hospital-acquired</strong> complications, but can also present as CAP, especially in elderly or those with chronic lung disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 3. Mycoplasma pneumonia</strong>: Classic <strong>“atypical”</strong> CAP pathogen; often causes a <strong>walking pneumonia</strong> in younger adults with dry cough and extrapulmonary symptoms.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 4. Chlamydia pneumonia</strong>: Another “atypical” pathogen causing mild CAP, often with prolonged cough and low-grade fever.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 5. Legionella pneumophila</strong>: Causes <strong>severe atypical pneumonia</strong>, often with GI symptoms, hyponatremia, and elevated liver enzymes; associated with contaminated water sources.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Incorrect Statement:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 2. Streptococcus pyogenes</strong>: Incorrect. While it can cause pharyngitis and skin/soft tissue infections, it is <strong>not</strong> a typical cause of community-acquired pneumonia.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Common causes of <strong>community-acquired pneumonia</strong> include <strong>typical</strong> pathogens (S. pneumoniae, H. influenzae, S. aureus) and <strong>atypical</strong> pathogens (M. pneumoniae, C. pneumoniae, L. pneumophila), whereas S. pyogenes is rarely implicated.</span></p>",
      "correct_choice_id": 358154,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89942/NEET_PG_aug_2025_MICROBIOLOGY_Question_6.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        6
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89942/NEET_PG_aug_2025_MICROBIOLOGY_Question_6.mp4",
      "question_images": [],
      "explanation_images": []
    }
  ]
}